concept_id	concept_synonym_name	language_concept_id
19474380	Agent 48 80	4180186
19474383	Red, Congo	4180186
19474383	1-Naphthalenesulfonic acid, 3,3'-((1,1'-biphenyl)-4,4'-diylbis(azo))bis(4-amino)-, disodium salt	4180186
19474386	Trehalose-6,6'-Dimycolate	4180186
19474386	Trehalose Dimycolates	4180186
19474386	Cord Factor	4180186
19474386	Factors, Cord	4180186
19474386	Dimycolates, Trehalose	4180186
19474386	Factor, Cord	4180186
19474386	Trehalose 6,6' Dimycolate	4180186
19474387	Units, Coronary Care	4180186
19474387	Coronary Care Unit	4180186
19474387	Care Units, Coronary	4180186
19474387	Care Unit, Coronary	4180186
19474387	Unit, Coronary Care	4180186
19474388	Pregn-4-ene-3,20-dione, 11,21-dihydroxy-, (11beta)-	4180186
19474389	Cortexolone	4180186
19474389	11-Desoxycortisol	4180186
19474389	Pregn-4-ene-3,20-dione, 17,21-dihydroxy-	4180186
19474389	Reichsteins Substance S	4180186
19474389	Reichstein Substance S	4180186
19474389	11-Deoxycortisol	4180186
19474389	11 Desoxycortisol	4180186
19474389	11 Desoxycortisone	4180186
19474389	Reichstein's Substance S	4180186
19474389	11 Deoxycortisol	4180186
19474389	Substance S, Reichstein's	4180186
19474389	11-Desoxycortisone	4180186
19474396	Cryoglobulin	4180186
19474396	Cryoproteins	4180186
19474396	Cryoprotein	4180186
19474397	Effects, Cryoprotective	4180186
19474397	Cryoprotective Effects	4180186
19474397	Cryoprotective Effect	4180186
19474397	Agents, Cryoprotective	4180186
19474397	Effect, Cryoprotective	4180186
19474397	Agent, Cryoprotective	4180186
19474397	Cryoprotective Agent	4180186
19474400	2,6-Methano-3-benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-	4180186
19474401	Cyclohexanol	4180186
19474402	2,6-Piperidinedione, 4-(2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-, (1S-(1alpha(S*),3alpha,5beta))-	4180186
19474402	Cicloheximide	4180186
19474402	Actidione	4180186
19474403	Cyclohexylamine	4180186
19474407	Phomin	4180186
19474407	24-Oxa(14)cytochalasa-6(12),13,21-triene-1,23-dione, 7,20-dihydroxy-16-methyl-10-phenyl-, (7S,13E,16R,20R,21E)-	4180186
19474410	Data Displays	4180186
19474410	Displays, Information	4180186
19474410	Display, Data	4180186
19474410	Information Displays	4180186
19474410	Information Display	4180186
19474410	Display, Information	4180186
19474410	Displays, Data	4180186
19474411	Management System, Data Base	4180186
19474411	Systems, Data Base Management	4180186
19474411	Data Base Management Systems	4180186
19474411	Database Management System	4180186
19474411	Management Systems, Data Base	4180186
19474411	System, Data Base Management	4180186
19474412	Dextran, 2-(diethylamino)ethyl ether	4180186
19474412	Pulsar	4180186
19474412	Sephadex, DEAE	4180186
19474412	DEAE Sephadex	4180186
19474412	DEAE Dextran	4180186
19474412	Diethylaminoethyldextran	4180186
19474414	Death Certificate	4180186
19474414	Certificates, Death	4180186
19474414	Records, Death	4180186
19474414	Death Record	4180186
19474414	Record, Death	4180186
19474414	Death Records	4180186
19474414	Certificate, Death	4180186
19474415	Hospital Birth Centers	4180186
19474415	Room, Delivery	4180186
19474415	Centers, Hospital Birth	4180186
19474415	Rooms, Delivery	4180186
19474415	Center, Hospital Birth	4180186
19474415	Birthing Center, Hospital	4180186
19474415	Delivery Room	4180186
19474415	Birth Center, Hospital	4180186
19474415	Hospital Birthing Centers	4180186
19474415	Hospital Birth Center	4180186
19474415	Center, Hospital Birthing	4180186
19474415	Centers, Hospital Birthing	4180186
19474415	Hospital Birthing Center	4180186
19474415	Birth Centers, Hospital	4180186
19474415	Birthing Centers, Hospital	4180186
19474416	Factor, Demographic	4180186
19474416	Population Spatial Distribution	4180186
19474416	Demographic Surveys	4180186
19474416	Methods, Stable Population	4180186
19474416	Stable Population Methods	4180186
19474416	Population Methods, Stable	4180186
19474416	Period Analyses	4180186
19474416	Population Spatial Distributions	4180186
19474416	Prehistoric Demographies	4180186
19474416	Demographic Impacts	4180186
19474416	Technic, Brass	4180186
19474416	Demographic Factors	4180186
19474416	Impact, Demographic	4180186
19474416	Demographies, Historical	4180186
19474416	Demographic and Health Surveys	4180186
19474416	Impacts, Demographic	4180186
19474416	Technique, Brass	4180186
19474416	Multiregional Analyses	4180186
19474416	Spatial Distributions, Population	4180186
19474416	Analyses, Demographic	4180186
19474416	Period Analysis	4180186
19474416	Method, Stable Population	4180186
19474416	Brass Technique	4180186
19474416	Prehistoric Demography	4180186
19474416	Survey, Demographic	4180186
19474416	Demographer	4180186
19474416	Analyses, Multiregional	4180186
19474416	Spatial Distribution, Population	4180186
19474416	Reverse Survival Methods	4180186
19474416	Stable Population Method	4180186
19474416	Distribution, Population Spatial	4180186
19474416	Demographic Impact	4180186
19474416	Historical Demography	4180186
19474416	Accounting, Demographic	4180186
19474416	Demographies, Prehistoric	4180186
19474416	Demographic Survey	4180186
19474416	Demographic Analysis	4180186
19474416	Historical Demographies	4180186
19474416	Distribution, Population	4180186
19474416	Analysis, Demographic	4180186
19474416	Surveys, Demographic	4180186
19474416	Analyses, Period	4180186
19474416	Demographic and Health Survey	4180186
19474416	Multiregional Analysis	4180186
19474416	Population Distributions	4180186
19474416	Demography, Prehistoric	4180186
19474416	Analysis, Multiregional	4180186
19474416	Family Reconstitution	4180186
19474416	Demographic Factor	4180186
19474416	Method, Reverse Survival	4180186
19474416	Distributions, Population	4180186
19474416	Population Distribution	4180186
19474416	Methods, Reverse Survival	4180186
19474416	Reconstitutions, Family	4180186
19474416	Reverse Survival Method	4180186
19474416	Factors, Demographic	4180186
19474416	Demographic Analyses	4180186
19474416	Analysis, Period	4180186
19474416	Distributions, Population Spatial	4180186
19474416	Demographers	4180186
19474416	Demography, Historical	4180186
19474416	Demographic Accounting	4180186
19474416	Brass Technic	4180186
19474416	Demographics	4180186
19474416	Family Reconstitutions	4180186
19474416	Reconstitution, Family	4180186
19474416	Demographic	4180186
19474417	Liner, Dental Cavity	4180186
19474417	Cavity Liner, Dental	4180186
19474417	Dental Cavity Liner	4180186
19474417	Cavity Lining, Dental	4180186
19474417	Dental Cavity Liners	4180186
19474417	Lining, Dental Cavity	4180186
19474417	Cavity Varnish	4180186
19474417	Cavity Lining Varnish	4180186
19474417	Cavity Linings, Dental	4180186
19474417	Varnish, Cavity	4180186
19474417	Cavity Lining Varnishes	4180186
19474417	Dental Cavity Linings	4180186
19474417	Cavity Varnishes	4180186
19474417	Varnishes, Cavity Lining	4180186
19474417	Varnishes, Cavity	4180186
19474417	Liners, Dental Cavity	4180186
19474417	Varnish, Cavity Lining	4180186
19474417	Cavity Liners, Dental	4180186
19474417	Linings, Dental Cavity	4180186
19474418	Cementum, Dental	4180186
19474418	Cementum	4180186
19474418	Cementoblast	4180186
19474418	Cementoblasts	4180186
19474420	Enamel, Dental	4180186
19474420	Cuticle, Enamel	4180186
19474420	Enamel	4180186
19474420	Dental Enamels	4180186
19474420	Enamel Cuticle	4180186
19474420	Enamels, Dental	4180186
19474420	Enamel Cuticles	4180186
19474420	Enamels	4180186
19474420	Cuticles, Enamel	4180186
19474421	Facilities, Dental	4180186
19474421	Dental Facility	4180186
19474421	Facility, Dental	4180186
19474425	Morphinan-3-ol, 17-methyl-, (9alpha,13alpha,14alpha)-	4180186
19474425	(+-)-17-Methylmorphinan-3-ol	4180186
19474427	Service, Diagnostic	4180186
19474427	Diagnostic Service	4180186
19474427	Services, Diagnostic	4180186
19474428	Diamphenethide	4180186
19474428	Acemidophen	4180186
19474428	Coriban	4180186
19474428	Di-(2-(4-acetamidophenoxy)ethyl) Ether	4180186
19474428	Acetamide, N,N'-(oxybis(2,1-ethanediyloxy-4,1-phenylene))bis-	4180186
19474429	Diazodicarboxylic Acid Bis(N,N-dimethyl)amide	4180186
19474429	Diazodicarboxylic Acid Bisdimethylamide	4180186
19474429	Diazenedicarboxamide, tetramethyl-	4180186
19474429	Tetramethylazoformamide	4180186
19474429	Bisdimethylamide, Diazodicarboxylic Acid	4180186
19474429	Dizene Dicarboxylic Acid Bis(N,N-dimethylamide)	4180186
19474429	Acid Bisdimethylamide, Diazodicarboxylic	4180186
19474429	Dizenedicarboxylic Acid Bis(N,N-dimethylamide)	4180186
19474430	1,2-5,6-Dianhydrogalactitol	4180186
19474430	Galactitol, 1,2:5,6-dianhydro-	4180186
19474430	NSC132313	4180186
19474430	NSC-132313	4180186
19474430	1,2,5,6-Dianhydrogalactitol	4180186
19474430	NSC 132313	4180186
19474430	Diepoxygalactitol	4180186
19474430	Diepoxydulcitol	4180186
19474430	Dianhydrodulcitol	4180186
19474432	Norleucine, 6-diazo-5-oxo-	4180186
19474432	6 Diazo 5 oxo L norleucine	4180186
19474432	6-Diazo-5-oxo-L-norleucine	4180186
19474433	Dibenamine	4180186
19474433	Benzenemethanamine, N-(2-chloroethyl)-N-(phenylmethyl)-	4180186
19474433	Chlorethylamine, Dibenzyl	4180186
19474433	Dibenzyl Chlorethylamine	4180186
19474435	5,6 Dichloro 1 beta ribofuranosylbenzimidazole	4180186
19474435	5,6-Dichloro-1-beta-ribofuranosylbenzimidazole	4180186
19474435	Riboside, Dichlorobenzimidazole	4180186
19474435	DRB	4180186
19474435	5,6 Dichloro 1 beta D ribofuranosyl 1 H benzimidazol	4180186
19474435	Dichlorobenzimidazole Riboside	4180186
19474435	1H-Benzimidazole, 5,6-dichloro-1-beta-D-ribofuranosyl-	4180186
19474435	5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazol	4180186
19474436	Glossaries as Topics	4180186
19474436	Dictionaries as Topics	4180186
19474436	Glossaries as Topic	4180186
19474437	Cyclohexanamine, N,N'-methanetetraylbis-	4180186
19474437	DCCD	4180186
19474438	Diethylpyrocarbonate	4180186
19474438	Dicarbonic acid, diethyl ester	4180186
19474438	Diethyl Dicarbonate	4180186
19474438	Oxydiformate, Diethyl	4180186
19474438	Pyrocarbonic Acid Diethyl Ester	4180186
19474438	Diethyl Oxydiformate	4180186
19474438	Pyrocarbonate, Diethyl	4180186
19474438	Ethoxyformic Anhydride	4180186
19474438	Anhydride, Ethoxyformic	4180186
19474438	Dicarbonate, Diethyl	4180186
19474439	Sodium Salt Ditiocarb	4180186
19474439	Ammonium Salt Ditiocarb	4180186
19474439	Carbamodithioic acid, diethyl-	4180186
19474439	Diethyldithiocarbamic Acid	4180186
19474439	Sodium, Ditiocarb	4180186
19474439	Diethyldithiocarbamate, Zinc	4180186
19474439	Diethyldithiocarbamate, Sodium	4180186
19474439	Diethyldithiocarbamate	4180186
19474439	Potassium Salt Ditiocarb	4180186
19474439	Thiocarb	4180186
19474439	Ditiocarb, Tin(4+) Salt	4180186
19474439	Dithiocarb	4180186
19474439	Ditiocarb, Sodium Salt, Trihydrate	4180186
19474439	Ditiocarb, Sodium Salt	4180186
19474439	Zinc Diethyldithiocarbamate	4180186
19474439	Ditiocarb, Bismuth Salt	4180186
19474439	Ditiocarb, Potassium Salt	4180186
19474439	Imuthiol	4180186
19474439	Ditiocarb, Zinc Salt	4180186
19474439	Ditiocarb Sodium	4180186
19474439	Bismuth Salt Ditiocarb	4180186
19474439	Zinc Salt Ditiocarb	4180186
19474439	Diethylcarbamodithioic Acid	4180186
19474439	Sodium Diethyldithiocarbamate	4180186
19474439	Lead Salt Ditiocarb	4180186
19474439	Ditiocarb, Ammonium Salt	4180186
19474439	Ditiocarb, Lead Salt	4180186
19474440	Di-2-Ethylhexylphthalate	4180186
19474440	Phthalate, Diethylhexyl	4180186
19474440	Bis(2-ethylhexyl)phthalate	4180186
19474440	1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester	4180186
19474440	Di(2-ethylhexyl)phthalate	4180186
19474440	Phthalate, Dioctyl	4180186
19474440	Dioctyl Phthalate	4180186
19474440	Di 2 Ethylhexylphthalate	4180186
19474440	DEHP	4180186
19474441	Glycosides, Digitalis	4180186
19474442	beta-D-Galactopyranoside, (2alpha,3beta,5alpha,15beta,25R)-2,15-dihydroxyspirostan-3-yl) O-beta-D-glucopyranosyl-(1-3)-O-beta-D-galactopyranosyl-(1-2)-O-(beta-D-xylopyranosyl-(1-3))-O-beta-D-glucopyranosyl-(1-4	4180186
19474442	Digitin	4180186
19474443	Diacylglycerols	4180186
19474443	Diacylglycerol	4180186
19474448	Trimethoxybenzoate, Biopropazepan	4180186
19474448	Cormelian	4180186
19474448	Benzoic acid, 3,4,5-trimethoxy-, (tetrahydro-1H-1,4-diazepine-1,4(5H)-diyl)di-3,1-propanediyl ester	4180186
19474448	Biopropazepan Trimethoxybenzoate	4180186
19474448	C 4898, Asta	4180186
19474448	Asta C 4898	4180186
19474450	Androst-4-en-3-one, 17-hydroxy-6-methyl-17-(1-propynyl)-, (6alpha,17beta)-	4180186
19474450	Dimethisterone Monohydrate	4180186
19474455	4,4' Diazoaminobenzamidine	4180186
19474455	Benzenecarboximidamide, 4,4'-(1-triazene-1,3-diyl)bis-	4180186
19474455	4,4'-Diazoaminobenzamidine	4180186
19474457	S Diphenylcarbazide	4180186
19474457	S-Diphenylcarbazide	4180186
19474457	1,5-Diphenylcarbazide	4180186
19474457	Carbonic dihydrazide, 2,2'-diphenyl-	4180186
19474457	1,5 Diphenylcarbazide	4180186
19474458	1,6-Diphenyl-1,3,5-hexatriene	4180186
19474458	1,6 Diphenylhexatriene	4180186
19474458	Benzene, 1,1'-(1,3,5-hexatriene-1,6-diyl)bis-	4180186
19474458	1,6-Diphenylhexatriene	4180186
19474459	Bisphosphonates	4180186
19474459	Bisphosphonate	4180186
19474461	Hydrochloride, Diprenorphine	4180186
19474461	Revivon	4180186
19474461	6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-	4180186
19474461	Diprenorphine Hydrochloride	4180186
19474462	Directories as Topics	4180186
19474464	Dizan	4180186
19474464	Cyanine Dye DiS-C2-(5)	4180186
19474464	3,3' Diethylthiadicarbocyanine	4180186
19474464	3,3'-Diethylthiadicarbocyanine	4180186
19474464	Iodide, Dithiazanine	4180186
19474464	Benzothiazolium, 3-ethyl-2-(5-(3-ethyl-2(3H)-benzothiazolylidene)-1,3-pentadienyl)-	4180186
19474464	Dithiazanine Iodide	4180186
19474466	Ellman Reagent	4180186
19474466	Benzoic acid, 3,3'-dithiobis(6-nitro)-	4180186
19474466	Ellmans Reagent	4180186
19474466	5,5'-Dithiobis(nitrobenzoate)	4180186
19474466	Acid, Dithionitrobenzoic	4180186
19474466	DTNB	4180186
19474466	Reagent, Ellman's	4180186
19474466	Ellman's Reagent	4180186
19474466	5,5'-Dithiobis(2-nitrobenzoic Acid)	4180186
19474470	DMF Indexe	4180186
19474470	Indexes, DMF	4180186
19474470	Index, DMF	4180186
19474470	DMF Indices	4180186
19474470	Decayed, Missing, and Filled Teeth	4180186
19474470	Indexe, DMF	4180186
19474470	Indices, DMF	4180186
19474470	DMF Indexes	4180186
19474471	Iodide, Dimethylphenylpiperazinium	4180186
19474471	Piperazinium, 1,1-dimethyl-4-phenyl-, iodide	4180186
19474471	1,1-Dimethyl-4-phenylpiperazine Iodide	4180186
19474471	1,1 Dimethyl 4 phenylpiperazine Iodide	4180186
19474471	DMPP	4180186
19474471	Dimethylphenylpiperazinium	4180186
19474471	Iodide, 1,1-Dimethyl-4-phenylpiperazine	4180186
19474472	Transferase, Terminal Deoxyribonucleotidyl	4180186
19474472	Deoxyribonucleotidyltransferase, Terminal	4180186
19474472	Deoxynucleotidyl Transferase	4180186
19474472	Terminal Addition Enzyme	4180186
19474472	Antigen, Tdt	4180186
19474472	Transferase, Desoxynucleotidyl	4180186
19474472	Nucleotidylexotransferase, DNA	4180186
19474472	Transferase, Deoxynucleotidyl	4180186
19474472	Nucleoside-triphosphate:DNA deoxynucleotidylexotransferase	4180186
19474472	Enzyme, Terminal Addition	4180186
19474472	Desoxynucleotidyl Transferase	4180186
19474472	Deoxyribonucleotidyl Transferase, Terminal	4180186
19474472	Terminal Deoxyribonucleotidyl Transferase	4180186
19474472	Deoxynucleotidyl Transferase, Terminal	4180186
19474472	Tdt Antigen	4180186
19474472	Addition Enzyme, Terminal	4180186
19474472	Desoxynucleotidyltransferase	4180186
19474472	Deoxynucleotidyltransferase	4180186
19474472	Terminal Deoxyribonucleotidyltransferase	4180186
19474472	Transferase, Terminal Deoxynucleotidyl	4180186
19474472	Terminal Deoxynucleotidyl Transferase	4180186
19474473	beta, Topoisomerase III	4180186
19474473	DNA Nicking-Closing Protein	4180186
19474473	IIIalpha, TOPO	4180186
19474473	TOP3 Topoisomerase	4180186
19474473	DNA Relaxing Enzymes	4180186
19474473	Topoisomerase IIIbeta	4180186
19474473	DNA Topoisomerase III beta	4180186
19474473	DNA Type 1 Topoisomerase	4180186
19474473	IIIalpha, Topoisomerase	4180186
19474473	DNA Untwisting Protein	4180186
19474473	Topoisomerase I	4180186
19474473	DNA Untwisting Enzyme	4180186
19474473	Topo III	4180186
19474473	Topoisomerase III	4180186
19474473	Topoisomerase III, DNA	4180186
19474473	DNA Relaxing Enzyme	4180186
19474473	Topoisomerase III beta	4180186
19474473	DNA Topoisomerase III alpha	4180186
19474473	III, DNA Topoisomerase	4180186
19474473	Topoisomerase, TOP3	4180186
19474473	TOPO IIIalpha	4180186
19474473	DNA Topoisomerase I	4180186
19474473	III beta, Topoisomerase	4180186
19474473	DNA Untwisting Enzymes	4180186
19474473	DNA Topoisomerase	4180186
19474473	Topoisomerase IIIalpha	4180186
19474473	TOP3alpha	4180186
19474473	III, Topoisomerase	4180186
19474473	DNA Relaxing Protein	4180186
19474473	DNA Untwisting Proteins	4180186
19474473	IIIbeta, Topoisomerase	4180186
19474473	Type I DNA Topoisomerase	4180186
19474473	DNA Nicking-Closing Proteins	4180186
19474473	DNA topoisomerase	4180186
19474473	III, Topo	4180186
19474473	DNA Topoisomerase III	4180186
19474474	Gene, Spliced	4180186
19474474	Recombination Joint	4180186
19474474	Recombinant DNA	4180186
19474474	Spliced Genes	4180186
19474474	Recombinant DNA Research	4180186
19474474	Spliced Gene	4180186
19474474	DNA Research, Recombinant	4180186
19474474	Joint, Recombination	4180186
19474474	Genes, Spliced	4180186
19474474	Research, Recombinant DNA	4180186
19474476	Drug Augmentations	4180186
19474476	Drug Potentiations	4180186
19474476	Drug Potentiation	4180186
19474476	Synergisms, Drug	4180186
19474476	Augmentation, Drug	4180186
19474476	Synergism, Drug	4180186
19474476	Drug Synergisms	4180186
19474476	Augmentations, Drug	4180186
19474476	Drug Augmentation	4180186
19474476	Potentiations, Drug	4180186
19474476	Potentiation, Drug	4180186
19474478	Extracts, Chinese Plant	4180186
19474478	Chinese Plant Extracts	4180186
19474478	Plant Extracts, Chinese	4180186
19474478	Herbal Drugs, Chinese	4180186
19474478	Chinese Drugs, Plant	4180186
19474478	Chinese Herbal Drugs	4180186
19474479	Housedust	4180186
19474479	House Dust	4180186
19474479	Dust, House	4180186
19474480	Tissue Stains	4180186
19474480	Tissue Stain	4180186
19474480	Stains, Tissue	4180186
19474480	Stain	4180186
19474480	Agent, Coloring	4180186
19474480	Coloring Agent	4180186
19474480	Organic Pigments	4180186
19474480	Stain, Tissue	4180186
19474480	Pigments, Organic	4180186
19474480	Organic Pigment	4180186
19474480	Dyes	4180186
19474480	Pigments, Inorganic	4180186
19474480	Stains	4180186
19474480	Pigment, Organic	4180186
19474480	Dye	4180186
19474480	Inorganic Pigments	4180186
19474481	NSC-526417	4180186
19474481	NSC526417	4180186
19474481	NSC 526417	4180186
19474481	Quinomycin A	4180186
19474482	Ecothiopate Iodide	4180186
19474482	Iodide, Echothiophate	4180186
19474482	Ecothiophate Iodide	4180186
19474482	2-((Diethoxyphosphinyl)thio)-N,N,N,-trimethylethanaminium iodide	4180186
19474482	Ethanaminium, 2-((diethoxyphosphinyl)thio)-N,N,N-trimethyl-, iodide	4180186
19474482	Phospholine Iodide	4180186
19474482	Iodide, Ecothiopate	4180186
19474482	Iodide, Phospholine	4180186
19474482	Iodide, Ecothiophate	4180186
19474489	Frangula Emodin	4180186
19474489	Frangulic Acid	4180186
19474489	Archin	4180186
19474489	9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl-	4180186
19474489	Peristim	4180186
19474489	Emodin, Frangula	4180186
19474489	Rheum Emodin	4180186
19474489	Casanthranol	4180186
19474489	Emodin, Rheum	4180186
19474492	Tuberactinomycin N	4180186
19474492	Tuberactinomycin-N	4180186
19474492	Viomycin, 1-((3R,4R)-4-hydroxy-3,6-diaminohexanoic acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine)-, (R)-	4180186
19474493	Environments	4180186
19474493	Impacts, Environmental	4180186
19474493	Environmental Impacts	4180186
19474493	Environmental Impact	4180186
19474493	Impact, Environmental	4180186
19474494	Area, Laminar Air-Flow	4180186
19474494	Room, Clean	4180186
19474494	Laminar Air Flow Areas	4180186
19474494	Environments, Controlled	4180186
19474494	Clean Rooms	4180186
19474494	Controlled Environments	4180186
19474494	Controlled Environment	4180186
19474494	Clean Room	4180186
19474494	Laminar Air-Flow Areas	4180186
19474494	Laminar Air-Flow Area	4180186
19474495	Immobilized Enzyme	4180186
19474495	Enzyme, Immobilized	4180186
19474495	Immobilized Enzymes	4180186
19474497	Mepirizole	4180186
19474497	Methopyrimazole	4180186
19474497	Pyrimidine, 4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methyl-	4180186
19474498	Epistatic Gene	4180186
19474498	Epistases, Genetic	4180186
19474498	Deviation, Epistatic	4180186
19474498	Gene, Epistatic	4180186
19474498	Epistatic Gene-Gene Interaction	4180186
19474498	Genes, Hypostatic	4180186
19474498	Interactions, Non-Allelic Gene	4180186
19474498	Gene Interaction, Non-Allelic	4180186
19474498	Gene Gene Interactions, Epistatic	4180186
19474498	Interaction, Epistatic Gene-Gene	4180186
19474498	Non Allelic Gene Interactions	4180186
19474498	Interaction, Non-Allelic Gene	4180186
19474498	Non-Allelic Gene Interaction	4180186
19474498	Gene, Hypostatic	4180186
19474498	Epistatic Genes	4180186
19474498	Hypostatic Gene	4180186
19474498	Non-Allelic Gene Interactions	4180186
19474498	Genes, Epistatic	4180186
19474498	Gene-Gene Interaction, Epistatic	4180186
19474498	Genetic Epistases	4180186
19474498	Gene-Gene Interactions, Epistatic	4180186
19474498	Gene Interactions, Non-Allelic	4180186
19474498	Interaction Deviation	4180186
19474498	Epistatic Gene-Gene Interactions	4180186
19474498	Gene Gene Interaction, Epistatic	4180186
19474498	Hypostatic Genes	4180186
19474498	Epistatic Deviation	4180186
19474498	Genetic Epistasis	4180186
19474498	Interactions, Epistatic Gene-Gene	4180186
19474499	Estra-1,3,5,7,9-pentaen-17-one, 3-hydroxy-	4180186
19474500	Estra-1,3,5(10),7-tetraen-17-one, 3-hydroxy-	4180186
19474501	D2, Pro-Vitamin	4180186
19474501	Lumisterol	4180186
19474501	Provitamin D 2	4180186
19474501	Ergosta-5,7,22-trien-3-ol, (3beta,22E)-	4180186
19474501	Pro Vitamin D2	4180186
19474501	Pro-Vitamin D2	4180186
19474508	Ethoxazolamide	4180186
19474508	Ethamide	4180186
19474508	2-Benzothiazolesulfonamide, 6-ethoxy-	4180186
19474508	Ethoxyzolamide	4180186
19474511	3-(3-Dimethylaminopropyl)-1-Ethylcarbodiimide	4180186
19474511	Carbodiimide, Ethyldimethylaminopropyl	4180186
19474511	EDAP Carbodiimide	4180186
19474511	EDAP-Carbodiimide	4180186
19474511	1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-	4180186
19474511	1-Ethyl-3-(3-Dimethylaminopropyl)Carbodiimide	4180186
19474512	Dichlorides, Ethylene	4180186
19474512	Dichloroethanes	4180186
19474513	1H-Pyrrole-2,5-dione, 1-ethyl-	4180186
19474513	N-Ethylmaleimide	4180186
19474513	N Ethylmaleimide	4180186
19474515	Ethylnorantifeine	4180186
19474515	Ethymizol	4180186
19474515	Aethimizole	4180186
19474515	Ethymisole	4180186
19474515	Ethimizol	4180186
19474515	Ethimizole	4180186
19474515	1H-Imidazole-4,5-dicarboxamide, 1-ethyl-N,N'-dimethyl-	4180186
19474517	6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-alpha-propyl-, (5alpha,7alpha(R))-	4180186
19474517	M99	4180186
19474517	Ethorphine	4180186
19474521	Eye Bank	4180186
19474521	Banks, Eye	4180186
19474521	Bank, Eye	4180186
19474522	Fat Emulsion, Intravenous	4180186
19474522	Intravenous Fat Emulsion	4180186
19474522	Intravenous Lipid Emulsion	4180186
19474522	Emulsion, Intravenous Lipid	4180186
19474522	Intravenous Fat Emulsions	4180186
19474522	Intravenous Lipid Emulsions	4180186
19474522	Lipid Emulsions, Intravenous	4180186
19474522	Emulsions, Intravenous Fat	4180186
19474522	Emulsions, Intravenous Lipid	4180186
19474522	Emulsion, Intravenous Fat	4180186
19474522	Lipid Emulsion, Intravenous	4180186
19474524	Ferritin	4180186
19474524	Isoferritin	4180186
19474524	Basic Isoferritin	4180186
19474524	Isoferritin, Basic	4180186
19474526	Agents, Fertility	4180186
19474526	Fertility Drugs	4180186
19474526	Infertility Agents	4180186
19474526	Infertility Effects	4180186
19474526	Effect, Fertility	4180186
19474526	Infertility Drugs	4180186
19474526	Fertility Effect	4180186
19474526	Effects, Infertility	4180186
19474526	Drugs, Fertility	4180186
19474526	Infertility Effect	4180186
19474526	Agents, Infertility	4180186
19474526	Fertility Effects	4180186
19474526	Effects, Fertility	4180186
19474526	Drugs, Infertility	4180186
19474526	Effect, Infertility	4180186
19474527	Antithrombin I	4180186
19474527	Fibrins	4180186
19474528	Foam, Fibrin	4180186
19474528	Spongostan	4180186
19474528	Fibrospum	4180186
19474530	alpha-D-Glucopyranoside, beta-D-fructofuranosyl, homopolymer	4180186
19474532	Badge Dosimetries, Film	4180186
19474532	Dosimetry, Film	4180186
19474532	Film Badges	4180186
19474532	Film Badge	4180186
19474532	Film Dosimetries	4180186
19474532	Film Badge Dosimetries	4180186
19474532	Film Badge Dosimetry	4180186
19474532	Dosimetries, Film	4180186
19474532	Badge Dosimetry, Film	4180186
19474532	Dosimetry, Film Badge	4180186
19474532	Badge, Film	4180186
19474532	Badges, Film	4180186
19474532	Dosimetries, Film Badge	4180186
19474533	DAMME	4180186
19474533	FK33824	4180186
19474533	FK 33824	4180186
19474533	FK-33-824	4180186
19474533	FK-33824	4180186
19474533	Tyr Ala Gly MePhe Met OH	4180186
19474533	FK 33 824	4180186
19474533	FK 33-824	4180186
19474533	Tyr-Ala-Gly-MePhe-Met-OH	4180186
19474534	1H-1,4-Diazepine, 1,1'-(dithiodicarbonothioyl)bis(hexahydro-4-methyl)	4180186
19474534	FLA 63	4180186
19474540	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	4180186
19474540	5 Fluoro 2' Deoxyuridine 5' Monophosphate	4180186
19474540	FdUMP	4180186
19474540	5'-Uridylic acid, 2'-deoxy-5-fluoro-	4180186
19474545	1H-Naphtho(2,1-b)pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-	4180186
19474545	N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl	4180186
19474545	NKH-477	4180186
19474545	Coleonol	4180186
19474545	NKH 477	4180186
19474545	Forskolin	4180186
19474545	NKH477	4180186
19474546	Ester, Fumaric Acid	4180186
19474546	Acid Esters, Fumaric	4180186
19474546	Acid Ester, Fumaric	4180186
19474546	Fumaric Acid Esters	4180186
19474546	Fumaric Acid Ester	4180186
19474546	Fumarate Esters	4180186
19474546	Esters, Fumaric Acid	4180186
19474546	Esters, Fumarate	4180186
19474546	Fumarate	4180186
19474548	5-Butyl-2-pyridinedicarboxylic Acid	4180186
19474548	Acid, 5-Butyl-2-pyridinedicarboxylic	4180186
19474548	2-Pyridinecarboxylic acid, 5-butyl-	4180186
19474548	Fusarate, Calcium	4180186
19474548	Acid, Fusaric	4180186
19474548	Calcium Fusarate	4180186
19474548	5 Butyl 2 pyridinedicarboxylic Acid	4180186
19474552	gamma-Globulin	4180186
19474552	gamma Globulin	4180186
19474552	gamma Globulins	4180186
19474554	Fuel, Diesel	4180186
19474554	Gasolines	4180186
19474554	Diesel Fuels	4180186
19474554	Diesel Fuel	4180186
19474554	Fuels, Diesel	4180186
19474555	Glucose Dependent Insulinotropic Peptide	4180186
19474555	Insulin-Releasing Peptide, Glucose-Dependent	4180186
19474555	Insulinotropic Peptide, Glucose-Dependent	4180186
19474555	Polypeptide, Gastric-Inhibitory	4180186
19474555	Glucose-Dependent Insulin-Releasing Peptide	4180186
19474555	Peptide, Glucose-Dependent Insulin-Releasing	4180186
19474555	Gastric-Inhibitory Polypeptide	4180186
19474555	Glucose Dependent Insulin Releasing Peptide	4180186
19474555	Peptide, Glucose-Dependent Insulinotropic	4180186
19474555	Polypeptide, Gastric Inhibitory	4180186
19474555	Glucose-Dependent Insulinotropic Peptide	4180186
19474555	Inhibitory Polypeptide, Gastric	4180186
19474556	Gastrin	4180186
19474557	Ulco	4180186
19474557	Gepharnate	4180186
19474557	Gefarnil	4180186
19474557	4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, 3,7-dimethyl-2,6-octadienyl ester, (E,E,E)-	4180186
19474557	Farnesylacetate, Geranyl	4180186
19474557	Geranyl Farnesylacetate	4180186
19474560	Germine 3 monoacetate	4180186
19474560	Germine-3-monoacetate	4180186
19474560	Acetates, Germine	4180186
19474562	Kirondrin	4180186
19474562	Picras-3-en-16-one, 11,20-epoxy-1,2,11,12-tetrahydroxy-15-(2-hydroxy-2-methyl-1-oxobutoxy)-, (1beta,2alpha,11beta,12alpha,15beta(S))-	4180186
19474563	Astrogliosis	4180186
19474563	Astrocytoses	4180186
19474563	Scar, Glial	4180186
19474563	Glial Scar	4180186
19474563	Astrocytosis	4180186
19474563	Glial Scars	4180186
19474564	Glucan	4180186
19474564	Glucose Polymer	4180186
19474564	Glucan (BO)	4180186
19474564	Polyglucose	4180186
19474564	Polyglucoses	4180186
19474564	Polymer, Glucose	4180186
19474564	Polycose	4180186
19474565	Glucocorticoid Effect	4180186
19474565	Glucorticoid Effects	4180186
19474565	Glucocorticoid	4180186
19474565	Effects, Glucorticoid	4180186
19474565	Effect, Glucocorticoid	4180186
19474568	Endoglucuronidase	4180186
19474568	beta-D-Glucuronoside glucuronosohydrolase	4180186
19474568	Exo beta D Glucuronidase	4180186
19474568	Endo beta D Glucuronidase	4180186
19474568	beta-Glucuronidase	4180186
19474568	Endo-beta-D-Glucuronidase	4180186
19474568	Exo-beta-D-Glucuronidase	4180186
19474568	beta Glucuronidase	4180186
19474572	Glycosphingolipid	4180186
19474572	Sphingoglycolipid	4180186
19474572	Sphingoglycolipids	4180186
19474572	Asialogangliosides	4180186
19474572	Asialoganglioside	4180186
19474574	Equine Gonadotropins	4180186
19474574	Pregnant Mare Serum Gonadotropins	4180186
19474574	PMS Gonadotropins	4180186
19474574	PMSG (Gonadotropins)	4180186
19474574	Gonadotropins, PMS	4180186
19474578	1H-1,2,4-Triazole-3,5-diamine	4180186
19474580	Psychedelic Agent	4180186
19474580	Drugs, Hallucinogenic	4180186
19474580	Hallucinogenic Agents	4180186
19474580	Psychotomimetic Agents	4180186
19474580	Hallucinogenic Substances	4180186
19474580	Hallucinogenic Agent	4180186
19474580	Agent, Psychedelic	4180186
19474580	Agents, Hallucinogenic	4180186
19474580	Substances, Hallucinogenic	4180186
19474580	Substance, Hallucinogenic	4180186
19474580	Agents, Psychedelic	4180186
19474580	Hallucinogenic Drugs	4180186
19474580	Psychedelic Agents	4180186
19474580	Drug, Hallucinogenic	4180186
19474580	Hallucinogenic Substance	4180186
19474580	Agent, Hallucinogenic	4180186
19474580	Psychedelic	4180186
19474580	Hallucinogenic Drug	4180186
19474580	Agent, Psychotomimetic	4180186
19474580	Psychotomimetic Agent	4180186
19474580	Psychedelics	4180186
19474580	Hallucinogen	4180186
19474580	Agents, Psychotomimetic	4180186
19474581	MK185	4180186
19474581	Benzeneacetic acid, 4-chloro-alpha-(3-(trifluoromethyl)phenoxy)-, 2-(acetylamino)ethyl ester	4180186
19474581	MK-185	4180186
19474581	MK 185	4180186
19474583	3H-Pyrido(3,4-b)indole, 4,9-dihydro-7-methoxy-1-methyl-	4180186
19474583	Dihydroharmine	4180186
19474583	Harmidine	4180186
19474588	Group Health Organizations, Prepaid	4180186
19474588	Organizations, Health Maintenance	4180186
19474588	Organization, Health Maintenance	4180186
19474588	Health Maintenance Organization	4180186
19474588	HMO	4180186
19474588	Prepaid Group Health Organizations	4180186
19474590	Agent, Erythropoiesis Stimulating	4180186
19474590	Hematinic	4180186
19474590	Hematopoietic Agents	4180186
19474590	Stimulating Agent, Erythropoiesis	4180186
19474590	Erythropoiesis Stimulating Agents	4180186
19474590	Erythropoiesis Stimulating Agent	4180186
19474594	Antibodies, Hepatitis	4180186
19474595	B Antigens, Anti-Hepatitis	4180186
19474595	Antigens, Anti-Australia	4180186
19474595	Antigens, Anti-Hepatitis B	4180186
19474595	Anti HBAg	4180186
19474595	Anti-Australia Antigens	4180186
19474595	B Antibodies, Hepatitis	4180186
19474595	Anti Australia Antigens	4180186
19474595	Antibodies, Hepatitis B	4180186
19474595	HBAg, Anti	4180186
19474595	Anti-Hepatitis B Antigens	4180186
19474595	Anti Hepatitis B Antigens	4180186
19474595	Hepatitis B Virus Antibodies	4180186
19474595	Anti-HBAg	4180186
19474596	HBe Ag-1	4180186
19474596	Hepatitis Be Antigen	4180186
19474596	Be Antigens, Hepatitis	4180186
19474596	Antigen, e	4180186
19474596	e Antigen	4180186
19474596	Antigens, Hepatitis Be	4180186
19474596	HBeAg	4180186
19474596	e Antigens	4180186
19474596	Be Antigen, Hepatitis	4180186
19474596	Hepatitis B e Antigen	4180186
19474596	Hepatitis Be Antigens	4180186
19474596	HBe Ag-2	4180186
19474596	Antigen, Hepatitis Be	4180186
19474596	Antigens, e	4180186
19474599	Dysplasia, Canine Hip	4180186
19474599	Canine Hip Dysplasia	4180186
19474601	Antihistamines	4180186
19474601	Antagonists, Histamine	4180186
19474601	Antagonist, Histamine	4180186
19474601	Antihistamine	4180186
19474601	Histamine Antagonist	4180186
19474602	Sedating Antihistamines	4180186
19474602	Histamine H1 Antagonist	4180186
19474602	H1 Antagonists, Histamine	4180186
19474602	Histamine H1 Receptor Antagonist	4180186
19474602	Antihistaminics, Classical	4180186
19474602	Histamine H1 Blockers	4180186
19474602	Classical Antihistaminics	4180186
19474602	Antihistamines, Classical	4180186
19474602	Antagonists, Histamine H1 Receptor	4180186
19474602	Antagonist, Histamine H1	4180186
19474602	Classical Antihistamines	4180186
19474602	Antihistamines, Sedating	4180186
19474602	Receptor Blockaders, H1	4180186
19474602	H1 Antihistaminics	4180186
19474602	Antagonists, Histamine H1	4180186
19474602	Histamine H1 Receptor Blockaders	4180186
19474602	H1 Receptor Blockaders	4180186
19474602	Blockaders, Histamine H1 Receptor	4180186
19474602	H1 Antagonist, Histamine	4180186
19474602	Antihistaminics, H1	4180186
19474602	Histamine H1 Receptor Antagonists	4180186
19474602	First Generation H1 Antagonists	4180186
19474605	Cytochemistry	4180186
19474607	Leukocyte Antigens, Human	4180186
19474607	Leukocyte Antigen, Human	4180186
19474607	Antigens, Leukocyte	4180186
19474607	Antigens, Human Leukocyte	4180186
19474607	Antigens, HL-A	4180186
19474607	Leukocyte Antigens	4180186
19474607	Antigen, Human Leukocyte	4180186
19474607	Human Leukocyte Antigens	4180186
19474607	Antigens, HLA	4180186
19474607	Human Leukocyte Antigen	4180186
19474607	HL A Antigens	4180186
19474607	HL-A Antigens	4180186
19474608	Antigens, HLA-Dw	4180186
19474608	Human Immune-Associated Antigens	4180186
19474608	Immune Associated Antigens, Human	4180186
19474608	Ia Like Antigens, Human	4180186
19474608	Immune Response Associated Antigens, Human	4180186
19474608	Human Immune-Response Antigens	4180186
19474608	Antigens, Human Ia-Like	4180186
19474608	HLA-Dw Antigens	4180186
19474608	Human Class II Antigens	4180186
19474608	Immune Response Antigens, Human	4180186
19474608	Ia-Like Antigens, Human	4180186
19474608	Human Ia-Like Antigens	4180186
19474608	Immune Response-Associated Antigens, Human	4180186
19474608	HLA-Dw	4180186
19474608	Immune-Response Antigens, Human	4180186
19474608	Antigens, HLA-D	4180186
19474608	Antigens, Human Immune-Response	4180186
19474608	Antigens, HLA D	4180186
19474608	Immune-Associated Antigens, Human	4180186
19474608	Class II Human Antigens	4180186
19474608	Antigens, Human Immune-Associated	4180186
19474608	HLA D Antigens	4180186
19474608	HLA-D	4180186
19474608	HLA Dw Antigens	4180186
19474610	Antigens, HLA-MB	4180186
19474610	Antigens, HLA-DS	4180186
19474610	HLA DC Antigens	4180186
19474610	HLA MB Antigens	4180186
19474610	Antigens, HLA-DQ	4180186
19474610	HLA-DC	4180186
19474610	HLA-LB	4180186
19474610	Antigens, HLA-LB	4180186
19474610	HLA-MB	4180186
19474610	HLA-DQ	4180186
19474610	HLA-DC Antigens	4180186
19474610	HLA-DS	4180186
19474610	Antigens, HLA-DC	4180186
19474610	HLA-MB Antigens	4180186
19474610	HLA-LB Antigens	4180186
19474610	HLA LB Antigens	4180186
19474610	HLA DS Antigens	4180186
19474610	HLA DQ Antigens	4180186
19474610	HLA-DS Antigens	4180186
19474613	Housing, Senior	4180186
19474613	Homes, Old Age	4180186
19474613	Old Age Homes	4180186
19474613	Home, Old Age	4180186
19474613	Residential Aged Care Facility	4180186
19474613	Senior Housing	4180186
19474613	Old Age Home	4180186
19474614	Peroxidase II, Horseradish	4180186
19474614	Ferrihorseradish Peroxidase	4180186
19474614	Alpha-Peroxidase	4180186
19474614	Horseradish Peroxidase II	4180186
19474614	Peroxidase III, Horseradish	4180186
19474614	III, Horseradish Peroxidase	4180186
19474614	II, Horseradish Peroxidase	4180186
19474614	Horseradish Peroxidase III	4180186
19474614	Alpha Peroxidase	4180186
19474614	Peroxidase, Ferrihorseradish	4180186
19474614	Peroxidase, Horseradish	4180186
19474615	Department, Hospital	4180186
19474615	Departments, Hospital	4180186
19474615	Hospital Department	4180186
19474617	Record, Hospital	4180186
19474617	Records, Hospital	4180186
19474617	Hospital Record	4180186
19474621	Chronic Disease Hospital	4180186
19474621	Chronic Disease Hospitals	4180186
19474621	Tuberculosis Sanitaria	4180186
19474621	Sanitoria, Tuberculosis	4180186
19474621	Hospital, Tuberculosis	4180186
19474621	Hospitals, Tuberculosis	4180186
19474621	Tuberculosis Hospital	4180186
19474621	Tuberculosis Sanitoria	4180186
19474621	Sanitaria, Tuberculosis	4180186
19474621	Tuberculosis Sanitorias	4180186
19474621	Tuberculosis Hospitals	4180186
19474621	Sanitarias, Tuberculosis	4180186
19474621	Hospital, Chronic Disease	4180186
19474621	Tuberculosis Sanitarias	4180186
19474621	Sanitorias, Tuberculosis	4180186
19474622	Community Hospitals	4180186
19474622	Community Hospital	4180186
19474622	Hospital, Community	4180186
19474623	Convalescent Hospital	4180186
19474623	Hospital, Convalescent	4180186
19474623	Convalescent Hospitals	4180186
19474625	Hospital, Federal	4180186
19474625	Federal Hospital	4180186
19474625	Federal Hospitals	4180186
19474626	General Hospital	4180186
19474626	Hospital, General	4180186
19474626	General Hospitals	4180186
19474628	Hospital, Army	4180186
19474628	Army Hospital	4180186
19474628	Hospital, Military	4180186
19474628	Air Force Hospitals	4180186
19474628	Air Force Hospital	4180186
19474628	Military Hospitals	4180186
19474628	Military Hospital	4180186
19474628	Hospitals, Army	4180186
19474628	Army Hospitals	4180186
19474628	Hospitals, Navy	4180186
19474628	Hospital, Air Force	4180186
19474628	Hospital, Navy	4180186
19474628	Navy Hospital	4180186
19474628	Navy Hospitals	4180186
19474628	Hospitals, Air Force	4180186
19474629	Municipal Hospital	4180186
19474629	Municipal Hospitals	4180186
19474629	Hospital, Municipal	4180186
19474629	Hospitals, City, Public-Owned	4180186
19474629	Hospitals, City, Public Owned	4180186
19474632	Hospitals, Private, Investor-Owned	4180186
19474632	Private, for-Profit Hospitals	4180186
19474632	Hospitals, Private, for-Profit	4180186
19474632	Hospital, Proprietary	4180186
19474632	Proprietary Hospitals	4180186
19474632	Private, Investor-Owned Hospitals	4180186
19474632	Proprietary Hospital	4180186
19474635	Hospital, Special	4180186
19474635	Special Hospitals	4180186
19474635	Special Hospital	4180186
19474636	Hospital, State	4180186
19474636	State Hospital	4180186
19474636	State Hospitals	4180186
19474637	Teaching Hospital	4180186
19474637	Hospital, Teaching	4180186
19474637	Teaching Hospitals	4180186
19474639	Veterans Hospital	4180186
19474639	Hospital, Veterans	4180186
19474639	Veterans Hospitals	4180186
19474640	9H-Thioxanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-(hydroxymethyl)-	4180186
19474641	Imidazolidine-2,4-Diones	4180186
19474641	Hydantoin	4180186
19474641	Imidazolidine 2,4 Diones	4180186
19474646	1-Propanone, 1-phenyl-, monohydroxy deriv.	4180186
19474647	Quinolinols	4180186
19474647	Chiniofon	4180186
19474652	5-Isoxazoleacetic acid, alpha-amino-2,3-dihydro-3-oxo-	4180186
19474652	Acid, Ibotenic	4180186
19474654	IgD	4180186
19474654	IgD2	4180186
19474654	IgD1	4180186
19474658	Constant Region, Ig	4180186
19474658	Immunoglobulin Constant Region	4180186
19474658	Constant Region, Immunoglobulin	4180186
19474658	Ig Constant Regions	4180186
19474658	Regions, Ig Constant	4180186
19474658	Constant Regions, Immunoglobulin	4180186
19474658	Constant Regions, Ig	4180186
19474659	Fragments, Immunoglobulin	4180186
19474659	Fragments, Ig	4180186
19474659	Fragment, Ig	4180186
19474659	Fragment, Immunoglobulin	4180186
19474659	Ig Fragments	4180186
19474659	Ig Fragment	4180186
19474659	Immunoglobulin Fragment	4180186
19474659	Fragment, Antibody	4180186
19474659	Fragments, Antibody	4180186
19474659	Antibody Fragment	4180186
19474659	Antibody Fragments	4180186
19474660	Ig Km Allotype	4180186
19474660	Allotype, Immunoglobulin Inv	4180186
19474660	Allotype, Ig Km	4180186
19474660	Ig Km Allotypes	4180186
19474660	Km Allotype	4180186
19474660	Allotypes, Inv	4180186
19474660	Km Allotype, Ig	4180186
19474660	Allotypes, Km	4180186
19474660	Inv Allotypes, Immunoglobulin	4180186
19474660	Inv Allotype, Immunoglobulin	4180186
19474660	Allotype, Inv	4180186
19474660	Km Allotypes, Ig	4180186
19474660	Allotype, Immunoglobulin Km	4180186
19474660	Allotype, Km	4180186
19474660	Immunoglobulin Inv Allotype	4180186
19474660	Km Allotypes	4180186
19474660	Km Allotype, Immunoglobulin	4180186
19474660	Allotypes, Ig Km	4180186
19474660	Immunoglobulin Km Allotype	4180186
19474660	Inv Allotype	4180186
19474660	Immunoglobulin Inv Allotypes	4180186
19474660	Allotypes, Immunoglobulin Km	4180186
19474660	Allotypes, Immunoglobulin Inv	4180186
19474660	Km Allotypes, Immunoglobulin	4180186
19474660	Inv Allotypes	4180186
19474661	Immunoglobulin Classes	4180186
19474661	Ig Isotypes	4180186
19474661	Class, Antibody	4180186
19474661	Isotypes, Ig	4180186
19474661	Isotype, Ig	4180186
19474661	Isotype, Immunoglobulin	4180186
19474661	Immunoglobulin Isotype	4180186
19474661	Class, Immunoglobulin	4180186
19474661	Isotypes, Immunoglobulin	4180186
19474661	Classes, Immunoglobulin	4180186
19474661	Classes, Antibody	4180186
19474661	Immunoglobulin Class	4180186
19474661	Ig Isotype	4180186
19474661	Antibody Classes	4180186
19474661	Antibody Class	4180186
19474662	Immunoglobulins, delta-Chain	4180186
19474662	delta-Chain Immunoglobulins	4180186
19474662	delta-Chain, Immunoglobulin	4180186
19474662	Immunoglobulin delta-Chain	4180186
19474662	Immunoglobulins, delta Chain	4180186
19474662	Immunoglobulin delta Chain	4180186
19474662	delta Immunoglobulin Heavy Chains	4180186
19474662	delta Immunoglobulin Heavy Chain	4180186
19474662	Chains, Ig delta	4180186
19474662	Immunoglobulin delta Chains	4180186
19474662	delta-Chains, Immunoglobulin	4180186
19474662	Ig delta Chains	4180186
19474662	delta Chains, Ig	4180186
19474662	delta Chain Immunoglobulins	4180186
19474663	Immunoglobulin epsilon-Chain	4180186
19474663	epsilon Immunoglobulin Heavy Chain	4180186
19474663	epsilon-Chain, Immunoglobulin	4180186
19474663	epsilon Chains, Ig	4180186
19474663	Immunoglobulin epsilon Chain	4180186
19474663	epsilon-Immunoglobulin Heavy Chain	4180186
19474663	Immunoglobulins, epsilon-Chain	4180186
19474663	epsilon-Immunoglobulin Heavy Chains	4180186
19474663	Chains, Ig epsilon	4180186
19474663	Heavy Chains, epsilon-Immunoglobulin	4180186
19474663	epsilon Chain Immunoglobulins	4180186
19474663	epsilon-Chain Immunoglobulins	4180186
19474663	Ig epsilon Chains	4180186
19474663	Heavy Chain, epsilon-Immunoglobulin	4180186
19474663	epsilon-Chains, Immunoglobulin	4180186
19474663	Immunoglobulin epsilon Chains	4180186
19474663	epsilon Immunoglobulin Heavy Chains	4180186
19474663	Immunoglobulins, epsilon Chain	4180186
19474664	Fab Immunoglobulin Fragments	4180186
19474664	Fab Fragment Immunoglobulins	4180186
19474664	Immunoglobulins, Fab	4180186
19474664	Immunoglobulins, Fab Fragment	4180186
19474664	Immunoglobulin Fab Fragment	4180186
19474664	Fab Fragments	4180186
19474664	Fab Fragment	4180186
19474664	Fragment Immunoglobulins, Fab	4180186
19474664	Ig Fab Fragments	4180186
19474664	Fab Fragment, Immunoglobulin	4180186
19474664	Fab Fragments, Immunoglobulin	4180186
19474664	Fragment, Fab	4180186
19474664	Immunoglobulin Fragments, Fab	4180186
19474666	Immunoglobulin Heavy Chain Subgroup VH III	4180186
19474666	Ig Heavy Chains	4180186
19474666	Heavy Chains, Ig	4180186
19474666	Heavy Chain Immunoglobulins	4180186
19474666	Immunoglobulins, Heavy-Chain	4180186
19474666	Immunoglobulin Heavy Chain Subgroup VH-III	4180186
19474666	Heavy Chains, Immunoglobulin	4180186
19474666	Immunoglobulin Heavy Chain Subgroup VH-I	4180186
19474666	Heavy Chain, Immunoglobulin	4180186
19474666	Heavy-Chain Immunoglobulins	4180186
19474666	Immunoglobulins, Heavy Chain	4180186
19474666	Immunoglobulin Heavy Chain	4180186
19474666	Immunoglobulin Heavy Chain Subgroup VH I	4180186
19474668	Immunoglobulins, kappa Chain	4180186
19474668	Light Chain, kappa-Immunoglobulin	4180186
19474668	kappa-Immunoglobulin Light Chains	4180186
19474668	kappa Immunoglobulin Light Chain	4180186
19474668	Immunoglobulin kappa Chains	4180186
19474668	kappa Immunoglobulin Subgroup VK 12	4180186
19474668	Ig kappa Chains	4180186
19474668	kappa Immunoglobulin Light Chains	4180186
19474668	kappa Immunoglobulin Subgroup VK 21	4180186
19474668	kappa-Immunoglobulin Subgroup VK-21	4180186
19474668	kappa-Immunoglobulin Light Chain	4180186
19474668	kappa-Chain Immunoglobulins	4180186
19474668	kappa-Immunoglobulin Subgroup VK-12	4180186
19474668	kappa-Chains, Immunoglobulin	4180186
19474668	kappa Chains, Ig	4180186
19474668	kappa Chain Immunoglobulins	4180186
19474668	Immunoglobulin kappa Chain	4180186
19474668	Chains, Ig kappa	4180186
19474668	Light Chains, kappa-Immunoglobulin	4180186
19474668	Immunoglobulin kappa-Chain	4180186
19474668	kappa-Chain, Immunoglobulin	4180186
19474668	Immunoglobulins, kappa-Chain	4180186
19474669	lambda 2 Immunoglobulin	4180186
19474669	lambda-Chain, Immunoglobulin	4180186
19474669	lambda x Immunoglobulin	4180186
19474669	lambda-Immunoglobulin Light Chains	4180186
19474669	Ig lambda Chains	4180186
19474669	Immunoglobulins, lambda Chain	4180186
19474669	lambda Immunoglobulin Light Chain	4180186
19474669	Chains, Ig lambda	4180186
19474669	lambda Chain Immunoglobulins	4180186
19474669	lambda-2-Immunoglobulin	4180186
19474669	lambda-x Immunoglobulin	4180186
19474669	lambda-Chains, Immunoglobulin	4180186
19474669	Light Chains, lambda-Immunoglobulin	4180186
19474669	Chains, lambda-Immunoglobulin Light	4180186
19474669	Immunoglobulin, lambda-x	4180186
19474669	lambda 1 Immunoglobulin	4180186
19474669	Immunoglobulins, lambda-Chain	4180186
19474669	Immunoglobulin lambda-Chain	4180186
19474669	lambda Chains, Ig	4180186
19474669	lambda-1-Immunoglobulin	4180186
19474669	Immunoglobulin lambda Chains	4180186
19474669	lambda-Immunoglobulin Light Chain	4180186
19474669	lambda-Chain Immunoglobulins	4180186
19474669	Immunoglobulin lambda Chain	4180186
19474669	Light Chain, lambda-Immunoglobulin	4180186
19474669	lambda Immunoglobulin Light Chains	4180186
19474670	Chains, Immunoglobulin Light	4180186
19474670	Light Chain, Immunoglobulin	4180186
19474670	Immunoglobulin Light-Chain	4180186
19474670	Chains, Ig Light	4180186
19474670	Light-Chain Immunoglobulins	4180186
19474670	Immunoglobulins, Light-Chain	4180186
19474670	Light Chains, Immunoglobulin	4180186
19474670	Light Chains, Ig	4180186
19474670	Light-Chain, Immunoglobulin	4180186
19474670	Ig Light Chains	4180186
19474670	Immunoglobulin Light Chain	4180186
19474670	Light Chain Immunoglobulins	4180186
19474670	Immunoglobulins, Light Chain	4180186
19474674	Benzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-alpha-methyl-	4180186
19474674	Dexindoprofen	4180186
19474675	Industrial Oil	4180186
19474675	Oil, Industrial	4180186
19474675	Commercial Oil	4180186
19474675	Polishes	4180186
19474675	Oil, Commercial	4180186
19474675	Commercial Oils	4180186
19474675	Oils, Industrial	4180186
19474675	Oils, Commercial	4180186
19474676	Feedings, Supplementary	4180186
19474676	Supplementary Feedings	4180186
19474676	Feedings, Complementary	4180186
19474676	Infant Nutrition Physiology	4180186
19474676	Feeding, Supplementary	4180186
19474676	Physiology, Infant Nutrition	4180186
19474676	Infant Nutritional Physiology	4180186
19474676	Complementary Feedings	4180186
19474676	Nutritional Physiology, Infant	4180186
19474676	Infant Nutritional Physiological Phenomenon	4180186
19474676	Complementary Feeding	4180186
19474676	Supplementary Feeding	4180186
19474676	Feeding, Complementary	4180186
19474676	Nutrition Physiology, Infant	4180186
19474676	Physiology, Infant Nutritional	4180186
19474678	Information Specialist	4180186
19474678	Services, Information	4180186
19474678	Networks, Information	4180186
19474678	Service, Information	4180186
19474678	Information Service	4180186
19474678	Information Networks	4180186
19474678	Specialist, Information	4180186
19474678	Information Network	4180186
19474678	Network, Information	4180186
19474678	Specialists, Information	4180186
19474678	Information Specialists	4180186
19474684	Neonatal ICU	4180186
19474684	Newborn Intensive Care Units (NICU)	4180186
19474684	Neonatal ICUs	4180186
19474684	ICUs, Newborn	4180186
19474684	ICU, Newborn	4180186
19474684	ICUs, Neonatal	4180186
19474684	Newborn Intensive Care Unit	4180186
19474684	Neonatal Intensive Care Units	4180186
19474684	Newborn ICU	4180186
19474684	Neonatal Intensive Care Unit	4180186
19474684	Newborn ICUs	4180186
19474684	ICU, Neonatal	4180186
19474684	Newborn Intensive Care Units	4180186
19474685	Interferons Type I	4180186
19474685	Interferons, Type I	4180186
19474685	Interferon, Type I	4180186
19474685	Type I Interferon	4180186
19474685	Type I Interferons	4180186
19474687	Interior Design	4180186
19474687	Interior Designs	4180186
19474687	Interior Furnishings	4180186
19474687	Furnishings, Interior	4180186
19474687	Furnishing, Interior	4180186
19474687	Interior Furnishing	4180186
19474687	Furniture	4180186
19474687	Designs, Interior	4180186
19474687	Design, Interior	4180186
19474688	Macrophage Cell Factor	4180186
19474688	T Helper Factor	4180186
19474688	Epidermal Cell Derived Thymocyte-Activating Factor	4180186
19474688	Lymphocyte-Activating Factor	4180186
19474688	Interleukin 1	4180186
19474688	Interleukin I	4180186
19474688	Epidermal Cell Derived Thymocyte Activating Factor	4180186
19474688	Lymphocyte Activating Factor	4180186
19474688	IL-1	4180186
19474691	Intermediate Care Facility	4180186
19474691	Care Facility, Intermediate	4180186
19474691	Care Facilities, Intermediate	4180186
19474691	Facility, Intermediate Care	4180186
19474691	Facilities, Intermediate Care	4180186
19474702	2,3 Dioxoindoline	4180186
19474702	1H-Indole-2,3-dione	4180186
19474702	2,3-Dioxoindoline	4180186
19474705	Kainate	4180186
19474705	Acid, Digenic	4180186
19474705	Digenic Acid	4180186
19474705	3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S-(2alpha,3beta,4beta))-	4180186
19474705	Acid, Kainic	4180186
19474707	alpha-Ketoglutaric Acid, Monopotassium Salt	4180186
19474707	alpha Ketoglutaric Acid, Sodium Salt	4180186
19474707	2 Oxoglutarate	4180186
19474707	alpha-Ketoglutarate, Calcium	4180186
19474707	2-Oxoglutarate	4180186
19474707	alpha Ketoglutaric Acid, Diammonium Salt	4180186
19474707	Oxoglutarates	4180186
19474707	alpha-Ketoglutaric Acid, Monosodium Salt	4180186
19474707	alpha-Ketoglutaric Acid, Dipotassium Salt	4180186
19474707	alpha Ketoglutaric Acid, Monopotassium Salt	4180186
19474707	alpha Ketoglutaric Acid, Disodium Salt	4180186
19474707	2-Ketoglutaric Acid	4180186
19474707	alpha Ketoglutaric Acid, Potassium Salt	4180186
19474707	Calcium alpha Ketoglutarate	4180186
19474707	2-Ketoglutarate	4180186
19474707	alpha Oxoglutarate	4180186
19474707	Ketoglutaric Acid	4180186
19474707	alpha-Ketoglutaric Acid, Potassium Salt	4180186
19474707	Calcium alpha-Ketoglutarate	4180186
19474707	alpha-Ketoglutaric Acid, Diammonium Salt	4180186
19474707	alpha-Ketoglutaric Acid, Disodium Salt	4180186
19474707	alpha-Ketoglutaric Acid, Calcium Salt (2:1)	4180186
19474707	alpha-Ketoglutaric Acid	4180186
19474707	2 Ketoglutarate	4180186
19474707	Oxogluric Acid	4180186
19474707	2 Oxoglutaric Acid	4180186
19474707	alpha Ketoglutaric Acid, Monosodium Salt	4180186
19474707	2-Oxoglutaric Acid	4180186
19474707	2 Ketoglutaric Acid	4180186
19474707	alpha-Ketoglutarate	4180186
19474707	alpha Ketoglutarate	4180186
19474707	alpha-Oxoglutarate	4180186
19474707	alpha Ketoglutaric Acid, Dipotassium Salt	4180186
19474707	alpha-Ketoglutaric Acid, Sodium Salt	4180186
19474707	Calcium Ketoglutarate	4180186
19474707	alpha Ketoglutaric Acid	4180186
19474710	Kynurenate	4180186
19474710	Acid, Kynurenic	4180186
19474710	2-Quinolinecarboxylic acid, 4-hydroxy-	4180186
19474712	Laboratory, Dental	4180186
19474712	Dental Laboratories	4180186
19474712	Dental Laboratory	4180186
19474713	Laboratory, Hospital	4180186
19474713	Hospital Laboratories	4180186
19474713	Hospital Laboratory	4180186
19474721	Migration Inhibition Factors, Leukocyte	4180186
19474721	Factors, Leukocyte Migration-Inhibition	4180186
19474721	Migration Inhibitory Factors, Leukocyte	4180186
19474721	Migration-Inhibition Factors, Leukocyte	4180186
19474721	Leukocyte Migration Inhibitory Factors	4180186
19474721	Leukocyte Migration-Inhibition Factors	4180186
19474721	Factors, Leukocyte Migration-Inhibitory	4180186
19474721	Migration-Inhibitory Factors, Leukocyte	4180186
19474721	Leukocyte Migration Inhibition Factors	4180186
19474726	Library, Nursing	4180186
19474726	Nursing Library	4180186
19474726	Nursing Libraries	4180186
19474733	Sign, Location	4180186
19474733	Location Directories	4180186
19474733	Directories, Location	4180186
19474733	Signs and Location Directories	4180186
19474733	Location Sign	4180186
19474733	Location Signs	4180186
19474733	Directory, Location	4180186
19474733	Signs, Location	4180186
19474733	Location Directory	4180186
19474737	1,4-Phthalazinedione, 5-amino-2,3-dihydro-	4180186
19474738	Luteolytic Effect	4180186
19474738	Effects, Luteolytic	4180186
19474738	Agents, Luteolytic	4180186
19474738	Effect, Luteolytic	4180186
19474738	Luteolytic Effects	4180186
19474738	Agent, Luteolytic	4180186
19474738	Luteolytic Agent	4180186
19474739	Mediators, Lymphocyte	4180186
19474739	Lymphocyte Mediators	4180186
19474740	alpha-Lymphotoxin	4180186
19474740	alpha Lymphotoxin	4180186
19474740	Soluble Lymphotoxin-alpha	4180186
19474740	TNF Superfamily, Member 1	4180186
19474740	Lymphotoxin alpha3	4180186
19474740	Tumor Necrosis Factor-beta	4180186
19474740	Tumor Necrosis Factor Ligand Superfamily Member 1	4180186
19474740	Lymphotoxin	4180186
19474740	Soluble Lymphotoxin alpha	4180186
19474740	Tumor Necrosis Factor beta	4180186
19474740	Lymphotoxin-alpha, Soluble	4180186
19474740	Lymphotoxin alpha	4180186
19474740	TNF-beta	4180186
19474740	Lymphotoxin-alpha3	4180186
19474743	Migration Inhibition Factors, Macrophage	4180186
19474743	Macrophage Migration Inhibition Factors	4180186
19474743	Migration Inhibition Factor, Macrophage	4180186
19474743	Macrophage Migration Inhibitory Factor	4180186
19474743	Migration-Inhibitory Factors, Macrophage	4180186
19474743	Macrophage Migration Inhibitory Factors	4180186
19474745	Experimental Mammary Neoplasms	4180186
19474745	Neoplasm, Experimental Mammary	4180186
19474745	Mammary Neoplasm, Experimental	4180186
19474745	Experimental Mammary Neoplasm	4180186
19474745	Neoplasms, Experimental Mammary	4180186
19474747	Mannan	4180186
19474748	Mannich Base	4180186
19474748	Bases, Mannich	4180186
19474748	Base, Mannich	4180186
19474749	D-Mannitol, 1,6-bis((2-chloroethyl)amino)-1,6-dideoxy-	4180186
19474749	Decranol	4180186
19474749	Mannitol Nitrogen Mustard	4180186
19474749	Mannitol Mustard	4180186
19474749	Mustard, Mannitol Nitrogen	4180186
19474749	Mannitlost	4180186
19474749	Nitrogen Mustard, Mannitol	4180186
19474749	Mustard, Mannitol	4180186
19474749	Degranol	4180186
19474751	Media, Broadcast	4180186
19474751	Broadcast Media	4180186
19474751	Media, Printed	4180186
19474751	Media, Folk	4180186
19474751	Printed Media	4180186
19474751	Media, Mass	4180186
19474751	Folk Media	4180186
19474752	Storerooms	4180186
19474752	Material Management, Hospital	4180186
19474752	Hospital Material Management	4180186
19474752	Hospital Material Managements	4180186
19474752	Managements, Hospital Material	4180186
19474752	Management, Hospital Material	4180186
19474752	Management, Hospital Materials	4180186
19474752	Storeroom	4180186
19474752	Hospital Materials Management	4180186
19474752	Material Managements, Hospital	4180186
19474753	Computings, Mathematical	4180186
19474753	Statistical Computing	4180186
19474753	Statistical Computings	4180186
19474753	Mathematic Computing	4180186
19474753	Computing, Mathematic	4180186
19474753	Computings, Statistical	4180186
19474753	Statistical Programs, Computer Based	4180186
19474753	Computing, Mathematical	4180186
19474753	Mathematic Computings	4180186
19474753	Mathematical Computings	4180186
19474753	Computing, Statistical	4180186
19474753	Computings, Mathematic	4180186
19474754	Ravtansine	4180186
19474754	Soravtansine	4180186
19474754	Mertansine	4180186
19474754	DMMO Maytansine	4180186
19474754	DMMO-Maytansine	4180186
19474754	Emtansine	4180186
19474754	N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine	4180186
19474754	Maytansinoid DM1	4180186
19474754	Maytansinoid DM4	4180186
19474754	Maitansine	4180186
19474754	DM1, Maytansinoid	4180186
19474754	DM4, Maytansinoid	4180186
19474755	McN A343	4180186
19474755	McNA343	4180186
19474755	A 343, McNeil	4180186
19474755	McN-A343	4180186
19474755	McN A 343	4180186
19474755	McNeil A 343	4180186
19474755	McN-A-343	4180186
19474755	McN A-343	4180186
19474755	2-Butyn-1-aminium, 4-((((3-chlorophenyl)amino)carbonyl)oxy)-N,N,N-trimethyl-, chloride	4180186
19474756	Medical Transcriptions	4180186
19474756	Health Diary	4180186
19474756	Transcriptions, Medical	4180186
19474756	Transcription, Medical	4180186
19474756	Diary, Health	4180186
19474756	Records, Medical	4180186
19474756	Diaries, Health	4180186
19474756	Medical Record	4180186
19474756	Health Diaries	4180186
19474756	Record, Medical	4180186
19474756	Medical Transcription	4180186
19474757	Areas, Medically Underserved	4180186
19474757	Population, Medically Underserved	4180186
19474757	Medically Underserved Population	4180186
19474757	Physician Shortage Area	4180186
19474757	Underserved Populations, Medically	4180186
19474757	Underserved Population, Medically	4180186
19474757	Medically Underserved Populations	4180186
19474757	Shortage Area, Physician	4180186
19474757	National Health Service Corps	4180186
19474757	Health Service Corps, National	4180186
19474757	Medically Underserved Areas	4180186
19474757	Underserved Areas, Medically	4180186
19474757	Underserved Area, Medically	4180186
19474757	Physician Shortage Areas	4180186
19474757	Populations, Medically Underserved	4180186
19474757	Area, Medically Underserved	4180186
19474757	Areas, Physician Shortage	4180186
19474757	Shortage Areas, Physician	4180186
19474757	Area, Physician Shortage	4180186
19474758	Medication System	4180186
19474758	System, Medication	4180186
19474758	Unit Dose Drug Distribution Systems	4180186
19474758	Systems, Medication	4180186
19474759	PMS-Mefenamic Acid	4180186
19474759	Ponmel	4180186
19474759	Pontal	4180186
19474759	Benzoic acid, 2-((2,3-dimethylphenyl)amino)-	4180186
19474759	Mefenaminic Acid	4180186
19474759	Coslan	4180186
19474759	Mefac	4180186
19474759	PMS Mefenamic Acid	4180186
19474759	Apo-Mefenamic	4180186
19474759	Contraflam	4180186
19474759	Pinalgesic	4180186
19474759	Nu Mefenamic	4180186
19474759	Mefacit	4180186
19474759	Parkemed	4180186
19474759	Ponsyl	4180186
19474759	Dysman	4180186
19474759	Acid, Mefenamic	4180186
19474759	Ponstan	4180186
19474759	Nu-Mefenamic	4180186
19474759	Ponstan Forte	4180186
19474759	Mefic	4180186
19474759	Ponstel	4180186
19474759	Ponalgic	4180186
19474759	Ponalar	4180186
19474759	Apo Mefenamic	4180186
19474766	Hydrazinecarbothioamide, 2-(1,2-dihydro-1-methyl-2-oxo-3H-indol-3-ylidene)-	4180186
19474766	Metisazone	4180186
19474766	Marboran	4180186
19474767	Altosid	4180186
19474767	Altosid PS-10	4180186
19474767	ZR 515	4180186
19474767	Altosid PS 10	4180186
19474767	ZR-515	4180186
19474767	Altosid PS10	4180186
19474767	2,4-Dodecadienoic acid, 11-methoxy-3,7,11-trimethyl-, 1-methylethyl ester, (E,E)-	4180186
19474767	ZR515	4180186
19474768	Green, Methyl	4180186
19474768	Green, Light	4180186
19474768	Light Green	4180186
19474768	Benzenaminium, 4-((4-(dimethylamino)phenyl)(4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene)methyl)-N,N,N-trimethyl-, dichloride	4180186
19474769	Dimethylsulfonate	4180186
19474769	Methanesulfonic acid, methyl ester	4180186
19474769	Methyl Mesylate	4180186
19474769	Mesilate, Methyl	4180186
19474769	Methyl Methylenesulfonate	4180186
19474769	Methanesulfonate, Methyl	4180186
19474769	Methyl Mesilate	4180186
19474769	Methylmethane Sulfonate	4180186
19474769	Mesylate, Methyl	4180186
19474769	Methylmesilate	4180186
19474771	Methosulfate, Methylphenazonium	4180186
19474771	Phenazine Methosulfate	4180186
19474771	Phenazinium, 5-methyl-, methyl sulfate	4180186
19474771	5 Methylphenazinium Methyl Sulfate	4180186
19474771	Methosulfate, Phenazine	4180186
19474771	Methyl Sulfate, 5-Methylphenazinium	4180186
19474771	5-Methylphenazinium Methyl Sulfate	4180186
19474771	Sulfate, 5-Methylphenazinium Methyl	4180186
19474773	Microform	4180186
19474773	Microfilmings	4180186
19474774	Microtubule-Associated Protein 3	4180186
19474774	Microtubule Associated Protein 7	4180186
19474774	Microtubule-Associated Protein, MAP2	4180186
19474774	Epithelial Microtubule Associate Protein, 115 kDa	4180186
19474774	E-MAP-115	4180186
19474774	Microtubule-Associated Protein 7	4180186
19474774	E MAP 115	4180186
19474774	MAP3 Microtubule-Associated Protein	4180186
19474774	Microtubule-Associated Protein, MAP3	4180186
19474774	Microtubule-Associated Protein 2	4180186
19474774	Microtubule-Associated Protein, MAP1	4180186
19474774	MAP2 Microtubule-Associated Protein	4180186
19474774	MAP1 Microtubule-Associated Protein	4180186
19474774	Microtubule Associated Protein	4180186
19474774	MAP4	4180186
19474774	7, Microtubule-Associated Protein	4180186
19474774	Protein 7, Microtubule-Associated	4180186
19474774	Microtubule Associated Protein 1	4180186
19474774	Epithelial MAP, 115 kDa	4180186
19474774	Epithelial Microtubule-Associate Protein, 115 kDa	4180186
19474774	MAP2 Microtubule Associated Protein	4180186
19474774	Microtubule-Associated Protein	4180186
19474774	MAP1 Microtubule Associated Protein	4180186
19474774	Microtubule Associated Protein 3	4180186
19474774	MAP3 Microtubule Associated Protein	4180186
19474774	Associated Protein, Microtubule	4180186
19474774	Microtubule Associated Protein 4	4180186
19474774	Microtubule-Associated Protein 1	4180186
19474774	Microtubule Associated Protein 2	4180186
19474774	Microtubule Associated Proteins	4180186
19474774	Ensconsin	4180186
19474774	Protein, Microtubule Associated	4180186
19474774	Protein, Microtubule-Associated	4180186
19474776	Miotic Effect	4180186
19474776	Effects, Miotic	4180186
19474776	Miotic Effects	4180186
19474776	Effect, Miotic	4180186
19474777	Ro 07-0582	4180186
19474777	Ro 07 0582	4180186
19474777	alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol	4180186
19474777	1H-Imidazole-1-ethanol, alpha-(methoxymethyl)-2-nitro-	4180186
19474777	Ro 70582	4180186
19474777	Ro 7-0582	4180186
19474777	Ro 7 0582	4180186
19474777	Ro 070582	4180186
19474778	Mitochondrial Contractions	4180186
19474778	Mitochondrion	4180186
19474778	Contraction, Mitochondrial	4180186
19474778	Mitochondrial Contraction	4180186
19474778	Contractions, Mitochondrial	4180186
19474779	Phytomitogens	4180186
19474779	Mitogen	4180186
19474779	Phytomitogen	4180186
19474784	Model, Anatomic	4180186
19474784	Surgical Model	4180186
19474784	Anatomical Model	4180186
19474784	Moulage	4180186
19474784	Models, Surgical	4180186
19474784	Anatomic Model	4180186
19474784	Surgical Models	4180186
19474784	Model, Anatomical	4180186
19474784	Models, Anatomical	4180186
19474784	Model, Surgical	4180186
19474784	Anatomic Models	4180186
19474784	Moulages	4180186
19474784	Anatomical Models	4180186
19474786	Monocyclic beta-Lactam	4180186
19474786	beta-Lactams, Monocyclic	4180186
19474786	Monobactam Antibiotics	4180186
19474786	beta-Lactam, Monocyclic	4180186
19474786	beta Lactams, Monocyclic	4180186
19474786	Monocyclic beta-Lactams	4180186
19474786	Monocyclic beta Lactam	4180186
19474786	Antibiotics, Monobactam	4180186
19474786	Monocyclic beta Lactams	4180186
19474786	Monobactam	4180186
19474787	Methylhydrazine	4180186
19474787	Hydrazine, methyl-	4180186
19474788	RA-233	4180186
19474788	Ethanol, 2,2',2'',2'''-((4-(1-piperidinyl)pyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-	4180186
19474788	Rapenton	4180186
19474789	Morphines	4180186
19474793	Hormone, Melanocyte Stimulating	4180186
19474793	Hormone, Melanocyte-Stimulating	4180186
19474793	Melanophore Stimulating Hormone	4180186
19474793	Hormone, Melanophore Stimulating	4180186
19474793	Melanocyte Stimulating Hormone	4180186
19474793	MSH (Melanocyte-Stimulating Hormones)	4180186
19474793	Melanocyte-Stimulating Hormone	4180186
19474793	Stimulating Hormone, Melanocyte	4180186
19474793	Melanocyte Stimulating Hormones	4180186
19474793	Stimulating Hormone, Melanophore	4180186
19474793	Melanotropin	4180186
19474793	Melanophore-Stimulating Hormone	4180186
19474793	MSH	4180186
19474797	Compounds, Mustard	4180186
19474798	Bay G 2821	4180186
19474798	G 2821, Bay	4180186
19474798	3H-Pyrazol-3-one, 5-amino-2-(1-(3,4-dichlorophenyl)ethyl)-2,4-dihydro-	4180186
19474800	Mydriatic Effects	4180186
19474800	Effect, Mydriatic	4180186
19474800	Mydriatic	4180186
19474800	Cycloplegic	4180186
19474800	Effects, Mydriatic	4180186
19474800	Cycloplegics	4180186
19474800	Mydriatic Effect	4180186
19474801	CH-13437	4180186
19474801	Melipan	4180186
19474801	SU-13,437	4180186
19474801	SU13,437	4180186
19474801	Propanoic acid, 2-methyl-2-(4-(1,2,3,4-tetrahydro-1-naphthalenyl)phenoxy)-	4180186
19474801	Acid, Nafenoic	4180186
19474801	SU 13,437	4180186
19474801	Nafenoic Acid	4180186
19474801	CH 13437	4180186
19474801	CH13437	4180186
19474804	Nalorphine, (14 alpha)-Isomer	4180186
19474804	Nalorphine Hydrobromide	4180186
19474804	Hydrochloride, Nalorphine	4180186
19474804	Lethidrone	4180186
19474804	Allylnormorphine	4180186
19474804	Nalorphine, L-tartrate (1:1)	4180186
19474804	Hydrobromide, Nalorphine	4180186
19474804	Nalorphine Hydrochloride	4180186
19474804	Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-, (5alpha,6alpha)-	4180186
19474806	Analgesics, Narcotic	4180186
19474806	Narcotic Analgesics	4180186
19474806	Narcotic Effects	4180186
19474806	Effects, Narcotic	4180186
19474806	Narcotic	4180186
19474806	Effect, Narcotic	4180186
19474806	Narcotic Effect	4180186
19474807	Chloronitrobenzoxadiazole	4180186
19474807	NBD Chloride	4180186
19474807	NBF Cl	4180186
19474807	NBF-Cl	4180186
19474807	Chloride, Nitrobenzoxadiazole	4180186
19474807	7-Chloro-4-nitrobenzofurazan	4180186
19474807	Benzofurazan, 4-chloro-7-nitro-	4180186
19474807	4 Chloro 7 nitrobenzofurazan	4180186
19474807	7 Chloro 4 nitrobenzofurazan	4180186
19474807	Nitrobenzoxadiazole Chloride	4180186
19474807	Chloride, NBD	4180186
19474808	Neocarzinostatin	4180186
19474810	Netropsin Hydrochloride	4180186
19474810	Sinanomycin	4180186
19474810	IA-887	4180186
19474810	T-1384	4180186
19474810	1H-Pyrrole-2-carboxamide, 4-((((aminoiminomethyl)amino)acetyl)amino)-N-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-1-methyl-	4180186
19474810	Congocidine	4180186
19474810	Hydrochloride, Netropsin	4180186
19474811	Effects, Neuromuscular	4180186
19474811	Skeletal Muscle Relaxants	4180186
19474811	Relaxants, Skeletal Muscle	4180186
19474811	Muscle Relaxants, Skeletal	4180186
19474811	Agents, Neuromuscular	4180186
19474811	Effect, Neuromuscular	4180186
19474811	Neuromuscular Effect	4180186
19474811	Neuromuscular Effects	4180186
19474812	Nuclear Fast Red (Basic Dye)	4180186
19474812	Toluylene Red	4180186
19474812	C.I. Basic Red 5	4180186
19474812	2,8-Phenazinediamine, N8,N8,3-trimethyl-, monohydrochloride	4180186
19474812	Red, Neutral	4180186
19474812	Red, Toluylene	4180186
19474813	Topics, Newspapers as	4180186
19474813	Newspapers as Topics	4180186
19474814	Niceritrol Tetrahydrochloride	4180186
19474814	Perycit	4180186
19474814	Tetrahydrochloride, Niceritrol	4180186
19474814	Pentaerythritoltetranicotinate	4180186
19474814	Pentaerythritol Tetranicotinate	4180186
19474814	3-Pyridinecarboxylic acid, 2,2-bis(((3-pyridinylcarbonyl)oxy)methyl)-1,3-propanediyl ester	4180186
19474814	Tetranicotinate, Pentaerythritol	4180186
19474815	Niclofan	4180186
19474815	Bayer 3625	4180186
19474815	Bilevon R	4180186
19474815	Bilevon M	4180186
19474815	Menichlopholan	4180186
19474815	Bayer 9015	4180186
19474815	Distolone	4180186
19474815	Dertil	4180186
19474815	Distolon	4180186
19474815	(1,1'-Biphenyl)-2,2'-diol, 5,5'-dichloro-3,3'-dinitro-	4180186
19474816	Acids, Nicotinic	4180186
19474819	BA, CIBA 32.644	4180186
19474819	CIBA 32.644 BA	4180186
19474819	Ambilar	4180186
19474819	2-Imidazolidinone, 1-(5-nitro-2-thiazolyl)-	4180186
19474819	Ambilhar	4180186
19474821	C-283	4180186
19474821	C 283	4180186
19474821	Ledakrin	4180186
19474821	1,3-Propanediamine, N,N-dimethyl-N'-(1-nitro-9-acridinyl)-	4180186
19474821	C283	4180186
19474822	Nitrile	4180186
19474824	Nitrite	4180186
19474827	Mustard Compounds, Nitrogen	4180186
19474827	Compounds, Nitrogen Mustard	4180186
19474828	Hydroxyiodonitrophenylacetate	4180186
19474828	NIP Acetyl Hapten	4180186
19474828	Benzeneacetic acid, 4-hydroxy-3-iodo-5-nitro-	4180186
19474828	NIP Hapten	4180186
19474828	(4-Hydroxy-5-iodo-3-nitrophenyl)acetyl	4180186
19474828	Acetyl Hapten, NIP	4180186
19474828	5-Iodo-4-hydroxy-3-nitrophenacetyl	4180186
19474828	(4-Hydroxy-3-iodo-5-nitrophenyl)acetyl	4180186
19474828	Hapten, NIP Acetyl	4180186
19474828	5 Iodo 4 hydroxy 3 nitrophenacetyl	4180186
19474828	NIP-Hapten	4180186
19474829	Nitroimidazole	4180186
19474830	CI 628	4180186
19474830	CI-628	4180186
19474830	Nitromifene, (E)-Isomer	4180186
19474830	Nitromiphene	4180186
19474830	CN-55,945-27	4180186
19474830	Nitromifene Citrate (1:1)	4180186
19474830	Pyrrolidine, 1-(2-(4-(1-(4-methoxyphenyl)-2-nitro-2-phenylethenyl)phenoxy)ethyl)-	4180186
19474830	Nitromifene, (Z)-Isomer	4180186
19474830	Nitromifene Citrate	4180186
19474830	CN-55945-27	4180186
19474830	CI628	4180186
19474831	Hydrazinecarboximidamide, 2-(3-(5-nitro-2-furanyl)-1-(2-(5-nitro-2-furanyl)ethenyl)-2-propenylidene)-	4180186
19474832	Benzonitrile, 4-hydroxy-3-iodo-5-nitro-	4180186
19474832	Nitroxynil	4180186
19474833	10H-Phenothiazine, 2-chloro-10-(3-(hexahydropyrrolo(1,2-a)pyrazin-2(1H)-yl)-1-oxopropyl)-, dihydrochloride	4180186
19474833	Nonachlazin	4180186
19474833	Nonakhlazin	4180186
19474833	Azaclorzine	4180186
19474836	Warfare, Nuclear	4180186
19474836	Warfare, Atomic	4180186
19474836	Atomic Warfare	4180186
19474837	Nucleoside	4180186
19474837	Nucleoside Analog	4180186
19474837	Nucleoside Analogs	4180186
19474837	Analog, Nucleoside	4180186
19474837	Analogs, Nucleoside	4180186
19474843	Dermalon	4180186
19474843	Supramids	4180186
19474843	Polyamide	4180186
19474843	Nylon	4180186
19474843	Supramid	4180186
19474843	Ethilon	4180186
19474843	Ethilons	4180186
19474843	Dermalons	4180186
19474843	Polyamides	4180186
19474844	Oligomycin	4180186
19474846	System, Online	4180186
19474846	System, On-Line	4180186
19474846	On-Line System	4180186
19474846	On Line Systems	4180186
19474846	Systems, On-Line	4180186
19474846	On-Line Systems	4180186
19474846	Systems, Online	4180186
19474846	Online System	4180186
19474847	Information Systems, Operating Room	4180186
19474850	Drugs, Orphan	4180186
19474850	Production, Orphan Drug	4180186
19474850	Orphan Drug	4180186
19474850	Drug, Orphan	4180186
19474850	Orphan Drugs	4180186
19474850	Drug Production, Orphan	4180186
19474852	Hospital Outpatient Clinics	4180186
19474852	Outpatient Clinic, Hospital	4180186
19474852	Clinics, Hospital Outpatient	4180186
19474852	Hospital Outpatient Clinic	4180186
19474852	Clinic, Hospital Outpatient	4180186
19474852	Ambulatory Care Facilities, Hospital	4180186
19474857	1H-Pyrazolo(3,4-d)pyrimidine-4,6(5H,7H)-dione	4180186
19474857	Alloxanthine	4180186
19474857	Oxipurinol	4180186
19474859	Stimulant, Uterine	4180186
19474859	Agent, Oxytocic	4180186
19474859	Uterine Stimulant	4180186
19474859	Oxytocic Drug	4180186
19474859	Oxytocic	4180186
19474859	Uterine Stimulants	4180186
19474859	Drug, Oxytocic	4180186
19474859	Stimulants, Uterine	4180186
19474859	Effects, Oxytocic	4180186
19474859	Oxytocic Agent	4180186
19474859	Oxytocic Effect	4180186
19474859	Oxytocic Effects	4180186
19474859	Oxytocic Drugs	4180186
19474859	Oxytocic Agents	4180186
19474859	Effect, Oxytocic	4180186
19474859	Agents, Oxytocic	4180186
19474859	Drugs, Oxytocic	4180186
19474860	4-(Phenyldiazenyl)aniline	4180186
19474860	p Aminoazobenzene	4180186
19474860	para-Aminoazobenzene	4180186
19474860	Aniline Yellow	4180186
19474860	C.I. Solvent Yellow 1	4180186
19474860	Benzenamine, 4-(phenylazo)-	4180186
19474860	para Aminoazobenzene	4180186
19474861	para-Azobenzenearsonate	4180186
19474861	p Azobenzenearsonate	4180186
19474861	Arsonic acid, (azodi-4,1-phenylene)bis-	4180186
19474861	Azophenylarsonate	4180186
19474861	para Azobenzenearsonate	4180186
19474862	LY121860	4180186
19474862	para Chloroamphetamine	4180186
19474862	p-Chloramphetamine	4180186
19474862	LY-121860	4180186
19474862	Ly 123362	4180186
19474862	Benzeneethanamine, 4-chloro-alpha-methyl-	4180186
19474862	Parachloroamphetamine	4180186
19474862	p Chloroamphetamine	4180186
19474862	p Chloramphetamine	4180186
19474862	para-Chloroamphetamine	4180186
19474862	LY 121860	4180186
19474862	Ly123362	4180186
19474862	Ly-123362	4180186
19474866	Extract, Pancreatic	4180186
19474866	Tissue Extracts, Pancreatic	4180186
19474866	Extracts, Pancreatic Tissue	4180186
19474866	Pancreatic Tissue Extracts	4180186
19474866	Extracts, Pancreatic	4180186
19474866	Pancreatic Tissue Extract	4180186
19474866	Extract, Pancreatic Tissue	4180186
19474866	Tissue Extract, Pancreatic	4180186
19474866	Pancreatic Extract	4180186
19474867	Hormones, Pancreatic	4180186
19474868	Pancreatic Polypeptide (PP)	4180186
19474868	Pancreatic Prohormone	4180186
19474868	Pancreatic Polypeptide Hormone	4180186
19474869	Paraben	4180186
19474869	para-Hydroxybenzoic Acids	4180186
19474869	para Hydroxybenzoic Acids	4180186
19474869	4 Hydroxybenzoic Acids	4180186
19474869	4-Hydroxybenzoic Acids	4180186
19474870	Paraprotein	4180186
19474872	Parasympathomimetic Effects	4180186
19474872	Parasympathomimetic Effect	4180186
19474872	Parasympathomimetic Agents	4180186
19474872	Drugs, Parasympathomimetic	4180186
19474872	Parasympathomimetic Drugs	4180186
19474872	Effects, Parasympathomimetic	4180186
19474872	Effect, Parasympathomimetic	4180186
19474872	Agents, Parasympathomimetic	4180186
19474873	Semi-Private Rooms	4180186
19474873	Room, Semi-Private	4180186
19474873	Rooms, Patient	4180186
19474873	Room, Private	4180186
19474873	Rooms, Semi-Private	4180186
19474873	Patient's Rooms	4180186
19474873	Private Room	4180186
19474873	General Ward	4180186
19474873	Patient Rooms	4180186
19474873	Patient Room	4180186
19474873	Private Rooms	4180186
19474873	General Wards	4180186
19474873	Wards, General	4180186
19474873	Semi Private Rooms	4180186
19474873	Semi-Private Room	4180186
19474873	Rooms, Private	4180186
19474873	Patients' Room	4180186
19474873	Room, Patient	4180186
19474873	Patients Rooms	4180186
19474873	Ward, General	4180186
19474873	Room, Patients'	4180186
19474873	Rooms, Patients'	4180186
19474875	Piperidine, 1,2,2,6,6-pentamethyl-	4180186
19474877	2,5-Hexadienoic acid, 3-methoxy-5-methyl-4-oxo-	4180186
19474877	Acid, Penicillic	4180186
19474881	Perchloric Acid Derivatives	4180186
19474881	Perchloric Acids	4180186
19474881	Acids, Perchloric	4180186
19474882	Periodic acid (H5IO6)	4180186
19474882	Paraperiodic Acid	4180186
19474882	Acid, Paraperiodic	4180186
19474882	Periodic Acid (HIO4)	4180186
19474882	Periodic Acids	4180186
19474882	Acid, Periodic	4180186
19474882	Acids, Periodic	4180186
19474883	Newsletter	4180186
19474883	Magazine	4180186
19474883	Magazines	4180186
19474883	Journals as Topic	4180186
19474883	Newsletters	4180186
19474885	Perilene	4180186
19474885	Peri Dinaphthalene	4180186
19474885	Peri-Dinaphthalene	4180186
19474889	GP121	4180186
19474889	Sernyl	4180186
19474889	Serylan	4180186
19474889	CL-395	4180186
19474889	CL395	4180186
19474889	GP-121	4180186
19474889	Piperidine, 1-(1-phenylcyclohexyl)-	4180186
19474889	GP 121	4180186
19474889	Phencyclidine Hydrobromide	4180186
19474889	Angel Dust	4180186
19474889	CL 395	4180186
19474889	Dust, Angel	4180186
19474889	Phencyclidine Hydrochloride	4180186
19474889	1-(1-Phenylcyclohexyl)piperidine	4180186
19474897	Benzenemethanesulfonyl fluoride	4180186
19474897	Benzenemethanesulfonyl Fluoride	4180186
19474897	Fluoride, Benzenemethanesulfonyl	4180186
19474897	Phenylmethanesulfonyl Fluoride	4180186
19474897	Fluoride, Phenylmethanesulfonyl	4180186
19474897	Fluoride, Phenylmethylsulfonyl	4180186
19474899	Eosin B	4180186
19474899	Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3',6'-dihydroxy-, disodium salt	4180186
19474899	Eosine I Bluish, Dipotassium Salt	4180186
19474899	D & C Red No. 27	4180186
19474899	Phloxin B	4180186
19474899	Bluish, Eosine I	4180186
19474899	D.C. Red No. 27	4180186
19474899	Eosine B	4180186
19474899	Phloxine B	4180186
19474899	Bluish, Eosine	4180186
19474899	Eosine Bluish	4180186
19474901	Phosphoglycerides, Choline	4180186
19474901	Phosphatidyl Cholines	4180186
19474901	Choline, Phosphatidyl	4180186
19474901	Phosphatidyl Choline	4180186
19474901	Cholines, Phosphatidyl	4180186
19474901	Choline Glycerophospholipids	4180186
19474901	Phosphatidylcholine	4180186
19474901	Glycerophospholipids, Choline	4180186
19474901	Choline Phosphoglycerides	4180186
19474904	Mustards, Phosphoramide	4180186
19474905	Acid, Phosphotungstic	4180186
19474905	Tungsten hydroxide oxide phosphate	4180186
19474906	Anhydrides, Phthalic	4180186
19474908	Physicians Offices	4180186
19474908	Physicians' Office	4180186
19474908	Physicians Office	4180186
19474908	Physician's Offices	4180186
19474908	Office, Physicians'	4180186
19474908	Physician Offices	4180186
19474908	Physician's Office	4180186
19474908	Physician Office	4180186
19474908	Offices, Physicians'	4180186
19474908	Office, Physician's	4180186
19474908	Offices, Physician's	4180186
19474910	Streptococcal OK-432	4180186
19474910	Streptococcal OK432	4180186
19474910	Picibanyl	4180186
19474910	Streptococcal Preparation OK 432	4180186
19474910	NSC-B116209	4180186
19474910	OK432	4180186
19474910	OK-432	4180186
19474910	Streptococcal OK 432	4180186
19474910	Streptococcal Preparation OK432	4180186
19474910	NSCB116209	4180186
19474910	Streptococcal Preparation OK-432	4180186
19474910	OK 432	4180186
19474910	NSC B116209	4180186
19474911	Pyrido(2,3-d)pyrimidine-6-carboxylic acid, 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)-	4180186
19474911	Piperamic Acid	4180186
19474911	Deblaston	4180186
19474911	Pipram	4180186
19474911	Palin	4180186
19474911	Urisan	4180186
19474911	Galusan	4180186
19474911	Acid, Piperamic	4180186
19474911	Acid, Pipemidic	4180186
19474911	Nuril	4180186
19474911	Uropipemid	4180186
19474912	Forneau 933	4180186
19474912	Benodain	4180186
19474912	Benodaine	4180186
19474912	Piperoxane	4180186
19474912	Piperidine, 1-((2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-	4180186
19474914	Pituitary Hormone-Release Inhibiting Hormones	4180186
19474914	Gonadostatin	4180186
19474915	Hormone, Hypothalamic Hypophysiotropic	4180186
19474915	Hypothalamic Releasing Hormone	4180186
19474915	Pituitary Hormone Releasing Hormones	4180186
19474915	Hypophysiotropic Hormones	4180186
19474915	Hypothalamic Releasing Hormones	4180186
19474915	Hypothalamic Releasing Factor	4180186
19474915	Hypophysiotropic Hormone, Hypothalamic	4180186
19474915	Hormones, Pituitary Hormone Releasing	4180186
19474915	Hormones, Hypophysiotropic	4180186
19474915	Hypothalamic Hypophysiotropic Hormone	4180186
19474915	Releasing Hormone, Hypothalamic	4180186
19474916	Hormones, Pituitary	4180186
19474917	Hormones, Adenohypophyseal	4180186
19474917	Adenohypophyseal Hormones	4180186
19474917	Anterior Pituitary Hormones	4180186
19474917	Hormones, Anterior Pituitary	4180186
19474918	Hormones, Placental	4180186
19474919	Medicines, Herbal	4180186
19474919	Herbal Medicines	4180186
19474919	Extracts, Plant	4180186
19474919	Extract, Plant	4180186
19474919	Plant Extract	4180186
19474920	Growth Regulators, Plant	4180186
19474920	Phytohormones	4180186
19474920	Plant Hormones	4180186
19474920	Regulator, Plant Growth	4180186
19474920	Plant Hormone	4180186
19474920	Growth Regulator, Plant	4180186
19474920	Phytohormone	4180186
19474920	Plant Growth Regulator	4180186
19474920	Regulators, Plant Growth	4180186
19474920	Hormones, Plant	4180186
19474920	Hormone, Plant	4180186
19474921	Blood Plasma	4180186
19474921	Frozen Plasma, Fresh	4180186
19474921	Plasma, Blood	4180186
19474921	Plasmas, Fresh Frozen	4180186
19474921	Frozen Plasmas, Fresh	4180186
19474921	Blood Plasmas	4180186
19474921	Fresh Frozen Plasmas	4180186
19474921	Fresh Frozen Plasma	4180186
19474921	Plasma, Fresh Frozen	4180186
19474921	Plasmas, Blood	4180186
19474921	Plasmas	4180186
19474922	Plasminogen Activator	4180186
19474922	Uterine Tissue Plasminogen Activator	4180186
19474922	Extrinsic Plasminogen Activators	4180186
19474922	Uterine-Tissue Plasminogen Activator	4180186
19474923	Blood platelet factor 4	4180186
19474923	Chemokine, CXCL4	4180186
19474923	PF4 (Platelet Factor 4)	4180186
19474923	Heparin Neutralizing Protein	4180186
19474923	Antiheparin Factor	4180186
19474923	CXCL4, Chemokine	4180186
19474923	gamma Thromboglobulin	4180186
19474923	CXCL4 Chemokine	4180186
19474923	gamma-Thromboglobulin	4180186
19474923	Chemokine CXCL4	4180186
19474926	Lectin, Pokeweed	4180186
19474926	Pokeweed Lectin	4180186
19474926	Mitogen, Pokeweed	4180186
19474926	Lectins, Pokeweed	4180186
19474926	Mitogen Isolectin, Pokeweed	4180186
19474926	Isolectin, Pokeweed Mitogen	4180186
19474926	Pokeweed Lectins	4180186
19474926	Pokeweed Mitogen Isolectin	4180186
19474926	Pokeweed Mitogen	4180186
19474926	Mitogens, Pokeweed	4180186
19474927	Acid, Polyadenylic-Polyuridylic	4180186
19474927	Poly(rA)-Poly(rU)	4180186
19474927	5'-Adenylic acid, homopolymer, complex with 5'-uridylic acid homopolymer (1:1)	4180186
19474927	Poly r(A-U)	4180186
19474927	Poly A U	4180186
19474927	Polyadenylic-Polyuridylic Acid	4180186
19474927	Polyadenylic Polyuridylic Acid	4180186
19474929	Sodium Polyanetholesulfonate	4180186
19474929	Homopolymer, Polyanetholesulfonate	4180186
19474929	Polyanethol Sulfonate	4180186
19474929	Liquoid	4180186
19474929	Polyanetholesulfonate, Sodium	4180186
19474929	Polyanetholesulfonate Homopolymer	4180186
19474929	Sulfonate, Polyanethol	4180186
19474929	Benzene, 1-methoxy-4-(1-propenyl)-, (E)-, homopolymer, sulfonated, sodium salt	4180186
19474932	Dacron	4180186
19474932	PET Polymer	4180186
19474932	Dacrons	4180186
19474932	Tedlars	4180186
19474932	Nalophan	4180186
19474932	PET Polymers	4180186
19474932	Tedlar	4180186
19474932	Poly(Ethylene Terephtalate)	4180186
19474932	Terephthalate, Polyethylene	4180186
19474932	Nalophans	4180186
19474932	Terephthalates, Polyethylene	4180186
19474932	Polyethylene Terephthalate	4180186
19474933	Acid Polyester, Glycolic-Lactic	4180186
19474933	Propanoic acid, 2-hydroxy-, polymer with hydroxyacetic acid	4180186
19474933	Poly(Lactide-Co-Glycolide)	4180186
19474933	Glycolic Lactic Acid Polyester	4180186
19474933	Poly(Lactide-Co-Glycoside)	4180186
19474933	Dimethyldioxanedione Polymer with Dioxanedione Polymer	4180186
19474933	Poly(Glycolide Lactide)Copolymer	4180186
19474933	Dioxanedione Polymer with Dimethyldioxanedione Polymer	4180186
19474933	Glycolic-Lactic Acid Polyester	4180186
19474933	Vicryl	4180186
19474933	Polygalactin 910	4180186
19474933	Polyglactin	4180186
19474933	Polyester, Glycolic-Lactic Acid	4180186
19474934	Dexon S	4180186
19474934	Dexon (Polyester)	4180186
19474934	Biofix	4180186
19474934	Polyglycolide	4180186
19474934	Dexon-S	4180186
19474934	DexonS	4180186
19474934	Poly(oxy(1-oxo-1,2-ethanediyl))	4180186
19474936	Acid Polymers, Methacrylic	4180186
19474936	Methacrylic Acid Polymers	4180186
19474936	Polymers, Methacrylic Acid	4180186
19474936	Acids, Polymethacrylic	4180186
19474939	Bacterial Polysaccharides	4180186
19474941	Kexiping	4180186
19474941	Bay 3504	4180186
19474941	Poly 2 vinylpyridine N Oxide	4180186
19474941	Polyvinylpyridine N Oxide	4180186
19474941	N-Oxide, Polyvinylpyridine	4180186
19474941	Polyvinoxide	4180186
19474941	N-Oxide, Poly-2-vinylpyridine	4180186
19474941	Poly-2-vinylpyridine N-Oxide	4180186
19474941	Pyridine, 2-ethenyl-, 1-oxide, homopolymer	4180186
19474942	Polyvinyl	4180186
19474943	Methylmitomycin C	4180186
19474943	Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-1,5-dimethyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-	4180186
19474944	Techniques, Post	4180186
19474944	Post Technique	4180186
19474944	Technics, Post-Core	4180186
19474944	Dental Dowel	4180186
19474944	Dental Dowels	4180186
19474944	Technique, Post	4180186
19474944	Post-Core Technic	4180186
19474944	Post Techniques	4180186
19474944	Technic, Post	4180186
19474944	Dowels, Dental	4180186
19474944	Post Technics	4180186
19474944	Technic, Post-Core	4180186
19474944	Technics, Post	4180186
19474944	Post Technic	4180186
19474944	Post and Core Technic	4180186
19474944	Dowel, Dental	4180186
19474944	Post-Core Technics	4180186
19474945	Mail Distribution	4180186
19474945	Postal Services	4180186
19474945	Services, Postal	4180186
19474945	Mail	4180186
19474945	Distribution, Mail	4180186
19474945	Distributions, Mail	4180186
19474945	Mails	4180186
19474945	Mail-Order	4180186
19474945	Mail-Orders	4180186
19474945	Mail Distributions	4180186
19474945	Service, Postal	4180186
19474945	Mail Order	4180186
19474946	Precipitates, Immune	4180186
19474946	Immune Precipitates	4180186
19474947	Preferred Provider Organization	4180186
19474947	Organizations, Preferred Provider	4180186
19474947	Organization, Preferred Provider	4180186
19474949	KWD2033	4180186
19474949	H-133-22	4180186
19474949	H8062	4180186
19474949	Hydrochloride, Prenalterol	4180186
19474949	A Ba C 50,005	4180186
19474949	ABaC50,005	4180186
19474949	Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (S)-	4180186
19474949	H13322	4180186
19474949	A-Ba-C-50,005	4180186
19474949	Prenalterol Hydrochloride	4180186
19474949	KWD-2033	4180186
19474949	H-80-62	4180186
19474952	2,2'-Bi-1H-pyrrole, 4-methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)-	4180186
19474953	Prodigiosan	4180186
19474956	Prolactin Release Inhibiting Factors	4180186
19474956	Prolactin Release-Inhibitory Factor	4180186
19474956	Prolactin Release Inhibitory Factor	4180186
19474956	Prolactin Release Inhibiting Hormone	4180186
19474956	Prolactin Release-Inhibiting Hormone	4180186
19474960	C3 Proactivator Convertase	4180186
19474960	Proactivator Convertase	4180186
19474960	Protein D, Complement	4180186
19474960	Adipsin	4180186
19474960	Factor D	4180186
19474960	Activator, C3 Convertase	4180186
19474960	GBGase	4180186
19474960	Properdin Factor D	4180186
19474960	Complement Protein D	4180186
19474960	Factor D, Complement	4180186
19474960	Convertase, C3PA	4180186
19474960	C3 Convertase Activator	4180186
19474960	28 kDa Protein, Adipocyte	4180186
19474960	Complement D Component	4180186
19474960	Convertase Activator, C3	4180186
19474960	D Component of Complement	4180186
19474960	Convertase, C3 Proactivator	4180186
19474960	Convertase, Proactivator	4180186
19474960	C3PAse	4180186
19474960	C3PA Convertase	4180186
19474960	Factor D, Properdin	4180186
19474965	PGA	4180186
19474967	1H-Indol-4-ol, 3-(2-(dimethylamino)ethyl)-, dihydrogen phosphate (ester)	4180186
19474967	Psilocybine	4180186
19474967	Psilocibin	4180186
19474968	Furanocoumarins	4180186
19474968	Furocoumarin	4180186
19474968	Psoralens	4180186
19474968	Furanocoumarin	4180186
19474968	Angelicins	4180186
19474971	Surfactant, Pulmonary	4180186
19474971	Pulmonary Surfactant	4180186
19474971	Surfactants, Pulmonary	4180186
19474972	Purine Nucleoside	4180186
19474972	Nucleosides, Purine	4180186
19474972	Nucleoside, Purine	4180186
19474974	MVE-5	4180186
19474974	NSC46015	4180186
19474974	Vinyl Ether Maleic Anhydride Polymer	4180186
19474974	Maleic Anhydride Divinyl Ether	4180186
19474974	Divinyl Ether Maleic Anhydride Copolymer	4180186
19474974	2,5-Furandione, polymer with 1,1'-oxybis(ethene)	4180186
19474974	NSC-46015	4180186
19474974	Copolymer, Pyran	4180186
19474974	Maleic Anhydride Vinyl Ether	4180186
19474974	MVE 2	4180186
19474974	DIVEMA	4180186
19474974	MVE-2	4180186
19474974	NSC 46015	4180186
19474974	MVE 5	4180186
19474976	4 Pyridoxinic Acid	4180186
19474976	4-Pyridoxinic Acid	4180186
19474976	4 Pyridoxic Acid	4180186
19474976	4-Pyridoxic Acid	4180186
19474976	4-Pyridinecarboxylic acid, 3-hydroxy-5-(hydroxymethyl)-2-methyl-	4180186
19474976	Pyridoxinecarboxylic Acid	4180186
19474976	4 Pyridoxylic Acid	4180186
19474976	4-Pyridoxylic Acid	4180186
19474977	Neopyrithiamine	4180186
19474977	B 1, Heterovitamin	4180186
19474977	1, Heterovitamin B	4180186
19474977	Heterovitamin B 1	4180186
19474977	Pyridinium, 1-((4-amino-2-methyl-5-pyrimidinyl)methyl)-3-(2-hydroxyethyl)-2-methyl-, bromide, monohydrobromide	4180186
19474979	Xanthylium, 3,6-bis(dimethylamino)-, chloride	4180186
19474979	Pyronin Y	4180186
19474979	Pyronine G	4180186
19474983	Pyrrovinyquinium	4180186
19474983	Viprynium	4180186
19474983	Compounds, Pyrvinium	4180186
19474987	Radiation-Sensitizing Drugs	4180186
19474987	Agents, Radiation-Sensitizing	4180186
19474987	Sensitizers, Radiation	4180186
19474987	Agents, Radiation Sensitizing	4180186
19474987	Drugs, Radiation-Sensitizing	4180186
19474987	Sensitizing Agents, Radiation	4180186
19474987	Radiation Sensitizing Effect	4180186
19474987	Sensitizer, Radiation	4180186
19474987	Radiosensitizing Agents	4180186
19474987	Radiation Sensitizers	4180186
19474987	Radiation Sensitizer	4180186
19474987	Radiation Sensitizing Effects	4180186
19474987	Radiosensitizing Effects	4180186
19474987	Radiosensitizing Effect	4180186
19474987	Radiation-Sensitizing Effect	4180186
19474987	Effects, Radiosensitizing	4180186
19474987	Effect, Radiation-Sensitizing	4180186
19474987	Agents, Radiosensitizing	4180186
19474987	Radiation-Sensitizing Effects	4180186
19474987	Radiosensitizing Drugs	4180186
19474987	Radiation Sensitizing Agents	4180186
19474987	Effect, Radiosensitizing	4180186
19474987	Agent, Radiosensitizing	4180186
19474987	Effects, Radiation-Sensitizing	4180186
19474987	Radiation Sensitizing Drugs	4180186
19474987	Drugs, Radiosensitizing	4180186
19474987	Radiosensitizing Agent	4180186
19474991	Rare Book	4180186
19474993	Receptor, Antigen	4180186
19474993	Antigen Receptor	4180186
19474993	Antigen Receptors	4180186
19474995	T Cell Receptor	4180186
19474995	Antigen Receptors, T Cell	4180186
19474995	Receptors, T-Cell Antigen	4180186
19474995	Antigen Receptors, T-Cell	4180186
19474995	T-Cell Antigen Receptor	4180186
19474995	T-Cell Antigen Receptors	4180186
19474995	Receptor, T-Cell	4180186
19474995	T-Cell Receptor	4180186
19474995	T Cell Receptors	4180186
19474995	T-Cell Receptors	4180186
19474995	Receptors, T-Cell	4180186
19474995	T Cell Antigen Receptor	4180186
19474995	Receptor, T-Cell Antigen	4180186
19474995	Receptors, T Cell Antigen	4180186
19474995	Antigen Receptor, T-Cell	4180186
19474998	Receptors, Immunological	4180186
19474998	Immunologic Receptors	4180186
19474998	Immunologic Receptor	4180186
19474998	Immunological Receptors	4180186
19474998	Receptor, Immunologic	4180186
19475001	Room, Hospital Recovery	4180186
19475001	Recovery Room, Hospital	4180186
19475001	Recovery Rooms, Hospital	4180186
19475001	Room, Recovery	4180186
19475001	Hospital Recovery Room	4180186
19475001	Recovery Rooms	4180186
19475001	Rooms, Recovery	4180186
19475001	Rooms, Hospital Recovery	4180186
19475001	Hospital Recovery Rooms	4180186
19475006	Relaxin B	4180186
19475007	Angiotensin-Forming Enzyme	4180186
19475007	Angiotensin Forming Enzyme	4180186
19475007	Angiotensinogenase	4180186
19475007	Big Renin	4180186
19475007	Preprorenin	4180186
19475007	Cryorenin	4180186
19475007	Pre Prorenin	4180186
19475007	Renin, Inactive	4180186
19475007	Inactive Renin	4180186
19475007	Pre-Prorenin	4180186
19475007	Renin, Big	4180186
19475007	Prorenin	4180186
19475010	meta-Dihydroxybenzenes	4180186
19475010	m Dihydroxybenzenes	4180186
19475010	meta Dihydroxybenzenes	4180186
19475010	m-Dihydroxybenzenes	4180186
19475013	Antigen D, Rh Blood Group	4180186
19475013	System, Rh-Hr Blood-Group	4180186
19475013	Rh Hr Blood Group System	4180186
19475013	Blood-Group Systems, Rh-Hr	4180186
19475013	Rhesus Blood Group System	4180186
19475013	Rh-Hr Blood-Group Systems	4180186
19475013	Blood-Group System, Rh-Hr	4180186
19475013	Rh Factors	4180186
19475013	Factors, Rh	4180186
19475013	Factor, Rh	4180186
19475013	Rh Factor	4180186
19475013	Rhesus Blood-Group System	4180186
19475013	Blood-Group System, Rhesus	4180186
19475013	Blood-Group Systems, Rhesus	4180186
19475013	Systems, Rh-Hr Blood-Group	4180186
19475013	System, Rhesus Blood-Group	4180186
19475013	Systems, Rhesus Blood-Group	4180186
19475013	Rhesus Blood-Group Systems	4180186
19475016	4-Thiazolidinone, 2-thioxo-	4180186
19475017	Ristomycin	4180186
19475018	Ro 1724	4180186
19475018	Ro 20-1724	4180186
19475018	Ro 20 1724	4180186
19475018	2-Imidazolidinone, 4-((3-butoxy-4-methoxyphenyl)methyl)-	4180186
19475018	Ro 201724	4180186
19475019	Ro 41284	4180186
19475019	Ro4-1284	4180186
19475019	Ro 4-1284	4180186
19475019	2H-Benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-	4180186
19475020	Robot, Socially Assistive	4180186
19475020	Robots, Social	4180186
19475020	Robot, Social	4180186
19475020	Robot, Companion	4180186
19475020	Telerobotics	4180186
19475020	Soft Robotics	4180186
19475020	Robots, Socially Assistive	4180186
19475020	Socially Assistive Robot	4180186
19475020	Operation, Remote (Robotics)	4180186
19475020	Remote Operation (Robotics)	4180186
19475020	Remote Operations (Robotics)	4180186
19475020	Social Robots	4180186
19475020	Robotics, Soft	4180186
19475020	Operations, Remote (Robotics)	4180186
19475020	Soft Robotic	4180186
19475020	Assistive Robot, Socially	4180186
19475020	Companion Robot	4180186
19475020	Robots, Companion	4180186
19475020	Social Robot	4180186
19475020	Robotic, Soft	4180186
19475020	Companion Robots	4180186
19475020	Socially Assistive Robots	4180186
19475020	Assistive Robots, Socially	4180186
19475022	Rural Populations	4180186
19475022	Community, Rural	4180186
19475022	Rural Communities	4180186
19475022	Population, Rural	4180186
19475022	Distributions, Rural Spatial	4180186
19475022	Rural Spatial Distribution	4180186
19475022	Rural Spatial Distributions	4180186
19475022	Residence, Rural	4180186
19475022	Rural Community	4180186
19475022	Rural Residence	4180186
19475022	Distribution, Rural Spatial	4180186
19475022	Communities, Rural	4180186
19475022	Rural Residences	4180186
19475022	Populations, Rural	4180186
19475024	Oxychloride, Ammoniated Ruthenium	4180186
19475024	Red, Ruthenium	4180186
19475024	Ruthenium Oxychloride, Ammoniated	4180186
19475024	Ammoniated Ruthenium Oxychloride	4180186
19475025	Ryanodol, 3-(1H-pyrrole-2-carboxylate)	4180186
19475026	Salicylic Acids	4180186
19475026	Salicylate	4180186
19475026	Acids, Salicylic	4180186
19475028	SC-19220	4180186
19475030	School, Primary	4180186
19475030	Schools, Secondary	4180186
19475030	Schools, Primary	4180186
19475030	Secondary School	4180186
19475030	Primary School	4180186
19475030	School	4180186
19475030	Primary Schools	4180186
19475030	School, Secondary	4180186
19475030	Secondary Schools	4180186
19475031	Dental Schools	4180186
19475031	Dental School	4180186
19475031	School, Dental	4180186
19475032	Health Occupations Schools	4180186
19475032	Health Occupations School	4180186
19475032	Occupations School, Health	4180186
19475032	School, Health Occupations	4180186
19475032	Occupations Schools, Health	4180186
19475033	Medical Schools	4180186
19475033	Medical School	4180186
19475033	School, Medical	4180186
19475034	School, Nursery	4180186
19475034	Nursery Schools	4180186
19475034	Nursery School	4180186
19475037	Health School, Public	4180186
19475037	Public Health Schools	4180186
19475037	Health Schools, Public	4180186
19475037	School, Public Health	4180186
19475037	Public Health School	4180186
19475039	Counter, Scintillation	4180186
19475039	Counting, Scintillation	4180186
19475039	Scintillation Counters	4180186
19475039	Counters, Scintillation	4180186
19475039	Scintillation Counter	4180186
19475041	Minimal Care Units	4180186
19475041	Self-Care Unit	4180186
19475041	Units, Minimal Care	4180186
19475041	Unit, Self-Care	4180186
19475041	Minimal Care Unit	4180186
19475041	Units, Self-Care	4180186
19475041	Self Care Units	4180186
19475041	Unit, Minimal Care	4180186
19475043	Publications, Serial	4180186
19475043	Publication, Serial	4180186
19475043	Serial Publication	4180186
19475044	Ship	4180186
19475044	Ships, Hospital	4180186
19475044	Ship, Hospital	4180186
19475044	Boats	4180186
19475044	Hospital Ship	4180186
19475044	Hospital Ships	4180186
19475044	Boat	4180186
19475045	1H-Pyrrole-2,5-dione, 3-beta-D-ribofuranosyl-	4180186
19475046	Proteins, Silver	4180186
19475046	Silver Proteinate	4180186
19475046	Proteinate, Silver	4180186
19475050	Computer Programs	4180186
19475050	Computer Program	4180186
19475050	Tools, Software	4180186
19475050	Program, Computer	4180186
19475050	Engineering, Software	4180186
19475050	Software Tool	4180186
19475050	Open Source Software	4180186
19475050	Open Source Softwares	4180186
19475050	Computer Software	4180186
19475050	Software Application, Computer	4180186
19475050	Software Applications, Computer	4180186
19475050	Software Tools	4180186
19475050	Softwares, Computer Applications	4180186
19475050	Software, Computer Applications	4180186
19475050	Applications Softwares, Computer	4180186
19475050	Software, Open Source	4180186
19475050	Software, Computer	4180186
19475050	Applications, Computer Software	4180186
19475050	Applications Software, Computer	4180186
19475050	Softwares, Open Source	4180186
19475050	Computer Applications Softwares	4180186
19475050	Source Software, Open	4180186
19475050	Computer Programs and Programming	4180186
19475050	Computer Software Application	4180186
19475050	Application, Computer Software	4180186
19475050	Computer Software Applications	4180186
19475050	Computer Applications Software	4180186
19475050	Tool, Software	4180186
19475050	Source Softwares, Open	4180186
19475050	Programs, Computer	4180186
19475050	Software Engineering	4180186
19475055	Speech Sonography	4180186
19475055	Sonographies, Sound	4180186
19475055	Sound Sonographies	4180186
19475055	Sound Sonography	4180186
19475055	Sonography, Sound	4180186
19475055	Sonography, Speech	4180186
19475055	Spectrography, Sound	4180186
19475057	L-Sparteine	4180186
19475057	Sparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer	4180186
19475057	Sparteine Hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	D-sparteine	4180186
19475057	Sparteine, (-)-Isomer	4180186
19475057	Sparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer	4180186
19475057	Lupinidine	4180186
19475057	Sparteine, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	Pachycarpine Sulfate (1:1), Pentahydrate, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	Genisteine Alkaloid	4180186
19475057	Sparteine Sulfate	4180186
19475057	Sparteine Monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-	4180186
19475057	Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	Pachycarpine	4180186
19475057	alpha Isosparteine	4180186
19475057	Sparteine Hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	Sparteine Monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	Sparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer	4180186
19475057	Sparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer	4180186
19475057	Sulfate Anhydrous, Sparteine	4180186
19475057	Lupinidin	4180186
19475057	Sparteine, (+)-Isomer	4180186
19475057	Anhydrous, Sparteine Sulfate	4180186
19475057	Depasan Retard	4180186
19475057	beta-Isosparteine	4180186
19475057	Sparteine Hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer	4180186
19475057	alpha-Isosparteine	4180186
19475057	beta Isosparteine	4180186
19475057	Sparteine Sulfate Anhydrous	4180186
19475058	Raman Spectroscopy	4180186
19475058	Analysis, Raman Spectrum	4180186
19475058	Scattering, Raman	4180186
19475058	Raman Spectrum Analysis	4180186
19475058	Spectroscopy, Raman	4180186
19475058	Raman Scattering	4180186
19475058	Raman Optical Activity Spectroscopy	4180186
19475060	1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-	4180186
19475060	Spiroperone	4180186
19475060	Spiroperidol	4180186
19475062	Dihydroepitestosterone	4180186
19475062	5-alpha-DHT	4180186
19475062	Stanolone	4180186
19475062	Dihydrotestosterone, 5-alpha	4180186
19475062	5 alpha DHT	4180186
19475062	17 beta-Hydroxy-5 beta-Androstan-3-One	4180186
19475062	Andractim	4180186
19475062	5 beta Dihydrotestosterone	4180186
19475062	Gelovit	4180186
19475062	5 beta-Dihydrotestosterone	4180186
19475062	Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-	4180186
19475062	beta-Hydroxy-5 beta-Androstan-3-One, 17	4180186
19475062	5-alpha Dihydrotestosterone	4180186
19475062	17 beta Hydroxy 5 beta Androstan 3 One	4180186
19475062	5 alpha-Dihydrotestosterone	4180186
19475062	17beta Hydroxy 5alpha Androstan 3 One	4180186
19475062	5 alpha Dihydrotestosterone	4180186
19475062	17beta-Hydroxy-5alpha-Androstan-3-One	4180186
19475062	Anaprotin	4180186
19475062	Androstanolone	4180186
19475067	Steroid	4180186
19475067	Steroids, Catatoxic	4180186
19475067	Catatoxic Steroids	4180186
19475070	Yazumycins	4180186
19475070	Streptothricin	4180186
19475070	Nourseothricin	4180186
19475070	Racemomycins	4180186
19475073	Strophanthin	4180186
19475074	Suburbanization	4180186
19475074	Population, Suburban	4180186
19475074	Suburban Residences	4180186
19475074	Suburban Residence	4180186
19475074	Nonmetropolitan Population	4180186
19475074	Residence, Suburban	4180186
19475074	Population, Nonmetropolitan	4180186
19475074	Suburban Populations	4180186
19475074	Nonmetropolitan Populations	4180186
19475077	Benzenesulfonamide, 4-amino-N-(6-methoxy-4-pyrimidinyl)-	4180186
19475079	Benzenesulfonamide, 4-amino-N-(1-phenyl-1H-pyrazol-5-yl)-	4180186
19475079	Phenylsulfapyrazole	4180186
19475079	Sulfaphenylpyrazol	4180186
19475079	Sulphaphenazole	4180186
19475080	Sulfates, Inorganic	4180186
19475080	Inorganic Sulfates	4180186
19475080	Sulfate	4180186
19475082	Sulfhydryl Compounds Antagonists	4180186
19475082	Sulfhydryl Compound Inhibitors	4180186
19475082	Reagents, Sulfhydryl	4180186
19475082	Reagents, Thiol	4180186
19475082	SH Reagents	4180186
19475082	Antagonists, Sulfhydryl Compound	4180186
19475082	Inhibitors, Sulfhydryl Compound	4180186
19475082	Compound Antagonists, Sulfhydryl	4180186
19475082	Sulfhydryl Compound Antagonists	4180186
19475082	Thiol Reagents	4180186
19475082	Antagonists, Sulfhydryl Compounds	4180186
19475082	Sulfhydryl Compounds Inhibitors	4180186
19475082	Inhibitors, Sulfhydryl Compounds	4180186
19475082	Compound Inhibitors, Sulfhydryl	4180186
19475082	SH-Reagents	4180186
19475083	Sulfonamide	4180186
19475083	Sulfonamide Mixtures	4180186
19475083	Sulfonamide Mixture	4180186
19475083	Mixture, Sulfonamide	4180186
19475083	Mixtures, Sulfonamide	4180186
19475087	Suppressor T Cell Factors	4180186
19475087	Factors, T Suppressor	4180186
19475087	Factors, Suppressor T-Cell	4180186
19475087	T-Cell Suppressive Factors	4180186
19475087	T-Suppressor Factors	4180186
19475087	Factors, T-Cell Suppressive	4180186
19475087	T Cell Suppressor Factors	4180186
19475087	T Cell Suppressive Factors	4180186
19475087	T Suppressor Factors	4180186
19475087	Factors, T-Suppressor	4180186
19475087	Suppressor Factor (SF4)	4180186
19475087	Suppressor Factors, T	4180186
19475087	Factors, Immunologic Suppressor	4180186
19475087	Suppressive Factors, T-Cell	4180186
19475087	Suppressor T-Cell Factors	4180186
19475087	T-Cell Factors, Suppressor	4180186
19475087	Immunologic Suppressor Factors	4180186
19475089	Sympatholytic	4180186
19475089	Agents, Sympatholytic	4180186
19475089	Agent, Sympatholytic	4180186
19475089	Sympatholytic Agents	4180186
19475089	Drugs, Sympatholytic	4180186
19475089	Sympatholytic Drug	4180186
19475089	Drug, Sympatholytic	4180186
19475089	Sympatholytic Agent	4180186
19475089	Agents, Sympathetic-Blocking	4180186
19475089	Sympatholytic Drugs	4180186
19475089	Sympatholytic Effect	4180186
19475089	Effect, Sympatholytic	4180186
19475089	Sympathetic Blocking Agents	4180186
19475089	Effects, Sympatholytic	4180186
19475089	Sympathetic-Blocking Agents	4180186
19475089	Sympatholytic Effects	4180186
19475090	Effects, Sympathomimetic	4180186
19475090	Agents, Sympathomimetic	4180186
19475090	Sympathomimetic	4180186
19475090	Sympathomimetic Agents	4180186
19475090	Drugs, Sympathomimetic	4180186
19475090	Amines, Sympathomimetic	4180186
19475090	Sympathomimetic Effects	4180186
19475090	Agent, Sympathomimetic	4180186
19475090	Sympathomimetic Agent	4180186
19475090	Effect, Sympathomimetic	4180186
19475090	Sympathomimetic Effect	4180186
19475090	Sympathomimetic Drugs	4180186
19475090	Sympathomimetic Drug	4180186
19475090	Sympathomimetic Amines	4180186
19475090	Drug, Sympathomimetic	4180186
19475093	Serum Albumin, 99mTc-Human	4180186
19475093	Tc99m-Albumin	4180186
19475093	Tc-99m-MAA	4180186
19475093	99mTcAlbures	4180186
19475093	99mTc-Albures	4180186
19475093	Colloid, Technetium-99m Albumin	4180186
19475093	Tc 99m-Albumin	4180186
19475093	Technetium-99m Albumin Colloid	4180186
19475093	Tc 99m-Albumin Colloid	4180186
19475093	Tc HAMM	4180186
19475093	99mTc Human Serum Albumin	4180186
19475093	Tc-99m-HAM	4180186
19475093	Colloid, Tc 99m-Albumin	4180186
19475093	Albumin, 99mTc-Human Serum	4180186
19475093	Tc-99m-Microalbumin	4180186
19475093	Technetium 99m Albumin Colloid	4180186
19475093	99m-Tc-HSA	4180186
19475093	Tc 99m Albumin	4180186
19475093	Tc 99m HAM	4180186
19475093	99mTc Albures	4180186
19475093	99mTc-HSA	4180186
19475093	Tc 99m MAA	4180186
19475093	Tc 99m Microalbumin	4180186
19475093	Tc-HAMM	4180186
19475093	Tc 99m Albumin Colloid	4180186
19475093	99mTc-Human Serum Albumin	4180186
19475093	Albumin Colloid, Technetium-99m	4180186
19475093	Tc99m Albumin	4180186
19475094	Service, Switchboard	4180186
19475094	Telephones	4180186
19475094	Switchboard Service	4180186
19475094	Switchboard Services	4180186
19475094	Services, Switchboard	4180186
19475095	Aziridine, 1,1',1''-phosphinylidynetris-	4180186
19475095	TEPA	4180186
19475097	Antitoxin, Tetanus	4180186
19475099	Tetrapeptide, Gastrin	4180186
19475099	AOC Tetrapeptide	4180186
19475099	AOC Tetragastrin	4180186
19475099	Cholecystokinin Tetrapeptide	4180186
19475099	AOC-Tetrapeptide	4180186
19475099	CKK-4	4180186
19475099	Cholecystokinin (30-33)	4180186
19475099	Gastrin Tetrapeptide	4180186
19475099	CCK-4	4180186
19475099	AOC-Tetragastrin	4180186
19475099	L-Phenylalaninamide, L-tryptophyl-L-methionyl-L-alpha-aspartyl-	4180186
19475099	CCK (30-33)	4180186
19475099	Cholecystokinin-Tetrapeptide	4180186
19475099	Cholecystokinin 4	4180186
19475100	Pregnan-20-one, 3,11,17,21-tetrahydroxy-, (3alpha,5beta,11beta)-	4180186
19475101	Pregnane-11,20-dione, 3,17,21-trihydroxy-, (3alpha,5beta)-	4180186
19475102	Iso-OMPA	4180186
19475102	Iso OMPA	4180186
19475102	Diphosphoramide, N,N',N'',N'''-tetrakis(1-methylethyl)-	4180186
19475106	Tetrathionate, Sodium	4180186
19475106	Tetrathionate, Potassium	4180186
19475106	Tetrathionic Acid, Calcium Salt (1:1)	4180186
19475106	Tetrathionic Acid, Dipotassium Salt	4180186
19475106	Potassium Tetrathionate	4180186
19475106	Sodium Tetrathionate	4180186
19475106	Tetrathionic Acid, Disodium Salt	4180186
19475106	Tetrathionic Acid, Disodium Salt, Dihydrate	4180186
19475107	Salts, Tetrazolium	4180186
19475107	Salt, Tetrazolium	4180186
19475107	Tetrazolium Salt	4180186
19475110	1,3-Butanedione, 4,4,4-trifluoro-1-(2-thienyl)-	4180186
19475110	4,4,4-trifluoro-1-(2-thienyl)-1,3-butanedione	4180186
19475110	TTFA cpd	4180186
19475110	Trifluorothienylacetone	4180186
19475111	Conteben	4180186
19475111	TBI698	4180186
19475111	TB I698	4180186
19475111	TB I 698	4180186
19475111	Acetamide, N-(4-(((aminothioxomethyl)hydrazono)methyl)phenyl)-	4180186
19475111	Thioacetazon	4180186
19475111	TBI-698	4180186
19475111	Ambathizon	4180186
19475111	Parazone	4180186
19475111	TBI 698	4180186
19475111	TB I-698	4180186
19475111	Amithiozone	4180186
19475111	Thiacetazone	4180186
19475112	Thiophene	4180186
19475113	Thiosulfate	4180186
19475116	1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxy-2-methyl-5-(1-methylethyl)phenyl)-	4180186
19475118	Thymosins	4180186
19475118	Thymosin Fs	4180186
19475119	Antagonists, Thyroid	4180186
19475119	Drugs, Antithyroid	4180186
19475119	Agents, Antithyroid	4180186
19475119	Antithyroid Drugs	4180186
19475119	Agent, Antithyroid	4180186
19475119	Antithyroid Drug	4180186
19475119	Effect, Antithyroid	4180186
19475119	Antithyroid Effects	4180186
19475119	Effects, Antithyroid	4180186
19475119	Antithyroid Effect	4180186
19475119	Drug, Antithyroid	4180186
19475119	Goitrogens	4180186
19475119	Thyroid Antagonists	4180186
19475119	Antithyroid Agent	4180186
19475119	Goitrogen	4180186
19475120	Thienylic Acid	4180186
19475120	Tienilic Acid	4180186
19475120	ANP3624	4180186
19475120	Acid, Thienylic	4180186
19475120	SKF-62698	4180186
19475120	Selacryn	4180186
19475120	SKF62698	4180186
19475120	ANP 3624	4180186
19475120	Acid, Tienilic	4180186
19475120	SKF 62698	4180186
19475120	Acetic acid, (2,3-dichloro-4-(2-thienylcarbonyl)phenoxy)-	4180186
19475120	ANP-3624	4180186
19475121	Hydrochloride, Tilorone	4180186
19475121	Bis DEAE Fluorenone	4180186
19475121	Bis-DEAE-Fluorenone	4180186
19475121	Amyxin	4180186
19475121	Amiksin	4180186
19475121	9H-Fluoren-9-one, 2,7-bis(2-(diethylamino)ethoxy)-	4180186
19475121	Tilorone Hydrochloride	4180186
19475121	Amixin	4180186
19475122	Stannous Polyphosphates	4180186
19475122	Pyrophosphates, Tin	4180186
19475122	Polyphosphates, Tin	4180186
19475122	Tin Pyrophosphates	4180186
19475122	Pyrophosphates, Stannous	4180186
19475122	Polyphosphates, Stannous	4180186
19475122	Stannous Pyrophosphates	4180186
19475123	1,3-Benzenedisulfonic acid, 4,5-dihydroxy-, disodium salt	4180186
19475123	Tiron	4180186
19475127	beta-D-Galactopyranoside, (3beta,5alpha,22beta,25S)-spirosolan-3-yl O-beta-D-glucopyranosyl-(1-2)-O-(beta-D-xylopyranosyl-(1-3))-O-beta-D-glucopyranosyl-(1-4)-	4180186
19475128	Polychlorocamphene	4180186
19475129	Toxiferine I, 2,2',16,16'-tetradehydro-16,16',17,17'-tetrahydro-	4180186
19475130	7H-Pyrrolo(2,3-d)pyrimidine-5-carbonitrile, 4-amino-7-beta-D-ribofuranosyl-	4180186
19475130	Toyokamycin	4180186
19475130	Deazacyanoadenosine	4180186
19475131	Toyomycin	4180186
19475131	Olivomycin D, 3D-O-(4-O-acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methyl-	4180186
19475131	Toyomicin	4180186
19475132	Elements, Trace	4180186
19475132	Trace Element	4180186
19475132	Biometal	4180186
19475132	Minerals, Trace	4180186
19475132	Trace Minerals	4180186
19475132	Element, Trace	4180186
19475132	Mineral, Trace	4180186
19475132	Trace Mineral	4180186
19475132	Biometals	4180186
19475133	Tracks	4180186
19475133	Field and Track	4180186
19475133	Track	4180186
19475134	Agents, Tranquilizing	4180186
19475134	Effect, Tranquilizing	4180186
19475134	Agents, Tranquillizing	4180186
19475134	Ataractics	4180186
19475134	Drugs, Tranquilizing	4180186
19475134	Tranquilizing Drugs	4180186
19475134	Tranquillizing Agents	4180186
19475134	Tranquillizing Drugs	4180186
19475134	Effects, Tranquilizing	4180186
19475134	Tranquilizing Effect	4180186
19475134	Drugs, Tranquillizing	4180186
19475134	Tranquilizing Effects	4180186
19475139	Acetate, Trenbolone	4180186
19475139	Acetate, Trienbolone	4180186
19475139	Progro T-S	4180186
19475139	Progro T S	4180186
19475139	Trenbolone	4180186
19475139	17 beta-acetoxyestra-4,9,11-trien-3-one	4180186
19475139	Progro TS	4180186
19475139	Trienbolone Acetate	4180186
19475139	Trienbolone	4180186
19475139	Trenbolone Acetate, (17beta)-isomer	4180186
19475140	Tretoquinol-(R)	4180186
19475140	6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((3,4,5-trimethoxyphenyl)methyl)-, (S)-	4180186
19475140	Tretoquinol Hydrochloride, (S)-Isomer	4180186
19475140	Tetroquinol	4180186
19475140	AQL-208	4180186
19475140	Tretoquinol Hydrochloride	4180186
19475140	CV 705	4180186
19475140	Tretoquinol Hydrochloride Anhydrous	4180186
19475140	Trimetoquinol	4180186
19475140	CV705	4180186
19475140	AQ 110	4180186
19475140	AQL208	4180186
19475140	AQ-110	4180186
19475140	AQ110	4180186
19475140	Trimethoquinol	4180186
19475140	CV-705	4180186
19475140	Tretoquinol-(S) HCl	4180186
19475140	AQL 208	4180186
19475142	2,3,5-Tris(ethyleneimine)benzoquinone	4180186
19475142	Trenimon	4180186
19475142	2,5-Cyclohexadiene-1,4-dione, 2,3,5-tris(1-aziridinyl)-	4180186
19475143	Triazole	4180186
19475144	Acide trichloracetique	4180186
19475144	trichloracetique, Acide	4180186
19475144	Rubidium Trichloroacetate	4180186
19475144	Acid, Trichloroacetic	4180186
19475144	Sodium Trichloroacetate	4180186
19475144	Acetic acid, trichloro-	4180186
19475144	Trichloroacetate, Rubidium	4180186
19475144	Trichloroacetate, Sodium	4180186
19475149	Mesocaine	4180186
19475149	Trimecaine Monohydrochloride	4180186
19475149	Acetamide, 2-(diethylamino)-N-(2,4,6-trimethylphenyl)-	4180186
19475149	Monohydrochloride, Trimecaine	4180186
19475152	Benzenesulfonic acid, 2,4,6-trinitro-	4180186
19475152	Trinitrobenzene Sulfonate	4180186
19475152	Sulfonate, Trinitrobenzene	4180186
19475152	2,4,6-Trinitrobenzene Sulfonate	4180186
19475152	Picrylsulfonic Acid	4180186
19475152	Trinitrobenzenesulfonic Acid, Sodium Salt	4180186
19475153	Bowman-Birk Soybean Trypsin Inhibitor	4180186
19475153	Trypsin Inhibitor, Bowman Birk Soybean	4180186
19475153	Bowman Birk Soybean Trypsin Inhibitor	4180186
19475154	Trypsin Inhibitor, Tumor-Associated	4180186
19475154	Serine Peptidase Inhibitor, Kazal Type 1	4180186
19475154	Trypsin Inhibitor Kazal Pancreatic	4180186
19475154	Pancreatic Secretory Trypsin Inhibitor	4180186
19475154	Tumor-Associated Trypsin Inhibitor	4180186
19475154	Pancreatic Secretory Trypsin Inhibitor, Kazal	4180186
19475154	Trypsin Inhibitor, Tumor Associated	4180186
19475154	Serine Peptidase Inhibitor, Kazal-Type 1	4180186
19475154	Pancreatic Trypsin Secretory Inhibitor, Kazal	4180186
19475154	Inhibitor, Tumor-Associated Trypsin	4180186
19475154	Serine Protease Inhibitor Kazal Type 1	4180186
19475154	Kazal Pancreatic Trypsin Inhibitor	4180186
19475154	Trypsin Inhibitor, Pancreatic Secretory	4180186
19475154	Serine Protease Inhibitor Kazal-Type 1	4180186
19475154	Tumor Associated Trypsin Inhibitor	4180186
19475154	SPINK1	4180186
19475154	Acidic Pancreatic Trypsin Inhibitor	4180186
19475155	Trypsin Inhibitor DE-3	4180186
19475155	Trypsin Inhibitor Kunitz Soybean	4180186
19475155	Kunitz Soybean Trypsin Inhibitor	4180186
19475155	Trypsin Inhibitor DE 3	4180186
19475156	Trypsin Inhibitor	4180186
19475156	Inhibitors, Trypsin	4180186
19475156	Inhibitor, Trypsin	4180186
19475157	Triptan	4180186
19475157	Indolylethylamines	4180186
19475157	Triptans	4180186
19475161	Typhoid Vaccines	4180186
19475161	Vaccines, Typhoid	4180186
19475161	Vaccine, Typhoid	4180186
19475161	Typhoid Vaccine	4180186
19475161	Paratyphoid Vaccines	4180186
19475161	Typhoid Paratyphoid Vaccines	4180186
19475161	Vaccines, Paratyphoid	4180186
19475161	Vaccine, Paratyphoid	4180186
19475161	Paratyphoid Vaccine	4180186
19475161	Vaccines, Typhoid-Paratyphoid	4180186
19475162	Skimmetin	4180186
19475162	7-Hydroxycoumarins	4180186
19475162	Hydrangin	4180186
19475162	7 Hydroxycoumarins	4180186
19475163	University	4180186
19475165	Central City	4180186
19475165	City, Central	4180186
19475165	Central Cities	4180186
19475165	Cities, Central	4180186
19475165	Urbanizations	4180186
19475167	Urotensin	4180186
19475168	Acid, Ursodeoxycholic	4180186
19475168	Cholofalk	4180186
19475168	Deoxyursocholic Acid	4180186
19475168	Ursobilane	4180186
19475168	Ursochol	4180186
19475168	Destolit	4180186
19475168	Ursogal	4180186
19475168	Sodium Ursodeoxycholate	4180186
19475168	3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid	4180186
19475168	Urso	4180186
19475168	Ursofalk	4180186
19475168	Ursodiol	4180186
19475168	Acid, Deoxyursocholic	4180186
19475168	Urdox	4180186
19475168	Urso Heumann	4180186
19475168	Ursolite	4180186
19475168	Cholan-24-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7beta)-	4180186
19475168	Ursacholic Acid	4180186
19475168	Ursolvan	4180186
19475168	3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid	4180186
19475168	Cholit-Ursan	4180186
19475168	Acid, Ursacholic	4180186
19475168	Delursan	4180186
19475168	Ursodeoxycholate, Sodium	4180186
19475170	Recombinant Vaccine	4180186
19475170	Vaccines, Chemical	4180186
19475170	Vaccines, Semisynthetic	4180186
19475170	Immunogens, Synthetic	4180186
19475170	Recombinant Vaccines	4180186
19475170	Synthetic Vaccine	4180186
19475170	Vaccine, Recombinant	4180186
19475170	Molecular Vaccine	4180186
19475170	Antigens, Synthetic	4180186
19475170	Semisynthetic Vaccine	4180186
19475170	Synthetic Immunogens	4180186
19475170	Vaccine, Chemical	4180186
19475170	Synthetic Antigen	4180186
19475170	Vaccine, Semisynthetic	4180186
19475170	Semisynthetic Vaccines	4180186
19475170	Chemical Vaccine	4180186
19475170	Vaccine, Synthetic	4180186
19475170	Synthetic Antigens	4180186
19475170	Vaccines, Molecular	4180186
19475170	Antigen, Synthetic	4180186
19475170	Vaccine, Molecular	4180186
19475170	Synthetic Vaccines	4180186
19475170	Chemical Vaccines	4180186
19475170	Vaccines, Recombinant	4180186
19475170	Molecular Vaccines	4180186
19475175	Cevadine	4180186
19475175	Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(2-methyl-2-butenoate), (3beta(Z),4alpha,16beta)-	4180186
19475176	Alkaloids, Veratrum	4180186
19475183	Wheat Germ Agglutinin Isolectin 2	4180186
19475183	Triticum Vulgare Lectins	4180186
19475183	Wheat Germ Agglutinin	4180186
19475183	Vulgare Lectin, Triticum	4180186
19475183	Triticum Vulgare Lectin	4180186
19475183	Lectin, Wheat Germ	4180186
19475183	Germ Agglutinin, Wheat	4180186
19475183	Agglutinins, Wheat Germ	4180186
19475183	Agglutinin, Wheat Germ	4180186
19475183	Wheat Germ Agglutinin Isolectin 1	4180186
19475183	Lectins, Wheat Germ	4180186
19475183	Lectins, Triticum Vulgare	4180186
19475183	Lectin, Triticum Vulgare	4180186
19475183	Wheat Germ Lectins	4180186
19475183	Germ Lectin, Wheat	4180186
19475183	Wheat Germ Lectin	4180186
19475184	Xylene	4180186
19475184	Dimethylbenzenes	4180186
19475185	Oxide-Eugenol Cement, Zinc	4180186
19475185	Caryosan	4180186
19475185	Cement, Zinc Oxide-Eugenol	4180186
19475185	Zinc Oxide Eugenol Cement	4180186
19475191	17 Hydroxycorticosteroids	4180186
19475195	Reagent I, Koshland's	4180186
19475195	Phenol, 2-(bromomethyl)-4-nitro-	4180186
19475195	Koshland Reagent I	4180186
19475195	Koshland Reagent	4180186
19475195	Reagent, Koshland	4180186
19475195	Koshlands Reagent	4180186
19475195	Koshland's Reagent I	4180186
19475195	Reagent, Koshlands	4180186
19475195	Koshlands Reagent I	4180186
19475195	2 Hydroxy 5 nitrobenzyl Bromide	4180186
19475202	4 Hydroxycoumarins	4180186
19475203	5 Androstane 3,17 diol	4180186
19475203	5alpha-Androstane-3beta,17alpha-diol	4180186
19475203	5 alpha-Androstane-3alpha,17 beta-diol	4180186
19475203	5 beta Androstane 3 alpha,17 beta diol	4180186
19475203	5 alpha Androstane 3 beta,17 beta diol	4180186
19475203	Androstane 3,17 diol	4180186
19475203	5 alpha-Androstane-3 alpha,17 beta-diol	4180186
19475203	5 alpha Androstane 3 beta,17 alpha diol	4180186
19475203	5 alpha Androstane 3 alpha,17 beta diol	4180186
19475203	5 alpha-Androstane-3 beta,17 alpha-diol	4180186
19475203	5alpha Androstane 3beta,17alpha diol	4180186
19475203	5-Androstane-3,17-diol	4180186
19475203	5 beta-Androstane-3 alpha,17 beta-diol	4180186
19475203	5 alpha-Androstane-3 beta,17 beta-diol	4180186
19475203	5 alpha Androstane 3alpha,17 beta diol	4180186
19475204	Delta 5-Androstenediol	4180186
19475204	Androst 5 ene 3,17 diol	4180186
19475204	5-Androstene-3,17-diol	4180186
19475204	Androst-5-ene-3,17-diol, (3beta,17beta)-	4180186
19475204	delta 5-Androstene-3 beta,17 beta-Diol	4180186
19475204	Bisexovister	4180186
19475204	Hermaphrodiol	4180186
19475204	Delta 5 Androstenediol	4180186
19475204	delta 5 Androstene 3 beta,17 beta Diol	4180186
19475204	Androst 5 ene 3 beta,17 beta Diol	4180186
19475204	5 Androstene 3beta 17beta Diol	4180186
19475204	Androst-5-ene-3,17-diol	4180186
19475204	5-Androstene-3beta-17beta-Diol	4180186
19475204	Androst-5-ene-3 beta,17 beta-Diol	4180186
19475204	5 Androstene 3,17 diol	4180186
19475205	3-(2-Aminoethyl)indole-5,6-diol	4180186
19475205	5,6 Dihydroxytryptamine	4180186
19475205	1H-Indole-5,6-diol, 3-(2-aminoethyl)-	4180186
19475206	3-(2-Aminoethyl)-1H-indole-5,7-diol	4180186
19475206	5,7 Dihydroxytryptamine	4180186
19475206	Sulfate, 5,7-Dihydroxytryptamine Creatine	4180186
19475206	1H-Indole-5,7-diol, 3-(2-aminoethyl)-	4180186
19475206	5,7-Dihydroxytryptamine Creatine Sulfate	4180186
19475206	5,7 Dihydroxytryptamine Creatine Sulfate	4180186
19475206	Creatine Sulfate, 5,7-Dihydroxytryptamine	4180186
19475208	Tocolytic	4180186
19475208	Effects, Tocolytic	4180186
19475208	Effect, Tocolytic	4180186
19475208	Agents, Tocolytic	4180186
19475208	Tocolytic Agent	4180186
19475208	Tocolytic Effects	4180186
19475208	Agent, Tocolytic	4180186
19475208	Tocolytic Effect	4180186
19475208	Tocolytics	4180186
19475209	Antigens, Myelomonocytic, Differentiation	4180186
19475209	Differentiation Antigens, Myelomonocytic	4180186
19475209	Antigens, Myelomonocytic Differentiation	4180186
19475209	Myelomonocytic Differentiation Antigens	4180186
19475210	HLA-B Antigen	4180186
19475210	HLA B Antigens	4180186
19475210	Antigens, HLA B	4180186
19475210	Antigen, HLA-B	4180186
19475210	HLA B Antigen	4180186
19475210	HLA-B	4180186
19475210	Antigens, HLA-B	4180186
19475212	Dopaminergic Effects	4180186
19475212	Effects, Dopaminergic	4180186
19475212	Agents, Dopamine	4180186
19475212	Effect, Dopamine	4180186
19475212	Dopamine Effect	4180186
19475212	Agents, Dopaminergic	4180186
19475212	Dopamine Drugs	4180186
19475212	Dopaminergic Agents	4180186
19475212	Dopaminergic Drugs	4180186
19475212	Drugs, Dopamine	4180186
19475212	Drugs, Dopaminergic	4180186
19475212	Effects, Dopamine	4180186
19475212	Dopamine Effects	4180186
19475212	Dopaminergic Effect	4180186
19475212	Effect, Dopaminergic	4180186
19475214	Cancer-Associated Carbohydrate Antigens	4180186
19475214	CA(Oxford) Antigen	4180186
19475214	Antigens, Carbohydrate, Tumor-Associated	4180186
19475214	Antigens, Cancer-Associated Carbohydrate	4180186
19475214	Carcinoma-Associated Antigen	4180186
19475214	Carbohydrate Antigens, Tumor Associated	4180186
19475214	Carbohydrate Antigens, Cancer-Associated	4180186
19475214	Carbohydrate Antigens, Tumor-Associated	4180186
19475214	CA Antigen	4180186
19475214	Cancer Associated Carbohydrate Antigens	4180186
19475214	Epitectin	4180186
19475214	Antigen, CA	4180186
19475214	Antigens, Tumor-Associated Carbohydrate	4180186
19475214	Tumor Associated Carbohydrate Antigens	4180186
19475214	Antigen, Carcinoma-Associated	4180186
19475214	Antigen, Carcinoma Associated	4180186
19475214	Tumor-Associated Carbohydrate Antigens	4180186
19475214	CA Antigens	4180186
19475214	Antigens, CA	4180186
19475214	Carcinoma Associated Antigen	4180186
19475217	Probes, Nucleic Acid	4180186
19475217	Acid Probes, Nucleic	4180186
19475220	Papilloma Virus DNA Probes	4180186
19475220	Human Papilloma Virus DNA Probes	4180186
19475220	Probes, HPV DNA	4180186
19475220	HPV DNA Probes	4180186
19475223	Biosensors	4180186
19475223	Biosensing Technic	4180186
19475223	Bioprobes	4180186
19475223	Biosensor	4180186
19475223	Technics, Biosensing	4180186
19475223	Technique, Biosensing	4180186
19475223	Electrode, Enzyme	4180186
19475223	Techniques, Biosensing	4180186
19475223	Biosensing Technique	4180186
19475223	Enzyme Electrode	4180186
19475223	Technic, Biosensing	4180186
19475223	Electrodes, Enzyme	4180186
19475223	Biosensing Technics	4180186
19475223	Bioprobe	4180186
19475223	Enzyme Electrodes	4180186
19475225	Class I Antigen	4180186
19475225	Class I Histocompatibility Antigens	4180186
19475225	Class I Histocompatibility Antigen	4180186
19475225	MHC-I Molecules	4180186
19475225	Class I Major Histocompatibility Antigen	4180186
19475225	I Antigen, Class	4180186
19475225	Molecules, MHC-I	4180186
19475225	MHC I Peptides	4180186
19475225	Class I Human Antigens	4180186
19475225	Human Class I Antigens	4180186
19475225	Antigen, Class I	4180186
19475225	Antigens, Class I	4180186
19475225	MHC-I Peptides	4180186
19475225	MHC I Peptide	4180186
19475225	Class I Major Histocompatibility Antigens	4180186
19475225	Peptides, MHC-I	4180186
19475225	Class I Major Histocompatibility Molecules	4180186
19475225	Class I Antigens	4180186
19475225	Peptide, MHC-I	4180186
19475225	MHC Class I Molecule	4180186
19475225	MHC I Molecules	4180186
19475225	MHC Class I Molecules	4180186
19475225	MHC-I Peptide	4180186
19475225	Class I MHC Proteins	4180186
19475225	Class I MHC Protein	4180186
19475229	Leukemia Virus Antigens, Human T-Cell	4180186
19475229	Leukemia Lymphoma Virus Antigens, Human T Cell	4180186
19475229	BLV Antigens	4180186
19475229	Leukemia Virus Antigens, Human T Cell	4180186
19475229	HTLV-BLV Antigens	4180186
19475229	Human T-Cell Leukemia Virus Antigens	4180186
19475229	Antigens, BLV	4180186
19475229	HTLV Antigens	4180186
19475229	Antigens, HTLV	4180186
19475229	Antigens, Deltaretrovirus	4180186
19475229	Leukemia-Lymphoma Virus Antigens, Human T-Cell	4180186
19475229	Antigens, HTLV-BLV	4180186
19475229	T-Cell Leukemia-Lymphoma Virus Antigens, Human	4180186
19475229	T Cell Leukemia Lymphoma Virus Antigens, Human	4180186
19475229	Human T Cell Leukemia Virus Antigens	4180186
19475229	HTLV BLV Antigens	4180186
19475233	Tissel	4180186
19475233	Autologous Fibrin Tissue Adhesive	4180186
19475233	Sealant, Human Fibrin	4180186
19475233	Adhesive, Fibrin	4180186
19475233	Tissucol	4180186
19475233	Transglutine	4180186
19475233	Sealant, Fibrin	4180186
19475233	Fibrin Glue	4180186
19475233	Tissue Adhesive, Fibrin	4180186
19475233	Adhesive, Fibrin Tissue	4180186
19475233	Adhesive, Fibrinogen	4180186
19475233	Glue, Fibrin	4180186
19475233	Beriplast	4180186
19475233	Fibrin Adhesive	4180186
19475233	Seal, Fibrin	4180186
19475233	Fibrin Seal	4180186
19475233	Crosseal	4180186
19475233	Fibrin Sealant System	4180186
19475233	Fibrin Klebe System Immuno	4180186
19475233	Fibrin Sealant, Human	4180186
19475233	Sealant System, Fibrin	4180186
19475233	Tisseel	4180186
19475233	Human Fibrin Sealant	4180186
19475233	Fibrin Sealant	4180186
19475233	Fibrinogen Adhesive	4180186
19475236	R 17934	4180186
19475236	NSC 238159	4180186
19475236	R-17934	4180186
19475236	Oncodazole	4180186
19475236	NSC238159	4180186
19475236	R17934	4180186
19475236	NSC-238159	4180186
19475236	Carbamic acid, (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl)-, methyl ester	4180186
19475237	Calcitonin Gene Related Peptide I	4180186
19475237	beta-Calcitonin Gene-Related Peptide	4180186
19475237	Gene-Related Peptide, Calcitonin	4180186
19475237	Calcitonin Gene-Related Peptide II	4180186
19475237	alpha Calcitonin Gene Related Peptide	4180186
19475237	beta Calcitonin Gene Related Peptide	4180186
19475237	alpha-Calcitonin Gene-Related Peptide	4180186
19475237	Calcitonin Gene Related Peptide II	4180186
19475237	beta-CGRP	4180186
19475237	alpha-CGRP	4180186
19475237	Calcitonin Gene-Related Peptide I	4180186
19475237	Calcitonin Gene Related Peptide	4180186
19475238	Methyltrienolone	4180186
19475238	Estra-4,9,11-trien-3-one, 17-hydroxy-17-methyl-, (17beta)-	4180186
19475238	R-1881	4180186
19475238	Ru-1881	4180186
19475238	17 beta-Hydroxy-17 alpha-methylestra-4,9,11-trien-3-one	4180186
19475238	R 1881	4180186
19475238	R1881	4180186
19475238	Ru1881	4180186
19475238	Ru 1881	4180186
19475241	Carbapenem	4180186
19475241	Antibiotics, Carbapenem	4180186
19475241	Carbapenem Antibiotics	4180186
19475242	HLA A1 Antigen	4180186
19475242	HLA Class I Histocompatibility Antigen, A-1 alpha Chain	4180186
19475242	HLA-A1	4180186
19475242	HLA Class I Histocompatibility Antigen, A 1 alpha Chain	4180186
19475242	Antigen, HLA-A1	4180186
19475243	HLA-A2	4180186
19475243	HLA Class I Histocompatibility Antigen, A 2 alpha Chain	4180186
19475243	HLA A2 Antigen	4180186
19475243	HLA Class I Histocompatibility Antigen, A-2 alpha Chain	4180186
19475243	Antigen, HLA-A2	4180186
19475244	Antigen, HLA-A3	4180186
19475244	HLA A3 Antigen	4180186
19475244	HLA-A3	4180186
19475244	HLA Class I Histocompatibility Antigen, A-3 alpha Chain	4180186
19475248	HLA Class I Histocompatibility Antigen, B 35 alpha Chain	4180186
19475248	HLA Class I Histocompatibility Antigen, B-35 alpha Chain	4180186
19475248	Antigen, HLA-B35	4180186
19475248	HLA-B35	4180186
19475248	HLA B35 Antigen	4180186
19475249	HLA-DR4	4180186
19475249	Antigen, HLA-DR4	4180186
19475249	HLA DR4 Antigen	4180186
19475255	Heparin Co-Factor II	4180186
19475255	Heparin Co Factor II	4180186
19475255	Protease Inhibitor Leuserpin 2	4180186
19475255	Heparin Cofactor 2	4180186
19475255	Leuserpin 2	4180186
19475255	Serpin D1	4180186
19475257	Type III Cystatins	4180186
19475257	Type 3 Cystatins	4180186
19475257	Cystatins, Type 3	4180186
19475257	Cystatin-Related Proteins	4180186
19475257	Type 1 Cystatins	4180186
19475257	Stefins	4180186
19475257	Cystatins, Type II	4180186
19475257	Cystatins, Type 1	4180186
19475257	Cystatins, Type I	4180186
19475257	Type I Cystatins	4180186
19475257	Cystatins, Type III	4180186
19475257	Cystatin	4180186
19475257	Stefin	4180186
19475257	Type 2 Cystatins	4180186
19475257	Cystatin Superfamily	4180186
19475257	Cystatin Related Proteins	4180186
19475257	Cystatins, Type 2	4180186
19475257	Type II Cystatins	4180186
19475258	C1q Complement	4180186
19475258	Complement, C1q	4180186
19475258	C1q, Complement	4180186
19475258	Complement Component 1q	4180186
19475258	Complement 1q	4180186
19475258	Component 1q, Complement	4180186
19475260	Complement, C3a	4180186
19475260	Component 3a, Complement	4180186
19475260	C3a, Complement	4180186
19475260	Complement Component 3a	4180186
19475260	Complement 3a	4180186
19475260	C3a Complement	4180186
19475261	C3c Fragment, Complement	4180186
19475261	Fragment, Complement C3c	4180186
19475261	Complement Component 3c	4180186
19475261	Complement 3c	4180186
19475261	Component 3c, Complement	4180186
19475261	C3c Complement	4180186
19475261	Complement C3c Fragment	4180186
19475261	Complement, C3c	4180186
19475261	C3c, Complement	4180186
19475262	Fragment, Complement C3d	4180186
19475262	Complement Component 3d	4180186
19475262	Complement, C3d	4180186
19475262	C3d Complement	4180186
19475262	C3d Fragment, Complement	4180186
19475262	C3d, Complement	4180186
19475262	Complement 3d	4180186
19475262	Complement C3d Fragment	4180186
19475262	Component 3d, Complement	4180186
19475264	Complement 4b	4180186
19475264	C4b, Complement	4180186
19475264	Component 4b, Complement	4180186
19475264	Complement, C4b	4180186
19475264	Complement Component 4b	4180186
19475264	C4b Complement	4180186
19475265	Complement Component 5a	4180186
19475265	C5a Complement	4180186
19475265	Complement 5a	4180186
19475265	C5a, Complement	4180186
19475265	Complement, C5a	4180186
19475265	Component 5a, Complement	4180186
19475266	des-Arginine C5a	4180186
19475266	des-Arg, C5a	4180186
19475266	C5a, des Arginine	4180186
19475266	C5 a, des-Arginine	4180186
19475266	Complement C5a, des Arginine	4180186
19475266	C5a, des-Arginine Complement	4180186
19475266	C5a, des Arg	4180186
19475266	C5a des-Arginine	4180186
19475266	C5a, des-Arg	4180186
19475266	des-Arg C5a	4180186
19475266	des-Arginine C5 a	4180186
19475266	C5a des-Arg	4180186
19475266	C5 a, des-Arg	4180186
19475266	Complement 5a, de-Arginine	4180186
19475266	de-Arginine Complement 5a	4180186
19475266	des-Arginine Complement 5a	4180186
19475266	Complement 5a, des Arginine	4180186
19475266	des-Arg C5 a	4180186
19475266	des-Arginine Complement C5a	4180186
19475266	Complement 5a, de Arginine	4180186
19475266	C5 a, des Arg	4180186
19475266	C5a, des-Arginine	4180186
19475266	C5 a, des Arginine	4180186
19475266	des-Arginine, C5a	4180186
19475266	Complement 5a, des-Arginine	4180186
19475266	C5a des Arginine	4180186
19475267	Terminal Complement Complex	4180186
19475267	Complement Complex, Terminal	4180186
19475267	C5b 8 poly C9	4180186
19475267	C 5b-9	4180186
19475267	C5b-8-poly-C9	4180186
19475267	Complement Complex C5b 9	4180186
19475267	C5b-9	4180186
19475267	Cytolytic Terminal Complement Complex	4180186
19475267	Membrane Attack Complex	4180186
19475267	Complement Complex C5b-9	4180186
19475267	Complex, Terminal Complement	4180186
19475268	Leucomycin	4180186
19475269	alpha-Trichosanthin	4180186
19475269	Tian-hua-fen	4180186
19475269	Compound Q	4180186
19475269	GLQ-223	4180186
19475269	Proteins, specific or class, trichosanthins	4180186
19475269	GLQ 223	4180186
19475269	T'ien-hua-fen	4180186
19475269	alpha Trichosanthin	4180186
19475269	GLQ223	4180186
19475270	Integrin	4180186
19475271	Extracellular Matrix Glycoprotein Receptors	4180186
19475271	Receptors, Extracellular Matrix Glycoprotein	4180186
19475271	Cytoadhesin Receptors	4180186
19475272	Receptors, Leukocyte Adhesion	4180186
19475272	Leukocyte Adhesion Receptor Family	4180186
19475272	Receptor, Leukocyte-Adhesion	4180186
19475272	Leu CAM Receptor Family	4180186
19475272	Family, Leu-CAM Receptor	4180186
19475272	Leukocyte-Adhesion Receptors	4180186
19475272	Receptor Family, Leu-CAM	4180186
19475272	Leukocyte-Adhesion Receptor Family	4180186
19475272	Leukocyte Adhesion Receptors	4180186
19475272	Leukocyte Adhesion Receptor	4180186
19475272	Leukocyte-Adhesion Receptor	4180186
19475272	Leu-CAM Receptor Family	4180186
19475273	Receptors, Very Late Activation Antigen	4180186
19475273	VLA Differentiation Antigens	4180186
19475273	Activation Antigens, VLA	4180186
19475273	Protein Complex, VLA	4180186
19475273	Very Late Antigen Receptors	4180186
19475273	VLA Activation Antigens	4180186
19475273	Very Late Activation Antigen Receptors	4180186
19475273	Receptors, VLA	4180186
19475273	Receptor, Very Late Antigen	4180186
19475273	Antigens, VLA Differentiation	4180186
19475273	VLA Receptors	4180186
19475273	Differentiation Antigens, VLA	4180186
19475273	VLA Protein Complex	4180186
19475273	Antigens, VLA Activation	4180186
19475274	Moon Phase	4180186
19475274	Lunar Cycles	4180186
19475274	Lunar Phases	4180186
19475274	Cycles, Moon	4180186
19475274	Moon Cycle	4180186
19475274	Phase, Lunar	4180186
19475274	Cycle, Moon	4180186
19475274	Lunar Phase	4180186
19475274	Moon Phases	4180186
19475274	Moons	4180186
19475274	Cycle, Lunar	4180186
19475274	Phases, Moon	4180186
19475274	Phase, Moon	4180186
19475274	Cycles, Lunar	4180186
19475274	Lunar Cycle	4180186
19475274	Phases, Lunar	4180186
19475274	Moon Cycles	4180186
19475279	CSF-1	4180186
19475279	Colony-Stimulating Factor 1	4180186
19475279	Colony-stimulating factor 1	4180186
19475279	Colony-Stimulating Factor, Macrophage	4180186
19475279	M-CSF	4180186
19475279	Colony Stimulating Factor, Macrophage	4180186
19475279	CSF-M	4180186
19475279	Colony Stimulating Factor 1	4180186
19475281	Receptor, CR3	4180186
19475281	Complement 3 Receptor	4180186
19475281	Receptor, Mo1 Antigen	4180186
19475281	Mac 1 Antigen	4180186
19475281	Receptor, Complement 3	4180186
19475281	Adhesive Receptor Mac-1	4180186
19475281	alpha-M beta-2, Integrin	4180186
19475281	Mac 1 Adhesive Receptor	4180186
19475281	Mac-1 Receptor	4180186
19475281	Glycoprotein Receptor, Mo1	4180186
19475281	Mo1 Glycoprotein Receptor	4180186
19475281	Receptor, Mo1 Glycoprotein	4180186
19475281	Mac 1 Receptor	4180186
19475281	Integrin alpha(M)beta(2)	4180186
19475281	Integrin alpha-M beta-2	4180186
19475281	Mac-1 Adhesive Receptor	4180186
19475281	Macrophage 1 Antigen	4180186
19475281	Integrin alphaMbeta2	4180186
19475281	Mo1 Antigen Receptor	4180186
19475281	alphaMbeta2, Integrin	4180186
19475281	Receptor, Mac-1 Adhesive	4180186
19475281	Adhesive Receptor, Mac-1	4180186
19475281	Mac-1 Antigen	4180186
19475281	Integrin alpha M beta 2	4180186
19475281	CR3 Receptor	4180186
19475281	Antigen Receptor, Mo1	4180186
19475281	Antigen, Macrophage-1	4180186
19475284	Colony Stimulating Factor Receptor	4180186
19475284	Receptor, Colony-Stimulating Factor	4180186
19475284	Colony Stimulating Factor Receptors	4180186
19475284	CSF Receptors	4180186
19475284	Receptors, Hematopoietic Growth Factors	4180186
19475284	Colony-Stimulating Factor Receptor	4180186
19475284	Receptors, Colony Stimulating Factor	4180186
19475284	Receptors, CSF	4180186
19475284	Hematopoietic Growth Factors Receptors	4180186
19475284	Colony-Stimulating Factor Receptors	4180186
19475284	Hematopoietic Growth Factor Receptor	4180186
19475288	Lymphocyte Homing Receptors	4180186
19475288	Hermes Antigen Family	4180186
19475288	Receptor, Lymph Node Homing	4180186
19475288	Homing Receptor, Lymph Node	4180186
19475288	Homing Receptors, T-Cell	4180186
19475288	Homing Receptors, Lymphocyte	4180186
19475288	T-Cell Homing Receptors	4180186
19475288	Lymph Node Homing Receptor	4180186
19475288	Homing Receptors, T Cell	4180186
19475288	Receptors, T-Cell Homing	4180186
19475288	Antigen Family, Hermes	4180186
19475290	Factors, Macrophage-Activating	4180186
19475290	Macrophage Activating Factors	4180186
19475291	Index Medicus	4180186
19475297	Sodium Dextran Sulfate	4180186
19475297	Dextran Sulfate, Sodium	4180186
19475297	Sulfate, Dextran	4180186
19475297	Sulfate, Sodium Dextran	4180186
19475297	Dextran Sulfate Sodium	4180186
19475297	Sulfate Sodium, Dextran	4180186
19475297	Dextran, hydrogen sulfate	4180186
19475299	MK-801	4180186
19475299	MK801	4180186
19475299	Dizocilpine	4180186
19475299	5H-Dibenzo(a,d)cyclohepten-5,10-imine, 10,11-dihydro-5-methyl-, (5S)-, (Z)-2-butenedioate (1:1)	4180186
19475299	MK 801	4180186
19475304	Centers, Drug Treatment	4180186
19475304	Treatment Centers, Substance Abuse	4180186
19475304	Drug Rehabilitation Centers	4180186
19475304	Rehabilitation Centers, Drug	4180186
19475304	Drug Treatment Centers	4180186
19475304	Drug Treatment Center	4180186
19475304	Rehabilitation Center, Drug	4180186
19475304	Centers, Drug Rehabilitation	4180186
19475304	Treatment Center, Drug	4180186
19475304	Treatment Centers, Drug	4180186
19475304	Center, Drug Rehabilitation	4180186
19475304	Drug Rehabilitation Center	4180186
19475304	Treatment Centers, Drug Abuse	4180186
19475304	Center, Drug Treatment	4180186
19475304	Drug Abuse Treatment Centers	4180186
19475306	Computerized Medical Record System	4180186
19475306	Medical Record System, Computerized	4180186
19475306	Automated Medical Record Systems	4180186
19475306	Medical Records System, Automated	4180186
19475306	Medical Record Systems, Automated	4180186
19475306	Medical Records Systems, Automated	4180186
19475306	Computerized Medical Records System	4180186
19475306	Computerized Medical Record Systems	4180186
19475306	Computerized Medical Records Systems	4180186
19475306	Automated Medical Record System	4180186
19475306	Medical Record Systems, Computerized	4180186
19475306	Automated Medical Records System	4180186
19475306	Medical Record System, Automated	4180186
19475306	Computerized Patient Medical Records	4180186
19475306	Automated Medical Records Systems	4180186
19475306	Medical Records System, Computerized	4180186
19475307	Group Home	4180186
19475307	Home, Group	4180186
19475307	Homes, Group	4180186
19475309	Anti Sense DNA	4180186
19475309	DNA, Anti-Sense	4180186
19475309	Anti-Sense DNA	4180186
19475309	Antisense DNA	4180186
19475310	Anti-Sense Elements	4180186
19475310	Probes, Anti-Sense	4180186
19475310	Anti-Sense Probes	4180186
19475310	Antisense Probes	4180186
19475310	Elements, Anti-Sense	4180186
19475310	Probes, Antisense	4180186
19475310	Anti Sense Probes	4180186
19475310	Anti Sense Elements	4180186
19475315	ICI-69653	4180186
19475315	ICI 69653	4180186
19475315	NSC351140	4180186
19475315	Aphidicolin, (3-S-(3alpha,4beta,4abeta,6aalpha,8alpha,9alpha,11aalpha,11balpha))-Isomer	4180186
19475315	NSC 234714	4180186
19475315	NSC234714	4180186
19475315	NSC 351140	4180186
19475315	NSC-234714	4180186
19475315	ICI69653	4180186
19475315	NSC-351140	4180186
19475315	9,15-Cyclo-C,18-dinor-14,15-secoandrostane-4,17-dimethanol, 3,17-dihydroxy-4-methyl-, (3alpha,4alpha,5alpha,17alpha)-	4180186
19475316	RS 84135	4180186
19475316	Enprostil, (1alpha,2alpha(1E,3S*),3beta)-(+-)-Isomer	4180186
19475316	Enprostil, (1alpha,2beta(1E,3R*),3alpha)-(+-)-Isomer	4180186
19475316	4,5-Heptadienoic acid, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-, methyl ester, (1alpha,2beta(1E,3R*),3alpha)-	4180186
19475316	RS84135	4180186
19475316	Gardrin	4180186
19475316	Enprostil, (1alpha(R*),2beta(1E,3R*),3alpha)-(+-)-Isomer	4180186
19475316	Enprostil, (1R-(1alpha,2beta(1E,3R*),3alpha))-Isomer	4180186
19475316	Enprostil, (1R-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer	4180186
19475316	Enprostil, (1S-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer	4180186
19475316	Enprostil, (1alpha(R*),2beta(1E,3S*),3alpha)-(+-)-Isomer	4180186
19475316	Enprostil, (1S-(1alpha(R*),2beta(1E,3R*),3alpha))-Isomer	4180186
19475316	Enprostil, (1R-(1(R*),2beta(1E,3R*),3alpha))-Isomer	4180186
19475316	RS-84135	4180186
19475317	ORF-15927	4180186
19475317	Prost-13-en-9-one, 1,11,16-trihydroxy-16-methyl-, (11alpha,13E)-	4180186
19475317	TR-4698	4180186
19475317	TR 4698	4180186
19475317	RWJ 15927	4180186
19475317	TR4698	4180186
19475317	RWJ-15927	4180186
19475317	RWJ15927	4180186
19475317	ORF15927	4180186
19475317	ORF 15927	4180186
19475319	Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3',6'-dihydroxy-5-isothiocyanato-	4180186
19475319	5-Isothiocyanatofluorescein	4180186
19475319	5 Isothiocyanatofluorescein	4180186
19475319	Fluorescein (5 or 6)-Isothiocyanate	4180186
19475319	Fluorescein 5 isothiocyanate Hydrochloride	4180186
19475319	FITC	4180186
19475319	Hydrochloride, Fluorescein-5-isothiocyanate	4180186
19475319	Fluorescein-5-isothiocyanate Hydrochloride	4180186
19475319	Fluorescein 5 isothiocyanate	4180186
19475321	Bacterial Capsule	4180186
19475321	Capsules, Bacterial	4180186
19475321	Capsule, Bacterial	4180186
19475323	Coagulation Inhibitor, Lupus	4180186
19475323	Autoantibody, Lupus Anticoagulant	4180186
19475323	Lupus Anticoagulant Autoantibodies	4180186
19475323	Lupus Anticoagulant	4180186
19475323	Anticoagulant Autoantibody, Lupus	4180186
19475323	Inhibitor, Lupus Coagulation	4180186
19475323	Lupus Anticoagulant Autoantibody	4180186
19475323	Anticoagulant, Lupus	4180186
19475326	T Cell Receptor, alpha beta	4180186
19475326	T Cell Receptor beta Chain	4180186
19475326	T-Cell Receptors beta-Chain	4180186
19475326	Receptors, Antigen, T Cell, alpha beta	4180186
19475326	T-Cell Receptor, alpha-beta	4180186
19475326	TcR alpha beta	4180186
19475326	Antigen T Cell Receptor, alpha Chain	4180186
19475326	T Cell Receptor alpha Chain	4180186
19475326	beta-Chain, T-Cell Receptors	4180186
19475326	T Cell Receptors, alpha beta	4180186
19475326	T-Cell Receptors, alpha-beta	4180186
19475326	Antigen Receptors, T-Cell, alpha-beta	4180186
19475326	alpha-beta T-Cell Receptor	4180186
19475326	alpha-beta, TcR	4180186
19475326	TcR alpha-beta	4180186
19475326	Antigen T Cell Receptor, beta Chain	4180186
19475326	alpha-beta T-Cell Receptors	4180186
19475326	alpha-Chain, T-Cell Receptor	4180186
19475326	T-Cell Receptors alpha-Chain	4180186
19475326	T-Cell Receptor alpha-Chain	4180186
19475326	beta-Chain, T-Cell Receptor	4180186
19475326	T Cell Receptors beta Chain	4180186
19475326	T Cell Receptors alpha Chain	4180186
19475326	alpha-Chain, T-Cell Receptors	4180186
19475326	T-Cell Receptor beta-Chain	4180186
19475328	Determinants, Mls	4180186
19475328	Mls Determinants	4180186
19475328	Mls Antigens	4180186
19475328	Antigens, Minor Lymphocyte-Stimulating	4180186
19475328	Lymphocyte Activating Determinants	4180186
19475328	Minor Lymphocyte Stimulating Determinants	4180186
19475328	Minor Lymphocyte-Stimulating Antigens	4180186
19475328	Antigens, Minor Lymphocyte Stimulatory	4180186
19475328	Minor Lymphocyte Stimulatory Determinants	4180186
19475328	Lymphocyte-Stimulating Antigens, Minor	4180186
19475328	Minor Lymphocyte Stimulating Antigens	4180186
19475328	Determinants, Lymphocyte-Activating	4180186
19475328	Lymphocyte Stimulatory Antigens, Minor	4180186
19475328	Lymphocyte-Activating Determinants	4180186
19475328	Determinants, Minor Lymphocyte-Stimulating	4180186
19475328	Minor Lymphocyte-Stimulating Determinants	4180186
19475328	Antigens, Mls	4180186
19475328	Lymphocyte-Stimulating Determinants, Minor	4180186
19475332	Swainsonine, (2 beta,8a alpha)-Isomer	4180186
19475332	1,2,8-Indolizinetriol, octahydro-, (1S-(1alpha,2alpha,8beta,8abeta))-	4180186
19475332	Swainsonine, (1R-(2 beta,8a alpha))-Isomer	4180186
19475332	Swainsonine, (8 alpha,8a alpha)-Isomer	4180186
19475332	Swainsonine, (8a alpha)-Isomer	4180186
19475332	Swainsonine, (8 alpha)-Isomer	4180186
19475333	Autoantibody, Phospholipid	4180186
19475333	Autoantibody, Antiphospholipid	4180186
19475333	Phospholipid Autoantibodies	4180186
19475333	Antiphospholipid Antibody	4180186
19475333	Antiphospholipid Antibodies	4180186
19475333	Antibody, Antiphospholipid	4180186
19475333	Antiphospholipid Autoantibody	4180186
19475333	Phospholipid Autoantibody	4180186
19475333	Antiphospholipid Autoantibodies	4180186
19475335	Factor H	4180186
19475335	Factor H, Complement	4180186
19475337	CD3 Antigen	4180186
19475337	Antigens, T3	4180186
19475337	Antigen, CD3	4180186
19475337	T3 Antigens	4180186
19475337	CD3 Antigens	4180186
19475337	T3 Complex	4180186
19475337	T3 Antigen	4180186
19475337	Antigens, CD3	4180186
19475337	Antigen, T3	4180186
19475341	Renocortin	4180186
19475341	Lipocortin 1	4180186
19475341	Annexin I	4180186
19475341	Lipocortin I	4180186
19475341	Calpactin II	4180186
19475341	Chromobindin 9	4180186
19475343	CGS 16949A	4180186
19475343	Hydrochloride, Fadrozole	4180186
19475343	CGS16949A	4180186
19475343	CGS020286A	4180186
19475343	Monohydrochloride, Fadrozole	4180186
19475343	Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-	4180186
19475343	FAD286	4180186
19475343	Fadrozole Monohydrochloride	4180186
19475343	Fadrozole Hydrochloride	4180186
19475343	FAD 286	4180186
19475343	CGS-020286A	4180186
19475343	CGS 020286A	4180186
19475343	CGS-16949A	4180186
19475343	FAD-286	4180186
19475344	Effect, Photosensitizing	4180186
19475344	Agents, Photosensitizing	4180186
19475344	Agent, Photosensitizing	4180186
19475344	Photosensitizer	4180186
19475344	Photosensitizing Effects	4180186
19475344	Photosensitizers	4180186
19475344	Photosensitizing Agent	4180186
19475344	Photosensitizing Effect	4180186
19475344	Effects, Photosensitizing	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin Hydrochloride, (R)-Isomer,	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin Hydrochloride, (S)-Isomer	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (S)-Isomer,	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin, (+-)-Isomer	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (+-)-Isomer	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide	4180186
19475348	1-Naphthalenol, 7-(dipropylamino)-5,6,7,8-tetrahydro-	4180186
19475348	8-OH-DPAT	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin, (S)-Isomer	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin Hydrobromide, (R)-Isomer,	4180186
19475348	8-Hydroxy-2-(di-n-propylamino)tetralin, (R)-Isomer	4180186
19475351	Concise White Sealant	4180186
19475351	Resin, Concise	4180186
19475351	Concise Resin	4180186
19475351	NuvaSeal	4180186
19475351	Conclude Resin	4180186
19475351	Enamel Bond, Concise	4180186
19475351	Bis-GMA Resin	4180186
19475351	Resins, Concise Composite	4180186
19475351	Resins, Bis-GMA	4180186
19475351	Bisphenol A-Glycidyl Methacrylate Homopolymer	4180186
19475351	Polymers, Bis-GMA	4180186
19475351	Bisphenol A Glycidyl Methacrylate Homopolymer	4180186
19475351	Nuva-Seal	4180186
19475351	Bisphenol A Glycidyl Methacrylate Polymer	4180186
19475351	Bis(Phenol A-Glycidyl Methacrylate)	4180186
19475351	Methacrylate, Bisphenol A-Glycidyl	4180186
19475351	Bond, Concise Enamel	4180186
19475351	Resin, Concise Composite	4180186
19475351	Bis-GMA Resins	4180186
19475351	Kerr Pit and Fissure Sealant	4180186
19475351	Epoxylite 9075	4180186
19475351	Bisphenol A-Glycidyl Methacrylate Polymer	4180186
19475351	Resin, Conclude	4180186
19475351	Bisphenol A Glycidyl Methacrylate	4180186
19475351	Polymer, Bis-GMA	4180186
19475351	Bis(Phenol A-Glycydyl Methacrylate)	4180186
19475351	Adaptic	4180186
19475351	Composite Resin, Concise	4180186
19475351	Concise Resins	4180186
19475351	Nuva Seal	4180186
19475351	Concise Composite Resins	4180186
19475351	Concise Enamel Bond System	4180186
19475351	Resins, Concise	4180186
19475351	Concise Composite Resin	4180186
19475351	Silux	4180186
19475351	Bis GMA Polymer	4180186
19475351	Epoxylite-9075	4180186
19475351	Bis GMA Resin	4180186
19475351	Bis-GMA	4180186
19475351	Bis(Phenol A-Glycidyl Methacrylate), Homopolymer	4180186
19475351	Resin, Conclude Composite	4180186
19475351	Retroplast	4180186
19475351	Composite Resin, Conclude	4180186
19475351	Epoxylite9075	4180186
19475351	Composite Resins, Concise	4180186
19475351	Poly(Bis-GMA)	4180186
19475351	Bis GMA	4180186
19475351	Bis-GMA Polymers	4180186
19475351	Opaque, Panavia	4180186
19475351	Concise Enamel Bond	4180186
19475351	Delton	4180186
19475351	Panavia Opaque	4180186
19475351	2-Propenoic acid, 2-methyl-, (1-methylethylidene)bis(4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)) ester	4180186
19475351	Kerr Sealer	4180186
19475351	2-Propenoic acid, 2-methyl-, (1-methylethylidene)bis(4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)) ester, homopolymer	4180186
19475351	Bis-GMA Polymer	4180186
19475351	Conclude Composite Resin	4180186
19475351	Resin, Bis-GMA	4180186
19475352	SKF92676	4180186
19475352	Impromidine Hydrochloride	4180186
19475352	Hydrochloride, Impromidine	4180186
19475352	SK&F92676	4180186
19475352	Trihydrochloride, Impromidine	4180186
19475352	Impromidine Oxalate (1:2)	4180186
19475352	SK&F-92676	4180186
19475352	SKF 92676	4180186
19475352	Guanidine, N-(3-(1H-imidazol-4-yl)propyl)-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-	4180186
19475352	SKF-92676	4180186
19475352	SK&F 92676	4180186
19475352	Impromidine Trihydrochloride	4180186
19475354	IgE Receptor	4180186
19475354	Antigens, CD 23	4180186
19475354	epsilon RII, Fc	4180186
19475354	Immunoglobulin E Receptor	4180186
19475354	Fc epsilon RII	4180186
19475354	Antigens, CD23	4180186
19475354	Receptors, Fc epsilon	4180186
19475354	Receptor, epsilon Fc	4180186
19475354	Antigen, CD23	4180186
19475354	CD23 Antigens	4180186
19475354	epsilon Receptors, Fc	4180186
19475354	Receptor, Immunoglobulin E	4180186
19475354	epsilon RI, Fc	4180186
19475354	Fc Receptor, epsilon	4180186
19475354	Receptors, epsilon Fc	4180186
19475354	epsilon Fc Receptors	4180186
19475354	Fc epsilon Receptor	4180186
19475354	Receptor, IgE	4180186
19475354	Fc epsilon RI	4180186
19475354	CD 23 Antigens	4180186
19475354	CD23 Antigen	4180186
19475354	epsilon Fc Receptor	4180186
19475354	IgE Receptors	4180186
19475354	Fc epsilon Receptors	4180186
19475354	Fc Receptors, epsilon	4180186
19475354	epsilon Receptor, Fc	4180186
19475354	Receptor, Fc epsilon	4180186
19475357	Receptors, CR2	4180186
19475357	Receptor, Complement 3d	4180186
19475357	Epstein-Barr Virus Receptor	4180186
19475357	Receptors, Epstein Barr Virus	4180186
19475357	Epstein Barr Virus Receptor	4180186
19475357	Virus Receptors, Epstein-Barr	4180186
19475357	Antigens, CD 21	4180186
19475357	Epstein Barr Virus Receptors	4180186
19475357	CD 21 Antigens	4180186
19475357	Epstein-Barr Virus Receptors	4180186
19475357	Complement Receptors 2	4180186
19475357	Virus Receptor, Epstein-Barr	4180186
19475357	Receptors, Epstein-Barr Virus	4180186
19475357	C3d Receptors	4180186
19475357	Antigen, CD21	4180186
19475357	Complement 3d Receptors	4180186
19475357	CR2 Receptors	4180186
19475357	Receptors, C3d	4180186
19475357	Complement Receptor 2	4180186
19475357	CD21 Antigen	4180186
19475357	CD21 Antigens	4180186
19475357	Complement 3d Receptor	4180186
19475357	Receptor, Epstein-Barr Virus	4180186
19475357	Receptors 2, Complement	4180186
19475357	Antigens, CD21	4180186
19475357	Herpesvirus 4 Receptors, Human	4180186
19475357	Receptor 2, Complement	4180186
19475359	Interferon Receptor	4180186
19475359	Interferon Receptors	4180186
19475359	Receptor, Interferon	4180186
19475360	Receptors, IL1	4180186
19475360	Interleukin 1 Receptors	4180186
19475360	Interleukin-1 Receptor	4180186
19475360	Receptor, IL1	4180186
19475360	IL 1 Receptor	4180186
19475360	IL-1 Receptors	4180186
19475360	IL1 Receptor	4180186
19475360	Receptor, Interleukin 1	4180186
19475360	Receptors, Interleukin 1	4180186
19475360	Receptors, IL-1	4180186
19475360	Receptor, IL-1	4180186
19475360	IL1 Receptors	4180186
19475360	Receptors, IL 1	4180186
19475360	Interleukin-1 Receptors	4180186
19475360	Interleukin 1 Receptor	4180186
19475360	IL 1 Receptors	4180186
19475360	IL-1 Receptor	4180186
19475360	Receptor, Interleukin-1	4180186
19475362	1 Deoxynojirimycin	4180186
19475362	1 Deoxymannojirimycin	4180186
19475362	1,5-Deoxy-1,5-imino-D-mannitol	4180186
19475362	1 Deoxynojirimycin Hydrochloride	4180186
19475362	1-Deoxynojirimycin Hydrochloride	4180186
19475362	Bay n 5595	4180186
19475362	1-Deoxymannojirimycin	4180186
19475362	1,5-Dideoxy-1,5-imino-D-mannitol	4180186
19475362	3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-	4180186
19475362	Moranoline	4180186
19475363	Leukocyte Common Antigen	4180186
19475363	Antigens, CD45R0	4180186
19475363	CD45RB Antigens	4180186
19475363	Antigens, Leukocyte Common	4180186
19475363	2H4 Antigens	4180186
19475363	B220 Antigens	4180186
19475363	L CA Antigens	4180186
19475363	Antigens, 2H4	4180186
19475363	Antigen, B220	4180186
19475363	CD45R Antigens	4180186
19475363	Antigen, CD45	4180186
19475363	CD45R0 Antigens	4180186
19475363	Antigens, CD45RB	4180186
19475363	B220 Antigen	4180186
19475363	Antigens, B220	4180186
19475363	Antigens, CD45R	4180186
19475363	Antigens, L-CA	4180186
19475363	L-CA Antigens	4180186
19475363	CD45RA Antigens	4180186
19475363	CD45RO Antigens	4180186
19475363	T200 Antigens	4180186
19475363	Antigens, CD45	4180186
19475363	Antigen, Leukocyte Common	4180186
19475363	Antigens, T200	4180186
19475363	Antigens, CD45RO	4180186
19475363	Protein Tyrosine Phosphatase, Receptor Type, C	4180186
19475363	CD45 Antigens	4180186
19475363	Antigens, CD45RA	4180186
19475363	CD45 Antigen	4180186
19475363	CD45RCAntigens	4180186
19475364	Proteins, Adenovirus E1	4180186
19475364	E1 Proteins, Adenovirus	4180186
19475365	Adenovirus E1A Protein	4180186
19475365	E1A Proteins, Adenovirus	4180186
19475365	Adenovirus E1A Protein Domain 3	4180186
19475365	E1A Protein, Adenovirus	4180186
19475366	Adenovirus E1B 19K Protein	4180186
19475366	Adenovirus E1B Protein	4180186
19475366	Adenovirus 12 Early Region 1B 19K Protein	4180186
19475366	E1B Proteins, Adenovirus	4180186
19475366	E1B Protein, Adenovirus	4180186
19475368	Adenovirus E3 Protein	4180186
19475368	Adenovirus E3 19K Protein	4180186
19475368	Adenovirus Type 2 E3 19K Protein	4180186
19475368	E3 Protein, Adenovirus	4180186
19475368	E3 Proteins, Adenovirus	4180186
19475368	Adenovirus Type 2 E3-19K Protein	4180186
19475368	E3 19K Protein, Adenovirus	4180186
19475370	TNFRSF8 Receptor	4180186
19475370	Ber H2 Antigen	4180186
19475370	Ber-H2 Antigen	4180186
19475370	Antigen, Ki-1	4180186
19475370	Tumor Necrosis Factor Receptor Superfamily, Member 8	4180186
19475370	Antigens, Ki 1	4180186
19475370	CD30 Antigens	4180186
19475370	Antigens, Ber-H2	4180186
19475370	Antigens, Ki-1	4180186
19475370	Antigens, CD30	4180186
19475370	Ki 1 Antigens	4180186
19475370	Ber-H2 Antigens	4180186
19475370	Antigen, CD30	4180186
19475370	Receptor, TNFRSF8	4180186
19475370	Ber H2 Antigens	4180186
19475370	Antigen, Ber-H2	4180186
19475370	Ki 1 Antigen	4180186
19475370	CD30 Antigen	4180186
19475370	Ki-1 Antigens	4180186
19475371	Biomes	4180186
19475371	Ecological Niche	4180186
19475371	Systems, Ecologic	4180186
19475371	System, Ecologic	4180186
19475371	Niche, Ecological	4180186
19475371	Systems, Ecological	4180186
19475371	System, Ecological	4180186
19475371	Ecological Systems	4180186
19475371	Ecologic System	4180186
19475371	Ecological System	4180186
19475371	Ecologic Systems	4180186
19475371	Habitats	4180186
19475371	Habitat	4180186
19475371	Biome	4180186
19475371	Ecosystems	4180186
19475373	Gold, Colloidal	4180186
19475373	Colloid, Gold	4180186
19475373	Colloidal Gold	4180186
19475374	Monoclonal Antibodies, Bispecific	4180186
19475374	Bispecific Antibodies	4180186
19475374	Bifunctional Antibodies	4180186
19475374	Antibodies, Bifunctional	4180186
19475374	Antibodies, Bispecific Monoclonal	4180186
19475374	Bispecific Monoclonal Antibodies	4180186
19475376	Antigen, CD28	4180186
19475376	T-Cell-Specific Surface Glycoprotein CD28	4180186
19475376	Antigens, CD28	4180186
19475376	Receptor, TP44	4180186
19475376	TP44 Receptor	4180186
19475376	CD28 Antigen	4180186
19475376	T Cell Specific Surface Glycoprotein CD28	4180186
19475378	CD80 Antigen	4180186
19475378	Ligand, B7-1	4180186
19475378	CD80 Antigens	4180186
19475378	B7 1 Ligand	4180186
19475378	B7-1 Ligand	4180186
19475378	Costimulatory Molecule, B7-1	4180186
19475378	B Cell Activation Antigen	4180186
19475378	B7-1 Costimulatory Molecule	4180186
19475378	B-Cell Activation Antigen	4180186
19475378	Antigen, B7-1	4180186
19475378	Antigens, CD80	4180186
19475378	Antigen, B7 1	4180186
19475378	B7 1 Antigen	4180186
19475378	B7 1 Costimulatory Molecule	4180186
19475380	Transforming Growth Factor beta Receptors	4180186
19475380	TGF-beta Receptor	4180186
19475380	Receptors, TGF beta	4180186
19475380	Receptors, TGF-beta	4180186
19475380	Transforming Growth Factor beta Receptor	4180186
19475380	Receptor, TGF-beta	4180186
19475380	TGF beta Receptor	4180186
19475380	TGF-beta Receptors	4180186
19475380	TGF beta Receptors	4180186
19475387	Simulation, Weightlessness	4180186
19475387	Weightlessness Model	4180186
19475387	Models, Weightlessness	4180186
19475387	Weightlessness Models	4180186
19475387	Microgravity Simulation	4180186
19475387	Simulation, Microgravity	4180186
19475389	Effects, Histamine	4180186
19475389	Drugs, Histaminergic	4180186
19475389	Histaminergic Drugs	4180186
19475389	Histamine Effect	4180186
19475389	Agents, Histamine	4180186
19475389	Histaminergic Effect	4180186
19475389	Agents, Histaminergic	4180186
19475389	Drugs, Histamine	4180186
19475389	Effect, Histaminergic	4180186
19475389	Effect, Histamine	4180186
19475389	Effects, Histaminergic	4180186
19475389	Histamine Effects	4180186
19475389	Histaminergic Effects	4180186
19475389	Histaminergic Agents	4180186
19475389	Histamine Drugs	4180186
19475391	Simulations, Orbital	4180186
19475391	Simulation, Space	4180186
19475391	Simulations, Space	4180186
19475391	Orbital Simulation	4180186
19475391	Orbital Simulations	4180186
19475391	Simulation, Orbital	4180186
19475391	Space Simulations	4180186
19475391	Space Model	4180186
19475391	Model, Space	4180186
19475391	Models, Space	4180186
19475391	Space Models	4180186
19475393	Contact Lens Disinfectant Solutions	4180186
19475393	Lens Solution, Contact	4180186
19475393	Lens Cleaners, Contact	4180186
19475393	Contact Lens Cleaners	4180186
19475393	Contact Lens Solution	4180186
19475393	Contact Lens Disinfectants	4180186
19475393	Cleaners, Contact Lens	4180186
19475393	Contact Lens Cleaning Solutions	4180186
19475393	Solutions, Contact Lens	4180186
19475393	Solution, Contact Lens	4180186
19475393	Disinfectants, Contact Lens	4180186
19475393	Lens Solutions, Contact	4180186
19475393	Lens Disinfectants, Contact	4180186
19475395	Center, Supervised Injecting	4180186
19475395	Injecting Centers, Supervised	4180186
19475395	Needle Exchange Programs	4180186
19475395	Syringe-Exchange Programs	4180186
19475395	Programs, Needle-Exchange	4180186
19475395	Centers, Supervised Injecting	4180186
19475395	Supervised Injecting Facilities	4180186
19475395	Supervised Injecting Facility	4180186
19475395	Program, Needle-Exchange	4180186
19475395	Program, Syringe-Exchange	4180186
19475395	Needle Exchange Program	4180186
19475395	Syringe Exchange Program	4180186
19475395	Facilities, Supervised Injecting	4180186
19475395	Supervised Injecting Centers	4180186
19475395	Injecting Center, Supervised	4180186
19475395	Injecting Facility, Supervised	4180186
19475395	Programs, Syringe-Exchange	4180186
19475395	Injecting Facilities, Supervised	4180186
19475395	Needle-Exchange Program	4180186
19475395	Facility, Supervised Injecting	4180186
19475395	Syringe-Exchange Program	4180186
19475395	Syringe Exchange Programs	4180186
19475395	Supervised Injecting Center	4180186
19475398	Amino Acids, Excitatory, Agents	4180186
19475398	Agents, Glutamatergic	4180186
19475398	Agents, Glutamate	4180186
19475398	Excitatory Amino Acid Effect	4180186
19475398	Agents, Excitatory Amino Acid	4180186
19475398	Excitatory Amino Acid Effects	4180186
19475398	Glutamate Agents	4180186
19475398	Amino Acid Agents, Excitatory	4180186
19475398	Glutamatergic Agents	4180186
19475398	EAA Agents	4180186
19475398	Agents, EAA	4180186
19475400	Inhalation Anesthetics	4180186
19475400	Inhalation Anesthetic	4180186
19475400	Gases, Anesthetic	4180186
19475400	Anesthetic Gases	4180186
19475400	Anesthetic, Inhalation	4180186
19475401	Antimanics	4180186
19475401	Effect, Antimanic	4180186
19475401	Antimanic Effects	4180186
19475401	Antimanic Drugs	4180186
19475401	Effects, Antimanic	4180186
19475401	Drugs, Antimanic	4180186
19475401	Agents, Antimanic	4180186
19475401	Antimanic Effect	4180186
19475407	Interleukin 13	4180186
19475407	IL 13	4180186
19475407	IL13	4180186
19475407	IL-13	4180186
19475410	Antigen, CD2	4180186
19475410	CD2 Antigen	4180186
19475410	T11 Erythrocyte-Binding Glycoprotein	4180186
19475410	T11 Erythrocyte Binding Glycoprotein	4180186
19475410	Antigens, CD2	4180186
19475410	Erythrocyte-Binding Glycoprotein, T11	4180186
19475411	N Methyl 3,4 methylenedioxyamphetamine	4180186
19475411	1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl-	4180186
19475411	Ecstasy (Drug)	4180186
19475411	Methylenedioxymethamphetamine	4180186
19475411	Hydrochloride, N-Methyl-3,4-methylenedioxyamphetamine	4180186
19475411	MDMA	4180186
19475411	N-Methyl-3,4-methylenedioxyamphetamine Hydrochloride	4180186
19475411	N Methyl 3,4 methylenedioxyamphetamine Hydrochloride	4180186
19475412	Antigen, CD26	4180186
19475412	Adenosine Deaminase Complexing Protein 2	4180186
19475412	CD26 Antigens	4180186
19475412	Antigens, CD26	4180186
19475412	Dipeptidyl-Peptidase IV	4180186
19475412	Dipeptidyl Peptidase IV	4180186
19475412	CD26 Antigen	4180186
19475415	Antibody, Thyroid Stimulating	4180186
19475415	Thyroid Stimulating Immunoglobulin	4180186
19475415	Thyroid-Stimulating Antibodies	4180186
19475415	Thyroid Stimulating Autoantibody	4180186
19475415	Thyroid Stimulating, Ig	4180186
19475415	Thyroid Stimulating Autoantibodies	4180186
19475415	Autoantibody, Thyroid-Stimulating	4180186
19475415	Thyroid Stimulating Antibodies	4180186
19475415	Thyroid-Stimulating Immunoglobulin	4180186
19475415	Antibodies, Thyroid-Stimulating	4180186
19475415	Thyroid-Stimulating Autoantibodies	4180186
19475415	Ig Thyroid Stimulating	4180186
19475415	Thyroid Stimulating Antibody	4180186
19475415	Stimulating Antibody, Thyroid	4180186
19475415	Immunoglobulin, Thyroid Stimulating	4180186
19475415	Thyroid Stimulating Immunoglobulins	4180186
19475415	Thyroid-Stimulating Immunoglobulins	4180186
19475415	Thyroid-Stimulating Autoantibody	4180186
19475415	Immunoglobulin, Thyroid-Stimulating	4180186
19475424	Macrolide	4180186
19475425	Monocyte Chemotactic Proteins	4180186
19475425	Protein, Monocyte Chemoattractant	4180186
19475425	Chemotactic Protein, Monocyte	4180186
19475425	Protein, Monocyte Chemotactic	4180186
19475425	Monocyte Chemotactic Protein	4180186
19475425	Chemoattractant Proteins, Monocyte	4180186
19475425	Chemotactic Proteins, Monocyte	4180186
19475425	Chemoattractant Protein, Monocyte	4180186
19475425	Monocyte Chemoattractant Protein	4180186
19475431	Antigens, CD36	4180186
19475431	GPIIIb Platelet Glycoprotein	4180186
19475431	Receptors, Thrombospondin	4180186
19475431	Platelet Glycoprotein, GPIV	4180186
19475431	Receptor, SR-BI	4180186
19475431	Thrombospondin Receptor	4180186
19475431	CD36 Protein	4180186
19475431	Antigen, CD36	4180186
19475431	SR BI Receptor	4180186
19475431	Glycoprotein IV, Platelet	4180186
19475431	Receptor, Thrombospondin	4180186
19475431	SR-BI Receptor	4180186
19475431	GPIV Platelet Glycoprotein	4180186
19475431	CD36 Antigen (Collagen Type I Receptor, Thrombospondin Receptor)	4180186
19475431	OKM5 Antigen	4180186
19475431	Platelet Membrane Glycoprotein IV	4180186
19475431	Adipocyte Membrane Protein p88	4180186
19475431	Platelet Membrane Glycoprotein IIIb	4180186
19475431	Antigen, OKM5	4180186
19475431	Platelet Glycoprotein IIIb	4180186
19475431	Platelet Glycoprotein, GPIIIb	4180186
19475431	Platelet Glycoprotein IV	4180186
19475431	FAT (Fatty Acid Translocase) - CD36 Antigen	4180186
19475431	CD36 Antigen	4180186
19475431	Glycoprotein IIIb, Platelet	4180186
19475431	Scavenger Receptors, Class B, Type I	4180186
19475431	SR-BI Protein	4180186
19475431	Thrombospondin Receptors	4180186
19475431	CD36 Fatty Acid Transporter	4180186
19475431	SR BI Protein	4180186
19475432	Antigens, CD5	4180186
19475432	CD5 Antigen	4180186
19475432	Leu-1 Antigen	4180186
19475432	Leu 1 Antigen	4180186
19475432	T1 Antigen	4180186
19475432	Antigen, CD5	4180186
19475433	Membrane Inhibitor of Reactive Lysis	4180186
19475433	Antigens, CD59	4180186
19475433	MACIF	4180186
19475433	CD59 Antigen	4180186
19475433	Membrane Attack Complex Inhibition Factor	4180186
19475433	Homologous Restriction Factor 20	4180186
19475433	HRF20	4180186
19475433	Protectin	4180186
19475434	Complement Decay Accelerating Factor	4180186
19475434	Decay-Accelerating Factor	4180186
19475434	Decay-Accelerating Factor, Complement	4180186
19475434	Complement Decay-Accelerating Factor	4180186
19475434	Decay Accelerating Factor	4180186
19475434	Antigens, CD55	4180186
19475434	CD55 Antigen	4180186
19475436	Receptors, Hyaluronan	4180186
19475436	Hyaluronan Receptor	4180186
19475436	Chondroitin Sulfate Proteoglycan 8	4180186
19475436	CD44 Antigens	4180186
19475436	CD44 Antigen	4180186
19475436	Hyaluronan-Binding Protein	4180186
19475436	Antigens, CD44	4180186
19475436	Receptor, Hyaluronan	4180186
19475436	Hyaluronic Acid Binding Protein	4180186
19475436	Antigen, CD44	4180186
19475436	Hyaluronan Binding Protein	4180186
19475437	LFA-3	4180186
19475437	CD58 Antigen	4180186
19475437	Lymphocyte Function Associated Antigen 3	4180186
19475437	Antigens, CD58	4180186
19475437	Antigen, CD58	4180186
19475437	Lymphocyte Function Associated Antigen-3	4180186
19475438	IGF-Binding Protein 3	4180186
19475438	IGF Binding Protein 3	4180186
19475438	Protein 3, IGF-Binding	4180186
19475438	IGFBP-3	4180186
19475440	CD56 Antigens	4180186
19475440	NKH 1 Antigen	4180186
19475440	Leu 19 Antigen	4180186
19475440	Leu-19 Antigen	4180186
19475440	Antigen, Leu-19	4180186
19475440	NKH-1 Antigen	4180186
19475440	Antigen, NKH-1	4180186
19475440	Antigen, CD56	4180186
19475440	Antigens, CD56	4180186
19475443	Vascular Cell Adhesion Molecule 1	4180186
19475443	CD106 Antigen	4180186
19475443	Antigen, CD106	4180186
19475443	CD106 Antigens	4180186
19475443	Antigens, CD106	4180186
19475443	Vascular Cell Adhesion Molecule	4180186
19475443	INCAM-110	4180186
19475443	Inducible Cell Adhesion Molecule 110	4180186
19475443	VCAM-1	4180186
19475449	Center, Rural Health	4180186
19475449	Centers, Rural Health	4180186
19475449	Rural Health Centers	4180186
19475449	Rural Health Center	4180186
19475449	Health Center, Rural	4180186
19475449	Service, Rural Health	4180186
19475449	Services, Rural Health	4180186
19475449	Health Services, Rural	4180186
19475449	Rural Health Service	4180186
19475449	Health Service, Rural	4180186
19475449	Health Centers, Rural	4180186
19475452	Antigen, CD62E	4180186
19475452	CD62E Antigen	4180186
19475452	Antigens, CD62E	4180186
19475452	LECAM-2	4180186
19475452	Endothelial Leukocyte Adhesion Molecule 1	4180186
19475452	Selectin, E	4180186
19475452	Endothelial Leukocyte Adhesion Molecule-1	4180186
19475452	ELAM-1	4180186
19475452	E Selectin	4180186
19475452	CD62E Antigens	4180186
19475455	Ig Receptor, Polymeric	4180186
19475455	Immunoglobulin Receptor, Polymeric	4180186
19475455	Polyimmunoglobulin Receptor	4180186
19475455	Receptor, Poly-Ig	4180186
19475455	Poly-Ig Receptor	4180186
19475455	Receptor, Polymeric Immunoglobulin	4180186
19475455	Immunoglobulin Receptors, Polymeric	4180186
19475455	Polymeric Immunoglobulin Receptor	4180186
19475455	Poly Ig Receptor	4180186
19475455	Polymeric Ig Receptor	4180186
19475455	Receptor, Polyimmunoglobulin	4180186
19475455	Polymeric Immunoglobulin Receptors	4180186
19475455	Receptor, Polymeric Ig	4180186
19475459	Antibodies, Enhancing	4180186
19475459	Blocking Antibodies	4180186
19475459	Enhancing Antibodies	4180186
19475461	1H-Pyrazolo(3,4-g)quinoline, 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-, (4aR-trans)-	4180186
19475461	Quinpirole Hydrochloride	4180186
19475461	Quinpirole Monohydrochloride	4180186
19475463	Radiopharmaceutical	4180186
19475464	2,4-DNP	4180186
19475464	2,4 Dinitrophenol	4180186
19475466	Palmitate, Sodium	4180186
19475466	Acid, Palmitic	4180186
19475466	Calcium Palmitate	4180186
19475466	Palmitate, Calcium	4180186
19475466	Acid, Hexadecanoic	4180186
19475466	Hexadecanoic Acid	4180186
19475466	Sodium Palmitate	4180186
19475467	Herpesvirus 4, Human Nuclear Antigens	4180186
19475467	EBV Nuclear Antigens	4180186
19475467	Nuclear Antigens, EBV	4180186
19475467	Nuclear Antigen, EBV	4180186
19475467	Epstein-Barr Virus Nuclear Antigen	4180186
19475467	Epstein Barr Virus Nuclear Antigen	4180186
19475467	Antigen, EBV Nuclear	4180186
19475467	Nuclear Antigens, Herpesvirus 4, Human	4180186
19475467	EBV Nuclear Antigen	4180186
19475467	Epstein Barr Virus Nuclear Antigens	4180186
19475469	5,6 Benzoflavone	4180186
19475469	beta Naphthoflavone	4180186
19475469	5,6-Benzoflavone	4180186
19475472	Lactate, Sodium	4180186
19475473	Orphanage	4180186
19475477	TPA Antigen	4180186
19475477	Antigen, TPA	4180186
19475477	Antigen, Tissue Polypeptide	4180186
19475478	Inflammatory Proteins, Macrophage	4180186
19475478	Protein, Macrophage Inflammatory	4180186
19475478	Macrophage Inflammatory Protein 1	4180186
19475478	Macrophage Inflammatory Protein-1	4180186
19475478	Inflammatory Protein, Macrophage	4180186
19475478	Inflammatory Protein-1, Macrophage	4180186
19475478	Protein-1, Macrophage Inflammatory	4180186
19475478	Macrophage Inflammatory Protein	4180186
19475481	Chemoattractant Factor, Lymphocyte	4180186
19475481	Lymphocyte Chemoattractant Factor	4180186
19475481	LCF Factor	4180186
19475481	IL-16	4180186
19475481	IL16	4180186
19475481	Interleukin 16	4180186
19475482	Laboratory Examinations and Diagnoses	4180186
19475482	Laboratory Techniques, Clinical	4180186
19475482	Clinical Laboratory Testing	4180186
19475482	Diagnoses and Laboratory Examinations	4180186
19475482	Clinical Laboratory Test	4180186
19475482	Clinical Laboratory Diagnoses	4180186
19475482	Technique, Clinical Laboratory	4180186
19475482	Diagnose, Clinical Laboratory	4180186
19475482	Laboratory Diagnosis	4180186
19475482	Testing, Clinical Laboratory	4180186
19475482	Laboratory Technique, Clinical	4180186
19475482	Laboratory Testing, Clinical	4180186
19475482	Laboratory Diagnoses	4180186
19475482	Diagnosis, Laboratory	4180186
19475482	Test, Clinical Laboratory	4180186
19475482	Clinical Laboratory Tests	4180186
19475482	Laboratory Test, Clinical	4180186
19475482	Clinical Laboratory Technique	4180186
19475482	Clinical Laboratory Testings	4180186
19475483	Inhibitors, Integrase	4180186
19475483	Integrase Inhibitor	4180186
19475483	Inhibitor, Integrase	4180186
19475485	Theses	4180186
19475485	Academic Dissertations	4180186
19475488	Book Plates	4180186
19475488	Bookplates	4180186
19475490	Outtakes	4180186
19475492	Herbal Supplement	4180186
19475492	Food Supplement	4180186
19475492	Supplement, Food	4180186
19475492	Nutriceutical	4180186
19475492	Food Supplementations	4180186
19475492	Food Supplements	4180186
19475492	Nutriceuticals	4180186
19475492	Dietary Supplementations	4180186
19475492	Herbal Supplements	4180186
19475492	Supplements, Food	4180186
19475492	Neutraceutical	4180186
19475492	Nutraceutical	4180186
19475492	Dietary Supplement	4180186
19475492	Supplementations, Dietary	4180186
19475492	Supplements, Dietary	4180186
19475492	Supplements, Herbal	4180186
19475492	Neutraceuticals	4180186
19475492	Supplement, Herbal	4180186
19475492	Nutraceuticals	4180186
19475493	Receptor, Chemokine	4180186
19475493	Chemokine Receptor	4180186
19475493	Chemokine Receptors	4180186
19475494	CCR5 Receptors	4180186
19475494	CD195 Antigens	4180186
19475494	CKR5 Receptors	4180186
19475494	CCR5 Receptor	4180186
19475494	CC-CKR5	4180186
19475494	Antigens, CD195	4180186
19475494	Receptors, CKR5	4180186
19475494	CC Chemokine Receptor 5	4180186
19475494	Receptor, CCR5	4180186
19475495	Tissue Inhibitor of Metalloproteinase	4180186
19475495	Metalloproteinases Tissue Inhibitor	4180186
19475495	Proteins, TIMP	4180186
19475495	TIMP Proteins	4180186
19475495	Metalloproteinase Tissue Inhibitor	4180186
19475498	Leukocyte-Derived Seven-Transmembrane Domain Receptor	4180186
19475498	CXCR4 Receptors	4180186
19475498	Leukocyte Derived Seven Transmembrane Domain Receptor	4180186
19475498	CXCR4 Receptor	4180186
19475498	Fusin	4180186
19475498	Receptor, CXCR4	4180186
19475498	Receptor, LESTR	4180186
19475498	LESTR Receptor	4180186
19475498	CXC Chemokine Receptor 4	4180186
19475499	beta Chemokines	4180186
19475499	C C Chemokines	4180186
19475499	C C Chemokine	4180186
19475499	Chemokines, C-C	4180186
19475499	beta-Chemokines	4180186
19475499	Chemokine, CC	4180186
19475499	Chemokine, C-C	4180186
19475499	beta Chemokine	4180186
19475499	CC Chemokine	4180186
19475499	beta-Chemokine	4180186
19475499	C-C Chemokines	4180186
19475499	CC Chemokines	4180186
19475499	C-C Chemokine	4180186
19475500	Chemokine, CXC	4180186
19475500	C X C Chemokine	4180186
19475500	Chemokines, C-X-C	4180186
19475500	CXC Chemokine	4180186
19475500	CXC Chemokines	4180186
19475500	alpha Chemokines	4180186
19475500	alpha-Chemokines	4180186
19475500	alpha Chemokine	4180186
19475500	C-X-C Chemokine	4180186
19475500	Chemokine, C-X-C	4180186
19475500	C-X-C Chemokines	4180186
19475500	alpha-Chemokine	4180186
19475503	Technetium Tc 99m Diethyl IDA	4180186
19475503	Tc-99m-Diethyl IDA	4180186
19475503	99mTc-Diethyl IDA	4180186
19475503	99m-Tc-Diethyl IDA	4180186
19475503	Tc 99m Diethyl IDA	4180186
19475503	Technetium Tc 99m Diethyl iminodiacetic Acid	4180186
19475503	IDA, Tc-99m-Diethyl	4180186
19475503	99mTc-EHIDA	4180186
19475503	99mTc-Diethyliminodiacetic Acid	4180186
19475503	Technetium-99m-Diethyl IDA	4180186
19475503	Technetium Tc 99m Diethylacetanitanildo IDA	4180186
19475503	99m Tc Diethyl IDA	4180186
19475503	IDA, Technetium-99m-Diethyl	4180186
19475503	99mTc Diethyliminodiacetic Acid	4180186
19475503	99mTc Diethyl IDA	4180186
19475503	IDA, 99mTc-Diethyl	4180186
19475503	IDA, 99m-Tc-Diethyl	4180186
19475503	Technetium 99m Diethyl IDA	4180186
19475503	Acid, 99mTc-Diethyliminodiacetic	4180186
19475503	Technetium Tc 99m Diethylacetanitanildo-IDA	4180186
19475503	99mTc EHIDA	4180186
19475505	9,11-Dideoxy-11 alpha,9 alpha-epoxymethanoprostaglandin F2 alpha	4180186
19475505	U 44619	4180186
19475505	U-46619	4180186
19475505	U44619	4180186
19475505	9,11-Dideoxy-11 alpha,9-alpha-epoxymethano-PGF2 alpha	4180186
19475505	11 alpha,9 alpha-Epoxymethano PGH2	4180186
19475505	U46619	4180186
19475505	(15S)hydroxy-9alpha,11alpha-(epoxymethano)prosta-5,13-dienoic acid	4180186
19475505	U 46619	4180186
19475505	9,11-epoxymethano-PGH2	4180186
19475505	5-Heptenoic Acid, 7-(6-(3-Hydroxy-1-Ocentyl)-2-Oxabicyclo(2.2.1)hept-5-yl)-, (1R-(1alpha,4alpha,5 beta(Z),6alpha(1E,3S*)))-	4180186
19475505	9,11 epoxymethano PGH2	4180186
19475505	(15S)-Hydroxy-11 alpha, 9 alpha-(epoxymethano)prosta-5Z, 13E-dienoic Acid	4180186
19475505	U-44619	4180186
19475505	11 alpha,9 alpha Epoxymethano PGH2	4180186
19475506	Cromakalim, (trans)-Isomer	4180186
19475506	BRL38226	4180186
19475506	BRL-38227	4180186
19475506	BRL-38226	4180186
19475506	Cromakalim, (3S-trans)-Isomer	4180186
19475506	Cromakalim, (3R-trans)-Isomer	4180186
19475506	2H-1-Benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-, trans-(+-)-	4180186
19475506	Levcromakalim	4180186
19475506	Cromakalim, (3S-cis)-Isomer	4180186
19475506	BRL 38226	4180186
19475506	Lemakalim	4180186
19475506	BRL-34915	4180186
19475506	BRL 38227	4180186
19475506	BRL38227	4180186
19475506	Cromakalim, (3R-cis)-Isomer	4180186
19475507	Sodium Iodoacetate	4180186
19475507	Monosodium Iodoacetate	4180186
19475507	Acetic acid, iodo-	4180186
19475507	Acid, Iodoacetic	4180186
19475507	Acid, Monoiodoacetic	4180186
19475507	Iodoacetate, Sodium	4180186
19475507	Monoiodoacetic Acid	4180186
19475507	Iodoacetate, Monosodium	4180186
19475510	Tetradecanoic Acid	4180186
19475510	Acid, Tetradecanoic	4180186
19475510	Myristate	4180186
19475510	Acid, Myristic	4180186
19475511	MSH, beta	4180186
19475511	beta-Melanotropin	4180186
19475511	Intermedin, beta	4180186
19475511	beta Melanotropin	4180186
19475511	beta Melanocyte Stimulating Hormone	4180186
19475511	Melanocyte-Stimulating Hormone, beta	4180186
19475511	beta Intermedin	4180186
19475511	Melanocyte Stimulating Hormone, beta	4180186
19475511	beta-Melanocyte-Stimulating Hormone	4180186
19475511	beta Melanocyte-Stimulating Hormone	4180186
19475511	beta MSH	4180186
19475514	Agglutinin, Peanut	4180186
19475514	Lectin, Peanut	4180186
19475514	Peanut Lectin	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-Isomer	4180186
19475516	trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-Isomer	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+-)-Isomer	4180186
19475516	U-50488H	4180186
19475516	U 50488	4180186
19475516	U 50488H	4180186
19475516	U-50488	4180186
19475516	U50,488H	4180186
19475516	U50488H	4180186
19475516	U-50,488H	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monohydrochloride, (trans)-(+-)-Isomer,	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+-)-Isomer	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1R-cis)-Isomer	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1S-cis)-Isomer	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-Isomer	4180186
19475516	Benzeneacetamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, (trans)-Isomer	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+)-Isomer	4180186
19475516	trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide Hydrochloride	4180186
19475516	3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+)-Isomer	4180186
19475516	U 50,488H	4180186
19475516	U50488	4180186
19475517	Plexiglass	4180186
19475517	Polymethyl Methacrylate, Surgical Simplex Bone Cement, Ammonium Salt	4180186
19475517	Polymethylmethacrylate	4180186
19475517	Acrylic Bone Cement	4180186
19475517	CMW Bone Cement	4180186
19475517	Polymethyl Methacrylate, Isostatic	4180186
19475517	PMMA	4180186
19475517	Polymethylmetacrylate	4180186
19475517	Methyl Acrylic Plastic	4180186
19475517	Poly(methyl methacrylate)	4180186
19475517	Isostatic Polymethyl Methacrylate	4180186
19475517	Syndiostatic Polymethyl Methacrylate	4180186
19475517	Polymethyl Methacrylate, Syndiostatic	4180186
19475517	Sol	4180186
19475517	Lucite	4180186
19475517	Plexiglas	4180186
19475517	Perspex	4180186
19475517	Superacryl	4180186
19475517	Implast	4180186
19475517	Palavit	4180186
19475517	Polymethyl Methacrylate, Surgical Simplex P	4180186
19475517	Acron	4180186
19475517	Methacrylate, Polymethyl	4180186
19475517	Kallocryl K	4180186
19475517	Methacrylate, Syndiostatic Polymethyl	4180186
19475517	Palacos R	4180186
19475517	Polymethyl Methacrylate, Simplex Opaque	4180186
19475519	Receptors, IL4	4180186
19475519	Receptor, IL4	4180186
19475519	IL-4 Receptor	4180186
19475519	Interleukin-4 Receptor	4180186
19475519	IL4 Receptors	4180186
19475519	Receptors, IL-4	4180186
19475519	Receptor, IL-4	4180186
19475519	IL 4 Receptors	4180186
19475519	Receptors, IL 4	4180186
19475519	Interleukin-4 Receptors	4180186
19475519	Interleukin 4 Receptor	4180186
19475519	IL-4 Receptors	4180186
19475519	Receptors, Interleukin 4	4180186
19475519	Interleukin 4 Receptors	4180186
19475519	IL4 Receptor	4180186
19475519	IL 4 Receptor	4180186
19475519	Receptor, Interleukin 4	4180186
19475519	Receptor, Interleukin-4	4180186
19475522	MK329	4180186
19475522	L 364,718	4180186
19475522	MK 329	4180186
19475522	1H-Indole-2-carboxamide, N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-, (S)-	4180186
19475522	L364,718	4180186
19475522	L-364,718	4180186
19475522	MK-329	4180186
19475529	PCMB	4180186
19475529	4 Chloromercuribenzoic Acid	4180186
19475529	para Chloromercuribenzoate	4180186
19475529	4-Chloromercuribenzoic Acid	4180186
19475529	p Chloromercuribenzoic Acid	4180186
19475529	Acid, p-Chloromercuribenzoic	4180186
19475529	para-Chloromercuribenzoate	4180186
19475529	Acid, 4-Chloromercuribenzoic	4180186
19475529	(4-carboxylatophenyl)chloromercurate(1-), hydrogen	4180186
19475530	Antisense Oligodeoxyribonucleotides	4180186
19475530	Anti Sense Oligodeoxyribonucleotides	4180186
19475530	Oligodeoxyribonucleotide, Antisense	4180186
19475530	Antisense Oligodeoxyribonucleotide	4180186
19475530	Antisense OligoDNA	4180186
19475530	OligoDNA, Antisense	4180186
19475530	Anti-Sense Oligodeoxyribonucleotides	4180186
19475530	Oligodeoxyribonucleotides, Anti-Sense	4180186
19475531	Iodine 123 IMP	4180186
19475531	N-Isopropyl-p-iodoamphetamine (I123) Hydrochloride	4180186
19475531	Hydrochloride, I-123 Iofetamine	4180186
19475531	N-Isopropyl-p-(Iodine-123)-Iodoamphetamine	4180186
19475531	N-Isopropyl-p-iodoamphetamine	4180186
19475531	Iofetamine I 123	4180186
19475531	N Isopropyl p iodoamphetamine	4180186
19475531	Iofetamine I-123	4180186
19475531	Iofetamine Hydrochloride, I-123	4180186
19475531	I-123, Iofetamine	4180186
19475531	Iofetamine Hydrochloride, I 123	4180186
19475531	I-123 Iofetamine Hydrochloride	4180186
19475531	Iodine-123-IMP	4180186
19475531	Benzeneethanamine, 4-iodo-alpha-methyl-N-(1-methylethyl)-	4180186
19475534	Receptor, Interleukin 7	4180186
19475534	Receptors, IL7	4180186
19475534	IL7 Receptor	4180186
19475534	Receptors, IL-7	4180186
19475534	Interleukin 7 Receptors	4180186
19475534	IL-7 Receptor	4180186
19475534	IL 7 Receptor	4180186
19475534	IL7 Receptors	4180186
19475534	IL-7 Receptors	4180186
19475534	Receptors, IL 7	4180186
19475534	Receptor, IL-7	4180186
19475534	Interleukin 7 Receptor	4180186
19475534	IL 7 Receptors	4180186
19475534	Receptors, Interleukin 7	4180186
19475534	Interleukin-7 Receptors	4180186
19475535	World Wide Web	4180186
19475535	Web, World Wide	4180186
19475535	Cyber Space	4180186
19475535	Wide Web, World	4180186
19475535	Cyberspace	4180186
19475536	Zebrafish Alcam protein	4180186
19475536	Neurolin	4180186
19475536	CD6 Ligand	4180186
19475536	ALCAM	4180186
19475536	Activated Leukocyte Cell Adhesion Molecule	4180186
19475536	KG-CAM	4180186
19475536	Alcam protein, Zebrafish	4180186
19475536	Antigens, CD166	4180186
19475536	CD166 Antigens	4180186
19475541	Activators, Enzyme	4180186
19475541	Enzymes Activators	4180186
19475541	Activators of Enzymes	4180186
19475547	Gene Expression Pattern Analysis	4180186
19475547	Transcriptome Profilings	4180186
19475547	Analyses, Transcriptome	4180186
19475547	Transcriptome Profiling	4180186
19475547	Gene Expression Profilings	4180186
19475547	Analyses, Transcript Expression	4180186
19475547	Profilings, Gene Expression	4180186
19475547	Gene Expression Analysis	4180186
19475547	Analysis, Transcript Expression	4180186
19475547	Transcript Expression Analyses	4180186
19475547	Transcriptomics	4180186
19475547	Monitoring, Gene Expression	4180186
19475547	Expression Analyses, Gene	4180186
19475547	Monitorings, Gene Expression	4180186
19475547	Profiling, Transcriptome	4180186
19475547	Gene Expression Monitorings	4180186
19475547	Gene Expression Monitoring	4180186
19475547	Transcript Expression Analysis	4180186
19475547	Profiling, Gene Expression	4180186
19475547	Analyses, Gene Expression	4180186
19475547	Analysis, Gene Expression	4180186
19475547	Profilings, Transcriptome	4180186
19475547	Differential Display, mRNA	4180186
19475547	Expression Analysis, Gene	4180186
19475547	Gene Expression Analyses	4180186
19475547	Transcriptome Analyses	4180186
19475547	Analysis, Transcriptome	4180186
19475547	mRNA Differential Displays	4180186
19475547	mRNA Differential Display	4180186
19475547	Transcriptome Analysis	4180186
19475547	Differential Displays, mRNA	4180186
19475549	NRG Proteins	4180186
19475549	Neuregulin	4180186
19475549	Neuronal Differentiation Factor, Cholinergic	4180186
19475550	Enkephalin, Penicillamine (2,5)-	4180186
19475550	Bis-Penicillamine-Enkephalin	4180186
19475550	DPDPE	4180186
19475550	D-Pen2, D-Pen5-Enkephalin	4180186
19475550	D-Pen5-Enkephalin D-Pen2	4180186
19475550	Bis-Pen-Enkephalin	4180186
19475550	DPDPE(SH)2	4180186
19475550	D Pen2, L Pen5 Enkephalin	4180186
19475550	L-Pen5-Enkephalin D-Pen2	4180186
19475550	Bis Pen Enkephalin	4180186
19475550	D-Pen2, L-Pen5-Enkephalin	4180186
19475550	DPLPE	4180186
19475550	D-Penicillamine (2,5)-Enkephalin	4180186
19475550	Enkephalin, Pen(2,5)-	4180186
19475550	D Pen2, D Pen5 Enkephalin	4180186
19475550	Bis Penicillamine Enkephalin	4180186
19475551	ZK 62711	4180186
19475551	ZK-62711	4180186
19475551	ZK62711	4180186
19475551	Pyrrolidone, 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-	4180186
19475552	Benzamide, 3,5-dichloro-N-((1-ethyl-2-pyrrolidinyl)-methyl)-2-hydroxy-6-methoxy-	4180186
19475552	FLA870	4180186
19475552	Raclopride C11	4180186
19475552	FLB 472	4180186
19475552	FLA 870	4180186
19475552	FLB472	4180186
19475552	C11, Raclopride	4180186
19475552	FLB-472	4180186
19475552	FLA-870	4180186
19475553	Radiation Hybrid Map	4180186
19475553	Radiation Hybrid	4180186
19475553	Radiation Hybrid Maps	4180186
19475553	Mapping, Radiation Hybrid	4180186
19475553	Hybrids, Radiation	4180186
19475553	Radiation Hybrids	4180186
19475553	Hybrid Maps, Radiation	4180186
19475553	Map, Radiation Hybrid	4180186
19475553	Hybrid, Radiation	4180186
19475554	Vaccines, Hepatitis A	4180186
19475554	Havrix	4180186
19475554	Hepatitis A Vaccine	4180186
19475554	Hepatovirus Vaccines	4180186
19475554	Vaccine, Hepatitis A	4180186
19475554	Vaqta	4180186
19475554	Vaccines, Hepatovirus	4180186
19475556	Vaccine, Pseudorabies	4180186
19475556	Pseudorabies Vaccine	4180186
19475556	Vaccines, Pseudorabies	4180186
19475557	Disease Vaccines, Marek	4180186
19475557	Marek's Disease Vaccines	4180186
19475557	Vaccines, Marek Disease	4180186
19475557	Vaccines, Marek's Disease	4180186
19475557	Mareks Disease Vaccines	4180186
19475558	Textbooks	4180186
19475559	CDw128a Antigens	4180186
19475559	Receptors, CXCR1	4180186
19475559	MDNCF Receptors	4180186
19475559	Receptors, Interleukin 8A	4180186
19475559	IL-8A Receptor	4180186
19475559	NAP 1 Receptor	4180186
19475559	IL 8A Receptor	4180186
19475559	NAP-1 Receptor	4180186
19475559	High Affinity Interleukin 8 Receptor A	4180186
19475559	Interleukin 8A Receptor	4180186
19475559	Receptor, IL-8A	4180186
19475559	Receptor, CXCR1	4180186
19475559	Interleukin 8A Receptors	4180186
19475559	Receptor, Interleukin 8A	4180186
19475559	Antigens, CDw128a	4180186
19475559	Receptor, NAP-1	4180186
19475559	CXCR1 Receptors	4180186
19475559	High Affinity Interleukin-8 Receptor A	4180186
19475559	Receptors, MDNCF	4180186
19475559	CXCR1 Receptor	4180186
19475559	IL-8A Receptors	4180186
19475559	Interleukin-8A Receptors	4180186
19475559	Receptors, IL-8A	4180186
19475559	IL 8A Receptors	4180186
19475559	Interleukin 8 Receptor Type A	4180186
19475559	CXC Chemokine Receptor 1	4180186
19475561	Defensin	4180186
19475563	Amphipathic Cationic Antimicrobial Peptides	4180186
19475563	Host Defense Peptides	4180186
19475563	Peptides, Host Defense	4180186
19475563	Cationic Proteins, Microbicidal	4180186
19475563	Cationic Antimicrobial Peptide	4180186
19475563	Peptide, Cationic Antimicrobial	4180186
19475563	Cationic Peptides, Antimicrobial	4180186
19475563	Microbicidal Cationic Proteins	4180186
19475563	Cationic Host Defense Peptides	4180186
19475563	Antimicrobial Peptides, Cationic	4180186
19475563	Proteins, Microbicidal Cationic	4180186
19475563	Peptides, Cationic Antimicrobial	4180186
19475563	Defense Peptide, Host	4180186
19475563	Defense Peptides, Host	4180186
19475563	Host Defense Peptide	4180186
19475563	Peptides, Antimicrobial Cationic	4180186
19475563	Antimicrobial Peptide, Cationic	4180186
19475563	Cationic Antimicrobial Peptides	4180186
19475563	Peptide, Host Defense	4180186
19475566	Fluoroquinolone	4180186
19475568	Group A Streptogramins	4180186
19475568	Group A, Streptogramin	4180186
19475568	Group A Streptogramin	4180186
19475568	Streptogramin, Group A	4180186
19475568	Streptogramins, Group A	4180186
19475570	Streptogramin, Group B	4180186
19475570	Streptogramins, Group B	4180186
19475570	Group B Streptogramin	4180186
19475570	Group B Streptogramins	4180186
19475570	Group B, Streptogramin	4180186
19475571	Mikamycins	4180186
19475573	Indole Alkaloid	4180186
19475573	Alkaloid, Indole	4180186
19475573	Alkaloids, Indole	4180186
19475575	Heymann's Antigen	4180186
19475575	Nephritogenic Antigen	4180186
19475575	Receptor-Associated Protein, Heymann Nephritis	4180186
19475575	Nephritis Antigen, Heyman	4180186
19475575	Receptor Associated Protein, Heymann Nephritis	4180186
19475575	Heyman Nephritis Antigen	4180186
19475575	Heymann Antigen	4180186
19475575	Heymanns Antigen	4180186
19475575	Fx1A Renal Tubular Antigen	4180186
19475579	Pimpinella anisum	4180186
19475579	Pimpinellas	4180186
19475579	anisums, Pimpinella	4180186
19475579	Anise	4180186
19475579	Pimpinella anisums	4180186
19475579	Anises	4180186
19475580	FSH-Releasing Protein	4180186
19475580	Protein, FSH-Releasing	4180186
19475580	FSH Releasing Protein	4180186
19475580	Activin	4180186
19475583	Pueraria tuberosas	4180186
19475583	Pueraria lobata	4180186
19475583	Pueraria lobatas	4180186
19475583	Pueraria montana	4180186
19475583	Pachyrhizus thunbergianus	4180186
19475583	Kudzus	4180186
19475583	Kudzu	4180186
19475583	tuberosa, Pueraria	4180186
19475583	lobatas, Pueraria	4180186
19475583	montana, Pueraria	4180186
19475583	Pueraria montanas	4180186
19475583	Pueraria tuberosa	4180186
19475583	Puerariae	4180186
19475583	Puerarias	4180186
19475587	Gastrodias	4180186
19475587	Tien ma	4180186
19475587	Gastrodia elata	4180186
19475589	Cascara Buckthorn	4180186
19475589	Frangula purshiana	4180186
19475589	Frangula alnus	4180186
19475589	Rhamnus frangula	4180186
19475589	Buckthorns, Cascara	4180186
19475589	Frangula	4180186
19475589	Sacred Bark	4180186
19475589	Cascara Sagrada	4180186
19475589	Buckthorn, Cascara	4180186
19475589	Frangulas	4180186
19475589	Rhamnus purshiana	4180186
19475590	Zhu Yus, Wu	4180186
19475590	Euodia ruticarpas	4180186
19475590	Evodiae Fructus	4180186
19475590	Euodia	4180186
19475590	Wu Zhu Yu	4180186
19475590	Evodias	4180186
19475590	Evodia rutaecarpas	4180186
19475590	Evodia rutaecarpa	4180186
19475590	Tetradium ruticarpums	4180186
19475590	Tetradium ruticarpum	4180186
19475590	Zhu Yu, Wu	4180186
19475590	Wu Zhu Yus	4180186
19475590	ruticarpas, Euodia	4180186
19475590	Yus, Wu Zhu	4180186
19475590	Euodias	4180186
19475590	Euodia ruticarpa	4180186
19475590	Yu, Wu Zhu	4180186
19475590	rutaecarpa, Evodia	4180186
19475590	ruticarpum, Tetradium	4180186
19475590	Fructus, Evodiae	4180186
19475596	Ginsenoside	4180186
19475596	Panaxosides	4180186
19475596	Sanchinosides	4180186
19475597	Polypeptide Hormones	4180186
19475597	Peptide Hormone	4180186
19475597	Polypeptide Hormone	4180186
19475597	Hormone, Polypeptide	4180186
19475597	Hormones, Polypeptide	4180186
19475597	Hormones, Peptide	4180186
19475597	Hormone, Peptide	4180186
19475599	Asialoorosomucoid-Binding Protein	4180186
19475599	Receptor, Asialoorosomucoid	4180186
19475599	Hepatic Asialoglycoprotein Receptor	4180186
19475599	Receptors, Asialoglycoprotein	4180186
19475599	Receptor, Asialoglycoprotein	4180186
19475599	Carbohydrate-Binding Protein, Liver	4180186
19475599	ASGP-R	4180186
19475599	Asialoglycoprotein Receptors	4180186
19475599	Asialoglycoprotein Receptor, Hepatic	4180186
19475599	Liver Carbohydrate-Binding Protein	4180186
19475599	Receptor, Hepatic Asialoglycoprotein	4180186
19475599	Asialoorosomucoid Receptor	4180186
19475599	Asialoorosomucoid Binding Protein	4180186
19475599	Receptors, Asialoorosomucoid	4180186
19475599	Lectin, Hepatic	4180186
19475599	Liver Carbohydrate Binding Protein	4180186
19475599	Hepatic Lectin	4180186
19475599	Asialoorosomucoid Receptors	4180186
19475601	Immune Conglutinins	4180186
19475601	Conglutinins, Immune	4180186
19475603	Nanoribbon	4180186
19475603	Buckytubes	4180186
19475603	Buckytube	4180186
19475603	Nanotube, Carbon	4180186
19475603	Nanoribbons	4180186
19475603	Carbon Nanotubes	4180186
19475603	Carbon Nanotube	4180186
19475606	Integrin, alpha2	4180186
19475606	Antigen, CD49b	4180186
19475606	VLA 2 alpha Chain	4180186
19475606	VLA-2 alpha Chain	4180186
19475606	Antigens, CD49b	4180186
19475606	Platelet Glycoprotein Ia	4180186
19475606	alpha2 Integrin	4180186
19475606	CD49b Antigen	4180186
19475606	GPIa	4180186
19475606	alpha2, Integrin	4180186
19475606	CD49b Antigens	4180186
19475606	Glycoprotein Ia, Platelet	4180186
19475606	alpha Chain, VLA-2	4180186
19475607	alpha4 Integrin	4180186
19475607	Integrin, alpha4	4180186
19475607	CD49d Antigen	4180186
19475607	CD49d Antigens	4180186
19475607	Antigens, CD49d	4180186
19475615	Calcium Binding Myeloid Protein P8,14	4180186
19475615	27E10 Antigen	4180186
19475615	Antigen L1, Myelomonocytic	4180186
19475615	Calcium-Binding Myeloid Protein P8,14	4180186
19475615	Leukocyte L1 Protein	4180186
19475615	Antigen, L1	4180186
19475615	Migratory Inhibitory Factor-Related Protein MRP	4180186
19475615	Myelomonocytic Antigen L1	4180186
19475615	Calprotectin	4180186
19475615	Calgranulin	4180186
19475615	L1 Protein, Leukocyte	4180186
19475615	L1 Antigen	4180186
19475615	Antigen, 27E10	4180186
19475615	Migratory Inhibitory Factor Related Protein MRP	4180186
19475616	Protein Biochips	4180186
19475616	Profiling Microarrays, Protein	4180186
19475616	Protein Array Analyses	4180186
19475616	ProteinChips	4180186
19475616	Protein Microchip	4180186
19475616	Analysis, Protein Microarray	4180186
19475616	Arrays, Protein	4180186
19475616	Protein Profiling Chips	4180186
19475616	Profiling Microarray, Protein	4180186
19475616	Chip, Protein	4180186
19475616	Microarrays, Protein	4180186
19475616	Microarray, Protein Profiling	4180186
19475616	Profiling Chips, Protein	4180186
19475616	Array Analyses, Protein	4180186
19475616	Protein Microarray Assays	4180186
19475616	Protein Array Assay	4180186
19475616	Biochips, Protein	4180186
19475616	ProteinChip	4180186
19475616	Array, Protein	4180186
19475616	Protein Profiling Chip	4180186
19475616	Microarray Analyses, Protein	4180186
19475616	Protein Chip	4180186
19475616	Protein Microarrays	4180186
19475616	Microarray, Protein	4180186
19475616	Microarray Assays, Protein	4180186
19475616	Assay, Protein Array	4180186
19475616	Analyses, Protein Array	4180186
19475616	Protein Array Assays	4180186
19475616	Array Assay, Protein	4180186
19475616	Profiling Chip, Protein	4180186
19475616	Protein Biochip	4180186
19475616	Microchip, Protein	4180186
19475616	Analysis, Protein Array	4180186
19475616	Biochip, Protein	4180186
19475616	Chip, Protein Profiling	4180186
19475616	Protein Profiling Microarray	4180186
19475616	Assays, Protein Array	4180186
19475616	Array Assays, Protein	4180186
19475616	Protein Microarray Assay	4180186
19475616	Protein Chips	4180186
19475616	Microarray Assay, Protein	4180186
19475616	Microarrays, Protein Profiling	4180186
19475616	Protein Arrays	4180186
19475616	Protein Microchips	4180186
19475616	Protein Array	4180186
19475616	Assays, Protein Microarray	4180186
19475616	Chips, Protein	4180186
19475616	Microchips, Protein	4180186
19475616	Array Analysis, Protein	4180186
19475616	Protein Profiling Microarrays	4180186
19475616	Protein Microarray Analysis	4180186
19475616	Protein Microarray Analyses	4180186
19475616	Microarray Analysis, Protein	4180186
19475616	Assay, Protein Microarray	4180186
19475616	Analyses, Protein Microarray	4180186
19475616	Chips, Protein Profiling	4180186
19475616	Protein Microarray	4180186
19475618	Systems, Global Positioning	4180186
19475618	System, Geographical Information	4180186
19475618	Information Systems, Geographical	4180186
19475618	Geographic Information System	4180186
19475618	Positioning System, Global	4180186
19475618	Positioning Systems, Global	4180186
19475618	System, Global Positioning	4180186
19475618	Geographical Information Systems	4180186
19475618	Systems, Geographical Information	4180186
19475618	Information System, Geographic	4180186
19475618	Geographical Information System	4180186
19475618	Information System, Geographical	4180186
19475618	Global Positioning System	4180186
19475618	Information Systems, Geographic	4180186
19475618	Global Positioning Systems	4180186
19475620	CABP-P14	4180186
19475620	MRP-14 Protein	4180186
19475620	Myeloid Calcium Binding Protein p14	4180186
19475620	MRP14 Protein	4180186
19475620	Antigen 60B8-A	4180186
19475620	60B8 A Antigen	4180186
19475620	60B8-A Antigen	4180186
19475620	S100A9 Protein	4180186
19475620	Antigen 60B8 A	4180186
19475620	Leukocyte L1 Protein Heavy Chain	4180186
19475620	Macrophage Related Protein 14	4180186
19475620	MRP 14 Protein	4180186
19475620	Myeloid Calcium-Binding Protein p14	4180186
19475620	Antigen, 60B8-A	4180186
19475620	Macrophage-Related Protein-14	4180186
19475622	Antigen, CD11a	4180186
19475622	Antigens, CD11a	4180186
19475622	Integrin alphaL	4180186
19475622	alphaL, Integrin	4180186
19475622	CD11a Antigens	4180186
19475625	Alkyl Estrogenic Steroids	4180186
19475625	Alkylated Estrogenic Steroids	4180186
19475626	Band, Oligoclonal	4180186
19475626	Oligoclonal Band	4180186
19475626	Oligoclonal IgG	4180186
19475626	Oligoclonal IgM	4180186
19475626	IgG, Oligoclonal	4180186
19475626	Oligoclonal Immunoglobulins	4180186
19475626	Immunoglobulins, Oligoclonal	4180186
19475626	Bands, Oligoclonal	4180186
19475626	IgM, Oligoclonal	4180186
19475626	Oligoclonal Immunoglobulin	4180186
19475626	Immunoglobulin, Oligoclonal	4180186
19475630	Isoquinolines, 1,2,3,4-tetrahydro-	4180186
19475630	Tetrahydro Isoquinoline	4180186
19475630	Tetrahydro Isoquinolines	4180186
19475630	1,2,3,4-Tetrahydroisoquinolines	4180186
19475630	Tetrahydro-Isoquinoline	4180186
19475630	Tetrahydro-Isoquinolines	4180186
19475631	Prostacyclins	4180186
19475631	Prostaglandin I	4180186
19475632	Receptors, C5a	4180186
19475632	Anaphylatoxin C5a Receptor	4180186
19475632	Receptor, C5a	4180186
19475632	Antigen, CD88	4180186
19475632	Receptor, Complement 5a	4180186
19475632	Complement 5a Receptor	4180186
19475632	C5a Receptor	4180186
19475632	CD88 Antigen	4180186
19475632	C5a Receptors	4180186
19475632	Antigens, CD88	4180186
19475632	CD88 Antigens	4180186
19475636	3-hydroxy-4-keto-Flavonoids	4180186
19475636	3 hydroxy 4 keto Flavonoids	4180186
19475636	2-Phenyl-3-Hydroxy-Benzopyran-4-Ones	4180186
19475636	2 Phenyl 3 Hydroxy Benzopyran 4 Ones	4180186
19475641	Analogs, Androgen	4180186
19475641	Androgen Analogs	4180186
19475641	Synthetic Androgen	4180186
19475641	Synthetic Androgens	4180186
19475641	Androgen Analogues	4180186
19475641	Analogues, Androgen	4180186
19475641	Androgens, Synthetic	4180186
19475641	Androgen, Synthetic	4180186
19475642	Estrogen Analogues	4180186
19475642	Estrogens, Synthetic	4180186
19475642	Estrogen Analogs	4180186
19475642	Congener, Estradiol	4180186
19475642	Analogs, Estrogen	4180186
19475642	Analog, Estrogen	4180186
19475642	Synthetic Estrogens	4180186
19475642	Estradiol Congener	4180186
19475642	Estrogen Analogue	4180186
19475642	Analogues, Estrogen	4180186
19475642	Estrogen Analog	4180186
19475642	Synthetic Estrogen	4180186
19475642	Estrogen, Synthetic	4180186
19475642	Analogue, Estrogen	4180186
19475645	Natriuretic Factor	4180186
19475645	Effects, Natriuretic	4180186
19475645	Natriuretic Factors	4180186
19475645	Natriuretic Hormones	4180186
19475645	Hormone, Chloriuretic	4180186
19475645	Hormone, Natriuretic	4180186
19475645	Chloriuretic Hormones	4180186
19475645	Chloriuretic Hormone	4180186
19475645	Natriuretic Effect	4180186
19475645	Factors, Natriuretic	4180186
19475645	Natriuretic Agent	4180186
19475645	Factor, Natriuretic	4180186
19475645	Agents, Natriuretic	4180186
19475645	Natriuretic Effects	4180186
19475645	Natriuretic Hormone	4180186
19475645	Hormones, Chloriuretic	4180186
19475645	Effect, Natriuretic	4180186
19475645	Hormones, Natriuretic	4180186
19475645	Agent, Natriuretic	4180186
19475646	Photosystem I Reaction Center	4180186
19475646	Photosystem I	4180186
19475648	Effect, Anabolic	4180186
19475648	Agents, Anabolic	4180186
19475648	Anabolic Effect	4180186
19475648	Anabolic Effects	4180186
19475648	Effects, Anabolic	4180186
19475653	Macrocyclic Lactams	4180186
19475653	Ansamycins	4180186
19475659	s-EPX	4180186
19475659	Serum Eosinophil Protein X	4180186
19475659	Neurotoxin, RNS2	4180186
19475659	Eosinophil Derived Neurotoxin	4180186
19475659	RNS2 Neurotoxin	4180186
19475659	Eosinophil Protein X	4180186
19475659	Neurotoxin, Eosinophil-Derived	4180186
19475661	3',4',5,7-Tetrahydroxyflavone	4180186
19475661	3',4',5,7-Tetrahydroxy-Flavone	4180186
19475661	Luteoline	4180186
19475662	Kinase Inhibitor, Protein	4180186
19475662	Inhibitor, Protein Kinase	4180186
19475662	Kinase Inhibitors, Protein	4180186
19475662	Protein Kinase Inhibitor	4180186
19475662	Inhibitors, Protein Kinase	4180186
19475664	120b Antigen, CD	4180186
19475664	CD120b Antigen	4180186
19475664	Antigens, CD120b	4180186
19475664	TNFR p75	4180186
19475664	Tumor Necrosis Factor Receptor Type 2	4180186
19475664	CD120b Antigens	4180186
19475664	TNFR p80	4180186
19475664	Tumor Necrosis Factor Receptor 75	4180186
19475664	Receptor, TNFRSF1B	4180186
19475664	Antigen, CD 120b	4180186
19475664	TNF-R2	4180186
19475664	CD 120b Antigen	4180186
19475664	TNF-sR75	4180186
19475664	TNFR2	4180186
19475664	Tumor Necrosis Factor Receptor Type II	4180186
19475664	TNF-R75	4180186
19475664	Tumor Necrosis Factor Receptor 2	4180186
19475664	Receptors, Tumor Necrosis Factor, Member 1B	4180186
19475664	TNFRSF1B Receptor	4180186
19475664	Antigen, CD120b	4180186
19475664	Tumor Necrosis Factor Receptor Superfamily, Member 1B	4180186
19475664	TNF-RII	4180186
19475665	TNF Receptor Ligands	4180186
19475665	Tumor Necrosis Factor Superfamily Ligands	4180186
19475665	Receptor Ligands, TNF	4180186
19475665	Necrosis Factors, Tumor	4180186
19475666	beta Sarcoglycan	4180186
19475666	Complexes, Sarcoglycan	4180186
19475666	delta-Sarcoglycan	4180186
19475666	50 kDa Dystrophin Associated glycoprotein	4180186
19475666	gamma Sarcoglycan	4180186
19475666	delta Sarcoglycan	4180186
19475666	Glycoprotein, 43-kDa Dystrophin-Associated	4180186
19475666	glycoprotein, 50-kDa Dystrophin-Associated	4180186
19475666	43 kDa Dystrophin Associated Glycoprotein	4180186
19475666	epsilon-Sarcoglycan	4180186
19475666	Adhalin	4180186
19475666	gamma-Sarcoglycan	4180186
19475666	Dystrophin-Associated glycoprotein, 50-kDa	4180186
19475666	beta-Sarcoglycan	4180186
19475666	alpha-Sarcoglycan	4180186
19475666	Complex, Sarcoglycan	4180186
19475666	alpha Sarcoglycan	4180186
19475666	50-kDa Dystrophin-Associated glycoprotein	4180186
19475666	zeta Sarcoglycan	4180186
19475666	Sarcoglycan Complexes	4180186
19475666	zeta-Sarcoglycan	4180186
19475666	Dystrophin-Associated Glycoprotein, 43-kDa	4180186
19475666	Sarcoglycan Complex	4180186
19475666	43-kDa Dystrophin-Associated Glycoprotein	4180186
19475666	epsilon Sarcoglycan	4180186
19475666	Sarcoglycan	4180186
19475668	SAP 1 Sphingolipid Activator	4180186
19475668	Sphingolipid Activator Protein 1	4180186
19475668	Gaucher Activator Protein	4180186
19475668	beta Glucosidase Stimulating Protein	4180186
19475668	Saposin A	4180186
19475668	SAP C Protein	4180186
19475668	Co-beta-Glucosidase	4180186
19475668	Glucosylceramidase Activator	4180186
19475668	Coglucosidase	4180186
19475668	SAP D Protein	4180186
19475668	SAP A Protein	4180186
19475668	SAP-A Protein	4180186
19475668	SAP-C Protein	4180186
19475668	Saposin D	4180186
19475668	beta-Glucosidase Stimulating Protein	4180186
19475668	Sphingolipid Activator Protein-1	4180186
19475668	Saposin C	4180186
19475668	SAP-D Protein	4180186
19475668	Co beta Glucosidase	4180186
19475668	Testibumin	4180186
19475668	Sphingolipid Activator Protein 2	4180186
19475668	beta Glucosidase Activator Protein	4180186
19475668	Sphingolipid Activator, SAP-1	4180186
19475668	beta-Glucosidase Activator Protein	4180186
19475668	Saposin B	4180186
19475668	Saposin	4180186
19475668	SAP-1 Sphingolipid Activator	4180186
19475670	Renilla Luciferases	4180186
19475670	Sea Pansy Luciferases	4180186
19475670	Renilla Luciferase	4180186
19475670	Luciferases, Sea Pansy	4180186
19475670	Luciferase, Renilla	4180186
19475672	Bacterial Luciferase beta Chain	4180186
19475672	Alkanal Monooxygenase alpha Chain	4180186
19475672	Alkanal Monooxygenase (FMN-Linked)	4180186
19475672	Bacterial Luciferase	4180186
19475672	Luciferases, Vibrio	4180186
19475672	Photobacterium Luciferases	4180186
19475672	Photorhabdus Luciferases	4180186
19475672	Vibrio Luciferases	4180186
19475672	Bacterial Luciferases	4180186
19475672	Luciferase, Bacterial	4180186
19475672	Luciferases, Photorhabdus	4180186
19475672	Luciferases, Photobacterium	4180186
19475672	Bacterial Luciferase alpha Chain	4180186
19475672	Alkanal Monooxygenase beta Chain	4180186
19475674	Mating-Type Genes, Fungal	4180186
19475674	Mating Types, Fungal	4180186
19475674	Fungal Mating Type Genes	4180186
19475674	Mating Type, Fungal	4180186
19475674	Types, Fungal Mating	4180186
19475674	Mating-Type Gene, Fungal	4180186
19475674	Fungal Mating Types	4180186
19475674	Fungal Mating Type	4180186
19475674	Genes, Fungal Mating Type	4180186
19475674	Gene, Fungal Mating-Type	4180186
19475674	Fungal Mating-Type Genes	4180186
19475674	Genes, Fungal Mating-Type	4180186
19475674	Type, Fungal Mating	4180186
19475674	Fungal Mating-Type Gene	4180186
19475676	Thiazide	4180186
19475678	Traits, X-Linked	4180186
19475678	X Linked Inheritance	4180186
19475678	Gene, X-Linked	4180186
19475678	X Linked Traits	4180186
19475678	X-Linked Alleles	4180186
19475678	X-Linked Allele	4180186
19475678	Alleles, X Linked	4180186
19475678	X-Chromosome Gene	4180186
19475678	X-Linked Traits	4180186
19475678	Allele, X-Linked	4180186
19475678	Inheritance, X-Linked	4180186
19475678	Inheritance, X Linked	4180186
19475678	Traits, X Linked	4180186
19475678	X-Linked Gene	4180186
19475678	X-Linked Trait	4180186
19475678	X Linked Genes	4180186
19475678	X Chromosome Genes	4180186
19475678	X-Linked Genes	4180186
19475678	Genes, X Chromosome	4180186
19475678	X-Linked Inheritance	4180186
19475678	Genes, X-Chromosome	4180186
19475678	Gene, X-Chromosome	4180186
19475678	Trait, X-Linked	4180186
19475678	Genes, X Linked	4180186
19475678	X-Chromosome Genes	4180186
19475678	Alleles, X-Linked	4180186
19475681	Polymerization Promoters, Tubulin	4180186
19475681	Polymerization Promoter, Tubulin	4180186
19475681	Modulators, Tubulin	4180186
19475681	Tubulin Inhibitors	4180186
19475681	Microtubule Modulators	4180186
19475681	Tubulin Polymerization Promoters	4180186
19475681	Inhibitors, Tubulin Polymerization	4180186
19475681	Promoters, Tubulin Polymerization	4180186
19475681	Modulator, Tubulin	4180186
19475681	Promoters, Tubulin	4180186
19475681	Polymerization Inhibitors, Tubulin	4180186
19475681	Modulators, Microtubule	4180186
19475681	Tubulin Promoter	4180186
19475681	Tubulin Modulator	4180186
19475681	Tubulin Polymerization Promoter	4180186
19475681	Inhibitors, Tubulin	4180186
19475681	Tubulin Promoters	4180186
19475681	Polymerization Inhibitor, Tubulin	4180186
19475681	Promoter, Tubulin	4180186
19475681	Inhibitor, Tubulin	4180186
19475681	Tubulin Inhibitor	4180186
19475681	Promoter, Tubulin Polymerization	4180186
19475681	Microtubule Modulator	4180186
19475681	Tubulin Polymerization Inhibitors	4180186
19475681	Modulator, Microtubule	4180186
19475681	Inhibitor, Tubulin Polymerization	4180186
19475681	Tubulin Polymerization Inhibitor	4180186
19475683	Alert System, Medication	4180186
19475683	Computerized Provider Order Entry	4180186
19475683	Computerized Provider Order Entry System	4180186
19475683	Medication Alert System	4180186
19475683	Medication Alert Systems	4180186
19475683	Alert Systems, Medication	4180186
19475683	Computerized Physician Order Entry System	4180186
19475683	Computerized Physician Order Entry	4180186
19475683	CPOE	4180186
19475683	Order Entry Systems, Medical	4180186
19475683	System, Medication Alert	4180186
19475685	C3 Activator	4180186
19475685	Convertases, Complement C3	4180186
19475685	C5 Cleaving Enzyme	4180186
19475685	Complement C3 Convertases	4180186
19475685	C3 Convertase	4180186
19475685	Convertases, Complement C5	4180186
19475685	Complement 3 Convertase	4180186
19475685	C3 Convertases, Complement	4180186
19475685	Activator, C3	4180186
19475685	Convertases, Complement C3-C5	4180186
19475685	C5 Convertase	4180186
19475685	C5 Convertases, Complement	4180186
19475685	C3 C5 Convertase	4180186
19475685	Complement C3 C5 Convertases	4180186
19475685	C3-C5 Convertase	4180186
19475685	Convertase, Complement 3	4180186
19475685	Convertase, C3	4180186
19475685	Complement C5 Convertases	4180186
19475685	Convertase, C3-C5	4180186
19475685	C3-C5 Convertases, Complement	4180186
19475685	C 3 Convertase	4180186
19475685	Convertase, C 3	4180186
19475685	Complement 5 Convertase	4180186
19475687	Classical Pathway C3 C5 Convertases	4180186
19475687	Classical Pathway C3-C5 Convertases	4180186
19475687	Complement C3 C5 Convertases, Classical Pathway	4180186
19475688	Protein, C4b-Binding	4180186
19475688	Complement C4b Binding Protein	4180186
19475688	C4bC3bINA Cofactor	4180186
19475688	Complement C3b-C4b Inactivator Cofactor	4180186
19475688	C4bC3bINA-Cofactor	4180186
19475688	Complement 4b Binding Protein	4180186
19475688	C4b-C3b Inactivator Cofactor	4180186
19475688	C4b-Binding Protein, Complement	4180186
19475688	Complement Component 4b Binding Protein	4180186
19475688	C4b Binding Protein	4180186
19475688	Complement Component 4b-Binding Protein	4180186
19475688	C4b-Binding Protein	4180186
19475688	Protein, Complement C4b-Binding	4180186
19475688	Cofactor, C4b-C3b Inactivator	4180186
19475688	Complement C3b C4b Inactivator Cofactor	4180186
19475688	C4b C3b Inactivator Cofactor	4180186
19475692	X Ray Inducible Protein 8	4180186
19475692	Sulfated Glycoprotein 2	4180186
19475692	SP 40,40 Protein	4180186
19475692	X-Ray-Inducible Protein 8	4180186
19475692	Ionizing Radiation-Induced Protein-8	4180186
19475692	Complement Lysis Inhibitor	4180186
19475692	Sulfated Glycoprotein-2	4180186
19475692	SGP 2 Protein	4180186
19475692	XIP8 Protein	4180186
19475692	TRPM 2 Protein	4180186
19475692	Complement Associated Protein SP 40,40	4180186
19475692	Ionizing Radiation Induced Protein 8	4180186
19475692	Radiation-Induced Protein-8, Ionizing	4180186
19475692	Complement-Associated Protein SP-40,40	4180186
19475692	ApoJ Protein	4180186
19475692	Testosterone Repressed Prostate Message 2 Protein	4180186
19475692	Testosterone-Repressed Prostate Message-2 Protein	4180186
19475692	Apolipoprotein J	4180186
19475692	SP-40,40, Complement-Associated Protein	4180186
19475692	SGP-2 Protein	4180186
19475692	TRPM-2 Protein	4180186
19475692	MAC393 Antigen	4180186
19475693	Desmosomal Glycoprotein 1	4180186
19475693	Dsg1 Antigen	4180186
19475693	Pemphigus Foliaceus Antigen	4180186
19475693	PFAN Protein	4180186
19475693	Desmoglein I	4180186
19475695	Receptor, TLR7	4180186
19475695	Toll Like Receptor 7	4180186
19475695	TLR7 Receptor	4180186
19475698	LY96 Protein	4180186
19475698	MD-2 Protein	4180186
19475699	Cdk4 Protein Kinase	4180186
19475699	Cell Division Protein Kinase 4	4180186
19475699	Cyclin D Dependent Kinase CDK4	4180186
19475699	Cdk4 Cyclin-Dependent Kinase	4180186
19475699	p34PSK J3 Kinase	4180186
19475699	PSK-J3 Kinase	4180186
19475699	Cdk4 Cyclin Dependent Kinase	4180186
19475699	Cyclin D-Dependent Kinase CDK4	4180186
19475699	Protein Kinase, Cdk4	4180186
19475699	PSK J3 Kinase	4180186
19475699	Cdk4 Protein	4180186
19475699	Cyclin-Dependent Kinase, Cdk4	4180186
19475699	p34PSK-J3 Kinase	4180186
19475699	Cyclin Dependent Kinase 4	4180186
19475702	Classical Pathway C3 Convertase	4180186
19475702	C3 Convertase, Classical	4180186
19475702	Classical C3 Convertase	4180186
19475702	C3 Convertase (C4b2a)	4180186
19475703	Classical C5 Convertase	4180186
19475703	Classical Pathway C5 Convertase	4180186
19475703	C5 Convertase, Classical	4180186
19475703	C5 Convertase (C4b2a3b)	4180186
19475704	S Modulin	4180186
19475704	Cancer-Associated Retinopathy Antigen	4180186
19475704	Cancer Associated Retinopathy Antigen	4180186
19475704	Sensitivity-Modulating Protein	4180186
19475704	Sensitivity Modulating Protein	4180186
19475704	S-Modulin	4180186
19475705	Inhibitory Smad Proteins	4180186
19475705	I-Smad Proteins	4180186
19475706	Lysosomal-Associated Membrane Protein	4180186
19475706	Protein, LAMP	4180186
19475706	Lysosomal Membrane Protein	4180186
19475706	Protein, Lysosome-Associated Membrane	4180186
19475706	Lysosome Associated Membrane Glycoprotein	4180186
19475706	LIMP Proteins	4180186
19475706	LIMP Protein	4180186
19475706	Lysosome Associated Membrane Glycoproteins	4180186
19475706	Membrane Protein, Lysosome-Associated	4180186
19475706	Protein, Lysosomal-Associated Membrane	4180186
19475706	Lysosome Associated Membrane Proteins	4180186
19475706	Lysosome Associated Membrane Protein	4180186
19475706	Lysosomal Associated Membrane Protein	4180186
19475706	Protein, LIMP	4180186
19475706	Lipophosphoglycan Proteins (Lysosome)	4180186
19475706	Protein, Lysosomal Membrane	4180186
19475706	Membrane Glycoproteins, Lysosomal	4180186
19475706	Lysosomal-Associated Membrane Proteins	4180186
19475706	Lysosomal Integral Membrane Proteins	4180186
19475706	Lysosomal Integral Membrane Protein	4180186
19475706	Lysosomal Associated Membrane Proteins	4180186
19475706	LAMP Proteins	4180186
19475706	Lysosomal Membrane Proteins	4180186
19475706	LGP Proteins (Lysosome)	4180186
19475706	Membrane Glycoprotein, Lysosomal	4180186
19475706	LAMP Protein	4180186
19475706	Glycoprotein, Lysosome-Associated Membrane	4180186
19475706	Glycoprotein, Lysosomal Membrane	4180186
19475706	Lysosome-Associated Membrane Protein	4180186
19475706	Lysosome-Associated Membrane Proteins	4180186
19475706	Lysosomal Membrane Glycoprotein	4180186
19475706	Membrane Proteins, Lysosomal	4180186
19475706	Membrane Glycoproteins, Lysosome-Associated	4180186
19475706	Membrane Protein, Lysosomal-Associated	4180186
19475706	Lysosomal Membrane Glycoproteins	4180186
19475706	Lysosome-Associated Membrane Glycoprotein	4180186
19475706	Membrane Protein, Lysosomal	4180186
19475706	Membrane Glycoprotein, Lysosome-Associated	4180186
19475708	Magainin	4180186
19475709	Siglec-2	4180186
19475709	Glycoprotein, CD22	4180186
19475709	Sialic Acid Binding Ig like Lectin 2	4180186
19475709	CD22 Antigen	4180186
19475709	Antigens, CD22	4180186
19475709	B-Lymphocyte Cell Adhesion Molecule	4180186
19475709	CD22 Antigens	4180186
19475709	B Lymphocyte Cell Adhesion Molecule	4180186
19475709	Antigen, CD22	4180186
19475709	CD22 Glycoprotein	4180186
19475711	B Cell Antigen Receptor Complex Associated Protein Beta Chain	4180186
19475711	B-Cell Antigen Receptor Complex Associated Protein Beta-Chain	4180186
19475711	IgM Alpha Component	4180186
19475711	Immunoglobulin Associated Beta Protein	4180186
19475711	Antigen, Igbeta	4180186
19475711	Immunoglobulin Associated Alpha Protein	4180186
19475711	CD79a Antigen	4180186
19475711	Antigens, CD79b	4180186
19475711	CD79b Antigen	4180186
19475711	CD79a Antigens	4180186
19475711	Antigen, CD79	4180186
19475711	IgM-Alpha Component	4180186
19475711	Immunoglobulin-Associated Alpha Protein	4180186
19475711	CD79 Antigen	4180186
19475711	Antigens, CD79a	4180186
19475711	Immunoglobulin-Associated Beta Protein	4180186
19475711	Antigens, CD79	4180186
19475711	Igbeta Antigen	4180186
19475711	Antigen, CD79b	4180186
19475711	CD79b Antigens	4180186
19475711	Antigen, CD79a	4180186
19475712	Basigin Protein	4180186
19475712	Emmprin Protein	4180186
19475712	Extracellular Matrix Metalloproteinase Inducer (EMMPRIN)	4180186
19475712	Antigens, CD147	4180186
19475712	Emmprin	4180186
19475712	Antigen, CD147	4180186
19475712	CD147 Antigens	4180186
19475712	CD147 Antigen	4180186
19475714	Antigens, CD47	4180186
19475714	IAP 50 Antigen	4180186
19475714	Integrin Associated Protein p50	4180186
19475714	Integrin-Associated Protein p50	4180186
19475714	Antigen, CD47	4180186
19475714	Antigen, IAP-50	4180186
19475714	CD47, Thrombospondin-1 Receptor	4180186
19475714	Thrombospondin-1 Receptor CD47	4180186
19475714	CD47 Antigens	4180186
19475714	IAP-50 Antigen	4180186
19475715	MUC18, Glycoprotein	4180186
19475715	Glycoprotein MUC18	4180186
19475715	Gicerin	4180186
19475715	Antigen, CD146	4180186
19475715	Melanoma Cell Adhesion Molecule	4180186
19475715	CD146 Antigens	4180186
19475715	Antigens, CD146	4180186
19475715	S-Endo 1 Endothelial-Associated Antigen	4180186
19475716	Early T Cell Costimulatory Molecule 1	4180186
19475716	B7-2 Costimulatory Molecule	4180186
19475716	CD86 Antigens	4180186
19475716	Antigen, CD86	4180186
19475716	Costimulatory Molecule, B7-2	4180186
19475716	Costimulatory Molecule, B70	4180186
19475716	Antigen, B7 2	4180186
19475716	CD86 Antigen	4180186
19475716	Antigens, CD86	4180186
19475716	B7 2 Antigen	4180186
19475716	Antigen, B7-2	4180186
19475716	B70 Costimulatory Molecule	4180186
19475727	Black, Carbon	4180186
19475727	Carbon Black	4180186
19475728	THANK Protein	4180186
19475728	Tumor Necrosis Factor Ligand Superfamily Member 13b	4180186
19475728	Activating Factor, B-Cell	4180186
19475728	BAFF Ligand	4180186
19475728	B Cell Activating Factor	4180186
19475728	TNF and APOL Related Leukocyte Expressed Ligand 1	4180186
19475728	TNFSF13B Protein	4180186
19475728	B Lymphocyte Stimulator	4180186
19475728	TALL 1 Protein	4180186
19475728	B Lymphocyte Activating Factor	4180186
19475728	CD257 Antigens	4180186
19475728	B-Lymphocyte Activating Factor	4180186
19475728	Antigens, CD257	4180186
19475728	TALL-1 Protein	4180186
19475728	Activating Factor, B-Lymphocyte	4180186
19475728	TNF and APOL-Related Leukocyte Expressed Ligand 1	4180186
19475728	TNF Superfamily, Member 13b	4180186
19475728	CD257 Antigen	4180186
19475728	BLyS Protein	4180186
19475728	Antigen, CD257	4180186
19475730	Antigens, CD70	4180186
19475730	Antigen, CD70	4180186
19475730	TNF Superfamily, Member 7	4180186
19475730	Tumor Necrosis Factor Ligand Superfamily Member 7	4180186
19475730	CD70 Antigen	4180186
19475730	CD70 Antigens	4180186
19475730	CD27L Protein	4180186
19475730	Ligand, CD27	4180186
19475731	HVEM-L Protein	4180186
19475731	Herpesvirus Entry Mediator-Ligand Protein	4180186
19475731	TNFSF14 Protein	4180186
19475731	TNF Superfamily, Member 14	4180186
19475731	LIGHT Protein	4180186
19475731	Herpesvirus Entry Mediator Ligand Protein	4180186
19475731	HVEM L Protein	4180186
19475737	Interleukin 1 Receptor, Type 2	4180186
19475737	Receptors, Interleukin 1 Type II	4180186
19475737	Interleukin-1 Receptor, Type 2	4180186
19475737	Interleukin 1 Receptors Type II	4180186
19475737	Interleukin 1 Receptor Type II	4180186
19475737	Interleukin-1 Receptors Type II	4180186
19475737	CDw121b Antigens	4180186
19475737	Antigens, CDw121b	4180186
19475737	Interleukin-1 Receptor Type II	4180186
19475738	TLR Signal Adaptor Protein MyD88	4180186
19475738	MyD88 Protein	4180186
19475738	Toll Like Receptor Signal Adaptor Protein MyD88	4180186
19475738	Toll-Like Receptor Signal Adaptor Protein MyD88	4180186
19475740	Receptors, Leukemia Inhibitory Factor	4180186
19475740	Leukemia Inhibitory Factor Oncostatin M Shared Receptor	4180186
19475740	Leukemia Inhibitory Factor Receptors	4180186
19475740	Receptors, OSM LIF	4180186
19475740	OSM-LIF Receptors	4180186
19475740	Oncostatin M Leukemia Inhibitory Factor Shared Receptor	4180186
19475740	LIF Receptors	4180186
19475740	Leukemia Inhibitory Factor-Oncostatin M Shared Receptor	4180186
19475740	Receptors, LIF	4180186
19475740	Oncostatin M Type I Receptor	4180186
19475740	Leukemia Inhibitory Factor Receptor	4180186
19475740	Oncostatin M-Leukemia Inhibitory Factor Shared Receptor	4180186
19475742	Opiate	4180186
19475742	Alkaloids, Opiate	4180186
19475742	Opiates, Alkaloid	4180186
19475742	Alkaloid Opiates	4180186
19475742	Opiates	4180186
19475745	alpha-Subunit, Receptor, Interleukin-3	4180186
19475745	Antigen, CD123	4180186
19475745	Interleukin 3 Receptor alpha Subunit	4180186
19475745	Interleukin 3 Receptor alpha Chain	4180186
19475745	CD123 Antigen	4180186
19475745	CD123 Antigens	4180186
19475745	Antigens, CD123	4180186
19475745	Interleukin-3 Receptor alpha Chain	4180186
19475746	Interleukin 5 Receptor alpha Subunit	4180186
19475746	CD125 Antigen	4180186
19475746	Antigen, CD125	4180186
19475746	Antigens, CD125	4180186
19475746	Receptor, Interleukin-5, alpha Subunit	4180186
19475746	alpha-Subunit, Receptor, Interleukin-5	4180186
19475746	Interleukin 5 Receptor alpha Chain	4180186
19475746	CD125 Antigens	4180186
19475746	Interleukin-5 Receptor alpha Chain	4180186
19475749	IL-23	4180186
19475749	Interleukin 23	4180186
19475753	Swamps, Mangrove	4180186
19475753	Mangrove Forest	4180186
19475753	Swamp	4180186
19475753	Mangrove Forests	4180186
19475753	Marsh	4180186
19475753	Mangrove Swamps	4180186
19475753	Wetland	4180186
19475753	Mangrove Swamp	4180186
19475753	Swamps	4180186
19475753	Marshes	4180186
19475753	Forests, Mangrove	4180186
19475753	Bog	4180186
19475753	Bogs	4180186
19475753	Forest, Mangrove	4180186
19475753	Swamp, Mangrove	4180186
19475759	Carbonyl Compounds, Iron	4180186
19475761	Chemokine I-TAC, CXC	4180186
19475761	Chemoattractant I TAC	4180186
19475761	Chemokine, CXCL11	4180186
19475761	CXC Chemokine I TAC	4180186
19475761	CXC Chemokine I-TAC	4180186
19475761	Small Inducible Cytokine Subfamily B, Member 11 Protein	4180186
19475761	Chemokine, H174 CXC	4180186
19475761	Chemoattractant I-TAC	4180186
19475761	CXCL11 Chemokine	4180186
19475761	CXCL11, Chemokine	4180186
19475761	CXC Chemokine, H174	4180186
19475761	H174 CXC Chemokine	4180186
19475762	Pre B Cell Growth Stimulating Factor	4180186
19475762	Stromal Cell-Derived Factor-1beta	4180186
19475762	Cell-Derived Factor-1beta, Stromal	4180186
19475762	CXCL12 Chemokine	4180186
19475762	SDF1 3'A	4180186
19475762	Stromal Cell Derived Factor 1	4180186
19475762	SDF-1beta	4180186
19475762	Pre-B-Cell Growth-Stimulating Factor	4180186
19475762	Chemokine, CXCL12	4180186
19475762	SDF1-3'A	4180186
19475762	SDF 1beta	4180186
19475762	Stromal Cell Derived Factor 1beta	4180186
19475762	CXCL12, Chemokine	4180186
19475762	Stromal Cell-Derived Factor 1	4180186
19475762	SDF-1alpha	4180186
19475762	Chemokine (C-X-C Motif) Ligand 12	4180186
19475762	Growth-Stimulating Factor, Pre-B-Cell	4180186
19475762	SDF 1alpha	4180186
19475762	Stromal Cell-Derived Factor-1alpha	4180186
19475762	Stromal Cell Derived Factor 1alpha	4180186
19475765	Chemokine, CCL3L3	4180186
19475765	BB 10010	4180186
19475765	CCL3L3, Chemokine	4180186
19475765	CCL3L1 Chemokine	4180186
19475765	Chemokine, CCL3L2	4180186
19475765	CCL3L2 Chemokine	4180186
19475765	Macrophage Inflammatory Protein 1-alpha	4180186
19475765	CCL3L3 Chemokine	4180186
19475765	CCL3, Chemokine	4180186
19475765	Chemokine (C-C Motif) Ligand 3-Like 1	4180186
19475765	Chemokine CCL3L2	4180186
19475765	MIP-1alpha	4180186
19475765	BB10010	4180186
19475765	BB-10010	4180186
19475765	Chemokine (C-C Motif) Ligand 3	4180186
19475765	Chemokine (C-C Motif) Ligand 3-Like 2	4180186
19475765	Chemokine, CCL3	4180186
19475765	Small Inducible Cytokine A3	4180186
19475765	LD78beta Chemokine	4180186
19475765	CCL3L2, Chemokine	4180186
19475765	Chemokine, LD78alpha	4180186
19475765	CCL3 Chemokine	4180186
19475765	LD78alpha Chemokine	4180186
19475765	Macrophage Inflammatory Protein 1 alpha	4180186
19475765	Chemokine, CCL3L1	4180186
19475765	Chemokine, LD78beta	4180186
19475765	Chemokine CCL3L3	4180186
19475765	CCL3L1, Chemokine	4180186
19475765	Chemokine CCL3L1	4180186
19475766	Chemokine CCL4L1	4180186
19475766	CCL4L2 Chemokine	4180186
19475766	MIP 1beta	4180186
19475766	CCL4L1, Chemokine	4180186
19475766	Macrophage Inflammatory Protein 1-beta	4180186
19475766	CCL4, Chemokine	4180186
19475766	Chemokine, CCL4	4180186
19475766	Macrophage Inflammatory Protein-1beta2	4180186
19475766	Inflammatory Protein-1beta2, Macrophage	4180186
19475766	Macrophage Inflammatory Protein 1beta2	4180186
19475766	CCL4L1 Chemokine	4180186
19475766	Chemokine, CCL4L2	4180186
19475766	CCL4L2, Chemokine	4180186
19475766	CCL4 Chemokine	4180186
19475766	Chemokine, CCL4L1	4180186
19475766	Chemokine CCL4L2	4180186
19475766	MIP-1beta	4180186
19475766	Macrophage Inflammatory Protein 1 beta	4180186
19475767	Chemoattractant Protein-3, Monocyte	4180186
19475767	Monocyte Chemotactic Protein-3	4180186
19475767	CCL7 Chemokine	4180186
19475767	Monocyte Chemotactic Protein 3	4180186
19475767	Chemokine, CCL7	4180186
19475767	CCL7, Chemokine	4180186
19475767	Chemotactic Protein-3, Monocyte	4180186
19475767	Monocyte Chemoattractant Protein 3	4180186
19475767	Monocyte Chemotactic Activating Factor 3	4180186
19475767	Monocyte Chemoattractant Protein-3	4180186
19475768	EBI1-Ligand Chemokine	4180186
19475768	Epstein Barr Virus Induced Molecule 1 Ligand Chemokine	4180186
19475768	ELC Chemokine	4180186
19475768	Macrophage Inflammatory Protein 3-beta	4180186
19475768	Chemokine, ELC	4180186
19475768	Chemokine, Exodus-3	4180186
19475768	Exodus 3 Chemokine	4180186
19475768	CCL19 Chemokine	4180186
19475768	EBI1 Ligand Chemokine	4180186
19475768	Macrophage Inflammatory Protein 3 beta	4180186
19475768	Chemokine, CCL19	4180186
19475768	MIP-3beta	4180186
19475768	Epstein-Barr Virus-Induced Molecule 1 Ligand Chemokine	4180186
19475768	Exodus-3 Chemokine	4180186
19475768	Chemokine, EBI1-Ligand	4180186
19475768	CCL19, Chemokine	4180186
19475768	MIP 3beta	4180186
19475769	Chemokine, SLC	4180186
19475769	CCL21 Chemokine	4180186
19475769	SLC Chemokine	4180186
19475769	Secondary Lymphoid-Tissue Chemokine	4180186
19475769	Chemokine, Secondary Lymphoid-Tissue	4180186
19475769	Exodus 2 Chemokine	4180186
19475769	Lymphoid-Tissue Chemokine, Secondary	4180186
19475769	Chemokine, Exodus-2	4180186
19475769	Exodus-2 Chemokine	4180186
19475769	6Ckine	4180186
19475769	Thymus-Derived Chemotactic Agent 4	4180186
19475769	CCL21, Chemokine	4180186
19475769	Chemokine, CCL21	4180186
19475769	Secondary Lymphoid Tissue Chemokine	4180186
19475769	Thymus Derived Chemotactic Agent 4	4180186
19475770	Small Inducible Cytokine A22	4180186
19475770	CC Chemokine STCP 1	4180186
19475770	Chemokine, SCYA22	4180186
19475770	STCP-1, CC Chemokine	4180186
19475770	Chemokine, Macrophage-Derived	4180186
19475770	CCL22 Chemokine	4180186
19475770	Stimulated T Cell Chemotactic Protein 1	4180186
19475770	Chemokine STCP-1, CC	4180186
19475770	Macrophage Derived Chemokine	4180186
19475770	SCYA22 Chemokine	4180186
19475770	CC Chemokine STCP-1	4180186
19475770	Chemokine, CCL22	4180186
19475770	Macrophage-Derived Chemokine	4180186
19475770	CCL22, Chemokine	4180186
19475775	VpreB lambda 5 SL Chain	4180186
19475775	Light Chains, Surrogate	4180186
19475775	VpreB-lambda 5 SL Chain	4180186
19475775	Surrogate kappa Light Chain	4180186
19475775	Surrogate Immunoglobulin Light Chains	4180186
19475775	Surrogate Immunoglobulin kappa Light Chain	4180186
19475775	Light Chain, Surrogate	4180186
19475775	VpreB lambda5 Surrogate Light Chain	4180186
19475775	Surrogate Light Chains	4180186
19475775	Pseudo Immunoglobulin Light Chain	4180186
19475775	Immunoglobulin psiL Chain	4180186
19475775	Surrogate Light Chain	4180186
19475775	psiL Chain, Immunoglobulin	4180186
19475775	Surrogate lambda Light Chain	4180186
19475775	psi lambda Light Chain	4180186
19475775	Immunoglobulin Light Chain Like lambda5 Peptide	4180186
19475775	Immunoglobulin Light Chain-Like lambda5 Peptide	4180186
19475775	Surrogate L Chain Protein	4180186
19475775	lambda5 Peptide, Immunoglobulin Light Chain-Like	4180186
19475775	VpreB-lambda5 Surrogate Light Chain	4180186
19475775	lambda5 Peptide, Immunoglobulin Light Chain Like	4180186
19475776	Alkylhydroperoxide Reductase	4180186
19475776	Protector Protein (Mixed-Function Oxidase Systems)	4180186
19475776	Thioredoxin-Dependent Peroxide Reductase 1	4180186
19475776	Peroxiredoxin 2	4180186
19475776	Peroxiredoxin 4	4180186
19475776	Thiol-Specific Antioxidant Protein	4180186
19475776	Thioredoxin Peroxidase PMP20	4180186
19475776	Peroxiredoxin 1	4180186
19475776	Thioredoxin Peroxidase 1	4180186
19475776	Peroxidoxin	4180186
19475776	Thioredoxin Peroxidase	4180186
19475776	Thioredoxin Dependent Peroxide Reductase 1	4180186
19475776	Thioredoxin-Dependent Peroxide Reductase 2	4180186
19475776	Thiol Specific Antioxidant Protein	4180186
19475776	Peroxiredoxin I	4180186
19475776	Alkyl Hydroperoxide Reductase	4180186
19475776	Thioredoxin Peroxidase 2	4180186
19475776	Peroxiredoxin IV	4180186
19475776	Peroxiredoxin-4	4180186
19475776	Thioredoxin Dependent Peroxide Reductase 2	4180186
19475776	Peroxiredoxin II	4180186
19475776	Hydroperoxide Reductase, Alkyl	4180186
19475776	Peroxiredoxin V	4180186
19475776	Peroxiredoxin 5	4180186
19475776	Alkyl Hydroperoxide Reductase C	4180186
19475776	Alkyl Hydroperoxide Reductase D	4180186
19475776	Peroxiredoxin	4180186
19475777	Phosphatase, PTPRN	4180186
19475777	Islet Cell Antigen 2	4180186
19475777	Insulinoma-Associated Protein 2	4180186
19475777	IA-2 Tyrosine Phosphatase	4180186
19475777	Receptor Like Protein Tyrosine Phosphatases, Class 8	4180186
19475777	Protein Tyrosine Phosphatase IA-2	4180186
19475777	Insulinoma Associated Protein 2	4180186
19475777	PTPase IA2	4180186
19475777	Islet Cell Antigen-2	4180186
19475777	Receptor-Like Protein Tyrosine Phosphatases, Class VIII	4180186
19475777	IA 2 Tyrosine Phosphatase	4180186
19475777	Receptor Like Protein Tyrosine Phosphatases, Class VIII	4180186
19475777	ICA512	4180186
19475777	PTPRN Phosphatase	4180186
19475777	Protein Tyrosine Phosphatase, Receptor-Type, N	4180186
19475777	Protein Tyrosine Phosphatase, Receptor Type N	4180186
19475777	ICA 105 Autoantigen	4180186
19475777	Protein Tyrosine Phosphatase IA 2	4180186
19475777	Islet Cell Antigen 512	4180186
19475779	Mulundocandins	4180186
19475779	Aculeacins	4180186
19475779	Echinocandin	4180186
19475779	Pneumocandin	4180186
19475779	Aculeacin	4180186
19475779	Pneumocandins	4180186
19475780	CamKK-beta	4180186
19475780	Calcium Calmodulin Dependent Protein Kinase Kinase alpha	4180186
19475780	Calcium Calmodulin Dependent Protein Kinase Kinase 1	4180186
19475780	CaMKK	4180186
19475780	Calcium-Calmodulin-Dependent Protein Kinase Kinase beta	4180186
19475780	CaM Kinase I Activator	4180186
19475780	Calcium Calmodulin Dependent Protein Kinase Kinase	4180186
19475780	Calcium Calmodulin Dependent Protein Kinase Kinase 2	4180186
19475780	CamKK-alpha	4180186
19475780	Calcium Calmodulin Dependent Protein Kinase Kinase beta	4180186
19475780	Calcium-Calmodulin-Dependent Protein Kinase Kinase alpha	4180186
19475780	Calcium-Calmodulin-Dependent Kinase Kinase	4180186
19475780	CaM-KK	4180186
19475780	Calcium Calmodulin Dependent Protein Kinase I Activator	4180186
19475780	CaM Kinase Kinase alpha	4180186
19475780	Calcium-Calmodulin-Dependent Protein Kinase Kinase 2	4180186
19475780	CaM Kinase Kinase beta	4180186
19475780	Calcium-Calmodulin-Dependent Protein Kinase I Activator	4180186
19475780	CaMKKalpha	4180186
19475780	CaMKKbeta	4180186
19475780	Calcium-Calmodulin-Dependent Protein Kinase Kinase 1	4180186
19475780	CamKK alpha	4180186
19475780	CaM-Kinase Kinase beta	4180186
19475780	CaM-Kinase Kinase alpha	4180186
19475780	Calcium Calmodulin Dependent Kinase Kinase	4180186
19475782	Cathelicidin Antimicrobial Peptide	4180186
19475782	Protein, CATH-1	4180186
19475782	Peptide, LL-37 Antibacterial	4180186
19475782	LL-37 Peptide	4180186
19475782	FA LL 37	4180186
19475782	Cathelicidin LL-37	4180186
19475782	CATH-1 Protein	4180186
19475782	CAP18 Lipopolysaccharide Binding Protein	4180186
19475782	Peptide, LL-37	4180186
19475782	hCAP-18	4180186
19475782	Peptide LL-37, Antibacterial	4180186
19475782	Ropocamptide	4180186
19475782	Cathelin-Related Antimicrobial Peptide	4180186
19475782	Antibacterial Peptide LL-37	4180186
19475782	eCATH 1 protein, Equus caballus	4180186
19475782	ALL-38 Peptide	4180186
19475782	FA-LL-37	4180186
19475782	eCATH-1 protein, Equus caballus	4180186
19475782	LL 37 Antibacterial Peptide	4180186
19475782	LL-37, Antibacterial Peptide	4180186
19475782	Protein, CAP18 Lipopolysaccharide-Binding	4180186
19475782	ALL 38 Peptide	4180186
19475782	Antibacterial Peptide, LL-37	4180186
19475782	Cathelicidin LL 37	4180186
19475782	eCATH 1	4180186
19475782	Antimicrobial Peptide LL 37	4180186
19475782	Antimicrobial Peptide, Cathelin-Related	4180186
19475782	Peptide LL-37, Antimicrobial	4180186
19475782	LL-37 Antibacterial Peptide	4180186
19475782	Myeloid Cathelicidin 1 Protein, Equus caballus	4180186
19475782	Protein, Cathelin-Like	4180186
19475782	Peptide, Cathelin-Related Antimicrobial	4180186
19475782	Antibacterial Peptide LL 37	4180186
19475782	LL-37, Antimicrobial Peptide	4180186
19475782	Cathelicidin 1	4180186
19475782	CAP18 Lipopolysaccharide-Binding Protein	4180186
19475782	K9CATH	4180186
19475782	Cathelicidin-1	4180186
19475782	Bac4 Protein, Bos taurus	4180186
19475782	CATH 1 Protein	4180186
19475782	Peptide, ALL-38	4180186
19475782	LL-37, Cathelicidin	4180186
19475782	hCAP 18	4180186
19475782	Antimicrobial Peptide LL-37	4180186
19475782	Cathelicidin	4180186
19475782	Lipopolysaccharide-Binding Protein, CAP18	4180186
19475782	CAP 18	4180186
19475782	CAP-18	4180186
19475782	Cathelin-Like Protein	4180186
19475782	CAP18	4180186
19475782	eCATH-1	4180186
19475782	LL 37 Peptide	4180186
19475784	Cecropin	4180186
19475786	Lipocalin, Tear	4180186
19475786	Tear Prealbumin Protein	4180186
19475786	Tear Lipocalin	4180186
19475786	Lipocalin LCN1	4180186
19475786	Von Ebner's Gland Protein	4180186
19475786	Von Ebner Gland Protein	4180186
19475787	Antiamoebins	4180186
19475787	Trichorzianines	4180186
19475787	Atroviridins	4180186
19475787	Culicinins	4180186
19475787	Emerimicins	4180186
19475787	Zervamicins	4180186
19475787	Chrysospermins	4180186
19475787	Alamethicins	4180186
19475787	Peptaibol	4180186
19475787	Emerimicin	4180186
19475787	Zervamicin	4180186
19475788	Metagenomes	4180186
19475790	Receptor, Pro Urokinase	4180186
19475790	Upar Receptor	4180186
19475790	Urokinase Plasminogen Activator Receptors	4180186
19475790	U-PA Receptor	4180186
19475790	U PA Receptor	4180186
19475790	Urokinase Type Plasminogen Activator Receptor	4180186
19475790	Receptor, Urokinase Plasminogen Activator	4180186
19475790	CD87 Antigens	4180186
19475790	CD87 Antigen	4180186
19475790	Receptor, U-PA	4180186
19475790	Urokinase Plasminogen Activator Receptor	4180186
19475790	Antigens, CD87	4180186
19475790	Receptor, Pro-Urokinase	4180186
19475790	Urokinase-Type Plasminogen Activator Receptors	4180186
19475790	Pro-Urokinase Receptor	4180186
19475790	Plasminogen Activator, Urokinase Receptors	4180186
19475790	Urokinase Type Plasminogen Activator Receptors	4180186
19475790	Plasminogen Activator Receptor, Urokinase Type	4180186
19475790	Urokinase-Type Plasminogen Activator Receptor	4180186
19475790	Plasminogen Activator, Urokinase Receptor	4180186
19475790	Antigen, CD87	4180186
19475790	Receptor, Upar	4180186
19475794	Cystatin-6	4180186
19475794	Cystatin 6	4180186
19475794	Cystatin E	4180186
19475794	CST6 Cystatin	4180186
19475799	Phenomena, Physical	4180186
19475799	Physical Concepts	4180186
19475799	Physical Process	4180186
19475799	Concepts, Physical	4180186
19475799	Process, Physical	4180186
19475799	Physical Processes	4180186
19475799	Processes, Physical	4180186
19475799	Concept, Physical	4180186
19475799	Physical Phenomenon	4180186
19475799	Physical Concept	4180186
19475799	Phenomenon, Physical	4180186
19475800	Concepts, Chemical	4180186
19475800	Processes, Chemical	4180186
19475800	Chemistry Process, Physical	4180186
19475800	Processes, Physicochemical	4180186
19475800	Process, Physical Chemistry	4180186
19475800	Phenomena, Physical Chemistry	4180186
19475800	Chemical Processes	4180186
19475800	Phenomena, Chemical	4180186
19475800	Chemical Concept	4180186
19475800	Chemical Process	4180186
19475800	Physical Chemistry Processes	4180186
19475800	Physicochemical Phenomena	4180186
19475800	Chemical Concepts	4180186
19475800	Physical Chemistry Concept	4180186
19475800	Physicochemical Phenomenon	4180186
19475800	Concept, Physical Chemistry	4180186
19475800	Chemistry Processes, Physical	4180186
19475800	Concepts, Physicochemical	4180186
19475800	Concept, Chemical	4180186
19475800	Processes, Physical Chemistry	4180186
19475800	Physicochemical Concept	4180186
19475800	Physicochemical Process	4180186
19475800	Physical Chemistry Concepts	4180186
19475800	Phenomena, Physicochemical	4180186
19475800	Process, Physicochemical	4180186
19475800	Physicochemical Concepts	4180186
19475800	Phenomenon, Physicochemical	4180186
19475800	Phenomenon, Chemical	4180186
19475800	Concept, Physicochemical	4180186
19475800	Process, Chemical	4180186
19475800	Concepts, Physical Chemistry	4180186
19475800	Physical Chemistry Phenomena	4180186
19475800	Physicochemical Processes	4180186
19475800	Physical Chemistry Process	4180186
19475800	Chemical Phenomenon	4180186
19475802	Receptor, NK-p30	4180186
19475802	p30 Natural Killer Cell Receptor	4180186
19475802	CD337 Antigens	4180186
19475802	NK-p30 Receptor	4180186
19475802	CD337 Antigen	4180186
19475802	Receptor, NKp30	4180186
19475802	NKp30 Receptor	4180186
19475802	Antigens, CD337	4180186
19475802	NK p30 Receptor	4180186
19475802	Antigen, CD337	4180186
19475803	Antigen, Ly49C	4180186
19475803	Antigen, Ly49F	4180186
19475803	Ly-49A Antigen	4180186
19475803	Natural Killer Cell Lectin Like Receptor Subfamily A	4180186
19475803	NK Cell Lectin-Like Receptor Subfamily A, Member 1	4180186
19475803	Ly49D Antigen	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A, Member 3	4180186
19475803	Ly49G Antigen	4180186
19475803	NK Cell Lectin-Like Receptor Subfamily A, Member 6	4180186
19475803	NK Cell Lectin-Like Receptor Subfamily A, Member 5	4180186
19475803	Natural Killer Cell Lectin-Like Receptor Subfamily A	4180186
19475803	Antigen, Ly49D	4180186
19475803	Ly49 Antigen	4180186
19475803	Ly 49A Antigen	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A, Member 8	4180186
19475803	Killer Cell Lectin-Like Receptor Subfamily A	4180186
19475803	Ly 49 Antigen	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A, Member 7	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A, Member 5	4180186
19475803	Ly49E Antigen	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A, Member 2	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A, Member 6	4180186
19475803	Antigen, Ly49A	4180186
19475803	NK Cell Lectin-Like Receptor Subfamily A, Member 4	4180186
19475803	Killer Cell Lectin Like Receptor Subfamily A	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A	4180186
19475803	Ly49F Antigen	4180186
19475803	Antigen, Ly49	4180186
19475803	Antigen, Ly49H	4180186
19475803	Antigen, Ly-49	4180186
19475803	Ly49B Antigen	4180186
19475803	Antigen, Ly-49A	4180186
19475803	Ly49H Antigen	4180186
19475803	Antigen, Ly49G	4180186
19475803	Ly-49 Antigen	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A, Member 1	4180186
19475803	NK Cell Lectin-Like Receptor Subfamily A, Member 2	4180186
19475803	NK Cell Lectin-Like Receptor Subfamily A, Member 7	4180186
19475803	Ly49C Antigen	4180186
19475803	NK Cell Lectin Like Receptor Subfamily A, Member 4	4180186
19475803	NK Cell Lectin-Like Receptor Subfamily A, Member 3	4180186
19475803	Antigen, Ly49E	4180186
19475803	Antigen, Ly49B	4180186
19475803	Ly49A Antigen	4180186
19475803	NK Cell Lectin-Like Receptor Subfamily A, Member 8	4180186
19475805	Solutions, Viscoelastic	4180186
19475805	Viscoelastic Foams	4180186
19475805	Viscoelastic Solutions	4180186
19475805	Substances, Viscoelastic	4180186
19475805	Foams, Viscoelastic	4180186
19475808	Ray, Cathode	4180186
19475808	Tube, Cathode Ray	4180186
19475808	Ray Tubes, Cathode	4180186
19475808	Tubes, Cathode Ray	4180186
19475808	Cathode Ray	4180186
19475808	Cathode Rays	4180186
19475808	Rays, Cathode	4180186
19475808	Cathode Ray Tube Display	4180186
19475808	Cathode Ray Tubes	4180186
19475808	Ray Tube, Cathode	4180186
19475810	Cell, Plant Germ	4180186
19475810	Cell, Plant Generative	4180186
19475810	Germ Cell, Plant	4180186
19475810	Generative Cell, Plant	4180186
19475810	Plant Germ Cells	4180186
19475810	Gametes, Plant	4180186
19475810	Plant Generative Cells	4180186
19475810	Plant Germ Cell	4180186
19475810	Plant Gametes	4180186
19475810	Cells, Plant Generative	4180186
19475810	Plant Gamete	4180186
19475810	Plant Generative Cell	4180186
19475810	Cells, Plant Germ	4180186
19475810	Generative Cells, Plant	4180186
19475810	Gametophyte	4180186
19475810	Gametophytes	4180186
19475810	Gamete, Plant	4180186
19475811	Structures, Fungal	4180186
19475811	Fungal Structure	4180186
19475811	Fungal Components	4180186
19475811	Structure, Fungal	4180186
19475812	Inhibitor, HDAC	4180186
19475812	HDAC Inhibitors	4180186
19475812	Inhibitors, HDAC	4180186
19475812	Deacetylase Inhibitors, Histone	4180186
19475812	Deacetylase Inhibitor, Histone	4180186
19475812	HDAC Inhibitor	4180186
19475812	Inhibitor, Histone Deacetylase	4180186
19475812	Histone Deacetylase Inhibitor	4180186
19475812	Inhibitors, Histone Deacetylase	4180186
19475818	Medical Records, Computerized	4180186
19475818	Health Record, Electronic	4180186
19475818	Medical Record, Electronic	4180186
19475818	Electronic Health Record	4180186
19475818	Electronic Health Record Data	4180186
19475818	Electronic Medical Record	4180186
19475818	Computerized Medical Records	4180186
19475818	Health Records, Electronic	4180186
19475818	Medical Record, Computerized	4180186
19475818	Electronic Medical Records	4180186
19475818	Computerized Medical Record	4180186
19475818	Medical Records, Electronic	4180186
19475821	Intravenous Feeding Solutions	4180186
19475821	Solutions, Intravenous Feeding	4180186
19475821	Feeding Solutions, Intravenous	4180186
19475823	Amyloid Polypeptide, Islet	4180186
19475823	Islet Amyloid Polypeptide Precursor	4180186
19475823	Polypeptide, Islet Amyloid	4180186
19475823	Pancreatic Amylin	4180186
19475823	Amylin, Pancreatic	4180186
19475823	Polypeptide, Insulinoma Amyloid	4180186
19475823	Amylin	4180186
19475823	Amlintide	4180186
19475823	IAPP Protein	4180186
19475823	Insulinoma Amyloid Polypeptide Precursor	4180186
19475823	IAPP Precursor	4180186
19475823	Insulinoma Amyloid Polypeptide	4180186
19475823	Amyloid Polypeptide, Insulinoma	4180186
19475824	Formation, Neointima	4180186
19475824	Neointimas	4180186
19475824	Neointima Formation	4180186
19475828	Acid Derivatives, Fibric	4180186
19475828	Methyl-2-Phenoxypropanoic Acid Derivatives	4180186
19475828	2-Phenoxy-2-Methylpropionic Acid Derivatives	4180186
19475828	Fibrate	4180186
19475828	2-Phenoxy Isobutyric Acids	4180186
19475828	2 Phenoxy Isobutyric Acids	4180186
19475828	Fibrates	4180186
19475828	Isobutyric Acids, 2-Phenoxy	4180186
19475828	Fibric Acid Derivatives	4180186
19475828	Methyl 2 Phenoxypropanoic Acid Derivatives	4180186
19475828	2 Phenoxy 2 Methylpropionic Acid Derivatives	4180186
19475831	Murine-Derived Monoclonal Antibodies	4180186
19475831	Monoclonal Antibodies, Murine-Derived	4180186
19475831	Antibodies, Murine-Derived Monoclonal	4180186
19475831	Murine Derived Monoclonal Antibodies	4180186
19475837	MelanA	4180186
19475837	Melanoma Antigen Recognized by T Cells 1	4180186
19475837	MART 1 Antigen	4180186
19475837	Antigen, MART-1	4180186
19475837	Melanoma Antigen Recognized by T-Cells 1	4180186
19475837	Antigens, MART1	4180186
19475837	MART1 Antigen	4180186
19475837	Antigen, MART1	4180186
19475837	Melan-A	4180186
19475837	MART1 Antigens	4180186
19475837	Melan A	4180186
19475838	Receptor, Fetal Folate	4180186
19475838	Receptor 2, Folate	4180186
19475838	Placental Folate Binding Protein	4180186
19475838	Receptor, Placental Folate	4180186
19475838	Folic Acid Receptor beta	4180186
19475838	Placental Folate Receptor	4180186
19475838	Fetal Folate Receptor	4180186
19475838	Protein, Placental Folate-Binding	4180186
19475838	Placental Folate-Binding Protein	4180186
19475838	Receptor beta, Folate	4180186
19475838	beta, Folate Receptor	4180186
19475838	Folate Receptor, Placental	4180186
19475838	Folate-Binding Protein, Placental	4180186
19475838	Folate Receptor beta	4180186
19475838	Folate Receptor, Fetal	4180186
19475839	Inhibitors, PDE3	4180186
19475839	Inhibitor, Phosphodiesterase 3	4180186
19475839	Inhibitors, PDE-3	4180186
19475839	Phosphodiesterase Type 3 Inhibitor	4180186
19475839	PDE-3 Inhibitors	4180186
19475839	Inhibitor, PDE3	4180186
19475839	PDE3 Inhibitors	4180186
19475839	Inhibitors, Phosphodiesterase 3	4180186
19475839	PDE3 Inhibitor	4180186
19475839	3 Inhibitor, Phosphodiesterase	4180186
19475839	PDE 3 Inhibitors	4180186
19475839	Phosphodiesterase 3 Inhibitor	4180186
19475839	Phosphodiesterase Type 3 Inhibitors	4180186
19475840	DNA Sequencing, High-Throughput	4180186
19475840	Sequencing, High-Throughput Nucleotide	4180186
19475840	Ion Torrent Sequencing	4180186
19475840	Next Generation Sequencing	4180186
19475840	Deep Sequencing	4180186
19475840	High-Throughput DNA Sequencing	4180186
19475840	RNA Sequencing, High-Throughput	4180186
19475840	Sequencing, Illumina	4180186
19475840	Ion Proton Sequencing	4180186
19475840	High Throughput Nucleotide Sequencing	4180186
19475840	Pyrosequencing	4180186
19475840	Illumina Sequencing	4180186
19475840	Sequencing, Deep	4180186
19475840	Nucleotide Sequencing, High-Throughput	4180186
19475840	Sequencing, Massively-Parallel	4180186
19475840	High Throughput RNA Sequencing	4180186
19475840	Sequencing, High-Throughput DNA	4180186
19475840	High Throughput Sequencing	4180186
19475840	Sequencing, Ion Torrent	4180186
19475840	Next-Generation Sequencing	4180186
19475840	Sequencing, Next-Generation	4180186
19475840	Sequencing, Ion Proton	4180186
19475840	Massively Parallel Sequencing	4180186
19475840	Sequencing, High-Throughput	4180186
19475840	Sequencing, High-Throughput RNA	4180186
19475840	High Throughput DNA Sequencing	4180186
19475840	High-Throughput Sequencing	4180186
19475840	Massively-Parallel Sequencing	4180186
19475840	High-Throughput RNA Sequencing	4180186
19475841	Vascular Stiffnesses	4180186
19475841	Stiffness, Aortic	4180186
19475841	Stiffness, Arterial	4180186
19475841	Arterial Stiffnesses	4180186
19475841	Stiffness, Vascular	4180186
19475841	Arterial Stiffness	4180186
19475841	Aortic Stiffnesses	4180186
19475841	Aortic Stiffness	4180186
19475842	Implant-Abutment Connections, Dental	4180186
19475842	Morse Taper Dental Implant-Abutment Connection	4180186
19475842	Morse Taper Dental Implant Abutment Interface	4180186
19475842	Morse Taper Dental Implant Abutment Connection	4180186
19475842	Dental Implant Abutment Design	4180186
19475842	Dental Implant Platform Switching	4180186
19475842	Implant-Abutment Design, Dental	4180186
19475842	Platform Switching, Dental Implant	4180186
19475842	Morse Taper Dental Implant-Abutment Interface	4180186
19475842	Connection, Dental Implant-Abutment	4180186
19475842	Interface, Dental Implant-Abutment	4180186
19475842	Dental Implant Abutment Connection	4180186
19475842	Implant-Abutment Interface, Dental	4180186
19475842	Implant-Abutment Interfaces, Dental	4180186
19475842	Implant-Abutment Designs, Dental	4180186
19475842	Dental Implant-Abutment Interface	4180186
19475842	Dental Implant-Abutment Connections	4180186
19475842	Dental Implant Abutment Designs	4180186
19475842	Implant-Abutment Connection, Dental	4180186
19475842	Connections, Dental Implant-Abutment	4180186
19475842	Designs, Dental Implant-Abutment	4180186
19475842	Dental Implant-Abutment Interfaces	4180186
19475842	Dental Implant-Abutment Connection	4180186
19475842	Dental Implant-Abutment Designs	4180186
19475842	Dental Implant Abutment Interface	4180186
19475842	Interfaces, Dental Implant-Abutment	4180186
19475842	Design, Dental Implant-Abutment	4180186
19475844	HLA-DR beta-Chain	4180186
19475844	HLA-DR Light Chain	4180186
19475844	Light Chain, HLA-DR	4180186
19475844	HLA Class II Histocompatibility Antigen, DR beta Chain	4180186
19475844	HLA DR beta Chain	4180186
19475844	HLA-DR beta	4180186
19475844	HLA DR beta	4180186
19475844	beta-Chain, HLA-DR	4180186
19475844	HLA DR Light Chain	4180186
19475846	HLA DR Serological Subtypes	4180186
19475846	Subtypes, HLA-DR Serological	4180186
19475846	Serological Subtypes, HLA-DR	4180186
19475849	Antigen, HLA-DRB4	4180186
19475849	HLA DRB4	4180186
19475849	HLA-DRB4	4180186
19475849	HLA DRB4 Chains	4180186
19475849	HLA DRB4 Antigen	4180186
19475849	HLA-DRB4 Antigen	4180186
19475850	Antigen, HLA-DRB5	4180186
19475850	HLA DRB5 Antigen	4180186
19475850	HLA-DRB5 Antigen	4180186
19475850	HLA-DRB5	4180186
19475850	HLA DRB5 Chains	4180186
19475850	HLA DRB5	4180186
19475852	HLA Class II Histocompatibility Antigen, DQ beta Chains	4180186
19475852	beta-Chains, HLA-DQ	4180186
19475852	HLA DQ beta Chains	4180186
19475858	HLA-B14	4180186
19475858	HLA Class I Histocompatibility Antigen, B-14 alpha Chain	4180186
19475858	Antigen, HLA-B14	4180186
19475858	HLA B14 Antigen	4180186
19475858	HLA B14	4180186
19475858	HLA Class I Histocompatibility Antigen, B 14 alpha Chain	4180186
19475858	Antigen, HLA B14	4180186
19475858	B14 Antigen, HLA	4180186
19475861	HLA-B37	4180186
19475861	HLA Class I Histocompatibility Antigen, B 37 alpha Chain	4180186
19475861	HLA B37 Antigen	4180186
19475861	HLA Class I Histocompatibility Antigen, B-37 alpha Chain	4180186
19475861	Antigen, HLA-B37	4180186
19475861	HLA B37	4180186
19475862	Antigen, HLA-B38	4180186
19475862	HLA Class I Histocompatibility Antigen, B 38 alpha Chain	4180186
19475862	HLA B38	4180186
19475862	Antigen, HLA B38	4180186
19475862	HLA Class I Histocompatibility Antigen, B-38 alpha Chain	4180186
19475862	B38 Antigen, HLA	4180186
19475862	HLA-B38	4180186
19475862	HLA B38 Antigen	4180186
19475863	HLA B39 Antigen	4180186
19475863	Antigen, HLA-B39	4180186
19475863	HLA-B39	4180186
19475863	HLA Class I Histocompatibility Antigen, B 39 alpha Chain	4180186
19475863	HLA B39	4180186
19475863	HLA Class I Histocompatibility Antigen, B-39 alpha Chain	4180186
19475864	Antigen, HLA-B40	4180186
19475864	HLA Class I Histocompatibility Antigen, B 40 alpha Chain	4180186
19475864	HLA Class I Histocompatibility Antigen, B-40 alpha Chain	4180186
19475864	HLA B40 Antigen	4180186
19475864	HLA-B40	4180186
19475865	HLA B44	4180186
19475865	B44 Antigen, HLA	4180186
19475865	HLA Class I Histocompatibility Antigen, B 44 alpha Chain	4180186
19475865	Antigen, HLA B44	4180186
19475865	HLA B44 Antigen	4180186
19475865	Antigen, HLA-B44	4180186
19475865	HLA-B44	4180186
19475865	HLA Class I Histocompatibility Antigen, B-44 alpha Chain	4180186
19475870	Lakes, Soda	4180186
19475870	Soda Lakes	4180186
19475870	Lake	4180186
19475871	LIMP-CD63	4180186
19475871	Antigen ME491, Melanoma	4180186
19475871	CD63 Antigen	4180186
19475871	Antigen, CD63	4180186
19475871	Platelet Glycoprotein 40 kDa	4180186
19475871	CD63 Antigens	4180186
19475871	Antigens, CD63	4180186
19475871	Melanoma Antigen ME491	4180186
19475871	Granulophysin	4180186
19475871	Pltgp40	4180186
19475873	TAPA 1 Antigen	4180186
19475873	TAPA-1 Antigen	4180186
19475873	Antigen, CD81	4180186
19475873	CD81 Antigens	4180186
19475873	Antigen, TAPA-1	4180186
19475873	CD81 Antigen	4180186
19475873	Antigens, CD81	4180186
19475876	Method, Inorganic Synthesis	4180186
19475876	Synthesis Technique, Organic	4180186
19475876	Synthesis Methods, Peptide	4180186
19475876	Technique, Peptide Synthesis	4180186
19475876	Inorganic Synthesis Techniques	4180186
19475876	Techniques, Synthetic Chemistry	4180186
19475876	Synthesis Techniques, Inorganic	4180186
19475876	Synthesis Method, Peptide	4180186
19475876	Organic Synthesis Methods	4180186
19475876	Organic Synthesis	4180186
19475876	Syntheses, Organic	4180186
19475876	Synthesis Techniques, Organic	4180186
19475876	Synthetic Chemistry Technique	4180186
19475876	Methods of Peptide Synthesis	4180186
19475876	Technique, Inorganic Synthesis	4180186
19475876	Techniques, Organic Synthesis	4180186
19475876	Peptide Synthesis Techniques	4180186
19475876	Methods of Organic Synthesis	4180186
19475876	Inorganic Synthesis Technique	4180186
19475876	Syntheses, Synthetic Peptide	4180186
19475876	Synthesis Technique, Inorganic	4180186
19475876	Inorganic Synthesis Method	4180186
19475876	Synthetic Peptide Syntheses	4180186
19475876	Methods, Peptide Synthesis	4180186
19475876	Techniques, Inorganic Synthesis	4180186
19475876	Synthesis Methods, Inorganic	4180186
19475876	Inorganic Synthesis Methods	4180186
19475876	Methods, Organic Synthesis	4180186
19475876	Synthesis Technique, Peptide	4180186
19475876	Organic Synthesis Techniques	4180186
19475876	Peptide Synthesis Method	4180186
19475876	Synthesis, Inorganic	4180186
19475876	Synthesis Techniques, Peptide	4180186
19475876	Organic Synthesis Technique	4180186
19475876	Synthetic Chemistry Techniques	4180186
19475876	Organic Syntheses	4180186
19475876	Peptide Synthesis Methods	4180186
19475876	Peptide Synthesis, Synthetic	4180186
19475876	Peptide Synthesis Technique	4180186
19475876	Methods, Inorganic Synthesis	4180186
19475876	Methods of Inorganic Synthesis	4180186
19475876	Synthetic Peptide Synthesis	4180186
19475876	Method, Peptide Synthesis	4180186
19475876	Technique, Organic Synthesis	4180186
19475876	Synthesis Method, Inorganic	4180186
19475876	Synthesis, Organic	4180186
19475876	Method, Organic Synthesis	4180186
19475876	Syntheses, Inorganic	4180186
19475876	Technique, Synthetic Chemistry	4180186
19475876	Chemistry Technique, Synthetic	4180186
19475876	Synthesis, Synthetic Peptide	4180186
19475876	Inorganic Synthesis	4180186
19475876	Techniques, Peptide Synthesis	4180186
19475876	Inorganic Syntheses	4180186
19475876	Peptide Syntheses, Synthetic	4180186
19475878	Aquifers	4180186
19475878	Subterranean Lakes	4180186
19475878	Aquifer	4180186
19475878	Underground Lake	4180186
19475878	Ground Waters	4180186
19475878	Ground-Water	4180186
19475878	Water, Underground	4180186
19475878	Lake, Underground	4180186
19475878	Streams, Underground	4180186
19475878	Subterranean Lake	4180186
19475878	Stream, Underground	4180186
19475878	Underground Stream	4180186
19475878	Water Tables	4180186
19475878	Underground Lakes	4180186
19475878	Lakes, Subterranean	4180186
19475878	Ground Water	4180186
19475878	Underground Water	4180186
19475878	Table, Water	4180186
19475878	Groundwaters	4180186
19475878	Waters, Underground	4180186
19475878	Underground Waters	4180186
19475878	Tables, Water	4180186
19475878	Ground-Waters	4180186
19475878	Lakes, Underground	4180186
19475878	Lake, Subterranean	4180186
19475878	Water Table	4180186
19475878	Underground Streams	4180186
19475879	Zyxin Protein	4180186
19475880	Bottom Ash	4180186
19475880	Soft Coal Fly Ash	4180186
19475880	Ash, Fly	4180186
19475880	Ash, Coal	4180186
19475880	Ash, Bottom	4180186
19475880	Pollutant, ROFA	4180186
19475880	Fly Ash, Oil	4180186
19475880	Oil Fly Ash	4180186
19475880	ROFA Pollutant	4180186
19475880	Fly Ash	4180186
19475880	Ash, Oil Fly	4180186
19475882	B7 Molecules	4180186
19475882	Antigen, B7	4180186
19475882	Antigens, B7	4180186
19475882	B7 Costimulatory Molecules	4180186
19475882	B 7 Antigen	4180186
19475882	B-7 Antigen	4180186
19475882	Antigen, B-7	4180186
19475882	Costimulatory Molecules, B7	4180186
19475882	B7 Antigen	4180186
19475882	Molecules, B7	4180186
19475884	B7 H1 Antigen	4180186
19475884	Programmed Cell Death 1 Ligand 1 Protein	4180186
19475884	PD-L1 Costimulatory Protein	4180186
19475884	PD L1 Protein	4180186
19475884	B7 H1 Immune Costimulatory Protein	4180186
19475884	Programmed Cell Death 1 Ligand 1	4180186
19475884	Antigen, B7-H1	4180186
19475884	Programmed Death Ligand 1	4180186
19475884	PD L1 Costimulatory Protein	4180186
19475884	Antigens, CD274	4180186
19475884	Costimulatory Protein, PD-L1	4180186
19475884	CD274 Antigens	4180186
19475884	Antigen, CD274	4180186
19475884	CD274 Antigen	4180186
19475884	B7-H1 Immune Costimulatory Protein	4180186
19475884	PD-L1 Protein	4180186
19475884	B7H1 Immune Costimulatory Protein	4180186
19475885	CD152 Antigen	4180186
19475885	CD152 Antigens	4180186
19475885	Cytotoxic T-Lymphocyte-Associated Antigen 4	4180186
19475885	Cytotoxic T Lymphocyte Antigen 4	4180186
19475885	Cytotoxic T Lymphocyte Associated Antigen 4	4180186
19475885	CTLA 4 Protein	4180186
19475885	Antigen, CTLA-4	4180186
19475885	CTLA-4 Protein	4180186
19475885	Antigen, CD152	4180186
19475885	Cytotoxic T-Lymphocyte Antigen 4	4180186
19475885	CTLA 4 Antigen	4180186
19475885	Antigens, CD152	4180186
19475889	Inhibitory T Cell Receptors	4180186
19475889	Costimulatory T-Cell Receptors	4180186
19475889	Costimulatory and Inhibitory T Cell Receptors	4180186
19475889	Receptors, Costimulatory T-Cell	4180186
19475889	Costimulatory T-Lymphocyte Receptors	4180186
19475889	Inhibitory T-Cell Receptors	4180186
19475889	Receptors, Costimulatory T-Lymphocyte	4180186
19475889	Costimulatory T Lymphocyte Receptors	4180186
19475889	Inhibitory T-Lymphocyte Receptors	4180186
19475889	Receptors, Costimulatory and Inhibitory, T-Lymphocyte	4180186
19475889	T-Lymphocyte Receptors, Costimulatory	4180186
19475889	Receptors, Inhibitory, T-Cell	4180186
19475889	Costimulatory and Inhibitory T-Lymphocyte Receptors	4180186
19475889	T-Cell Receptors, Inhibitory	4180186
19475889	Receptors, Inhibitory T-Cell	4180186
19475889	T-Lymphocyte Receptors, Inhibitory	4180186
19475889	Costimulatory and Inhibitory T Lymphocyte Receptors	4180186
19475889	Inhibitory T Lymphocyte Receptors	4180186
19475889	Receptors, Inhibitory T-Lymphocyte	4180186
19475889	Receptors, Costimulatory, T-Lymphocyte	4180186
19475889	Costimulatory T Cell Receptors	4180186
19475889	T-Cell Receptors, Costimulatory	4180186
19475890	PD 1 Protein	4180186
19475890	PD-1 Receptor	4180186
19475890	Programmed Cell Death Protein 1	4180186
19475890	Antigens, CD279	4180186
19475890	PD1 Receptor	4180186
19475890	Antigen, CD279	4180186
19475890	PD-1 Protein	4180186
19475890	Receptor, PD1	4180186
19475890	CD279 Antigen	4180186
19475890	CD279 Antigens	4180186
19475890	PD 1 Receptor	4180186
19475890	Receptor, PD-1	4180186
19475890	Programmed Cell Death 1 Protein	4180186
19475892	Ketides	4180186
19475892	Polyketide	4180186
19475894	Layer Cells, Feeder	4180186
19475894	Cells, Feeder	4180186
19475894	Cell, Feeder	4180186
19475894	Layer, Feeder	4180186
19475894	Cells, Feeder Layer	4180186
19475894	Feeder Cell Layers	4180186
19475894	Cell, Feeder Layer	4180186
19475894	Layer, Feeder Cell	4180186
19475894	Feeder Cell Layer	4180186
19475894	Feeder Layer	4180186
19475894	Cell Layers, Feeder	4180186
19475894	Feeder Layer Cells	4180186
19475894	Feeder Layer Cell	4180186
19475894	Layers, Feeder Cell	4180186
19475894	Cell Layer, Feeder	4180186
19475894	Feeder Layers	4180186
19475894	Feeder Cell	4180186
19475894	Layer Cell, Feeder	4180186
19475894	Layers, Feeder	4180186
19475902	High Volume Hospitals	4180186
19475902	Hospital, High-Volume	4180186
19475902	High-Volume Hospital	4180186
19475902	Hospitals, High Volume	4180186
19475902	High-Volume Hospitals	4180186
19475903	Immobilized RNA	4180186
19475903	Immobilized Oligonucleotides	4180186
19475903	DNA, Immobilized	4180186
19475903	Oligonucleotides, Immobilized	4180186
19475903	Nucleic Acids, Immobilized	4180186
19475903	RNA, Immobilized	4180186
19475903	Immobilized DNA	4180186
19475903	Acids, Immobilized Nucleic	4180186
19475906	Tertiary Hospital	4180186
19475906	Tertiary Care Center	4180186
19475906	Referral Center, Tertiary	4180186
19475906	Tertiary Referral Center	4180186
19475906	Hospital, Tertiary Referral	4180186
19475906	Tertiary Referral Centers	4180186
19475906	Tertiary Referral Hospital	4180186
19475906	Centers, Tertiary Care	4180186
19475906	Tertiary Referral Hospitals	4180186
19475906	Care Center, Tertiary	4180186
19475906	Centers, Tertiary Referral	4180186
19475906	Hospitals, Tertiary	4180186
19475906	Hospital, Tertiary	4180186
19475906	Referral Hospitals, Tertiary	4180186
19475906	Center, Tertiary Care	4180186
19475906	Referral Centers, Tertiary	4180186
19475906	Tertiary Hospitals	4180186
19475906	Center, Tertiary Referral	4180186
19475906	Referral Hospital, Tertiary	4180186
19475906	Hospitals, Tertiary Referral	4180186
19475906	Care Centers, Tertiary	4180186
19475908	Bidis Tobacco	4180186
19475908	Pipe Tobaccos	4180186
19475908	Kreteks Tobacco	4180186
19475908	Bidi	4180186
19475908	Pipe Tobacco	4180186
19475908	Bidi Tobacco	4180186
19475908	Tobacco, Kreteks	4180186
19475908	Product, Tobacco	4180186
19475908	Kretek	4180186
19475908	Cigar	4180186
19475908	Tobacco Product	4180186
19475908	Cigarillos	4180186
19475908	Bidis	4180186
19475908	Cigars	4180186
19475908	Products, Tobacco	4180186
19475908	Tobaccos, Bidis	4180186
19475908	Cigarettes	4180186
19475908	Tobaccos, Kreteks	4180186
19475908	Tobacco, Bidis	4180186
19475908	Bidi Tobaccos	4180186
19475908	Bidis Tobaccos	4180186
19475908	Kreteks	4180186
19475908	Cigarette	4180186
19475908	Kreteks Tobaccos	4180186
19475908	Tobaccos, Pipe	4180186
19475908	Cigarillo	4180186
19475908	Tobaccos, Bidi	4180186
19475908	Tobacco, Bidi	4180186
19475908	Tobacco, Pipe	4180186
19475910	Siglec	4180186
19475910	Sialic Acid Binding Ig like Lectin	4180186
19475910	Siglecs	4180186
19475910	Sialic Acid-binding Hemagglutinin	4180186
19475910	Hemagglutinin, Sialic Acid-binding	4180186
19475910	Sialic Acid Binding Ig-like Lectin	4180186
19475910	Sialic Acid binding Hemagglutinin	4180186
19475910	Sialic Acid Binding Immunoglobulin like Lectins	4180186
19475911	Siglec-1	4180186
19475911	Antigens, CD169	4180186
19475911	CD169 Antigens	4180186
19475911	Sialoadhesin	4180186
19475911	Sialic Acid Binding Ig like Lectin 1	4180186
19475915	Cannabis, Medicinal	4180186
19475915	Dispensaries, Marijuana	4180186
19475915	Marijuana Dispensaries	4180186
19475915	Treatment, Marijuana	4180186
19475915	Marijuana, Medical	4180186
19475915	Medical Cannabis	4180186
19475915	Medicinal Cannabis	4180186
19475915	Marijuana Treatment	4180186
19475915	Marijuana, Medicinal	4180186
19475915	Medicinal Marijuana	4180186
19475915	Cannabis, Medical	4180186
19475917	Interleukin-17D	4180186
19475917	IL-17D	4180186
19475917	Interleukin 27	4180186
19475917	IL-27	4180186
19475917	IL27	4180186
19475917	Interleukin 17D	4180186
19475922	Protein Mx	4180186
19475922	Mx, Interferon-Induced Protein	4180186
19475922	Mx, Protein	4180186
19475922	Protein Mx, Interferon-Induced	4180186
19475922	Protein Mx, Interferon Induced	4180186
19475922	Interferon-Induced Protein Mx	4180186
19475923	Derivative, Diaryl Quinoline	4180186
19475923	Derivatives, Diaryl Quinoline	4180186
19475923	Derivative, Diarylquinoline	4180186
19475923	Quinoline Derivative, Diaryl	4180186
19475923	Quinoline Derivatives, Diaryl	4180186
19475923	Derivatives, Diarylquinoline	4180186
19475923	Diarylquinoline Derivative	4180186
19475923	Diarylquinoline Derivatives	4180186
19475923	Diarylquinoline	4180186
19475923	Diaryl Quinoline Derivative	4180186
19475923	Diaryl Quinoline Derivatives	4180186
19475926	Mimetics, Amylin	4180186
19475926	Receptor Agonist, Amylin	4180186
19475926	Agonists, Amylin Receptor	4180186
19475926	Receptor Agonists, Amylin	4180186
19475926	Agonists, Amylin	4180186
19475926	Agonist, Amylin Receptor	4180186
19475926	Amylin Mimetics	4180186
19475926	Amylin Receptor Agonist	4180186
19475926	Amylin Agonists	4180186
19475927	beta-Lactamase Inhibitor	4180186
19475927	Lactamase Inhibitors, beta	4180186
19475927	Inhibitor, beta Lactamase	4180186
19475927	beta Lactamase Inhibitor	4180186
19475927	beta Lactamase Antagonists	4180186
19475927	beta Lactamase Inhibitors	4180186
19475927	Lactamase Inhibitor, beta	4180186
19475927	Inhibitor, beta-Lactamase	4180186
19475927	Antagonists, beta Lactamase	4180186
19475927	Inhibitors, beta-Lactamase	4180186
19475927	Inhibitors, beta Lactamase	4180186
19475927	Lactamase Antagonists, beta	4180186
19475929	Decarboxylase Inhibitors, Dihydroxyphenylalanine	4180186
19475929	DOPA Decarboxylase Inhibitors	4180186
19475929	Inhibitors, Aromatic-L-Amino-Acid Decarboxylase	4180186
19475929	Inhibitors, DOPA Decarboxylase	4180186
19475929	Decarboxylase Inhibitors, Aromatic-L-Amino-Acid	4180186
19475929	Aromatic-L-Amino-Acid Decarboxylase Inhibitors	4180186
19475929	Inhibitors, Dihydroxyphenylalanine Decarboxylase	4180186
19475929	Aromatic L Amino Acid Decarboxylase Inhibitors	4180186
19475929	Decarboxylase Inhibitors, DOPA	4180186
19475929	Dihydroxyphenylalanine Decarboxylase Inhibitors	4180186
19475932	Direct-Acting Oral Anticoagulant	4180186
19475932	Direct-Acting Oral Anticoagulants	4180186
19475932	Oral Anticoagulant, Direct-Acting	4180186
19475932	Direct Acting Oral Anticoagulant	4180186
19475932	Anticoagulants, Direct-Acting Oral	4180186
19475932	Direct Acting Oral Anticoagulants	4180186
19475932	Oral Anticoagulants, Direct-Acting	4180186
19475932	Direct Factor Xa Inhibitors	4180186
19475932	Inhibitor, Factor Xa	4180186
19475932	Factor Xa Inhibitor	4180186
19475932	Direct Factor Xa Inhibitor	4180186
19475932	Xa Inhibitor, Factor	4180186
19475932	Anticoagulant, Direct-Acting Oral	4180186
19475934	CYP2C9 Inducers, P450	4180186
19475934	CYP2C9 Inducers	4180186
19475934	P450 CYP2C9 Inducers	4180186
19475934	Inducers, CYP2C9	4180186
19475934	Inducers, P450 CYP2C9	4180186
19475934	Cytochrome P 450 CYP2C9 Inducers	4180186
19475939	SF HB EGF	4180186
19475939	Heparin binding EGF like Growth Factor	4180186
19475939	Diphtheria Toxin Receptors	4180186
19475939	Heparin-binding EGF-like Growth-Factor	4180186
19475939	SF HB-EGF	4180186
19475939	Diphtheria Toxin Receptor	4180186
19475939	Receptor, Diphtheria Toxin	4180186
19475939	Toxin Receptor, Diphtheria	4180186
19475939	HB EGF Precursor	4180186
19475939	Toxin Receptors, Diphtheria	4180186
19475939	HB EGF	4180186
19475939	Heparin-binding Epidermal Growth Factor-like Growth Factor Precursor Protein	4180186
19475939	HB-EGF	4180186
19475939	HB-EGF, Short Form	4180186
19475939	HB-EGF Precursor	4180186
19475939	Short Form HB EGF	4180186
19475939	Heparin binding Epidermal Growth Factor like Growth Factor Precursor Protein	4180186
19475939	Receptors, Diphtheria Toxin	4180186
19475939	Short Form HB-EGF	4180186
19475940	Technique, In Vitro	4180186
19475940	Tests, In Vitro	4180186
19475940	Vitro Testing, In	4180186
19475940	In Vitro as Topic	4180186
19475940	In Vitro Test	4180186
19475940	In Vitro Technique	4180186
19475940	In Vitro Tests	4180186
19475940	Techniques, In Vitro	4180186
19475940	Testings, In Vitro	4180186
19475940	In Vitro Testings	4180186
19475940	In Vitro Testing	4180186
19475940	Test, In Vitro	4180186
19475940	Testing, In Vitro	4180186
19475940	In Vitro	4180186
21490516	Breathing; In; Insp; Inspiratory; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490516	Insp time	4180186
21490516	吸气:时间:时间点:呼吸系统:定量型	4182948
21490517	地氟醚靶值^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490517	Away adap; Desfl target; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490517	Desfl target end exp VFr/PPres Away adap	4180186
21490518	Des set; Gas DS; Gases; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490518	Des set during insp VFr/PPres Gas DS	4180186
21490518	地氟醚设置^在吸气过程中:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490520	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490520	Des during expir VFr/PPres Away adap	4180186
21490520	地氟醚^在呼气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490521	Away adap; Compound 347; Ethrane; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490521	Enf VFr/PPres Away adap	4180186
21490521	安氟醚:体积分数/分压:时间点:气道连接器:定量型	4182948
21490522	Anestan; Away adap; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Halan; Halotan; Halsan; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan	4180186
21490522	Hal VFr/PPres Away adap	4180186
21490522	氟烷:体积分数/分压:时间点:气道连接器:定量型	4182948
21490525	Away adap; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490525	Isofl during insp VFr/PPres Away adap	4180186
21490525	异氟醚^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490526	Away adap; Laughing gas; Lung; N2O; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490526	N2O VFr/PPres Away adap	4180186
21490526	氧化亚氮:体积分数/分压:时间点:气道连接器:定量型	4182948
21490528	Away adap; In; Insp; Inspiratory; Lung; O2; O2 partial pressure; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490528	O2 during insp VFr/PPres Away adap	4180186
21490528	氧^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490529	Post-discharge provider ID	4180186
21490529	After; Chemistry; Disch; Ident; Identifier; Intradermal; Nominal; Point in time; PST; Random	4180186
21490529	出院后服务提供者标识符:标识符:时间点:服务提供者:名义型	4182948
21490532	After; Chemistry; Disch; Ident; Identifier; Nominal; Point in time; Post-disch prov practice name; PST; Random	4180186
21490532	出院后服务提供者执业姓名:标识符:时间点:服务提供者:名义型	4182948
21490535	Exp; Gas DS; Gas DS.EL; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490535	Des during expir VFr/PPres Gas DS.EL	4180186
21490535	地氟醚^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490538	安氟醚靶值^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490538	Away adap; Compound 347; Ethrane; Exp; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Target enfl	4180186
21490538	Target enfl end exp VFr/PPres Away adap	4180186
21490544	Anestan; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; Exp; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Gas DS; Gas DS.EL; Gases; Halan; Halotan; Halsan; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan	4180186
21490544	Hal during expir VFr/PPres Gas DS.EL	4180186
21490544	氟烷^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490546	异氟醚靶值^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490546	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Target isofl	4180186
21490546	Target isofl end exp VFr/PPres Away adap	4180186
21490548	Exp; Gas DS; Gas DS.EL; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490548	Isofl during expir VFr/PPres Gas DS.EL	4180186
21490548	异氟醚^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490549	Gas DS; Gases; Isofl gas del dur case; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490549	Isofl gas del dur case Vol Gas DS	4180186
21490549	所输送的异氟醚气体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490553	Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Sevo gas del dur case; Volume	4180186
21490553	Sevo gas del dur case Vol Gas DS	4180186
21490553	所输送的七氟醚气体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490555	Carbonic anhydride; cO2; CO2 gas del dur case; Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490555	CO2 gas del dur case Vol Gas DS	4180186
21490555	所输送的二氧化碳气体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490558	Breathing; Dynamic; Flow; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490558	Expiratory gas flow on vent Airway	4180186
21490558	呼气气体流量^采用呼吸机:体积速率:时间点:呼吸系统.气道:定量型	4182948
21490559	Breathing; Dynamic; Flow; Gases; Largest; Lung; Lungs; Maximal; Maximum; Peak; Peak expiratory flow; PEF; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490559	PEF on vent Airway	4180186
21490559	呼气气体流量.最大值^采用呼吸机:体积速率:时间点:呼吸系统.气道:定量型	4182948
21490560	Breathing; Dynamic; Flow; Gases; Insp gas flow; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490560	Insp gas flow on vent Airway	4180186
21490560	吸气气体流量^采用呼吸机:体积速率:时间点:呼吸系统.气道:定量型	4182948
21490561	Breathing; Dynamic; Flow; Gases; Insp gas flow; Insp gas flow.max; Largest; Lung; Lungs; Maximal; Maximum; Peak; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490561	Insp gas flow.max on vent Airway	4180186
21490561	吸气气体流量.最大值^采用呼吸机:体积速率:时间点:呼吸系统.气道:定量型	4182948
21490565	Breathing; Lung; Lungs; Point in time; Press.plat; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490565	Plateau dynamic Airway	4180186
21490565	压力.动态平台期:压力或压强:时间点:呼吸系统.气道:定量型	4182948
21490566	ALV; Lung; MAC for anesthesia; Misc; Miscellaneous; Other; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Spec; To be specified in another part of the message; Unspecified; Volfr; Volume fraction	4180186
21490566	MAC for anesthesia VFr Anesthetic	4180186
21490566	适合于麻醉的最低肺泡浓度.XXX:体积分数:时间点:麻醉剂.XXX:定量型	4182948
21490567	Away adap; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490567	Des during insp VFr/PPres Away adap	4180186
21490567	地氟醚^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490569	二氧化碳^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490569	Away adap; Carbonic anhydride; cO2; End tidal pCO2; ETCO2; Exp; Lung; PCO2; PetCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490569	CO2 end exp VFr/PPres Away adap	4180186
21490571	氦^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490571	Away adap; Exp; He; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490571	Helium end exp VFr/PPres Away adap	4180186
21490573	ALV; Anesthetic+N2O; Lung; MAC sum; Misc; Miscellaneous; Other; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Spec; To be specified in another part of the message; Unspecified; Volfr; Volume fraction	4180186
21490573	MAC sum VFr Anesthetic+N2O	4180186
21490573	最低肺泡浓度总计:体积分数:时间点:麻醉剂.XXX+一氧化二氮:定量型	4182948
21490575	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Carbonic anhydride; cO2; CO2 gastric-BldA; Gastro; Gastroenterology; GI; Glaucoma testing; Point in time; QNT; Quan; Quant; Quantitative; Random; Tonometry	4180186
21490575	Gastric-art pCO2 gap	4180186
21490575	二氧化碳.胃+二氧化碳.动脉全血:分压差:时间点:胃+动脉全血:定量型:胃张力测定法	4182948
21490576	Carbonic anhydride; cO2; end expir; Exp; Gastric CO2-ET CO2; Gastro; Gastroenterology; GI; Glaucoma testing; Point in time; QNT; Quan; Quant; Quantitative; Random; Tonometry	4180186
21490576	Gastric-ET pCO2 gap	4180186
21490576	二氧化碳.胃-二氧化碳.气道^呼气结束:分压差:时间点:胃+气道:定量型:胃张力测定法	4182948
21490577	Carbonic anhydride; cO2; Gastro; Gastroenterology; GI; Glaucoma testing; Lung; Partial pressure; PCO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tonometry	4180186
21490577	Gastric pCO2	4180186
21490577	二氧化碳:分压:时间点:胃:定量型:胃张力测定法	4182948
21490578	Breathing; Durat; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490578	呼吸暂停持续时间:时间:时间点:呼吸系统:定量型	4182948
21490580	Breathing; Carbonic anhydride; cO2; CO2 production; Flow; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490580	CO2 production Respiratory	4180186
21490580	二氧化碳产生:体积速率:时间点:呼吸系统:定量型	4182948
21490581	Compliance; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490581	Compliance Lung	4180186
21490581	顺应性:顺应性:时间点:肺:定量型	4182948
21490582	Compliance; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490582	Compliance.dynamic Lung	4180186
21490582	顺应性.动态:顺应性:时间点:肺:定量型	4182948
21490585	Toe temp	4180186
21490585	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Phalange; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490585	体温:温度:时间点:脚趾:定量型	4182948
21490586	Bdy temp; Blood; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature; WB; Whole blood	4180186
21490586	Blood temp	4180186
21490586	体温:温度:时间点:全血:定量型	4182948
21490587	Art sys; Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490587	Arterial blood temp	4180186
21490587	体温:温度:时间点:动脉系统:定量型	4182948
21490590	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490590	Nasoph temp	4180186
21490590	体温:温度:时间点:鼻咽部:定量型	4182948
21490591	Skin temp in microenvt	4180186
21490591	Bdy temp; bod; Bodies; Dermatologic; Epidermis; Integument; NEONAT; Point in time; QNT; Quan; Quant; Quantitative; Random; Skn; Temp; Temperature	4180186
21490591	体温^在微环境中:温度:时间点:皮肤:定量型	4182948
21490595	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-AI; Voltage	4180186
21490595	ST Amp L-AI	4180186
21490595	ST 波振幅.导联 AI:电势:时间点:心脏:定量型:心电图	4182948
21490596	Arterial Stenosis; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-AS; Voltage	4180186
21490596	ST Amp L-AS	4180186
21490596	ST 波振幅.导联 AS:电势:时间点:心脏:定量型:心电图	4182948
21490597	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp dL-V1; Voltage	4180186
21490597	ST Amp dL-V1	4180186
21490597	ST 波振幅.衍生导联 V1:电势:时间点:心脏:定量型:心电图	4182948
21490599	Average; Avg; Cereb; Ctx; Electroencephalogram; MDF; NEURO; Neurology; Point in time; Power spec.mean dom freq; QNT; Quan; Quant; Quantitative; Random	4180186
21490599	Mean dominant freq EEG	4180186
21490599	功率谱.平均优势频率:频率:时间点:大脑皮质:定量型:脑电图	4182948
21490602	Cereb; Cnt; Count; Ctx; Electroencephalogram; NEURO; Neurology; Number; QNT; Quan; Quant; Quantitative	4180186
21490602	Seizure count Ctx EEG	4180186
21490602	发作计数:数量(计数):操作持续时间:大脑皮质:定量型:脑电图	4182948
21490603	Alfa; Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; Power.alpha; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
21490603	Alpha freq rel power EEG	4180186
21490603	功率谱.alpha 频率/功率谱.总计:功率比率:时间点:大脑皮质:定量型:脑电图	4182948
21490604	B; Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; Power.beta; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
21490604	Beta freq rel power EEG	4180186
21490604	功率谱.beta 频率/功率谱.总计:功率比率:时间点:大脑皮质:定量型:脑电图	4182948
21490609	Compound 347; Ethrane; Gas DS; Gases; Lung; Methylflurether; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490609	Enf VFr/PPres Gas DS	4180186
21490609	安氟醚:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490611	Anestan; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Gas DS; Gases; Halan; Halotan; Halsan; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan	4180186
21490611	Hal VFr/PPres Gas DS	4180186
21490611	氟烷:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490612	Anestan; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Gas DS; Gas DS.IL; Gases; Halan; Halotan; Halsan; In; Insp; Inspiratory; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan	4180186
21490612	Hal during insp VFr/PPres Gas DS.IL	4180186
21490612	氟烷^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490613	Gas DS; Gases; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490613	Isofl VFr/PPres Gas DS	4180186
21490613	异氟醚:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490614	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490614	Isofl during insp VFr/PPres Gas DS.IL	4180186
21490614	异氟醚^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490615	Gas DS; Gases; Laughing gas; Lung; N2O; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490615	N2O VFr/PPres Gas DS	4180186
21490615	氧化亚氮:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490616	Exp; Gas DS; Gas DS.EL; Gases; Laughing gas; Lung; N2O; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490616	N2O during expir VFr/PPres Gas DS.EL	4180186
21490616	氧化亚氮^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490617	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Laughing gas; Lung; N2O; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490617	N2O during insp VFr/PPres Gas DS.IL	4180186
21490617	氧化亚氮^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490619	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490619	Sevofl during insp VFr/PPres Gas DS.IL	4180186
21490619	七氟醚^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490620	Away adap; Lung; O2; O2 partial pressure; PO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490620	O2 VFr/PPres Away adap	4180186
21490620	氧:体积分数/分压:时间点:气道连接器:定量型	4182948
21490623	Breathing; Lung; Lungs; Phys dead space; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; TV; Vol; Volume ratio; VT	4180186
21490623	Phys dead space/TV on vent Respiratory	4180186
21490623	生理死腔/潮气量^采用呼吸机:体积比率:时间点:呼吸系统:定量型	4182948
21490625	Away adap; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490625	Anesthetic during insp Away adap	4180186
21490625	麻醉剂.XXX^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490626	Away adap; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490626	Des VFr/PPres Away adap	4180186
21490626	地氟醚:体积分数/分压:时间点:气道连接器:定量型	4182948
21490627	地氟醚^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490627	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490627	Des end exp VFr/PPres Away adap	4180186
21490631	异氟醚^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490631	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490631	Isofl end exp VFr/PPres Away adap	4180186
21490632	氧化亚氮^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490632	Away adap; Exp; Laughing gas; Lung; N2O; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490632	N2O end exp VFr/PPres Away adap	4180186
21490633	Away adap; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490633	Sevofl during insp VFr/PPres Away adap	4180186
21490633	七氟醚^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490634	七氟醚^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490634	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490634	Sevofl end exp VFr/PPres Away adap	4180186
21490637	Away adap; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490637	Argon during insp VFr/PPres Away adap	4180186
21490637	氩^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490638	氩^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490638	Away adap; Exp; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490638	Argon end exp VFr/PPres Away adap	4180186
21490639	Away adap; Lung; N; N2; Nit; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490639	N2 VFr/PPres Away adap	4180186
21490639	氮:体积分数/分压:时间点:气道连接器:定量型	4182948
21490640	氮^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490640	Away adap; Exp; Lung; N; N2; Nit; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490640	N2 end exp VFr/PPres Away adap	4180186
21490641	Away adap; In; Insp; Inspiratory; Lung; N; N2; Nit; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490641	N2 during insp VFr/PPres Away adap	4180186
21490641	氮^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490642	Away adap; Carbonic anhydride; cO2; In; Insp; Inspiratory; Lung; PCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490642	CO2 during insp VFr/PPres Away adap	4180186
21490642	二氧化碳^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490645	Away adap; He; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490645	Helium during insp VFr/PPres Away adap	4180186
21490645	氦^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490649	Breathing; Dynamic; Flow; Lung; Lungs; Pmax; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490649	Pmax Airway	4180186
21490649	峰值吸气流量:体积速率:时间点:呼吸系统.气道:定量型	4182948
21490650	Breathing; In; Insp; Inspiratory; Largest; Lung; Lungs; Maximal; Maximum; Peak; Point in time; Press.max; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490650	Pressure max during insp Airway	4180186
21490650	压力最大值^在吸气过程中:压力或压强:时间点:呼吸系统.气道:定量型	4182948
21490653	Cranial; Cranium; Head; NEURO; Neurology; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490653	ICP	4180186
21490653	颅内:压力或压强:时间点:颅骨:定量型	4182948
21490654	Cranial; Cranium; Dias; Diast; Diastoli; Head; NEURO; Neurology; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490654	ICP diastolic	4180186
21490654	颅内心脏舒张期:压力或压强:时间点:颅骨:定量型	4182948
21490655	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp dL-V2; Voltage	4180186
21490655	ST Amp dL-V2	4180186
21490655	ST 波振幅.衍生导联 V2:电势:时间点:心脏:定量型:心电图	4182948
21490656	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp dL-V3; Voltage	4180186
21490656	ST Amp dL-V3	4180186
21490656	ST 波振幅.衍生导联 V3:电势:时间点:心脏:定量型:心电图	4182948
21490657	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp dL-V4; Voltage	4180186
21490657	ST Amp dL-V4	4180186
21490657	ST 波振幅.衍生导联 V4:电势:时间点:心脏:定量型:心电图	4182948
21490661	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-MCL; Voltage	4180186
21490661	ST Amp L-MCL	4180186
21490661	ST 波振幅.导联 MCL:电势:时间点:心脏:定量型:心电图	4182948
21490665	Before; Cardiac; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Hrt; Hrt ventr; L; LT; Lung; LV; LVPEP; PEP; Point in time; Pre eject time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Ventricular	4180186
21490665	LV Pre eject Time	4180186
21490665	在射血时间之前:时间:时间点:心脏.心室.左侧:定量型:NI-ICG	4182948
21490668	Cardiac; Cardio; Cardiology; Energy; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; Job; Occupation; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Ventricular	4180186
21490668	RV Work	4180186
21490668	工作:能量:时间点:心脏.心室.右侧:定量型	4182948
21490672	AO; Aortic; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490672	Aorta BP dias	4180186
21490672	血管内心脏舒张期:压力或压强:时间点:主动脉:定量型	4182948
21490675	BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; Cardio; Cardiology; Cath; CVP; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490675	CVP	4180186
21490675	血管内:压力或压强:时间点:中心静脉导管:定量型	4182948
21490676	Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; Cath; CVP; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490676	CVP dias	4180186
21490676	血管内心脏舒张期:压力或压强:时间点:中心静脉导管:定量型	4182948
21490681	Atrial; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP diastolic; Cardiac; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Hrt; Intrachamber dias pres; Intrachamber pres; Point in time; Pressure; QNT; Quan; Quant; Quantitative; R; RA; Random; RAP; RT	4180186
21490681	RA pressure dias	4180186
21490681	心腔内舒张期:压力或压强:时间点:心脏.心房.右侧:定量型	4182948
21490684	Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Umb v; Ven; Venous	4180186
21490684	Umb vein BP dias	4180186
21490684	血管内心脏舒张期:压力或压强:时间点:脐静脉:定量型	4182948
21490686	Blood pressure; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP; Umb v; Ven; Venous	4180186
21490686	Umb vein BP sys	4180186
21490686	血管内心脏收缩期:压力或压强:时间点:脐静脉:定量型	4182948
21490687	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Bld ven; Bld venous; Blood - venous; Blood arterial; Blood ven; Blood venus; Est; estimation; Lung; O2; O2 BldA-BldV; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Venous	4180186
21490687	O2 BldA-BldV VFrDiff BldA+BldV Est	4180186
21490687	氧.动脉全血-氧.静脉全血:体积分数差:时间点:动脉全血+静脉全血:定量型:估计法	4182948
21490688	Body surf temp	4180186
21490688	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf; Temp; Temperature	4180186
21490688	体温:温度:时间点:表面:定量型	4182948
21490689	Myocard temp	4180186
21490689	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490689	体温:温度:时间点:心肌:定量型	4182948
21490699	Anestan; Away adap; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Halan; Halotan; Halsan; In; Insp; Inspiratory; Lung; Narcotan; Narkotan; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Rhodialothan	4180186
21490699	Hal during insp VFr/PPres Away adap	4180186
21490699	氟烷^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490700	Desfl gas del.total; Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490700	Desfl gas del.total RptPeriod Vol Gas DS	4180186
21490700	所输送的地氟醚气体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490701	Compound 347; Enfl gas del.total; Ethrane; Gas DS; Gases; Lung; Methylflurether; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490701	Enfl gas del.total RptPeriod Vol Gas DS	4180186
21490701	所输送的安氟醚气体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490702	Anestan; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Gas DS; Gases; Halan; Halo gas del.total; Halotan; Halsan; Lung; Narcotan; Narkotan; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Rhodialothan; Tot; Totl; Volume	4180186
21490702	Halo gas del.total RptPeriod Vol Gas DS	4180186
21490702	所输送的氟烷气体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490703	Gas DS; Gases; Isofl gas del.total; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490703	Isofl gas del.total RptPeriod Vol Gas DS	4180186
21490703	所输送的异氟醚气体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490708	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B pert; B pert.PT; B pert.PT Ab; B pert.PT IgG; B pertussis; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pertussis; Point in time; PR; PT; QL; Qual; Qualitative; Random; Screen; Serum; SR; Whooping cough	4180186
21490708	B pert.PT IgG Ser Ql Line blot	4180186
21490708	百日咳博德特菌.百日咳毒素 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
21490709	Bord sp FHA + PT IgA+IgG pnl; FHA; Filament; HA; ID; Immune globulin A; Immune globulin G; Immunoglobulin A; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; species; spp; SR	4180186
21490709	Bord sp FHA + PT IgA+IgG pnl Ser Ln blot	4180186
21490709	博德特氏菌纤维状红细胞凝集素与百日咳毒素抗体.IgA 与 IgG 组套:-:时间点:血清:-:线点印迹法	4182948
21490710	Air curtain status Inf microenvt.incub	4180186
21490710	Finding; Findings; Inf microenvt; Inf microenvt.incub; NEONAT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21490710	空气幕状态:发现:时间点:婴儿微环境.暖箱:序数型	4182948
21490712	Bdy surface; bod; Bodies; BSA; Cardiac; Cardio; Cardiology; CO; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf; Ventricular; Volume rate/area; Volume Rate/Ratio	4180186
21490712	LV Cardiac index	4180186
21490712	心输出量/体表面积:单位面积体积速率:时间点:心脏.心室.左侧:定量型	4182948
21490713	Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; Resist; Resistanc; Resistance; Resistant; Resistent	4180186
21490713	Transthor imped	4180186
21490713	阻抗:阻尼:时间点:^患者:定量型:经胸壁	4182948
21490721	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
21490721	Hgb BldA-sCnc	4180186
21490721	血红蛋白:物质的量浓度:时间点:动脉全血:定量型	4182948
21490725	Breathing; Exp; In; Insp; Inspiratory; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490725	Insp time percent	4180186
21490725	吸气/吸气+呼气:时间分数:时间点:呼吸系统:定量型	4182948
21490727	Away adap; Lung; N; N2; Nit; NO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490727	NO2 VFr/PPres Away adap	4180186
21490727	二氧化氮:体积分数/分压:时间点:气道连接器:定量型	4182948
21490730	二氧化氮^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490730	Away adap; Exp; Lung; N; N2; Nit; NO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490730	NO2 end exp VFr/PPres Away adap	4180186
21490731	O2/Gas.total VFr Inf microenvt.incub	4180186
21490731	Gases; Inf microenvt; Inf microenvt.incub; NEONAT; O2; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Tot; Totl; Volfr; Volume fraction	4180186
21490731	氧/气体.总计:体积分数:时间点:婴儿微环境.暖箱:定量型	4182948
21490732	Gases; Inf microenvt; Inf microenvt.incub; NEONAT; O2; O2/gas .tot set; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Tot; Total gas setting; Totl; Volfr; Volume fraction	4180186
21490732	O2 set VFr Inf microenvt.incub	4180186
21490732	氧/气体.总计设置:体积分数:时间点:婴儿微环境.暖箱:定量型	4182948
21490734	Cereb; Ctx; Electroencephalogram; Energy/time; NEURO; Neurology; Point in time; Power; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
21490734	Total power EEG	4180186
21490734	功率谱.总计:功率:时间点:大脑皮质:定量型:脑电图	4182948
21490735	Breathing; In; Insp; Inspiratory; Lung; Lungs; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490735	Press during insp Airway	4180186
21490735	压力^在吸气过程中:压力或压强:时间点:呼吸系统.气道:定量型	4182948
21490738	Eye; EYE.PX; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Vision; Visual	4180186
21490738	L eye Pupil reaction [Time]	4180186
21490738	瞳孔反应:时间:时间点:眼睛.左侧:定量型	4182948
21490739	Eye; EYE.PX; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; React; RT; Rxn; Vision; Visual	4180186
21490739	R eye Pupil reaction [Time]	4180186
21490739	瞳孔反应:时间:时间点:眼睛.右侧:定量型	4182948
21490741	Airway resist; Breathing; Exp; Fluid resistance; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; RAW; Resist; Resistanc; Resistant; Resistent; Respiratory; RS	4180186
21490741	Airway resist during expir	4180186
21490741	阻力.气道^在呼气过程中:液体阻力:时间点:呼吸系统.气道:定量型	4182948
21490742	Airway resist; Breathing; Fluid resistance; In; Insp; Inspiratory; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; RAW; Resist; Resistanc; Resistant; Resistent; Respiratory; RS	4180186
21490742	Airway resist during insp	4180186
21490742	阻力.气道^在吸气过程中:液体阻力:时间点:呼吸系统.气道:定量型	4182948
21490743	Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21490743	Response entropy Score Ctx EEG	4180186
21490743	反应熵:评分:时间点:大脑皮质:定量型:脑电图	4182948
21490745	Skin temperature setting Inf microenvt	4180186
21490745	Inf microenvt; Integument; NEONAT; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temp setting; Temperature	4180186
21490745	皮肤温度设置:温度:时间点:婴儿微环境:定量型	4182948
21490746	Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21490746	SNAP index Score Ctx EEG	4180186
21490746	SNAP 指数:评分:时间点:大脑皮质:定量型:脑电图	4182948
21490748	Cereb; Ctx; Electroencephalogram; NEURO; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21490748	State entropy Score Ctx EEG	4180186
21490748	状态熵:评分:时间点:大脑皮质:定量型:脑电图	4182948
21490751	Inf microenvt; Inf microenvt.incub; NEONAT; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temp setting; Temperature	4180186
21490751	Temp setting Inf microenvt.incub	4180186
21490751	温度设置:温度:时间点:婴儿微环境.暖箱:定量型	4182948
21490752	Breathing; End tidal volume; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; TV; Vet; Vol; Vol exp; Volume; VT; VT.expired	4180186
21490752	VT.expired Airway	4180186
21490752	潮气量.呼出:体积型属性:时间点:呼吸系统.气道:定量型	4182948
21490753	1 minute; Breathing; End tidal volume; Flow; Lung; Lungs; Minute ventilation; Minute volume; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; RS; Total ventilation; Vet; Vol; Vol exp; Vol.exp/M; Volume Rate; vRate	4180186
21490753	Vol.exp/M Resp system	4180186
21490753	体积.每分钟呼出:体积速率:1分钟:呼吸系统:定量型	4182948
21490757	Gases; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Rosetta GASMON Pnl	4180186
21490757	Rosetta GASMON Pnl	4180186
21490757	IEEE Rosetta 气体监测组套:-:-:^患者:-	4182948
21490761	Inf pump; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Rosetta INFUS Pnl	4180186
21490761	Rosetta INFUS Pnl Inf pump	4180186
21490761	IEEE Rosetta 输注组套:-:-:输液泵:-	4182948
21490763	CNS; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Rosetta CNS Pnl	4180186
21490763	Rosetta CNS Pnl	4180186
21490763	IEEE Rosetta 中枢神经系统组套:-:-:^患者:-	4182948
21490766	Air del dur case; Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490766	Air del dur case Vol Gas DS	4180186
21490766	所输送的空气.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490768	AO; Aortic; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Vel; Velocity	4180186
21490768	Velocity index Aorta NI-ICG	4180186
21490768	速度指数:速度:时间点:主动脉:定量型:NI-ICG	4182948
21490770	Cardiac; Cardio; Cardiology; CARDIO-PULM; Dias; Diast; Diastoli; ED vol; Heart Disease; Hrt; Hrt ventr; L; LT; Lung; LV; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Ventricular; Vol; Volume	4180186
21490770	LV ED Vol	4180186
21490770	心脏舒张末期容积:体积型属性:时间点:心脏.心室.左侧:定量型	4182948
21490771	Cardiac; Cardio; Cardiology; CARDIO-PULM; ES vol; Heart Disease; Hrt; Hrt ventr; L; LT; Lung; LV; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Ventricular; Vol; Volume	4180186
21490771	LV ES Vol	4180186
21490771	心脏收缩末期容积:体积型属性:时间点:心脏.心室.左侧:定量型	4182948
21490773	Lung; O2; O2 extraction; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; tO2; Volume ratio	4180186
21490773	O2 extraction ratio	4180186
21490773	氧摄取:体积比率:报告期:^患者:定量型	4182948
21490775	Art; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; Cardio; Cardiology; Fem a; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Thigh	4180186
21490775	Fem a BP	4180186
21490775	血管内:压力或压强:时间点:股动脉:定量型	4182948
21490776	Art; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; Cardio; Cardiology; Heart Disease; Intravenous; IV; PA; PAP; PAW; PAWP; PCWP; Point in time; Pressure; Pulmonary capillary wedge pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490776	PAW pressure	4180186
21490776	血管内:压力或压强:时间点:肺动脉.楔:定量型	4182948
21490777	Art sys; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490777	BP dias by CNAP	4180186
21490777	血管内心脏舒张期:压力或压强:时间点:动脉系统:定量型:CNAP	4182948
21490778	Art sys; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP mean; Cardio; Cardiology; Heart Disease; Intravenous; IV; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490778	BP mean by CNAP	4180186
21490778	血管内平均值:压力或压强:时间点:动脉系统:定量型:CNAP	4182948
21490780	Gas DS; Gases; Lung; O2; O2 gas del dur case; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; tO2; Volume	4180186
21490780	O2 gas del dur case Vol Gas DS	4180186
21490780	所输送的氧气.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490783	Breathing; Lung; Lungs; Phys dead space; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume	4180186
21490783	Phys dead space Vol Respiratory	4180186
21490783	生理死腔:体积型属性:时间点:呼吸系统:定量型	4182948
21490784	Breathing; Lung; Lungs; Phys dead space; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; TV; Vol; Volume ratio; VT	4180186
21490784	Phys dead space/TV Respiratory	4180186
21490784	生理死腔/潮气量:体积比率:时间点:呼吸系统:定量型	4182948
21490787	Point in time; QNT; Quan; Quant; Quantitative; Random; TC monitor; TC monitor sensor; Temp; Temperature	4180186
21490787	TC monitor sensor temp	4180186
21490787	温度:温度:时间点:经皮肤监测仪传感器:定量型	4182948
21490789	Breathing; End tidal volume; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; TV; Vet; Vol; Vol exp; Volume; VT; VT.expired	4180186
21490789	VT.expired on vent Airway	4180186
21490789	潮气量.呼出^采用呼吸机:体积型属性:时间点:呼吸系统.气道:定量型	4182948
21490791	bod; Bodies; Pan; PANEL.IEEE ROSETTA; Panl; Pnl; Point in time; Random; Rosetta body meas Pnl	4180186
21490791	Rosetta body meas Pnl	4180186
21490791	IEEE Rosetta 身体测量组套:-:时间点:^患者:-	4182948
21490793	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-V2; Voltage	4180186
21490793	ST Amp L-V2	4180186
21490793	ST 波振幅.导联 V2:电势:时间点:心脏:定量型:心电图	4182948
21490794	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-V3; Voltage	4180186
21490794	ST Amp L-V3	4180186
21490794	ST 波振幅.导联 V3:电势:时间点:心脏:定量型:心电图	4182948
21490796	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-V5; Voltage	4180186
21490796	ST Amp L-V5	4180186
21490796	ST 波振幅.导联 V5:电势:时间点:心脏:定量型:心电图	4182948
21490800	3; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-III; Voltage	4180186
21490800	ST Amp L-III	4180186
21490800	ST 波振幅.导联 III:电势:时间点:心脏:定量型:心电图	4182948
21490801	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-aVF; Voltage	4180186
21490801	ST Amp L-aVF	4180186
21490801	ST 波振幅.导联 aVF:电势:时间点:心脏:定量型:心电图	4182948
21490803	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Amp L-aVR; Voltage	4180186
21490803	ST Amp L-aVR	4180186
21490803	ST 波振幅.导联 aVR:电势:时间点:心脏:定量型:心电图	4182948
21490804	Away adap; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490804	Anesthetic Away adap	4180186
21490804	麻醉剂.XXX:体积分数/分压:时间点:气道连接器:定量型	4182948
21490808	Carbonic anhydride; cO2; Exp; Gas DS; Gas DS.EL; Gases; Lung; PCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490808	CO2 during expir VFr/PPres Gas DS.EL	4180186
21490808	二氧化碳^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490809	Carbonic anhydride; cO2; Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; PCO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490809	CO2 during insp VFr/PPres Gas DS.IL	4180186
21490809	二氧化碳^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490812	Exp; Gas DS; Gas DS.EL; Gases; Lung; NO; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490812	NO during expir VFr/PPres Gas DS.EL	4180186
21490812	一氧化氮^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490816	Exp; Gas DS; Gas DS.EL; Gases; Lung; N; N2; Nit; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490816	N2 during expir VFr/PPres Gas DS.EL	4180186
21490816	氮^在呼气过程中:体积分数/分压:时间点:气体输送系统.呼气支路:定量型	4182948
21490817	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; N; N2; Nit; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490817	N2 during insp VFr/PPres Gas DS.IL	4180186
21490817	氮^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490824	Gas DS; Gases; Lung; NO; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490824	NO VFr/PPres Gas DS	4180186
21490824	一氧化氮:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490825	Gas DS; Gases; Lung; N; N2; Nit; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490825	N2 VFr/PPres Gas DS	4180186
21490825	氮:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490826	Gas DS; Gases; Lung; N; N2; Nit; NO2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490826	NO2 VFr/PPres Gas DS	4180186
21490826	二氧化氮:体积分数/分压:时间点:气体输送系统:定量型	4182948
21490828	一氧化氮^呼气末:体积分数/分压:时间点:气道连接器:定量型	4182948
21490828	Away adap; Exp; Lung; NO; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490828	NO end exp VFr/PPres Away adap	4180186
21490833	Away adap; In; Insp; Inspiratory; Lung; NO; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490833	NO during insp VFr/PPres Away adap	4180186
21490833	一氧化氮^在吸气过程中:体积分数/分压:时间点:气道连接器:定量型	4182948
21490836	Gas DS; Gases; Lung; NO; NO gas del.tot; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490836	NO gas del.tot RptPeriod Vol Gas DS	4180186
21490836	所输送的一氧化氮气体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490838	Gas DS; Gases; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume; Xe; Xe gas del.total	4180186
21490838	Xe gas del.total RptPeriod Vol Gas DS	4180186
21490838	所输送的氙气.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490840	Sugar absorption test Pnl 5h Ur-sRto	4180186
21490840	5 hours; 5.0Hr; 5HR; Absorp; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Scrto; Substance concentration ratio; Substance ratio; Sugar absorption test Pnl; UA; UR; Urn	4180186
21490840	糖吸收试验组套:物质的量比率:5小时:尿液:-	4182948
21490844	ALV; Alv vent; Breathing; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume	4180186
21490844	Alv vent on vent Vol Respiratory	4180186
21490844	肺泡通气^采用呼吸机:体积型属性:时间点:呼吸系统:定量型	4182948
21490850	Invasive BP	4180186
21490850	Art sys; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490850	血管内:压力或压强:时间点:动脉系统:定量型:侵袭性	4182948
21490851	Art sys; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490851	Invasive dias BP	4180186
21490851	血管内心脏舒张期:压力或压强:时间点:动脉系统:定量型:侵袭性	4182948
21490852	Art sys; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP mean; Cardio; Cardiology; Heart Disease; Intravenous; IV; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490852	Invasive mean BP	4180186
21490852	血管内平均值:压力或压强:时间点:动脉系统:定量型:侵袭性	4182948
21490853	Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
21490853	Invasive sys BP	4180186
21490853	血管内心脏收缩期:压力或压强:时间点:动脉系统:定量型:侵袭性	4182948
21490854	Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; TV; Vol; Volume; VT	4180186
21490854	Vt on vent Vent	4180186
21490854	潮气量^采用呼吸机:体积型属性:时间点:呼吸机:定量型	4182948
21490855	Breathing; Lung; Lungs; PEEP; Point in time; Pos; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21490855	PEEP on vent Respiratory	4180186
21490855	压力.呼气末正^采用呼吸机:压力或压强:时间点:呼吸系统:定量型	4182948
21490858	O2 cylinder Press	4180186
21490858	Cyl.O2; O2; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490858	压力:压力或压强:时间点:压缩气体钢瓶.氧气:定量型	4182948
21490859	O2; Pipe.O2; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490859	O2 pipeline Press	4180186
21490859	压力:压力或压强:时间点:管道.氧气:定量型	4182948
21490860	Air cylinder Press	4180186
21490860	Cyl.air; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490860	压力:压力或压强:时间点:压缩气体钢瓶.空气:定量型	4182948
21490862	Breathing; Dynamic; Flow; Gases; Largest; Lung; Lungs; Maximal; Maximum; Peak; Peak expiratory flow; PEF; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
21490862	Deprecated PEF Airway	4180186
21490864	Bdy weight; bod; Bodies; Breathing; Carbonic anhydride; cO2; CO2 production; Flow; IBW; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate; Wt	4180186
21490864	CO2 production/IBW Respiratory	4180186
21490864	二氧化碳产生/理想体重:体积速率:时间点:呼吸系统:定量型	4182948
21490865	Lung; Point in time; Press.ambient; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490865	Press.ambient Room	4180186
21490865	压力.环境:压力或压强:时间点:房间:定量型	4182948
21490873	Bld flow; Bld flow rate; Cardio; Cardiology; CARDIO-PULM; Dynamic; Flow; Heart Disease; Lung; Point in time; Pulm cap; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
21490873	Bld flow rate Pulm cap	4180186
21490873	血液流速:体积速率:时间点:肺毛细血管:定量型	4182948
21490875	BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; Cardio; Cardiology; Est; estimation; Heart Disease; Intravenous; IV; Point in time; Pressure; Pulm cap; QNT; Quan; Quant; Quantitative; Random	4180186
21490875	Pulm cap BP	4180186
21490875	血管内:压力或压强:时间点:肺毛细血管:定量型:估计法	4182948
21490876	Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP dias; BP diastolic; Cardio; Cardiology; DBP; Dias; Dias BP; Diast; Diastoli; Est; estimation; Heart Disease; Intravenous; IV; Point in time; Pressure; Pulm cap; QNT; Quan; Quant; Quantitative; Random	4180186
21490876	Pulm cap dias BP	4180186
21490876	血管内心脏舒张期:压力或压强:时间点:肺毛细血管:定量型:估计法	4182948
21490877	Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP mean; Cardio; Cardiology; Est; estimation; Heart Disease; Intravenous; IV; MBP; Point in time; Pressure; Pulm cap; QNT; Quan; Quant; Quantitative; Random	4180186
21490877	Pulm cap mean BP	4180186
21490877	血管内平均值:压力或压强:时间点:肺毛细血管:定量型:估计法	4182948
21490881	Gastro; Gastroenterology; GI; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21490881	Gastric press	4180186
21490881	压力:压力或压强:时间点:胃:定量型	4182948
21490882	Time int btwn dose start Inf pump	4180186
21490882	Inf pump; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Time int btwn start of doses	4180186
21490882	剂量药物起始之间的时间间隔:时间:时间点:输液泵:定量型	4182948
21490883	Cnt; Count; Inf pump; IO_IN.INFUS; IO_INTAKE; Number; QNT; Quan; Quant; Quantitative; Report period	4180186
21490883	Doses.del RptPeriod Inf pump	4180186
21490883	剂量药物.所输送:数量(计数):报告期:输液泵:定量型	4182948
21490887	Inf pump; IO_IN.INFUS; IO_INTAKE; Largest; Maximal; Maximum; PCA dose vol.max; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume	4180186
21490887	PCA dose vol.max Inf pump	4180186
21490887	PCA 剂量体积.最大值:体积型属性:时间点:输液泵:定量型	4182948
21490888	Inf pump; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490888	PCA lockout time Inf pump	4180186
21490888	病人自控镇痛锁定时间:时间:时间点:输液泵:定量型	4182948
21490891	Inf pump Vol.start	4180186
21490891	Inf pump; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Vol; Vol.start; Volume	4180186
21490891	体积.起始:体积型属性:时间点:输液泵:定量型	4182948
21490892	Ident; Identifier; Nominal; Point in time; Random	4180186
21490892	制造商名称:标识符:时间点:注射器:名义型	4182948
21490895	Cardiac; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Hrt; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Sys time; Sys time rto; Time ratio	4180186
21490895	Sys time rto	4180186
21490895	收缩时间比率:时间比率:时间点:心脏:定量型	4182948
21490896	Acc; Accel; Accel index; Acceleration; ACCT1; AO; Aortic; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random	4180186
21490896	ACI	4180186
21490896	加速指数:加速度:时间点:主动脉:定量型	4182948
21490897	Inf pump Alert type	4180186
21490897	Inf pump; Nominal; Point in time; Random; Typ	4180186
21490897	警示类型:类型:时间点:输液泵:名义型	4182948
21490900	Inf pump; Nominal; Point in time; Random; Typ	4180186
21490900	Inf pump Alarm trigger	4180186
21490900	警示触发条件:类型:时间点:输液泵:名义型	4182948
21490901	Inf pump; Nominal; Point in time; Random; Typ	4180186
21490901	Inf pump Alert priority	4180186
21490901	警示优先级别:类型:时间点:输液泵:名义型	4182948
21490902	Inf pump; Nominal; Point in time; Random; Typ	4180186
21490902	Inf pump Pump mode	4180186
21490902	泵模式:类型:时间点:输液泵:名义型	4182948
21490903	Inf pump Pump mode.current	4180186
21490903	Inf pump; Nominal; Point in time; Random; Typ	4180186
21490903	泵模式.当前:类型:时间点:输液泵:名义型	4182948
21490904	Inf pump Pump mode.set	4180186
21490904	Inf pump; Nominal; Point in time; Random; Typ	4180186
21490904	泵模式.设置:类型:时间点:输液泵:名义型	4182948
21490906	Nasal temp	4180186
21490906	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Nasal; Nos; Nose (nasal passage); Point in time; QNT; Quan; Quant; Quantitative; Random; Smell; Temp; Temperature	4180186
21490906	体温:温度:时间点:鼻:定量型	4182948
21490907	Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature	4180186
21490907	Ear temp	4180186
21490907	体温:温度:时间点:耳:定量型	4182948
21490909	Desfl liq del.tot; Gas DS; Gases; Liquids; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490909	Desfl liq del.tot RptPeriod Vol Gas DS	4180186
21490909	所输送的地氟醚液体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490910	Compound 347; Enfl liq del dur case; Ethrane; Gas DS; Gases; Liquids; Lung; Methylflurether; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Volume	4180186
21490910	Enfl liq del dur case Vol Gas DS	4180186
21490910	所输送的安氟醚液体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490911	Compound 347; Enfl liq del.total; Ethrane; Gas DS; Gases; Liquids; Lung; Methylflurether; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Report period; Respiratory; Tot; Totl; Volume	4180186
21490911	Enfl liq del.total RptPeriod Vol Gas DS	4180186
21490911	所输送的安氟醚液体.总计:体积型属性:报告期:气体输送系统:定量型	4182948
21490912	Anestan; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Gas DS; Gases; Halan; Halo liq del dur case; Halotan; Halsan; Liquids; Lung; Narcotan; Narkotan; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Rhodialothan; Volume	4180186
21490912	Halo liq del dur case Vol Gas DS	4180186
21490912	所输送的氟烷液体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490914	Gas DS; Gases; Liquids; Lung; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Sevo liq del dur case; Volume	4180186
21490914	Sevo liq del dur case Vol Gas DS	4180186
21490914	所输送的七氟醚液体.案例:体积型属性:操作持续时间:气体输送系统:定量型	4182948
21490916	Gas DS; Gas DS.IL; Gases; In; Insp; Inspiratory; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
21490916	Argon during insp VFr/PPres Gas DS.IL	4180186
21490916	氩^在吸气过程中:体积分数/分压:时间点:气体输送系统.吸气支路:定量型	4182948
21490920	Inf vol.single cont; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume	4180186
21490920	Inf vol.single cont	4180186
21490920	已输注体积.单个容器:体积型属性:时间点:^患者:定量型	4182948
21490922	Inf dose.prog; Inf pump; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490922	Inf dose.prog Inf pump	4180186
21490922	输注剂量.程序化:质量:时间点:输液泵:定量型	4182948
21490925	Inf pump; Inf time.remain; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490925	Inf time.remain Inf pump	4180186
21490925	输注时间.剩余:时间:时间点:输液泵:定量型	4182948
21490926	Inf time.remain Based on container vol	4180186
21490926	Based on contain vol; Inf pump; Inf time.remain; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490926	输注时间.剩余:时间:时间点:输液泵:定量型:基于容器容积的方法	4182948
21490930	Away adap; Exp O2; Insp O2; Insp O2-Exp O2; Lung; O2; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
21490930	PiO2-PeO2	4180186
21490930	氧气.吸入-氧气.呼出:压差:时间点:气道连接器:定量型	4182948
21490933	DHP Reduct RBC-cCnt	4180186
21490933	Catalytic Content; Chemistry; DHP Reduct; DHPR; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21490933	二氢蝶啶还原酶:催化含量:时间点:红细胞:定量型	4182948
21490934	Cerebrose; Chemistry; Erythrocytes; GAL-1-P; Gal1PO4; GAL-1-PO4; GAL1PTS; Gal1PUT; GAL-1-PUT; Galactose 1 Phosphate Uridyltransferase; Galactosemia; GALT; GPUT; Hexose-1-phosphate uridyltransferase; i; i Phos; Inorganic phosphate; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21490934	Gal1PUT cSub RBC	4180186
21490934	半乳糖-1-磷酸尿苷酰转移酶:单位物质的量相对型催化活性:时间点:红细胞:定量型	4182948
21490936	Iduronate2Sulfatas DBS-cCnc	4180186
21490936	Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Hunter disease; Iduronate2Sulfatas; II; MPS II; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21490936	艾杜糖-2-硫酸酯酶:催化浓度:时间点:全血.斑点:定量型	4182948
21490942	Chemistry; Level; Pl; Plasma; Plsm; Point in time; PPG; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490942	PPG SerPl-sCnc	4180186
21490942	苯丙酰甘氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490944	3,4-Dihydroxybutyrate/Creat Ur-sRto	4180186
21490944	Chemistry; CR; Crea; Creat; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21490944	3,4-二羟基丁酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21490945	2,5-Furandicarboxylate SerPl-sCnc	4180186
21490945	Chemistry; Furan 2,5-dicarboxylate; Furan 2,5-dicarboxylic acid; Furan-2,5-dicarboxylate; Furan-2,5-dicarboxylic acid; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490945	2,5-呋喃二羧酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490950	1-(2-aminoacetyl)pyrrolidine-2-carboxylic acid; 1-(Aminoacetyl)proline; 1-Glycyl-L-proline; 1-Glycylproline; Chemistry; Esoteric; Glycyl-L-proline; Gly-pro; Level; N-glycylproline; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490950	Gly-pro SerPl-sCnc	4180186
21490950	甘氨酰脯氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490951	Chemistry; Esoteric; Left; Level; Levo; Levo-serine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490951	L-serine SerPl-sCnc	4180186
21490951	L-丝氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490954	Phe + Tyr Pnl DBS	4180186
21490954	苯丙氨酸与酪氨酸组套:-:时间点:全血.斑点:-	4182948
21490954	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Pan; PANEL.CHEMISTRY; Panl; Phe; Phe + Tyr Pnl; Phe+Tyr; Phenylalanine +Tyrosine; PKU; Pnl; Point in time; PPA; Random; Tyr; WB; Whole blood	4180186
21490961	by KM; Corneal; EYE; EYE.PX; EYE.PX.NEI; Inverse Length; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT	4180186
21490961	R cornea Corneal curvature by KM	4180186
21490961	角膜曲率:长度倒数:时间点:角膜.右侧:定量型:角膜曲率测量法	4182948
21490962	by KM; Corneal; EYE; EYE.PX; EYE.PX.NEI; Inverse Length; L; L cornea; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21490962	L cornea Corneal curvature by KM	4180186
21490962	角膜曲率:长度倒数:时间点:角膜.左侧:定量型:角膜曲率测量法	4182948
21490963	EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R pupil; Random; RT	4180186
21490963	R pupil Pupillary resp	4180186
21490963	瞳孔反应:发现:时间点:瞳孔.右侧:名义型	4182948
21490965	EYE; EYE.OCT; EYE.OCT.NEI; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick	4180186
21490965	L ret Foveal thickness OCT	4180186
21490965	黄斑中心凹厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
21490969	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; Largest; LT; LV; LV.basal ant; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Syst; TDI; Time to S Vmax; ULS; Ultrasound; V sys; Vel; Ventricular	4180186
21490969	LV.basal ant Time to S Vmax TDI	4180186
21490969	达到最大组织速度的时间.收缩期:时间:时间点:心脏.心室.左侧.前底部:定量型:超声.组织多普勒	4182948
21490972	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; Largest; Lat; LT; LV; LV.basal lat; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Syst; TDI; Time to S Vmax; ULS; Ultrasound; V sys; Vel; Ventricular	4180186
21490972	LV.basal lat Time to S Vmax TDI	4180186
21490972	达到最大组织速度的时间.收缩期:时间:时间点:心脏.心室.左侧.底部侧面:定量型:超声.组织多普勒	4182948
21490974	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; Largest; LT; LV; LV.basal sept; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Syst; TDI; Time to S Vmax; ULS; Ultrasound; V sys; Vel; Ventricular	4180186
21490974	LV.basal sept Time to S Vmax TDI	4180186
21490974	达到最大组织速度的时间.收缩期:时间:时间点:心脏.心室.左侧.底部间隔:定量型:超声.组织多普勒	4182948
21490976	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; Largest; LT; LV; LV.mid ant; LV.mid ant septum; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Syst; TDI; Time to S Vmax; ULS; Ultrasound; V sys; Vel; Ventricular	4180186
21490976	LV.mid ant septum Time to S Vmax TDI	4180186
21490976	达到最大组织速度的时间.收缩期:时间:时间点:心脏.心室.左侧.室间隔中前部:定量型:超声.组织多普勒	4182948
21490979	3-hydroxy-adipate; 3-hydroxyadipic acid; 3-Hydroxyadipolactone; 3OH-Adipate; 3OH-adipate 3,6-lactone; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21490979	3OH-adipate 3,6-lactone SerPl-sCnc	4180186
21490979	3-羟基己二酸 3,6-内酯:物质的量浓度:时间点:血清/血浆:定量型	4182948
21490981	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490983	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490986	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21490990	Atrial wave; A-wave; A-wave duration; CARD.US; Cardio; Cardiology; DOP; DOP.PW; DUPLEX; Durat; Echography; Heart Disease; Point in time; Pulm v; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ven; Venous	4180186
21490990	Pulm vein A wave duration DOP.PW	4180186
21490990	A 波持续时间:时间:时间点:肺静脉:定量型:超声.多普勒.PW	4182948
21490995	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
21490995	Ophthalmol Summary note	4180186
21490995	摘要:发现:时间点:{环境}:文档型:眼科学	4182948
21490996	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Summary encounters; Visit note	4180186
21490996	Ophthalmol Summary encounters	4180186
21490996	就医摘要记录:发现:时间点:{环境}:文档型:眼科学	4182948
21490997	A,B; Antigen; Antigens; E coli; E coli K1; ID; Infectious Disease; InfectiousDisease; LAT; Latex agglutination; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men A+B+C+W135+Y+EcK1 Ag; N men sg A+B+C+W135+Y; N men sg A+B+C+W135+Y+EcK1; N menigitidis; N meningitidis; o002; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
21490997	N men sg A+B+C+W135+Y+EcK1 Ag Spec Ql LA	4180186
21490997	脑膜炎奈瑟菌 A+B+C+w135+Y 血清群+大肠埃希菌 K1 群 抗原:存在情况或阈值:时间点:XXX:序数型:胶乳凝集试验法	4182948
21491002	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Clopidogrel response assay; COAGULATION; Hematology; Heme; II; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelet rich plasma; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491002	PA ADP 2 umol/L PRP	4180186
21491002	血小板聚集.二磷酸腺苷诱导型^2 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491003	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelet rich plasma; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491003	PA ADP 2.5 umol/L PRP	4180186
21491003	血小板聚集.二磷酸腺苷诱导型^2.5 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491008	5,8,11,14 Eicosatetraenoic acid; AA; Agg; Aggr; Arachidonic acid; Arch acid; Aspirin Assay; C20:4w6; COAGULATION; Eicosatetraenoate; Hematology; Heme; Left; Levo; PA; PA AA; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
21491008	PA AA 1.6 mmol/L PRP	4180186
21491008	血小板聚集.花生四烯酸诱导型^1.6 毫摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491011	Agg; Aggr; COAGULATION; Hematology; Heme; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes	4180186
21491011	PA Rist 1.25 mg/ml PRP	4180186
21491011	血小板聚集.瑞斯托菌素诱导型^1.25 毫克/毫升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
21491014	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vesicular stomatitis virus Indiana 1; Vet; Veterinary; VS; VSIV; VSV-IN	4180186
21491014	VSIV RNA Ct Spec Qn NAA+probe	4180186
21491014	水泡性口炎病毒 Indiana 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
21491015	120 min; 120 minutes; 120min; 2 hours; Chemistry; CR; Crea; Creat; Diaf; DiafP; Dialysate; Dialysis fluid; Kidney; Level; Nephrology; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Spec; Substance concentration	4180186
21491015	Creat 2H dwell spec DiafP-sCnc	4180186
21491015	肌酐^2小时存放标本:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21491016	Chemistry; CR; Crea; Creat; Diaf; DiafP; Dialysate; Dialysis fluid; Kidney; Level; Nephrology; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Spec; Substance concentration	4180186
21491016	Creat 4H dwell spec DiafP-sCnc	4180186
21491016	肌酐^4小时存放标本:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21491017	120 min; 120 minutes; 120min; 2 hours; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Glu; Gluc; Glucoseur; Level; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance concentration	4180186
21491017	Glucose 2H dwell spec DiafP-sCnc	4180186
21491017	葡萄糖^2小时存放标本:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21491018	Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Glu; Gluc; Glucoseur; Level; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance concentration	4180186
21491018	Glucose 4H dwell spec DiafP-sCnc	4180186
21491018	葡萄糖^4小时存放标本:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21491019	Urea nit 2H dwell spec DiafP-sCnc	4180186
21491019	120 min; 120 minutes; 120min; 2 hours; Blood urea nitrogen; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Level; N; N2; Nit; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance concentration; UN	4180186
21491019	尿素氮^2小时存放标本:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21491020	Urea nit 4H dwell spec DiafP-sCnc	4180186
21491020	Blood urea nitrogen; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Level; N; N2; Nit; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance concentration; UN	4180186
21491020	尿素氮^4小时存放标本:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21491021	Palliative care Admit H&P note	4180186
21491021	Admit H&P note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
21491021	入院史与体格检查记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491023	OMS Checklist	4180186
21491023	DOC.ONT; Document; Finding; Findings; OMS; Point in time; Random; Surg	4180186
21491023	检查清单:发现:时间点:{环境}:文档型:口腔颌面外科学	4182948
21491025	DOC.ONT; Document; Finding; Findings; Point in time; Random; Surg	4180186
21491025	检查清单:发现:时间点:{环境}:文档型:血管外科学	4182948
21491026	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Finding; Findings; Heart Disease; Point in time; Random; Surg	4180186
21491026	Cardiothor surg Checklist	4180186
21491026	检查清单:发现:时间点:{环境}:文档型:胸心外科学	4182948
21491027	Peds surgery Checklist	4180186
21491027	DOC.ONT; Document; Finding; Findings; PEDS; Peds surgery; Point in time; Random; Surg	4180186
21491027	检查清单:发现:时间点:{环境}:文档型:小儿外科学	4182948
21491028	DOC.ONT; Document; Finding; Findings; Point in time; Random; Surg	4180186
21491028	检查清单:发现:时间点:{环境}:文档型:成形外科学	4182948
21491029	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491029	会诊记录:发现:时间点:{环境}:文档型:疼痛医学	4182948
21491030	Consult note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491030	会诊记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491031	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Lung; notes; Point in time; Pulmonary; Pulmonology; Random; Resp therapy; Respiratory; Visit note	4180186
21491031	Resp therapy Counseling note	4180186
21491031	咨询记录:发现:时间点:{环境}:文档型:呼吸疗法	4182948
21491032	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Path; Point in time; Random; Speech pathology; Speech therapy; Speech-lang path; Visit note	4180186
21491032	Speech-lang path Counseling note	4180186
21491032	咨询记录:发现:时间点:{环境}:文档型:言语-语言病理学	4182948
21491034	Cancer; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Study report; Visit note	4180186
21491034	Radiation Onc Diag study note	4180186
21491034	诊断性检查记录:发现:时间点:{环境}:文档型:放射肿瘤学	4182948
21491036	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report; Visit note	4180186
21491036	Optometry Diag study note	4180186
21491036	诊断性检查记录:发现:时间点:{环境}:文档型:视力测定	4182948
21491037	Diag study note; DOC.ONT; Document; Ear Nose Throat; Encounter; ENT; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oto; Otolaryngology; Otorhinolaryngology; Point in time; Random; Study report; Visit note	4180186
21491037	Otolaryngology Diag study note	4180186
21491037	诊断性检查记录:发现:时间点:{环境}:文档型:耳鼻喉科学	4182948
21491043	Disch; DOC.ONT; Document; Finding; Findings; Point in time; Random; Rec therapy	4180186
21491043	Rec therapy Discharge instruct	4180186
21491043	出院指导:发现:时间点:{环境}:文档型:娱乐疗法	4182948
21491047	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491047	Vanilloylglycine/Creat Ur-sRto	4180186
21491047	香草酰甘氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491049	4OH-valerate/Creat Ur-sRto	4180186
21491049	4OH-valerate; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491049	4-羟基戊酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491050	3,5-Dihydroxybenzoic acid; Benzoate; Chemistry; CR; Crea; Creat; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491050	3,5-Dihydroxybenzoate/Creat Ur-sRto	4180186
21491050	3,5-二羟基苯甲酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491051	Lactyl lactate/Creat Ur-sRto	4180186
21491051	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; CR; Crea; Creat; Lact; Lactic acid; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491051	缩二乳酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491053	3OH-benzoate SerPl-sCnc	4180186
21491053	3OH-benzoate; Chemistry; Hydroxybenzoic acid; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491053	3-羟基苯甲酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491057	3OH-hippurate/Creat Ur-sRto	4180186
21491057	3-Hydroxyhippuric acid; 3OH-hippurate; Chemistry; CR; Crea; Creat; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491057	3-羟基马尿酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491061	3-Methoxy-4-Hydroxyphenylacetic Acid; 3-Methoxy-4-hydroxyphenyllactate; 4OH3methoxyphenyllactate; Chemistry; Hydrox; III; Level; OH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vanillactate; Vanillactic acid	4180186
21491061	4OH3methoxyphenyllactate SerPl-sCnc	4180186
21491061	4-羟基-3-甲氧基苯基乳酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491065	Decenedioate SerPl-sCnc	4180186
21491065	Chemistry; Decenedioic acid; Level; Medium chain acyl-CoA dehydrogenase deficiency; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491065	癸烯二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491068	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491068	Vanilloylglycine SerPl-sCnc	4180186
21491068	香草酰甘氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491073	Desaminotyrosine/Creat Ur-sRto	4180186
21491073	3-(para-Hydroxyphenyl)propionate; 4-Hydroxy-(9CI)benzenepropanoate; Chemistry; CR; Crea; Creat; Phloretate; Phloretic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491073	脱氨基酪氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491075	Pimelate SerPl-sCnc	4180186
21491075	Chemistry; Heptanedioate; Heptanedioic acid; Level; Pimelic Acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491075	庚二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491077	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Lact; Lactic acid; Level; L-lactate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491077	Lactyl lactate SerPl-sCnc	4180186
21491077	缩二乳酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491078	Chemistry; CR; Crea; Creat; Furan 2,5-dicarboxylate; Furan 2,5-dicarboxylic acid; Furan-2,5-dicarboxylate; Furan-2,5-dicarboxylic acid; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491078	2,5-Furandicarboxylate/Creat Ur-sRto	4180186
21491078	2,5-呋喃二羧酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491079	3-(3-Hydroxyphenyl)propanoic acid; 3-Hydroxyphenylpropanoate; Chemistry; hMPP; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491079	hMPP SerPl-sCnc	4180186
21491079	3-(3-羟基苯基)丙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491081	3OHsebacate.unsaturated SerPl-sCnc	4180186
21491081	3-hydroxy sebacate; 3-hydroxysebacic acid; 3OHsebacate; 3OHsebacate.unsaturated; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Unsat	4180186
21491081	3-羟基癸二酸.不饱和型:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491083	4-Deoxythreonate/Creat Ur-sRto	4180186
21491083	(2S,3R)-2,3-dihydroxybutanoic acid; 2,3-dihydroxybutanoate; 2,3-Dihydroxybutyrate; 2,3-Threo-dihydroxybutyrate; 4-deoxy-threonic acid; Chemistry; CR; Crea; Creat; Diabetes Mellitus, Juvenile Onset; Diabetes Mellitus, Type I; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491083	4-脱氧苏氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491084	5OH-methyl-2-furoate SerPl-sCnc	4180186
21491084	2-Furaldehyde metabolite; 5-hydroxymethyl-2-furoic acid; 5OH-methyl-2-furoate; Chemistry; Furancarboxylic Acid; Furfural metabolite; Furoic acid; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491084	5-羟甲基-2-糠酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491086	APTA; Basic mobility score SE; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21491086	Basic mobility score SE [AM-PAC]	4180186
21491087	APTA; Cnt; Count; Number; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random	4180186
21491087	Basic mobility items # [AM-PAC]	4180186
21491091	APTA; Physical Therapy; Point in time; Post Acute Care; PT; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21491094	Addiction; c700; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Formic acid; GCMS; Illicit; Level; methanoate; methanoic acid; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491094	Formate SerPl Cfm-sCnc	4180186
21491094	甲酸:物质的量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
21491095	HEDIS 2016-18 Urine Prot Tests	4180186
21491095	HEDIS 2016-18 Urine Prot Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; PR; Prot; Random	4180186
21491095	HEDIS 2016-2018 取值集合 - 尿液蛋白检验项目:-:时间点:^患者:-	4182948
21491096	HEDIS 2016-18 PHQ-9 Total Score	4180186
21491096	HEDIS 2016-18 PHQ-9 Total Score; Pan; Panel; PANEL.HEDIS; Panl; Patient Health Questionnaire; PHQ9; Pnl; Point in time; Random; Tot; Totl	4180186
21491096	HEDIS 2016-2018 取值集合 - PHQ-9 总评分:-:时间点:^患者:-	4182948
21491099	D phenotyping; D typing; HEDIS 2016-19 ABO and Rh; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing	4180186
21491099	HEDIS 2016-19 ABO and Rh	4180186
21491099	HEDIS 2016-2019 取值集合 - ABO 与 Rh:-:时间点:^患者:-	4182948
21491100	Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
21491100	HEDIS 2016 取值集合类:-:时间点:^患者:-	4182948
21491105	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21491105	Sports medicine Initial eval note	4180186
21491105	初步评价记录:发现:时间点:{环境}:文档型:运动医学	4182948
21491106	Sports medicine Prog note	4180186
21491106	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491106	病程记录:发现:时间点:{环境}:文档型:运动医学	4182948
21491107	Cancer; DOC.ONT; Document; Finding; Findings; Oncology; Point in time; Random	4180186
21491107	表单:发现:时间点:{环境}:文档型:肿瘤学	4182948
21491108	DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491108	危机干预记录:发现:时间点:{环境}:文档型:心理健康	4182948
21491109	PT Discharge instruct	4180186
21491109	Disch; DOC.ONT; Document; Finding; Findings; Point in time; PT; Random	4180186
21491109	出院指导:发现:时间点:{环境}:文档型:物理疗法	4182948
21491111	Disch; DOC.ONT; Document; Finding; Findings; Path; Point in time; Random; Speech pathology; Speech therapy; Speech-lang path	4180186
21491111	Speech-lang path Discharge instruct	4180186
21491111	出院指导:发现:时间点:{环境}:文档型:言语-语言病理学	4182948
21491113	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Lung; notes; Point in time; Pulmonary; Pulmonology; Random; Resp therapy; Respiratory; Visit note	4180186
21491113	Resp therapy Discharge teach note	4180186
21491113	出院宣教记录:发现:时间点:{环境}:文档型:呼吸疗法	4182948
21491114	Palliative care Discharge teach note	4180186
21491114	Continuity assessment record and evaluation; Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491114	出院宣教记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491115	Rec therapy Discharge teach note	4180186
21491115	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Rec therapy; Visit note	4180186
21491115	出院宣教记录:发现:时间点:{环境}:文档型:娱乐疗法	4182948
21491118	PT Discharge teach note	4180186
21491118	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; PT; Random; Visit note	4180186
21491118	出院宣教记录:发现:时间点:{环境}:文档型:物理疗法	4182948
21491120	Orthopaedic surgery Educ note	4180186
21491120	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Visit note	4180186
21491120	教育记录:发现:时间点:{环境}:文档型:矫形外科学	4182948
21491123	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
21491123	Cardiothor surg Educ note	4180186
21491123	教育记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
21491124	Vascular surgery Educ note	4180186
21491124	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
21491124	教育记录:发现:时间点:{环境}:文档型:血管外科学	4182948
21491128	Pharmacology Educ note	4180186
21491128	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Pharmacy; Point in time; Random; Visit note	4180186
21491128	教育记录:发现:时间点:{环境}:文档型:药理学	4182948
21491130	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; notes; Point in time; Random; URO; Urology; Visit note	4180186
21491130	Urology Educ note	4180186
21491130	教育记录:发现:时间点:{环境}:文档型:泌尿外科学	4182948
21491131	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; PT; Random; Visit note	4180186
21491131	PT Educ note	4180186
21491131	教育记录:发现:时间点:{环境}:文档型:物理疗法	4182948
21491132	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Eye; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
21491132	Optometry Educ note	4180186
21491132	教育记录:发现:时间点:{环境}:文档型:视力测定	4182948
21491133	Peds surgery Educ note	4180186
21491133	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PEDS; Peds surgery; Point in time; Random; Surg; Visit note	4180186
21491133	教育记录:发现:时间点:{环境}:文档型:小儿外科学	4182948
21491135	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
21491135	Ophthalmol Educ note	4180186
21491135	教育记录:发现:时间点:{环境}:文档型:眼科学	4182948
21491136	DOC.ONT; Document; Finding; Findings; PEDS; Peds surgery; Point in time; Random; Surg	4180186
21491136	Peds surgery Flowsheet	4180186
21491136	流程记录单:发现:时间点:{环境}:文档型:小儿外科学	4182948
21491138	DOC.ONT; Document; Finding; Findings; Point in time; Random; Surg; Transpl surg	4180186
21491138	Transpl surg Flowsheet	4180186
21491138	流程记录单:发现:时间点:{环境}:文档型:移植外科学	4182948
21491139	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
21491139	流程记录单:发现:时间点:{环境}:文档型:足病学	4182948
21491142	DOC.ONT; Document; Finding; Findings; Point in time; Random; Surg	4180186
21491142	流程记录单:发现:时间点:{环境}:文档型:成形外科学	4182948
21491144	DOC.ONT; Document; Finding; Findings; Point in time; Random; Rec therapy	4180186
21491144	Rec therapy Flowsheet	4180186
21491144	流程记录单:发现:时间点:{环境}:文档型:娱乐疗法	4182948
21491145	Continuity assessment record and evaluation; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
21491145	流程记录单:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491146	PT Flowsheet	4180186
21491146	DOC.ONT; Document; Finding; Findings; Point in time; PT; Random	4180186
21491146	流程记录单:发现:时间点:{环境}:文档型:物理疗法	4182948
21491151	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
21491151	表单:发现:时间点:{环境}:文档型:公共卫生	4182948
21491152	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
21491152	Palliative care H&P note	4180186
21491152	病史与体格检查记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491155	Rec therapy Initial eval note	4180186
21491155	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Rec therapy; Visit note	4180186
21491155	初步评价记录:发现:时间点:{环境}:文档型:娱乐疗法	4182948
21491156	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; H&P; History and physical; Initial eval note; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
21491156	Ophthalmol Initial eval note	4180186
21491156	初步评价记录:发现:时间点:{环境}:文档型:眼科学	4182948
21491157	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Eye; Finding; Findings; H&P; History and physical; Initial eval note; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
21491157	Optometry Initial eval note	4180186
21491157	初步评价记录:发现:时间点:{环境}:文档型:视力测定	4182948
21491159	Palliative care Initial eval note	4180186
21491159	Assessment; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21491159	初步评价记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491161	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21491161	Rheumatology Initial eval note	4180186
21491161	初步评价记录:发现:时间点:{环境}:文档型:风湿病学	4182948
21491163	Palliative care Prog note	4180186
21491163	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491163	病程记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491166	Rheumatology Prog note	4180186
21491166	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491166	病程记录:发现:时间点:{环境}:文档型:风湿病学	4182948
21491167	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491167	Optometry Prog note	4180186
21491167	病程记录:发现:时间点:{环境}:文档型:视力测定	4182948
21491170	Fluid in enteral tube nutr form Vol Meas	4180186
21491170	Fld; Fld int Entertube nutr frm; Fluid intake enteral tube; IO_INTAKE; IO_INTAKE.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; UGI; Up; Upr GI Tract; Volume	4180186
21491170	液体摄入.肠内管.营养配方:体积型属性:时间点:上消化道:定量型:测量法	4182948
21491171	Intravascular lipids fluid in Vol Meas	4180186
21491171	BP; Fld; Fluid intake IV; Fluid intake IV lipids; Intravenous; IO_INTAKE; IO_INTAKE.MOLEC; IV; Lip; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
21491171	液体摄入.血管内.脂类:体积型属性:时间点:血管系统:定量型:测量法	4182948
21491172	Fluid intake total intraop Vol Meas	4180186
21491172	Fld; Fluid intake total; Fluid intake total intraop; IO_INTAKE; IO_INTAKE.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume	4180186
21491172	液体摄入.手术中总计:体积型属性:操作持续时间:^患者:定量型:测量法	4182948
21491173	Fluid output urine nephrostomy Measured	4180186
21491173	Fld; Fluid output urine; Fluid output urine nephrostomy; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
21491173	液体排出.肾造口尿液:体积型属性:时间点:尿路:定量型:测量法	4182948
21491175	Cnt; Count; IO_OUTPUT; IO_OUTPUT.ATOM; LGI; Low; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491175	Num stools	4180186
21491175	大便:数量(计数):时间点:下消化道:定量型	4182948
21491177	Cnt; Count; Fld; Fluid output emesis; IO_OUTPUT; IO_OUTPUT.MOLEC; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; UGI; Up; Upr GI Tract; Vomitus	4180186
21491177	Fluid output emesis	4180186
21491177	液体排出.呕吐:数量(计数):时间点:上消化道:定量型	4182948
21491178	Cnt; Count; GU; IO_OUTPUT; IO_OUTPUT.MOLEC; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491178	Num sanitary pads	4180186
21491178	卫生巾:数量(计数):时间点:泌尿生殖系统:定量型	4182948
21491179	Fld; Fluid output total; Fluid output total intraop; IO_OUTPUT; IO_OUTPUT.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume	4180186
21491179	Fluid output total intraop Vol Meas	4180186
21491179	液体排出.手术中总计:体积型属性:操作持续时间:^患者:定量型:测量法	4182948
21491180	Fld; Fluid output neuro drain; IO_OUTPUT; IO_OUTPUT.MOLEC; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
21491180	Fluid output neuro drain Vol Meas	4180186
21491180	液体排出.神经系统引流:体积型属性:时间点:神经系统:定量型:测量法	4182948
21491186	DIA; Diam; ETT diam; Intub tube; Length; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tub; Tube, unspecified	4180186
21491186	ETT Diam	4180186
21491186	气管内插管直径:长度:时间点:插管术管道:定量型	4182948
21491188	alpha-L-Iduronidase; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; IDUA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MPS I; MPS-I; Nominal; Point in time; Random; WB; Whole blood	4180186
21491188	MPS I DBS-Imp	4180186
21491188	粘多糖贮积症 I 型:印象:时间点:全血.斑点:名义型	4182948
21491189	alpha-L-Iduronidase; Asympt; Asymptomatic; Blood; Chemistry; cmmt; cmnt; Com; Comm; Comments; Commt; DBS; Dried blood spot; Filter paper; FP; IDUA; MPS I; MPS I NBS comment; MPS-I; Narrative; NBS comment; New born; Point in time; Random; Remarks; Report; Scn; Text; WB; Whole blood	4180186
21491189	MPS I NBS comment	4180186
21491189	粘多糖贮积症 I 型 新生儿筛查注释-讨论:文本型属性:时间点:全血.斑点:叙述型	4182948
21491191	LysoPC(26:0) DBS LC/MS/MS-sCnc	4180186
21491191	Adrenoleukodystrophies; Adrenoleukodystrophies, X-Linked; Blood; C26:0; C26:0-LPC; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; LysoPC(26:0); Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood; X-ALD	4180186
21491191	溶血磷脂酰胆碱(26:0):物质的量浓度:时间点:全血.斑点:定量型:LC/MS/MS	4182948
21491193	Gvn; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
21491193	Blood product Gvn Type	4180186
21491193	血液制品 给予的:类型:时间点:^患者:名义型	4182948
21491195	Blood; butyrylcholinesterase; Butyrylcholinesterase gene; CHE1; CHE2; Document; E1; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Pseudocholinesterase gene; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491195	BCHE gene Full Mut Anl Bld/T Seq	4180186
21491195	BCHE 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
21491196	c244; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Folat; Folate + Tryp + Metabs Pnl; Folic acid; L-tryptophan; Metabolite; Metb; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Pteroylglutamate; Pteroylglutamic acid; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Trp; Vit M; Vitamin M	4180186
21491196	Folate + Tryp + Metabs Pnl CSF	4180186
21491196	叶酸与色氨酸与代谢产物组套:-:时间点:脑脊液:-	4182948
21491197	B4 Hemosan; Chemistry; FAD; Flavins Pnl; FMN; Leuco-4; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit B2; Vit B4; Vitamin B2; Vitamin B4	4180186
21491197	Flavins Pnl SerPl	4180186
21491197	核黄素与黄素单核苷酸与黄素腺嘌呤二核苷酸组套:-:时间点:血清/血浆:定量型	4182948
21491198	Folate + Tryp + Metabs Pattern CSF-Imp	4180186
21491198	c244; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Folat; Folate + Tryp + Metabs Pattern; Folic acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L-tryptophan; Metabolite; Metb; Narrative; Point in time; Pteroylglutamate; Pteroylglutamic acid; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Trp; Vit M; Vitamin M	4180186
21491198	叶酸与色氨酸与代谢产物模式:印象:时间点:脑脊液:叙述型	4182948
21491199	1 day; 24 hours; 24HR; 3Me-tyramine; Chemistry; CR; Crea; Creat; Creat Pnl; Dopamine metabolite; III; Metaneph; Metaneph+Normetaneph; Metanephrine fractionated; Metanephrines panel; Metanephrne; Metenephrine; Mtnphs+3MT+Creat pnl; Normeta; Normetaneph; Normetanephrn; Pan; PANEL.CHEMISTRY; Panl; Pnl; UA; UCr; UR; Urn	4180186
21491199	Mtnphs+3MT+Creat pnl 24h Ur	4180186
21491199	间甲肾上腺素, 去甲间肾上腺素, 3-甲氧酪氨酸和肌酐组套:-:24小时:尿液:-	4182948
21491201	3,4-Dihydroxyphenylalanine; 3-Hydroxy-L-tyrosine; Chemistry; CR; Crea; Creat; Dihydroxyphenylalanine; Esoteric; L-Dopa; Levo-dopa; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Sinemet; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491201	L-Dopa/Creat Ur-sRto	4180186
21491201	左旋多巴/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491210	Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491210	Allocystathionine/Creat Ur-sRto	4180186
21491210	别胱硫醚/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491212	ADMA; Asymmetric Dimethylarginine; Chemistry; dimethyl-L-arginine; Esoteric; guanidino-N(1),N(2)-dimethylarginine; Level; N(G)-dimethylarginine; N(G1),N(G1)-dimethylarginine; N(G1),N(G2)-dimethylarginine; N,N-dimethylarginine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SDMA; sDMA arginine; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; symmetric dimethylarginine	4180186
21491212	N,N'-dimethylarginine SerPl-sCnc	4180186
21491212	N,N'-二甲基精氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491213	Chemistry; CR; Crea; Creat; Dextro; Dextro-serine; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Ser; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491213	D-serine/Creat Ur-sRto	4180186
21491213	D-丝氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491214	(2S)-2-amino-5-(3-methylcarbamimidamido)pentanoic acid; Chemistry; CR; Crea; Creat; Esoteric; L-Monomethylarginine; L-NMMA; L-targinine; N(G)-Monomethyl-L-arginine; N-Monomethyl-L-arginine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Targinine; UA; UCr; UR; Urn	4180186
21491214	N-monomethylarginine/Creat Ur-sRto	4180186
21491214	N-单甲基精氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491216	beta sulfoalanine; Chemistry; CR; Crea; Creat; Cysteic acid; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491216	Cysteate/Creat Ur-sRto	4180186
21491216	磺基丙氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491219	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491219	Homocarnosine SerPl-sCnc	4180186
21491219	高肌肽:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491221	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S-B-AIB; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491221	S-B-AIB SerPl-sCnc	4180186
21491221	S-beta 氨基异丁酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491223	beta sulfoalanine; Chemistry; Cysteic acid; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491223	Cysteate SerPl-sCnc	4180186
21491223	磺基丙氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491225	DOC.ONT; Document; Ear Nose Throat; Encounter; ENT; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oto; Otolaryngology; Otorhinolaryngology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491225	Otolaryngology Prog note	4180186
21491225	病程记录:发现:时间点:{环境}:文档型:耳鼻喉科学	4182948
21491226	Peds Referral note	4180186
21491226	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Visit note	4180186
21491226	转诊记录:发现:时间点:{环境}:文档型:儿科学	4182948
21491227	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491227	转诊记录:发现:时间点:{环境}:文档型:初级保健服务	4182948
21491228	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491228	转诊记录:发现:时间点:{环境}:文档型:疼痛医学	4182948
21491229	Peds surgery Referral note	4180186
21491229	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PEDS; Peds surgery; Point in time; Random; Surg; Visit note	4180186
21491229	转诊记录:发现:时间点:{环境}:文档型:小儿外科学	4182948
21491231	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491231	转诊记录:发现:时间点:{环境}:文档型:牧养关怀	4182948
21491232	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21491232	转诊记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491234	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OMS; Operative note; Point in time; Random; Surg; Visit note	4180186
21491234	OMS Operative note	4180186
21491234	外科手术记录:发现:时间点:{环境}:文档型:口腔颌面外科学	4182948
21491235	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Operative note; Point in time; Random; Surg; Visit note	4180186
21491235	Cardiothor surg Operative note	4180186
21491235	外科手术记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
21491237	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Transfer sum note; Visit note	4180186
21491237	Cardiothor surg Transfer sum note	4180186
21491237	移交摘要记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
21491238	Palliative care Transfer sum note	4180186
21491238	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Transfer sum note; Visit note	4180186
21491238	移交摘要记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
21491241	Agg; Aggr; Arbitrary concentration; Blood; COAGULATION; Hematology; Heme; PA; PA Coll; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
21491241	PA Coll Bld-aCnc	4180186
21491241	血小板聚集.胶原诱导型:任意型浓度:时间点:全血:定量型	4182948
21491243	Agg; Aggr; Arbitrary concentration; Blood; COAGULATION; Hematology; Heme; PA; PA TRAP-6 induced; Pept; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Throm; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
21491243	PA TRAP-6 induced Bld-aCnc	4180186
21491243	血小板聚集.凝血酶受体活化肽-6 诱导型:任意型浓度:时间点:全血:定量型	4182948
21491245	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Succinyl AMP; UA; UCr; UR; Urn	4180186
21491245	Adenylosuccinate/Creat Ur-sRto	4180186
21491245	腺苷酸琥珀酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491247	2-Amino-9-Beta-D-Ribofuranosyl-9H-Purine-6(1H)-One; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491247	Guanosine/Creat Ur-sRto	4180186
21491247	鸟嘌呤核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491248	(1S)-1,4-Anhydro-1-(2,4-dihydroxy-5-pyrimidinyl)-D-ribitol; 5-ribosyluracil; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491248	Pseudouridine/Creat Ur-sRto	4180186
21491248	假尿嘧啶核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491249	5,6-dihydrothymine; 5-methyl-1,3-diazinane-2,4-dione; Chemistry; CR; Crea; Creat; Dihydropyrimidinase deficiency; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491249	Dihydrothymine/Creat Ur-sRto	4180186
21491249	二氢胸腺嘧啶/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491251	2-amino-3,7-dihydropurin-6-one; C5H5N5O; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491251	Guanine/Creat Ur-sRto	4180186
21491251	鸟嘌呤/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491254	Liver fibr score Pnl SerPl HepaScore	4180186
21491254	Calc; Calc.HepaScore; Calculation; Chemistry; Liver fibr score; Liver fibr score Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491254	肝脏纤维化评分组套:-:时间点:血清/血浆:-:计算法.HepaScore	4182948
21491255	Calc; Calc.FibroMeter; Calculation; Chemistry; Liver fibr score; Liver fibr score Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491255	Liver fibr score Pnl SerPl FibroMeter	4180186
21491255	肝脏纤维化评分组套:-:时间点:血清/血浆:-:计算法.FibroMeter	4182948
21491260	cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21491260	Cardiology Prog note	4180186
21491260	病程记录:发现:时间点:{环境}:文档型:心血管疾病	4182948
21491263	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; H&P note; Hx; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
21491263	Ophthalmol Admit H&P note	4180186
21491263	入院史与体格检查记录:发现:时间点:{环境}:文档型:眼科学	4182948
21491265	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; OMS; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Surg; Visit note	4180186
21491265	OMS Pre-op note	4180186
21491265	术前评价与管理记录:发现:时间点:{环境}:文档型:口腔颌面外科学	4182948
21491267	DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; OBGYN; Obstetric; Obstetrics; Point in time; Prenatal; Random	4180186
21491267	OBGYN Checklist	4180186
21491267	检查清单:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
21491268	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P note; Hx; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
21491268	OBGYN Admit H&P note	4180186
21491268	入院史与体格检查记录:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
21491269	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Operative note; Point in time; Prenatal; Random; Surg; Visit note	4180186
21491269	OBGYN Operative note	4180186
21491269	外科手术记录:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
21491270	Disch; DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; OBGYN; Obstetric; Obstetrics; Point in time; Prenatal; Random	4180186
21491270	OBGYN Discharge instruct	4180186
21491270	出院指导:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
21491271	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
21491271	OBGYN Discharge teach note	4180186
21491271	出院宣教记录:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
21491272	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
21491272	OBGYN Educ note	4180186
21491272	教育记录:发现:时间点:{环境}:文档型:产科学与妇科学	4182948
21491274	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; PEDS; Peds surgery; Point in time; Random; Surg; Visit note	4180186
21491274	Peds surgery Admit H&P note	4180186
21491274	入院史与体格检查记录:发现:时间点:{环境}:文档型:小儿外科学	4182948
21491275	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Operative note; PEDS; Peds surgery; Point in time; Random; Surg; Visit note	4180186
21491275	Peds surgery Operative note	4180186
21491275	外科手术记录:发现:时间点:{环境}:文档型:小儿外科学	4182948
21491277	Plastic surgery Admit H&P note	4180186
21491277	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Surg; Visit note	4180186
21491277	入院史与体格检查记录:发现:时间点:{环境}:文档型:成形外科学	4182948
21491278	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; Lung; notes; Point in time; Pulmonary; Pulmonology; Random; Resp therapy; Respiratory; Visit note	4180186
21491278	Resp therapy Initial eval note	4180186
21491278	初步评价记录:发现:时间点:{环境}:文档型:呼吸疗法	4182948
21491281	Transpl surg Admit H&P note	4180186
21491281	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Surg; Transpl surg; Visit note	4180186
21491281	入院史与体格检查记录:发现:时间点:{环境}:文档型:移植外科学	4182948
21491283	2Me-tyrosine; Chemistry; Esoteric; II; Level; Metyrosine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491283	2Me-tyrosine SerPl-sCnc	4180186
21491283	2-甲基酪氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491284	Chemistry; Esoteric; GSS; GSSG; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491284	GSS SerPl-sCnc	4180186
21491284	谷胱甘肽.氧化型:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491285	Chemistry; Dextro; Dextro-serine; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491285	D-serine SerPl-sCnc	4180186
21491285	D-丝氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491290	Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491290	Aspartylglycine/Creat Ur-sRto	4180186
21491290	天冬氨酰甘氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491291	(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carboxylic acid; Chemistry; CR; Crea; Creat; Esoteric; Left; Leucylproline; Levo; L-leu-L-pro; Point in time; Pro; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491291	L-leu-L-pro/Creat Ur-sRto	4180186
21491291	L-亮氨酰-L-脯氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491292	A-Acetyllysine; Alfa; Chemistry; CR; Crea; Creat; Esoteric; N-A-acetyllysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491292	N-A-acetyllysine/Creat Ur-sRto	4180186
21491292	N-alpha 乙酰赖氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491293	Chemistry; Esoteric; FIGLU; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491293	Formiminoglutamate SerPl-sCnc	4180186
21491293	亚胺甲基谷氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491296	(S)-2-amino-4-hydroxybutanoic acid; (S)-homoserine; 2-Amino-4-hydroxybutyric acid; Chemistry; Esoteric; Homo-L-serine; Homoserine; Isothreonine; Left; Level; Levo; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491296	L-homoserine SerPl-sCnc	4180186
21491296	L-高丝氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491297	Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491297	Homocarnosine/Creat Ur-sRto	4180186
21491297	高肌肽/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491301	Acetylglucosaminylasparagine; Asparaginylglucosamine; Aspartylglucosamine; Aspartylglucosylamine; Chemistry; CR; Crea; Creat; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491301	Aspartylglycosamine/Creat Ur-sRto	4180186
21491301	天冬氨酰氨基葡萄糖/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491302	Chemistry; CR; Crea; Creat; Esoteric; GSS; GSSG; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491302	GSS/Creat Ur-sRto	4180186
21491302	谷胱甘肽.氧化型/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491304	ADMA; Asymmetric Dimethylarginine; Chemistry; CR; Crea; Creat; dimethyl-L-arginine; Esoteric; guanidino-N(1),N(2)-dimethylarginine; N(G)-dimethylarginine; N(G1),N(G1)-dimethylarginine; N(G1),N(G2)-dimethylarginine; N,N-dimethylarginine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SDMA; sDMA arginine; Substance concentration ratio; Substance ratio; symmetric dimethylarginine; UA; UCr; UR; Urn	4180186
21491304	N,N'-dimethylarginine/Creat Ur-sRto	4180186
21491304	N,N'-二甲基精氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491307	3-aminoisobutyrate; 3-aminoisobutyric acid; 4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Ala; Alpha alanine; Aminobutric; Aminobutyric; Amino-n-butyrate; B; B-AIB; Bala; B-Ala; B-Alanine; B-Alanine + B-AIB + GABA patt; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L-alanine; Narrative; Piperidic acid; Point in time; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21491307	B-Alanine + B-AIB + GABA patt CSF-Imp	4180186
21491307	Beta 丙氨酸与 Beta 氨基异丁酸与 Gamma 氨基丁酸模式:印象:时间点:脑脊液:叙述型	4182948
21491310	Chemistry; CR; Crea; Creat; Esoteric; Left; Levo; Levo-serine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Ser; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491310	L-serine/Creat Ur-sRto	4180186
21491310	L-丝氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491313	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dextro; Dextro-serine; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491313	D-serine CSF-sCnc	4180186
21491313	D-丝氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21491314	2-amino-4-[(2-amino-2-carboxyethyl)disulfanyl]butanoic acid; Chemistry; CR; Crea; Creat; Cys; Cys-homo-Cys-mixed disulfide; Cysteine-homocysteine mixed disulfide; Cysteinylhomocysteine mixed disulfide; Esoteric; HCY; Hcys; Hcyst; Homocyst(e)ine; Homocysteine-cysteine mixed disulfide; Hycs-Cys diS; Hycs-Cys Disulfide; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491314	Hycs-Cys diS/Creat Ur-sRto	4180186
21491314	同型半胱氨酸-半胱氨酸二硫化物/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491315	3-aminoisobutyrate; 3-aminoisobutyric acid; 4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Ala; Alpha alanine; Aminobutric; Aminobutyric; Amino-n-butyrate; B; B-AIB; Bala; B-Ala; B-Alanine; B-Alanine + B-AIB + GABA Pnl; Chemistry; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; L-alanine; Pan; PANEL.CHEMISTRY; Panl; Piperidic acid; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491315	B-Alanine + B-AIB + GABA Pnl SerPl	4180186
21491315	Beta 丙氨酸与 Beta 氨基异丁酸与 Gamma 氨基丁酸组套:-:时间点:血清/血浆:-	4182948
21491316	5,6-dihydrothymine; 5-methyl-1,3-diazinane-2,4-dione; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dihydropyrimidinase deficiency; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491316	Dihydrothymine CSF-sCnc	4180186
21491316	二氢胸腺嘧啶:物质的量浓度:时间点:脑脊液:定量型	4182948
21491318	2,6-dioxo-1,3-diazinane-4-carboxylate; 4,5-dihydroorotate; 5,6-dihydroorotate; Chemistry; Esoteric; Hydroorotic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
21491318	Dihydroorotate Ur-sCnc	4180186
21491318	二氢乳清酸:物质的量浓度:时间点:尿液:定量型	4182948
21491320	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491320	Cytosine SerPl-sCnc	4180186
21491320	胞嘧啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491322	(1S)-1,4-Anhydro-1-(2,4-dihydroxy-5-pyrimidinyl)-D-ribitol; 5-ribosyluracil; Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491322	Pseudouridine SerPl-sCnc	4180186
21491322	假尿嘧啶核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491326	2,6-dioxo-1,3-diazinane-4-carboxylate; 4,5-dihydroorotate; 5,6-dihydroorotate; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Hydroorotic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491326	Dihydroorotate CSF-sCnc	4180186
21491326	二氢乳清酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21491328	2-amino-3,7-dihydropurin-6-one; C5H5N5O; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491328	Guanine CSF-sCnc	4180186
21491328	鸟嘌呤:物质的量浓度:时间点:脑脊液:定量型	4182948
21491330	Purine + Pyrimidine Pnl SerPl	4180186
21491330	Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Purine + Pyrimidine Pnl; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491330	嘌呤与嘧啶组套:-:时间点:血清/血浆:-	4182948
21491331	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Esoteric; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Purine + Pyrimidine pattern; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21491331	Purine + Pyrimidine pattern CSF-Imp	4180186
21491331	嘌呤与嘧啶模式:印象:时间点:脑脊液:叙述型	4182948
21491333	Purine + Pyrimidine Pnl CSF	4180186
21491333	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Purine + Pyrimidine Pnl; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21491333	嘌呤与嘧啶组套:-:时间点:脑脊液:-	4182948
21491334	5,6-dihydrothymine; 5-methyl-1,3-diazinane-2,4-dione; Chemistry; Dihydropyrimidinase deficiency; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491334	Dihydrothymine SerPl-sCnc	4180186
21491334	二氢胸腺嘧啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491341	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; notes; Point in time; Random; Transfer sum note; URO; Urology; Visit note	4180186
21491341	Urology Transfer sum note	4180186
21491341	移交摘要记录:发现:时间点:{环境}:文档型:泌尿外科学	4182948
21491342	Vascular surgery Pre-op note	4180186
21491342	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Surg; Visit note	4180186
21491342	术前评价与管理记录:发现:时间点:{环境}:文档型:血管外科学	4182948
21491344	Agg; Aggr; Arbitrary concentration; Blood; COAGULATION; Hematology; Heme; lo dose; PA; PA Rist; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
21491344	PA Rist lo dose Bld-aCnc	4180186
21491344	血小板聚集.瑞斯托菌素诱导型^小剂量:任意型浓度:时间点:全血:定量型	4182948
21491345	#/area; Auto; Automated detection; Cast; Elec; Elect; Electr; Kidney; Nephrology; Number areic; Path; Path casts; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn	4180186
21491345	Path casts #/area Ur Auto	4180186
21491345	病理性管型:单位面积数量或计数:时间点:尿液:定量型:自动化计数方法	4182948
21491347	#/area; Auto; Automated detection; Elec; Elect; Electr; ID; Infectious Disease; InfectiousDisease; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn	4180186
21491347	Yeast #/area Ur Auto	4180186
21491347	酵母:单位面积数量或计数:时间点:尿液:定量型:自动化计数方法	4182948
21491349	FDA label Drug for further processing	4180186
21491349	DOCUMENT.REGULATORY; Drugs; FDA label; Narrative; Report	4180186
21491349	进一步加工的药物标签:-:-:^FDA 产品标签:叙述型	4182948
21491350	Acd; Acids; DOCUMENT.REGULATORY; FDA label; Narrative; rDNA construct; Report	4180186
21491350	FDA label rDNA construct	4180186
21491350	重组型脱氧核糖核酸构造标签:-:-:^FDA 产品标签:叙述型	4182948
21491357	11-hydroxy-delta(9)-THC; 11-hydroxytetrahydrocannabinol; 11-hydroxy-THC; 11-OH-THC; 11OH-THC; 7-hydroxy-delta(1)-tetrahydrocannabinol; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Hydrox; Marijuana; Nabilone; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC; THC metabolite	4180186
21491357	11OH-THC Fld Ql Scn	4180186
21491357	11-羟基-δ-9-四氢大麻酚:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
21491358	11-hydroxy-delta(9)-THC; 11-hydroxytetrahydrocannabinol; 11-hydroxy-THC; 11-OH-THC; 11OH-THC; 7-hydroxy-delta(1)-tetrahydrocannabinol; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Delta-9-tetrahydrocannabinol metabolite; Dronabinol; DRUG/TOXICOLOGY; Drugs; Hydrox; Marijuana; Nabilone; OH; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; THC; THC metabolite	4180186
21491358	11OH-THC SerPl Ql Scn	4180186
21491358	11-羟基-δ-9-四氢大麻酚:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
21491361	2-oxo-3-OH-LDS Bld Ql Scn	4180186
21491361	2-oxo-3-OH-LDS; Blood; DRUG/TOXICOLOGY; Drugs; Hydrox; II; III; LSD; LSD metabolite; Lysergic acid; Lysergic acid diethylamide; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; WB; Whole blood	4180186
21491361	2-氧代-3-羟基-麦角二乙胺:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
21491366	7-amino clonazepam; 7Aminoclonazepam; Addiction; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Mass Content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
21491366	7Aminoclonazepam Hair-mCnt	4180186
21491366	7-氨基氯硝安定:质量含量:时间点:毛发:定量型	4182948
21491377	1592U89; ABC; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Ziagen	4180186
21491377	Abacavir Amn-mCnc	4180186
21491377	阿巴卡韦:质量浓度:时间点:羊水:定量型	4182948
21491381	ACE; Acetylpromazine; AcP; Atravet; DRUG/TOXICOLOGY; Drugs; Har; Mass content; Notensil; Plegicil; Point in time; QNT; Quan; Quant; Quantitative; Random; Vet; Veterinary	4180186
21491381	Acepromazine Hair-mCnt	4180186
21491381	乙酰丙嗪:质量含量:时间点:毛发:定量型	4182948
21491385	Alminoprofen Bld-mCnc	4180186
21491385	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21491385	阿明洛芬:质量浓度:时间点:全血:定量型	4182948
21491387	Aluminum Wat-sCnc	4180186
21491387	AL; Aluminium; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Wat	4180186
21491387	铝:物质的量浓度:时间点:水:定量型	4182948
21491388	AM-2201 4OH-pentyl; AM-2201 N-(4-hydroxypentyl) metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; Synthetic marijuana; UA; UR; Urn; Yucatan Fire	4180186
21491388	AM-2201 4OH-pentyl CtO Ur Cfm-mCnc	4180186
21491388	AM-2201 4-羟戊基 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491395	1-beta-D-Ribofuranosylcytosine; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; Chemistry; Cytosine Riboside; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491395	Cytidine SerPl-sCnc	4180186
21491395	胞嘧啶核苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491402	1,3-diazinane-2,4-dione; 5,6-Dihydro-2,4-dihydroxypyrimidine; Chemistry; Dihydrouracil; Esoteric; Hydrouracil; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491402	5,6-Dihydrouracil SerPl-sCnc	4180186
21491402	5,6-二氢尿嘧啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491405	1,3-diazinane-2,4-dione; 5,6-Dihydro-2,4-dihydroxypyrimidine; Chemistry; CR; Crea; Creat; Dihydrouracil; Esoteric; Hydrouracil; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491405	5,6-Dihydrouracil/Creat Ur-sRto	4180186
21491405	5,6-二氢尿嘧啶/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491407	6-amino-2,8-dihydroxypurine; Chemistry; CR; Crea; Creat; Esoteric; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21491407	2,8-dihydroxyadenine/Creat Ur-sRto	4180186
21491407	2,8-二羟基腺嘌呤/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21491410	2-amino-3,7-dihydropurin-6-one; C5H5N5O; Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491410	Guanine SerPl-sCnc	4180186
21491410	鸟嘌呤:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491411	Allopurinol metabolite; alloxanthine; Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Level; Oxyprim; oxypurinol; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491411	Oxipurinol CSF-sCnc	4180186
21491411	奥昔嘌醇:物质的量浓度:时间点:脑脊液:定量型	4182948
21491412	6-amino-2,8-dihydroxypurine; Chemistry; Esoteric; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491412	2,8-dihydroxyadenine SerPl-sCnc	4180186
21491412	2,8-二羟基腺嘌呤:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491415	Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491415	Octadecatetraenoate SerPl-sCnc	4180186
21491415	十八碳四烯酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491417	Chemistry; Entitic substance; Erythrocytes; Esoteric; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491417	Docosadienoate EntSub RBC	4180186
21491417	二十二碳二烯酸:实体物质的量:时间点:红细胞:定量型	4182948
21491419	Chemistry; Esoteric; Gondoic acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491419	cis-11-Eicosenoate SerPl-sCnc	4180186
21491419	cis-11-二十碳烯酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491422	Chemistry; Entitic substance; Erythrocytes; Esoteric; Paullinic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491422	cis-13-Eicosenoate EntSub RBC	4180186
21491422	cis-13-二十碳烯酸:实体物质的量:时间点:红细胞:定量型	4182948
21491423	Chemistry; Esoteric; Level; Paullinic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491423	cis-13-Eicosenoate SerPl-sCnc	4180186
21491423	cis-13-二十碳烯酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491428	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
21491428	B burgdor IgG SerPl Ql IF	4180186
21491428	伯氏疏螺旋体 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
21491429	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
21491429	B burgdor IgG CSF Ql IF	4180186
21491429	伯氏疏螺旋体 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
21491430	Chemistry; Har; k; K+; Mass content; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random	4180186
21491430	Potassium Hair-mCnt	4180186
21491430	钾:质量含量:时间点:毛发:定量型	4182948
21491431	HLA-B*58:01 Bld/T Ql	4180186
21491431	Blood; Human Leukocyte Antigen; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491431	HLA-B*58:01:存在情况或阈值:时间点:全血/组织:序数型	4182948
21491434	Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Nasogastric; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;1000 ng/mL; Scr; Screen; Scrn; TCA; Tricyclics; UA; UR; Urn	4180186
21491434	Tricyclics Ur Ql Scn>1000 ng/mL	4180186
21491434	三环类抗抑郁药:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 1000 纳克/毫升	4182948
21491435	Alimazine; Amisal; Apamezin; Benalgen; Coplexens; Crasin; DRUG/TOXICOLOGY; Drugs; Har; Mass content; Meparil; Nedeltran; Normain A; Palpex; Panectyl; Point in time; Pramin; QNT; Quan; Quant; Quantitative; Random; Repeltin; Spansule; Telmatin; Temaridin; Temaril; Theralen; Theralene; Trixin; Turysin; Vallergan; Variargil; Vetalen	4180186
21491435	Trimeprazine Hair-mCnt	4180186
21491435	三甲泼拉嗪:质量含量:时间点:毛发:定量型	4182948
21491440	Arbitrary concentration; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; sCD27; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T14	4180186
21491440	sCD27 SerPl-aCnc	4180186
21491440	可溶性 CD27:任意型浓度:时间点:血清/血浆:定量型	4182948
21491446	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification; UA; UR; Urn	4180186
21491446	C trach+GC rRNA Ur Ql NAA+probe	4180186
21491446	沙眼衣原体+淋病奈瑟菌 rRNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
21491448	Amoxapine Hair-mCnt	4180186
21491448	Amox; Asendin; Defanyl; Demolox; DRUG/TOXICOLOGY; Drugs; Har; Mass content; Moxadil; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491448	阿莫沙平:质量含量:时间点:毛发:定量型	4182948
21491450	Deprecated Amprenavir Trough SerPl-mCnc	4180186
21491450	Agenerase; Amp; APV; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VX-478	4180186
21491451	Anakinra SerPl-mCnc	4180186
21491451	DRUG/TOXICOLOGY; Drugs; Interleukin-1-receptor antagonist; Kineret; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491451	阿那白滞素:质量浓度:时间点:血清/血浆:定量型	4182948
21491454	Arsenic Tiss-sCnt	4180186
21491454	AS; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Tissue; Tissue, unspecified	4180186
21491454	砷:物质的量含量:时间点:组织与涂片:定量型	4182948
21491455	Blood; DRUG/TOXICOLOGY; Drugs; Enlon; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21491455	Atropine Bld-mCnc	4180186
21491455	阿托品:质量浓度:时间点:全血:定量型	4182948
21491456	Addiction; Baclosan; Beklo; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Gablofen; Har; Illicit; Kemstro; Liofen; Lioresal; Mass content; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
21491456	Baclofen Hair-mCnt	4180186
21491456	巴氯芬:质量含量:时间点:毛发:定量型	4182948
21491457	Addiction; Barbitone; Barbiturate; Diethylmalonylurea; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Mass Content; Megal; Neurinase; Pneumogeine-barbital; Point in time; PotentialForAbuse; Provervon n; QNT; Quan; Quant; Quantitative; Random; Veraine buriat; Veronal; Vitanerton N Kerne	4180186
21491457	Barbital Hair-mCnt	4180186
21491457	巴比妥:质量含量:时间点:毛发:定量型	4182948
21491458	Addiction; Barbitone; Barbiturate; Blood; Diethylmalonylurea; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Megal; Neurinase; Pneumogeine-barbital; Point in time; PotentialForAbuse; Provervon n; QNT; Quan; Quant; Quantitative; Random; Veraine buriat; Veronal; Vitanerton N Kerne; WB; Whole blood	4180186
21491458	Barbital Bld-mCnc	4180186
21491458	巴比妥:质量浓度:时间点:全血:定量型	4182948
21491460	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491460	Alminoprofen Fld-mCnc	4180186
21491460	阿明洛芬:质量浓度:时间点:体液:定量型	4182948
21491461	Ba; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21491461	Barium SerPl-sCnc	4180186
21491461	钡:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491463	Addiction; BZP; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Mass Content; N-Benzylpiperazine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
21491463	Benzylpiperazine Hair-mCnt	4180186
21491463	苄基哌嗪:质量含量:时间点:毛发:定量型	4182948
21491465	Buprenorphine CtO Sal Cfm-mCnc	4180186
21491465	BU; BUP; Bupe; Buprenex; buprenorphine HCI; Buprex; Butrans; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Finobrin; GCMS; Level; Mass concentration; Norspan; Oral fluid; Point in time; Prefin; QNT; Quan; Quant; Quantitative; Random; Sal; Suboxone; Subutex; Temgesic	4180186
21491465	丁丙诺啡 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21491468	Cannabicyclohexanol CtO Ur Cfm-mCnc	4180186
21491468	CCH; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CP 47; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; UA; UR; Urn	4180186
21491468	大麻环己醇 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491469	Blood; Carisoma; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flexartal; GCMS; Isopropylmeprobamate; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rela; Sanoma; Soma; Somadril; Somalgit; WB; Whole blood	4180186
21491469	Carisoprodol Bld Cfm-mCnc	4180186
21491469	异丙基甲丁双脲:质量浓度:时间点:全血:定量型:毒理学确认试验	4182948
21491470	Addiction; Blood; Carisoma; Carisoprodol metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; Flexartal; GCMS; Illicit; Isopropylmeprobamate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Rela; Sanoma; Screen; Soma; Somadril; Somalgit; WB; Whole blood	4180186
21491470	Carisoprodol+Meprob Bld Ql Cfm	4180186
21491470	异丙基甲丁双脲+氨甲丙二酯:存在情况或阈值:时间点:全血:序数型:毒理学确认试验	4182948
21491471	Addiction; benzoylethanamine; beta-keto-amphetamine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; hagigat; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491471	Cathinone Ur Cfm-mCnc	4180186
21491471	卡西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491472	Citalopram CtO Ur Cfm-mCnc	4180186
21491472	Celexa; Cfm; Cipramil; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491472	西酞普兰 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491474	Cyclobenzaprine CtO Ur Cfm-mCnc	4180186
21491474	Amrix; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Flexaril; Flexeril; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491474	环苯扎林 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491476	Doxepin CtO Ur Cfm-mCnc	4180186
21491476	Adapin; Aponal; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Dox; Doxpin; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sinequan; UA; UR; Urn	4180186
21491476	多虑平 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491477	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Cymbalta; DRUG/TOXICOLOGY; Drugs; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Yentreve	4180186
21491477	DULoxetine Ur Ql Cfm	4180186
21491477	度洛西汀:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
21491478	DULoxetine CtO Ur Cfm-mCnc	4180186
21491478	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Cymbalta; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Yentreve	4180186
21491478	度洛西汀 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491479	Addiction; Cocaine metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EME; Esters; Har; Illicit; Mass Content; Methylecgonine; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
21491479	EME Hair-mCnt	4180186
21491479	芽子碱甲酯:质量含量:时间点:毛发:定量型	4182948
21491480	Acetic acid; Acetic acid ethyl ester; Acetic ether; Acetoxyethane; DRUG/TOXICOLOGY; Drugs; Ethanoate; Ethanoic acid; EtOAc; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491480	Ethyl Acetate Ur-mCnc	4180186
21491480	乙酸乙酯:质量浓度:时间点:尿液:定量型	4182948
21491482	Actiq; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; Illicit; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Standard score; Sublimaze; UA; UR; Urn; Z score; Z value; Z-score	4180186
21491482	fentaNYL Z-score Ur	4180186
21491482	芬太尼:Z评分:时间点:尿液:定量型	4182948
21491484	Addiction; Anexsia; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Standard score; UA; UR; Urn; Vicodin; Z score; Z value; Z-score	4180186
21491484	HYDROcodone Z-score Ur	4180186
21491484	氢可酮:Z评分:时间点:尿液:定量型	4182948
21491485	6-hydroxybupropion; Bupropion metabolite; BW 306U; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; OH-bupropion; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
21491485	OH-bupropion Ur Ql Cfm	4180186
21491485	羟基丁氨苯丙酮:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
21491486	6-hydroxybupropion; Bupropion metabolite; BW 306U; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; OH-bupropion; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491486	OH-bupropion CtO Ur Cfm-mCnc	4180186
21491486	羟基丁氨苯丙酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491488	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Lurasidone metabolite; Mass concentration; OH-Lurasidone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491488	OH-Lurasidone CtO Ur Cfm-mCnc	4180186
21491488	羟基鲁拉西酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491490	JWH-018 5-hydroxypenty CtO Ur Cfm-mCnc	4180186
21491490	AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH 018 metabolite; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491490	JWH-018 5-羟戊基 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491491	JWH-018 pentanoate CtO Ur Cfm-mCnc	4180186
21491491	AM-678; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH-018 N-pentanoate metabolite; JWH-018 N-pentanoic acid metabolite; JWH-018 N-valeric metabolite; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491491	JWH-018 戊酸 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491494	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH-081 5-hydroxypentyl metabolite; JWH-081 5OH-pentyl; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Synthetic cannabinoid; UA; UR; Urn	4180186
21491494	JWH-081 5OH-pentyl CtO Ur Cfm-mCnc	4180186
21491494	JWH-081 5-羟戊基 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491499	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; JWH 200 metabolite; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491499	JWH-200 6-Hydroxyindole Ur Cfm-mCnc	4180186
21491499	JWH-200 6-羟基吲哚:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491500	Egg source	4180186
21491500	FERTILITY TESTING; Nominal; Point in time; Random; Srce; Typ	4180186
21491500	卵子来源:类型:时间点:^患者:名义型	4182948
21491503	CLIN; Nominal; Point in time; Random; Typ	4180186
21491503	认证:类型:时间点:服务提供者:名义型	4182948
21491506	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491506	符合 CDC 现场分诊准则:发现:时间点:^患者:序数型	4182948
21491509	EM incident location	4180186
21491509	DEEDS; EM incident location; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Location; Nominal; Point in time; Random	4180186
21491509	突发事件管理事件位置:位置:时间点:^事件:名义型	4182948
21491510	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Location; Nominal; Point in time; Random	4180186
21491510	就医位置:位置:时间点:^患者:名义型	4182948
21491511	Transferred to	4180186
21491511	H+P; H+P.HX; Location; Nominal; P prime; Point in time; Random	4180186
21491511	移交至:位置:时间点:^患者:名义型	4182948
21491512	Abd; Abdo; Abdomen; AC; Echoencephalogram; Echoencephalography; Echography; Est; estimation; Fetal; Girth; Gyn; Gynecology; HC; Length Ratio; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
21491512	HC/AC from Campbell 1991	4180186
21491512	头围/腹围:长度比率:时间点:^胎儿:定量型:超声+依据 Campbell 1991 的估计法	4182948
21491516	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; HIV type 1; HIV type I; HIV1; HIV1 RNA tropism; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Nominal; Pl; Plasma; Plsm; Point in time; Random; Ribonucleic acid	4180186
21491516	HIV1 RNA tropism Plas	4180186
21491516	HIV 1 型 RNA 嗜性:存在与否或特征标识:时间点:血浆:名义型	4182948
21491517	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; high-throughput sequencing; HIV 1 RNA RT + PR + IN; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Next generation sequencing; NGS; Nominal; Pl; Plasma; Plsm; Point in time; PR; Random; REV; Ribonucleic acid; RT	4180186
21491517	HIV 1 RNA RT + PR + IN Mut Det Plas Seq	4180186
21491517	HIV 1 型 RNA 逆转录酶与蛋白酶与整合酶基因 已检出的突变:存在与否或特征标识:时间点:血浆:名义型:序列测定	4182948
21491519	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Blood; Deoxyribonucleic acid; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA IN; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Next generation sequencing; NGS; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; Random; WB; Whole blood	4180186
21491519	HIV1 proviral DNA IN Mut Det Bld MC Seq	4180186
21491519	HIV 1 型前病毒 DNA 整合酶基因 已检出的突变:存在与否或特征标识:时间点:全血单个核细胞:名义型:序列测定	4182948
21491520	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Blood; Deoxyribonucleic acid; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA RT + PR; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Next generation sequencing; NGS; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; PR; Random; REV; RT; WB; Whole blood	4180186
21491520	HIV1 proviral DNA RT + PR Mut Det Seq	4180186
21491520	HIV 1 型前病毒 DNA 逆转录酶与蛋白酶基因 已检出的突变:存在与否或特征标识:时间点:全血单个核细胞:名义型:序列测定	4182948
21491521	1 day; 24 hours; 24HR; Diet; Dietetics; Ile; Mass rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative	4180186
21491521	Isoleucine intake 24h Measured	4180186
21491521	异亮氨酸摄入:质量速率:24小时:^患者:定量型:测量法	4182948
21491522	1 day; 24 hours; 24HR; Diet; Dietetics; Est; estimation; Leu; Mass rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative	4180186
21491522	Leucine intake 24h Est	4180186
21491522	亮氨酸摄入:质量速率:24小时:^患者:定量型:估计法	4182948
21491523	1 day; 24 hours; 24HR; Diet; Dietetics; Leu; Mass rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative	4180186
21491523	Leucine intake 24h Measured	4180186
21491523	亮氨酸摄入:质量速率:24小时:^患者:定量型:测量法	4182948
21491524	1 day; 24 hours; 24HR; Diet; Dietetics; Est; estimation; Mass rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative; Thr	4180186
21491524	Threonine intake 24h Est	4180186
21491524	苏氨酸摄入:质量速率:24小时:^患者:定量型:估计法	4182948
21491525	1 day; 24 hours; 24HR; Diet; Dietetics; Mass Rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative; Thr	4180186
21491525	Threonine intake 24h Measured	4180186
21491525	苏氨酸摄入:质量速率:24小时:^患者:定量型:测量法	4182948
21491528	1 day; 24 hours; 24HR; Diet; Dietetics; Est; estimation; Mass rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative; Sucro	4180186
21491528	Sucrose intake 24h Est	4180186
21491528	蔗糖摄入:质量速率:24小时:^患者:定量型:估计法	4182948
21491536	Activ; Actvty; Blood; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; thiopurine S-methyltransferase; Thiopurine S-methyltransferase gene; Tissue; Tissue, unspecified; TPMT gene prod met act imp; WB; Whole blood; Whole blood or Tissue	4180186
21491536	TPMT gene prod met act imp Bld/T-Imp	4180186
21491536	TPMT 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491539	Activ; Actvty; Blood; CPC9; CYP2C; CYP2C10; CYP2C9 gene prod met act imp; CYPIIC9; Cytochrome P450 2C9 Genotyping; cytochrome P450, family 2, subfamily C, polypeptide 9; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; P450IIC9; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491539	CYP2C9 gene prod met act imp Bld/T-Imp	4180186
21491539	CYP2C9 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491542	Activ; Actvty; Blood; DHP; DHPDHASE; dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase gene; Dihydrothymine dehydrogenase gene; Dihydrouracil dehydrogenase gene; DPD; DPYD gene prod met act imp; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491542	DPYD gene prod met act imp Bld/T-Imp	4180186
21491542	DPYD 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21491548	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
21491548	弱视:类型:时间点:眼睛:名义型	4182948
21491549	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; R; R eye; Random; RT; Screen; Vision; Visual	4180186
21491549	Eye-R Can elevate above midline	4180186
21491549	能够抬升至中线以上:发现:时间点:眼睛.右侧:序数型	4182948
21491551	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual; Visual converg exam	4180186
21491551	Eye Visual converg exam	4180186
21491551	视轴会聚检查:发现:时间点:眼睛:名义型	4182948
21491553	JWH-200 6-Hydroxyindole CtO Ur Cfm-mCnc	4180186
21491553	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH 200 metabolite; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491553	JWH-200 6-羟基吲哚 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491557	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
21491557	Methadone Z-score Ur	4180186
21491557	美沙酮:Z评分:时间点:尿液:定量型	4182948
21491560	Mirtazapine CtO Ur Cfm-mCnc	4180186
21491560	Avanza; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Reflex; Remeron; UA; UR; Urn; Zispin	4180186
21491560	米氮平 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491561	Addiction; c260; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Morphine sulfate; MS; MSO4; OMPH; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
21491561	Morphine Z-score Ur	4180186
21491561	吗啡:Z评分:时间点:尿液:定量型	4182948
21491564	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Narcan; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491564	Naloxone CtO Ur Cfm-mCnc	4180186
21491564	钠洛酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491566	Norbuprenorphine CtO Sal Cfm-mCnc	4180186
21491566	Buprenorphine metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; NBU; norBUP; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
21491566	去甲基丁丙诺啡 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21491568	Norhydrocodone CtO Ur Cfm-mCnc	4180186
21491568	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Hydrocodone metabolite; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491568	去甲基氢可酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491570	OPC3373 Ur Cfm-mCnc	4180186
21491570	Aripiprazole metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491570	OPC3373:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491572	Aripiprazole metabolite; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
21491572	OPC3373 Z-score Ur	4180186
21491572	OPC3373:Z评分:时间点:尿液:定量型	4182948
21491574	14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Numorphan; Numorphone; Opana; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
21491574	oxyMORphone Z-score Ur	4180186
21491574	羟吗啡酮:Z评分:时间点:尿液:定量型	4182948
21491575	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Paxil; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491575	PARoxetine CtO Ur Cfm-mCnc	4180186
21491575	帕罗西汀 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491577	QUEtiapine Ur Cfm-mCnc	4180186
21491577	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Ketipinor; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Seroquel; UA; UR; Urn; Xeroquel	4180186
21491577	喹硫平:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491579	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; RCS-4 N-(5-carboxypentyl) metabolite; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491579	RCS-4 5-carboxypentyl CtO Ur Cfm-mCnc	4180186
21491579	RCS-4 5-羧戊基 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491580	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; RCS-4 5OH-pentyl; RCS-4 N-(5-hydroxypentyl) metabolite; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491580	RCS-4 5OH-pentyl Ur Cfm-mCnc	4180186
21491580	RCS-4 5-羟戊基:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491581	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; K2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; RCS-4 5OH-pentyl; RCS-4 N-(5-hydroxypentyl) metabolite; Spice; Spike; Synthetic cannabinoid; Synthetic cannabinoids; UA; UR; Urn; Yucatan Fire	4180186
21491581	RCS-4 5OH-pentyl CtO Ur Cfm-mCnc	4180186
21491581	RCS-4 5-羟戊基 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491582	Sertraline CtO Ur Cfm-mCnc	4180186
21491582	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Zoloft	4180186
21491582	舍曲林 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491583	Triazolam Sal Cfm-mCnc	4180186
21491583	APO-TRIAZO; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Halcion; Level; Mass concentration; Novo-triolam; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
21491583	三唑苯二氮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21491587	trans-3-OH-cotinine Sal-mCnc	4180186
21491587	3-hydroxy cotinine; DRUG/TOXICOLOGY; Drugs; III; Level; Mass concentration; Nicotine metabolite; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; trans-3-OH cotinine; trans-3-OH-cotinine	4180186
21491587	反-3-羟基可铁宁:质量浓度:时间点:唾液:定量型	4182948
21491588	Alimazine; Amisal; Apamezin; Benalgen; Coplexens; Crasin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Meparil; Nedeltran; Normain A; Palpex; Panectyl; Point in time; Pramin; QNT; Quan; Quant; Quantitative; Random; Repeltin; Spansule; Telmatin; Temaridin; Temaril; Theralen; Theralene; Trixin; Turysin; UA; UR; Urn; Vallergan; Variargil; Vetalen	4180186
21491588	Trimeprazine Ur-mCnc	4180186
21491588	三甲泼拉嗪:质量浓度:时间点:尿液:定量型	4182948
21491589	Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Nasogastric; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scn&gt;300 ng/mL; Scr; Screen; Scrn; TCA; Tricyclics; UA; UR; Urn	4180186
21491589	Tricyclics Ur Ql Scn>300 ng/mL	4180186
21491589	三环类抗抑郁药:存在情况或阈值:时间点:尿液:序数型:筛查试验 > 300 纳克/毫升	4182948
21491590	Barium Bld-sCnc	4180186
21491590	Ba; Blood; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
21491590	钡:物质的量浓度:时间点:全血:定量型	4182948
21491591	Tricyclics Hair Ql	4180186
21491591	Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Har; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TCA; Tricyclics	4180186
21491591	三环类抗抑郁药:存在情况或阈值:时间点:毛发:序数型	4182948
21491593	Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TCA; Tricyclics	4180186
21491593	Tricyclics Gast Ql	4180186
21491593	三环类抗抑郁药:存在情况或阈值:时间点:胃液:序数型	4182948
21491596	Ang; Angio; Angm; CARD.PROC; Cardio; Cardiology; Coronary aa; Finding; Findings; Heart; Heart Disease; No; Nominal; Num; Num dis coronary segments; Point in time; Random	4180186
21491596	Num dis coronary segments on Card Angio	4180186
21491596	病变冠状动脉节段数量:发现:时间点:冠状动脉类:名义型:血管造影	4182948
21491599	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 3; dRCA; Heart Disease; Length Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; Sten deg	4180186
21491599	Percent sten of dRCA by Angiogram	4180186
21491599	狭窄程度:长度分数:时间点:远段右侧冠状动脉:定量型:血管造影	4182948
21491600	Ang; Angio; Angm; Art; AV nodal; CARD.PROC; Cardio; Cardiology; Heart Disease; Length Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491600	Percent sten of AV nodal by Angiogram	4180186
21491600	狭窄程度:长度分数:时间点:房室结动脉:定量型:血管造影	4182948
21491601	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 4; Heart Disease; Length Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; R; Random; R-PDA; RT; Sten deg	4180186
21491601	Percent sten of R-PDA by Angiogram	4180186
21491601	狭窄程度:长度分数:时间点:右侧冠状动脉后降支:定量型:血管造影	4182948
21491602	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 5; Heart Disease; L; Length Fraction; LM; LT; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491602	Percent sten of LM by Angiogram	4180186
21491602	狭窄程度:长度分数:时间点:左侧主干冠状动脉:定量型:血管造影	4182948
21491603	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 6; Heart Disease; L; Length Fraction; LT; Percent; pLAD; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491603	Percent sten of pLAD by Angiogram	4180186
21491603	狭窄程度:长度分数:时间点:近段左侧前降动脉:定量型:血管造影	4182948
21491604	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 7; Heart Disease; L; Length Fraction; LT; mLAD; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491604	Percent sten of mLAD by Angiogram	4180186
21491604	狭窄程度:长度分数:时间点:中段左侧前降动脉:定量型:血管造影	4182948
21491609	ERG; EYE; EYE.ERG; EYE.ERG.NEI; Flicker resp wave impl time; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT	4180186
21491609	Flick resp wave imp time Ret-R lt-ad ERG	4180186
21491609	闪烁光反应波潜伏时间^明适应型:时间:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491612	ERG; EYE; EYE.ERG; EYE.ERG.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Typ	4180186
21491612	ERG ISCEV standard protocol used	4180186
21491612	所采用的 ISCEV 标准方案:类型:时间点:^患者:名义型:视网膜电图	4182948
21491613	记录电极:类型:时间点:视网膜电图装置:名义型	4182948
21491613	EYE; EYE.ERG; EYE.ERG.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Rec electrode; Typ	4180186
21491613	Type of ERG rec electrode	4180186
21491618	Eye; EYE.VISUAL_FIELD; EYE.VISUAL_FIELD.NEI; Eyeball; Meth; Method of; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Typ; Vision; Visual	4180186
21491618	视野检查方法:类型:时间点:眼睛.右侧:名义型:*	4182948
21491619	Eye; EYE.VISUAL_FIELD; EYE.VISUAL_FIELD.NEI; Eyeball; Finding; Findings; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Vision; Visual	4180186
21491619	R eye Visual field def Confrontation	4180186
21491619	视野缺损:发现:时间点:眼睛.右侧:名义型:面对面视野检查法	4182948
21491621	Angio; EYE; EYE.ANGIO; EYE.ANGIO.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R ocular fund; Random; RT; Study report; W fluoresc IV	4180186
21491621	Study obs Ocular fund-R Angio W fluor IV	4180186
21491621	检查观察结果^采用静脉注射荧光素:发现:时间点:眼底.右侧:名义型:血管造影术	4182948
21491624	Angio; EYE; EYE.ANGIO; EYE.ANGIO.NEI; Finding; Findings; ICG; L; L ocular fund; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report; W indocyan green IV	4180186
21491624	Study obs Ocul fund-L Angio W indocy gr	4180186
21491624	检查观察结果^采用静脉注射靛氰绿:发现:时间点:眼底.左侧:名义型:血管造影术	4182948
21491625	EYE; EYE.OCT; EYE.OCT.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; R; R ret; Random; RT; Study report	4180186
21491625	Study obs R ret OCT	4180186
21491625	检查观察结果:发现:时间点:视网膜.右侧:名义型:光学相干断层扫描术	4182948
21491626	EYE; EYE.OCT; EYE.OCT.NEI; Finding; Findings; L; L ret; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; Random; Study report	4180186
21491626	Study obs L ret OCT	4180186
21491626	检查观察结果:发现:时间点:视网膜.左侧:名义型:光学相干断层扫描术	4182948
21491628	Exam; Examination; EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; L; L macula; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Phys find; Point in time; Random	4180186
21491628	L macula Phys find Ophthalmoscopy	4180186
21491628	体格检查发现:发现:时间点:黄斑.左侧:名义型:检眼镜检查法	4182948
21491630	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
21491630	Type of Glaucoma Ophthalmoscopy	4180186
21491630	青光眼:类型:时间点:眼睛:名义型:检眼镜检查法	4182948
21491633	Cent corn thickness; Corneal; EYE; EYE.PX; EYE.PX.NEI; L; Length; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick	4180186
21491633	L cornea Cent corn thickness Pachymetry	4180186
21491633	中央角膜厚度:长度:时间点:角膜.左侧:定量型:角膜厚度测量法	4182948
21491635	c; Contr; Contr sens; Contra; Contrst; Eye; EYE.PX; EYE.PX.NEI; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
21491635	L eye Contr sens Pelli-Robson	4180186
21491635	对比敏感度:对数型逆百分数:时间点:眼睛.左侧:定量型:Pelli-Robson 对比敏感度视力表	4182948
21491636	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
21491636	R eye Axis--W cyclo Obj refraction	4180186
21491636	轴^采用睫状肌麻痹:角度:时间点:眼睛.右侧:定量型:客观式屈光度检测方法	4182948
21491638	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
21491638	R eye Axis--WO cyclo Obj refraction	4180186
21491638	轴^不采用睫状肌麻痹:角度:时间点:眼睛.右侧:定量型:客观式屈光度检测方法	4182948
21491640	CYL; Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
21491640	R eye Cylinder--W cyclo Obj refraction	4180186
21491640	柱镜^采用睫状肌麻痹:长度倒数:时间点:眼睛.右侧:定量型:客观式屈光度检测方法	4182948
21491641	CYL; Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; L; L eye; LT; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
21491641	L eye Cylinder--W cyclo Obj refraction	4180186
21491641	柱镜^采用睫状肌麻痹:长度倒数:时间点:眼睛.左侧:定量型:客观式屈光度检测方法	4182948
21491642	CYL; Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
21491642	R eye Cylinder--WO cyclo Obj refraction	4180186
21491642	柱镜^不采用睫状肌麻痹:长度倒数:时间点:眼睛.右侧:定量型:客观式屈光度检测方法	4182948
21491643	CYL; Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; L; L eye; LT; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
21491643	L eye Cylinder--WO cyclo Obj refraction	4180186
21491643	柱镜^不采用睫状肌麻痹:长度倒数:时间点:眼睛.左侧:定量型:客观式屈光度检测方法	4182948
21491644	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
21491644	R eye Sphere--W cyclo Obj refraction	4180186
21491644	球面^采用睫状肌麻痹:长度倒数:时间点:眼睛.右侧:定量型:客观式屈光度检测方法	4182948
21491645	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; L; L eye; LT; Obj refraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
21491645	L eye Sphere--W cyclo Obj refraction	4180186
21491645	球面^采用睫状肌麻痹:长度倒数:时间点:眼睛.左侧:定量型:客观式屈光度检测方法	4182948
21491648	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Meth; Method of; Nominal; Obj refract method; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Refract method; Typ; Vision; Visual	4180186
21491648	Type of Obj refract method	4180186
21491648	客观式屈光度检测方法:类型:时间点:眼睛类:名义型	4182948
21491651	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Subj refraction; Vision; Visual	4180186
21491651	R eye Axis--WO cyclo Subj refraction	4180186
21491651	轴^不采用睫状肌麻痹:角度:时间点:眼睛.右侧:定量型:主观式屈光度检测方法	4182948
21491652	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Subj refraction; Vision; Visual	4180186
21491652	L eye Axis--WO cyclo Subj refraction	4180186
21491652	轴^不采用睫状肌麻痹:角度:时间点:眼睛.左侧:定量型:主观式屈光度检测方法	4182948
21491654	CYL; Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Subj refraction; Vision; Visual	4180186
21491654	L eye Cylinder--W cyclo Subj refraction	4180186
21491654	柱镜^采用睫状肌麻痹:长度倒数:时间点:眼睛.左侧:定量型:主观式屈光度检测方法	4182948
21491655	CYL; Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Subj refraction; Vision; Visual	4180186
21491655	R eye Cylinder--WO cyclo Subj refraction	4180186
21491655	柱镜^不采用睫状肌麻痹:长度倒数:时间点:眼睛.右侧:定量型:主观式屈光度检测方法	4182948
21491656	CYL; Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Subj refraction; Vision; Visual	4180186
21491656	L eye Cylinder--WO cyclo Subj refraction	4180186
21491656	柱镜^不采用睫状肌麻痹:长度倒数:时间点:眼睛.左侧:定量型:主观式屈光度检测方法	4182948
21491657	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Subj refraction; Vision; Visual	4180186
21491657	R eye Sphere--W cyclo Subj refraction	4180186
21491657	球面^采用睫状肌麻痹:长度倒数:时间点:眼睛.右侧:定量型:主观式屈光度检测方法	4182948
21491658	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Subj refraction; Vision; Visual	4180186
21491658	L eye Sphere--W cyclo Subj refraction	4180186
21491658	球面^采用睫状肌麻痹:长度倒数:时间点:眼睛.左侧:定量型:主观式屈光度检测方法	4182948
21491659	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Subj refraction; Vision; Visual	4180186
21491659	R eye Sphere--WO cyclo Subj refraction	4180186
21491659	球面^不采用睫状肌麻痹:长度倒数:时间点:眼睛.右侧:定量型:主观式屈光度检测方法	4182948
21491660	Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; GAS; Group A Strep; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S pyogenes; Screen; Steptococcus Group A; Strep; Strept; Streptococci group A; Streptococcus group A; SUDS; Throat; UniversalLabOrders; Upper respiratory	4180186
21491660	S pyo Ag Throat Ql IA.rapid	4180186
21491660	化脓性链球菌 抗原:存在情况或阈值:时间点:咽喉:序数型:免疫测定法.快速	4182948
21491662	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; D2; Heart Disease; II; Length Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491662	Percent sten of D2 by Angiogram	4180186
21491662	狭窄程度:长度分数:时间点:对角动脉 2:定量型:血管造影	4182948
21491665	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 13; dLCX; Heart Disease; L; LCx; Length Fraction; LT; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491665	Percent sten of LCx by Angiogram	4180186
21491665	狭窄程度:长度分数:时间点:中段左侧旋动脉:定量型:血管造影	4182948
21491666	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 14; Heart Disease; L; Length Fraction; L-PLB; LT; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
21491666	Percent sten of L-PLB by Angiogram	4180186
21491666	狭窄程度:长度分数:时间点:左侧旋动脉后侧支:定量型:血管造影	4182948
21491668	Ang; Angio; Angm; Art; CARD.PROC; Cardio; Cardiology; Coronary segment 16; Coronary segment 5; Heart Disease; L; Length Fraction; LM; LT; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RI; Sten deg	4180186
21491668	Percent sten of RI by Angiogram	4180186
21491668	狭窄程度:长度分数:时间点:左侧主干冠状动脉中间支:定量型:血管造影	4182948
21491669	Cardiac; Cardio; Cardiology; Heart Disease; Hrt; Pan; PANEL.CARDIAC; Panl; PCI; PCI Pnl; Perc; Pnl; Point in time; Random	4180186
21491669	PCI Pnl	4180186
21491669	经皮冠状动脉介入治疗组套:-:时间点:心脏:-:心导管插入术	4182948
21491670	Basic fibroblast growth factor receptor 1 precursor; BFGFR; bFGF-R-1; Blood; CD331; CEK; C-FGR; FGFBR; FGFR-1; fibroblast growth factor receptor 1; fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome); FLG; FLT2; FLT-2; Fluorescent in situ hybridization; Genetics; H2; H3; H4; H5; HBGFR; Heredity; Heritable; HH2; HRTFDS; Inherited; KAL2; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; N-SAM; OGD; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21491670	FGFR1 gene rearr Bld/T Ql FISH	4180186
21491670	FGFR1 基因重排:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21491673	7-Hydroxy Quetiapine; 7OH-quetiapine; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Quetiapine metabolite; Random; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
21491673	7OH-quetiapine Z-score Ur	4180186
21491673	7-羟基喹硫平:Z评分:时间点:尿液:定量型	4182948
21491674	Sens or speech stat	4180186
21491674	Finding; Findings; HL7CCDA; Nominal; Point in time; Random; Sens or speech stat	4180186
21491674	感觉或言语状态:发现:时间点:^患者:名义型	4182948
21491675	cycloSPORINE Bld IA-sCnc	4180186
21491675	Blood; Ciclosporin; Ciclosporine; CsA; Cyclosporin a; Cyclosporins; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; Gengraf; IAA; Level; MEIA; Neoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Restasis; Sandimmune; SangCya; Substance concentration; SUDS; WB; Whole blood	4180186
21491675	环孢菌素:物质的量浓度:时间点:全血:定量型:免疫测定法	4182948
21491676	B parapert; B parapertussis; B pert; B pert+parapert Pnl; B pertussis; ID; Infectious Disease; InfectiousDisease; Microbiology; Nasopharynx; Pan; PANEL.MICROBIOLOGY; Panl; Pertussis; Pnl; Point in time; Random; Whooping cough	4180186
21491676	B pert+parapert DNA+cult Pnl Nph	4180186
21491676	百日咳博德特菌与副百日咳博德特菌组套:-:时间点:鼻咽:-	4182948
21491678	CLIN; Ordinal; Point in time; Proc urgency; Ql; Qual; Qualitative; Random; Screen; Typ	4180186
21491678	Proc urgency	4180186
21491678	操作项目紧急情况:类型:时间点:^患者:序数型	4182948
21491680	CARD.PROC; Cardio; Cardiology; Finding; Findings; Heart Disease; Ordinal; Periph; Periph ves fluoro angio; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491680	Periph ves fluoro angio	4180186
21491680	已执行外周血管荧光造影术:发现:时间点:^患者:序数型	4182948
21491682	CARD.PROC; Cardio; Cardiology; Finding; Findings; Heart Disease; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491682	已执行痉挛负荷试验:发现:时间点:^患者:序数型	4182948
21491683	CARD.PROC; Cardio; Cardiology; Finding; Findings; Heart Disease; OCT performed; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491683	OCT performed	4180186
21491683	已执行光学相干断层成像:发现:时间点:^患者:序数型	4182948
21491684	Assist circ proc perf Pnl; Cardio; Cardiology; Finding; Findings; Heart Disease; Pan; PANEL.CARDIAC; Panl; Pnl; Point in time; Random	4180186
21491684	Assist circ proc perf Pnl	4180186
21491684	已执行辅助循环操作项目组套:发现:时间点:^患者:-	4182948
21491686	CARD.PROC; Cardio; Cardiology; Finding; Findings; Heart Disease; Ordinal; PCPS performed; Perc; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491686	PCPS performed	4180186
21491686	已执行经皮心肺支持:发现:时间点:^患者:序数型	4182948
21491690	Cardio; Cardiology; Heart Disease; Pan; PANEL.CARDIAC; Panl; PCI; PCI device Pnl; Perc; Pnl; Point in time; Random	4180186
21491690	PCI device Pnl	4180186
21491690	经皮冠状动脉介入治疗装置组套:-:时间点:^患者:-	4182948
21491691	CAD risk factor Pnl	4180186
21491691	CAD; CAD risk factor Pnl; Dis; Diseases; Dz; Fac; Fact; H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random	4180186
21491691	冠状动脉疾病危险因素组套:-:时间点:^患者:-	4182948
21491693	Cath+angio device Pnl	4180186
21491693	Cath+angio device Pnl; Pan; Panel.devices; Panl; Pnl; Point in time; Random	4180186
21491693	导管插入术与血管造影术操作项目装置组套:-:时间点:^患者:-	4182948
21491694	Card proc complications Pnl; Cardio; Cardiology; Complications pnl; Heart Disease; Pan; PANEL.CARDIAC; Panl; Pnl; Point in time; Random	4180186
21491694	Card proc complications Pnl	4180186
21491694	心脏操作项目并发症组套:-:时间点:^患者:-	4182948
21491698	Angio device; Cor stent len; Len; Length; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491698	Cor stent len	4180186
21491698	冠状动脉支架长度:长度:时间点:血管成形术装置:定量型	4182948
21491699	BI; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Scale	4180186
21491699	BI Score	4180186
21491699	Brinkman 指数:评分:时间点:^患者:定量型	4182948
21491700	Ang; Angio; Angm; CARD.PROC; Cardiac; Cardio; Cardiology; Finding; Findings; Heart Disease; Hrt; Hrt ventr; L; LT; LV; LV.basal post; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; SWM; Ventricular; WM	4180186
21491700	LV.basal post SWM by Angiogram	4180186
21491700	节段性壁运动:发现:时间点:心脏.心室.左侧.后底部:序数型:血管造影	4182948
21491702	Ang; Angio; Angm; CARD.PROC; Cardiac; Cardio; Cardiology; Finding; Findings; Heart Disease; Hrt; Hrt ventr; L; Lat; LT; LV; LV.lat post; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; SWM; Ventricular; WM	4180186
21491702	LV.lat post SWM by Angiogram	4180186
21491702	节段性壁运动:发现:时间点:心脏.心室.左侧.侧面后部:序数型:血管造影	4182948
21491705	Aldosterone + ARC + ARR Pnl; Angiotensin forming enzyme; Angiotensinogenase; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491705	Aldosterone + ARC + ARR Pnl Plas	4180186
21491705	醛固酮与肾素浓度组套:-:时间点:血浆:定量型	4182948
21491709	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; NAAG; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21491709	NAAG CSF-sCnc	4180186
21491709	N-乙酰天冬氨酰谷氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21491710	NfM Ab CSF-mCnc	4180186
21491710	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Chains; Chemistry; Chn; Level; Mass concentration; NfM; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21491710	神经丝中链 抗体:质量浓度:时间点:脑脊液:定量型	4182948
21491711	Document; EXT; Extr-R; Films; Finding; Findings; GE 2V; Hip-R; II; Imaging; LE; Leg; LE-R; Low; Lower extremity joint; Minimum 2 views; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT; View; VWS; Xray; X-ray	4180186
21491711	XR Hip-R GE 2V	4180186
21491711	多重视图 GE 双重:发现:时间点:下肢.右侧>髋关节:文档型:X射线摄影术	4182948
21491716	Bil; Bilat; Both; CXR; Document; Films; Finding; Findings; GE 3V; III; Imaging; Minimum 3 views; Plain Films; Point in time; Rad; RADIOLOGY; Random; Ribs-Bl; Thorax; View; VWS; Xray; X-ray	4180186
21491716	XR Ribs-Bl GE 3V	4180186
21491716	多重视图 GE 三重:发现:时间点:胸部>肋骨.双侧:文档型:X射线摄影术	4182948
21491719	EYE; EYE.PX; EYE.PX.NEI; Length; Opening ht; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R palpebral fiss; Random; RT	4180186
21491719	R palpebral fiss Opening ht	4180186
21491719	睑裂开口高度:长度:时间点:睑裂.右侧:定量型	4182948
21491720	EYE; EYE.PX; EYE.PX.NEI; L; L palpebral fiss; Length; LT; Opening ht; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491720	L palpebral fiss Opening ht	4180186
21491720	睑裂开口高度:长度:时间点:睑裂.左侧:定量型	4182948
21491723	Conj+Sclera; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R conj+sclera; Random; RT; Study report	4180186
21491723	Study obs R conj+sclera Slit lamp	4180186
21491723	检查观察结果:发现:时间点:结膜+巩膜.右侧:名义型:裂隙灯活组织显微镜检查	4182948
21491725	Corneal; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R cornea; Random; RT; Study report	4180186
21491725	Study obs R cornea Slit lamp	4180186
21491725	检查观察结果:发现:时间点:角膜.右侧:名义型:裂隙灯活组织显微镜检查	4182948
21491726	Corneal; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; L; L cornea; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Study report	4180186
21491726	Study obs L cornea Slit lamp	4180186
21491726	检查观察结果:发现:时间点:角膜.左侧:名义型:裂隙灯活组织显微镜检查	4182948
21491727	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R iris; Random; RT; Study report	4180186
21491727	Study obs R iris Slit lamp	4180186
21491727	检查观察结果:发现:时间点:虹膜.右侧:名义型:裂隙灯活组织显微镜检查	4182948
21491729	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R optic lens; Random; RT; Study report	4180186
21491729	Study obs R optic lens Slit lamp	4180186
21491729	检查观察结果:发现:时间点:晶状体.右侧:名义型:裂隙灯活组织显微镜检查	4182948
21491732	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; L; L optic lens; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Typ	4180186
21491732	Type of Opac Optic lens-L by Slit lamp	4180186
21491732	不透明性:类型:时间点:晶状体.左侧:名义型:裂隙灯活组织显微镜检查	4182948
21491734	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R pupil; Random; RT	4180186
21491734	Pupil shape eye-R Slit lamp	4180186
21491734	瞳孔形状:形状:时间点:瞳孔.右侧:名义型:裂隙灯活组织显微镜检查	4182948
21491739	EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; L; L iris; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491739	L iris Transillumination Slit lamp	4180186
21491739	透照度:发现:时间点:虹膜.左侧:序数型:裂隙灯活组织显微镜检查	4182948
21491740	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
21491740	R eye VA--corr ETDRS	4180186
21491740	视力^经过最佳校正的:对数型长度比率:时间点:眼睛.右侧:定量型:ETDRS 视力表	4182948
21491741	L eye VA--corr ETDRS	4180186
21491741	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
21491741	视力^经过最佳校正的:对数型长度比率:时间点:眼睛.左侧:定量型:ETDRS 视力表	4182948
21491745	L eye VA--corr Snellen	4180186
21491745	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; Length Ratio; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
21491745	视力^经过最佳校正的:长度比率:时间点:眼睛.左侧:定量型:Snellen 视力表	4182948
21491750	Ant chamber; Cell; Cellularity; Cnt; Count; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Number; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ant chamber; Random; RT	4180186
21491750	R ant chamber Cells Slit lamp	4180186
21491750	细胞:数量(计数):时间点:前房.右侧:定量型:裂隙灯活组织显微镜检查	4182948
21491753	Ant chamber; EYE; EYE.SLITLAMP; EYE.SLITLAMP.NEI; Finding; Findings; L; L Ant chamber; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21491753	L Ant chamber Flare Slit lamp	4180186
21491753	闪辉:发现:时间点:前房.左侧:序数型:裂隙灯活组织显微镜检查	4182948
21491760	Eye; Eyeball; Glaucoma testing; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random; Tonometry Pnl; Vision; Visual	4180186
21491760	Tonometry Pnl	4180186
21491760	眼压测量组套:-:时间点:眼睛:-:眼压测量法	4182948
21491763	EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; L; L pupil; LT; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random	4180186
21491763	L pupil Pupillary resp	4180186
21491763	瞳孔反应:发现:时间点:瞳孔.左侧:名义型	4182948
21491765	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
21491765	Eye Nystagmus dir	4180186
21491765	眼球震颤方向:发现:时间点:眼睛:名义型	4182948
21491767	Exam; Examination; EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Phys find; Point in time; R; R retinal ves; Random; RT; Vesl; Ves-R; Vessels.XXX	4180186
21491767	R retinal ves Phys find Ophthalmoscopy	4180186
21491767	体格检查发现:发现:时间点:视网膜血管类.右侧:名义型:检眼镜检查法	4182948
21491769	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; Length Ratio; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ped visual acuity; PEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
21491769	L eye Ped visual acuity--uncorr	4180186
21491769	儿童视力^未经校正的:长度比率:时间点:眼睛.左侧:定量型	4182948
21491770	Eye; EYE.REFRACTION; EYE.REFRACTION.NEI; Eyeball; L; L eye; Length Ratio; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ped visual acuity; PEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
21491770	L eye Ped visual acuity--corr	4180186
21491770	儿童视力^经过最佳校正的:长度比率:时间点:眼睛.左侧:定量型	4182948
21491771	Chemistry; ELFA; ELISA; Endometrial cancer; Enzyme immunoassay; HE4; IAA; Level; MEIA; Ovarian cancer; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; SUDS; Tumor marker; WAP four-disulfide core domain protein 2	4180186
21491771	Deprecated HE4 SerPl EIA-sCnc	4180186
21491773	2; Finding; Findings; III; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491777	2; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491778	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; Upper extremity joint	4180186
21491781	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491782	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491787	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491789	Finding; Findings; Limit climbing 1 flight stairs; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491792	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491793	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491794	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491795	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491796	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491797	Finding; Findings; Last; NDL; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491801	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491802	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491806	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491810	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491814	Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Tenormin; WB; Whole blood	4180186
21491814	Atenolol Bld-mCnc	4180186
21491814	氨酰心安:质量浓度:时间点:全血:定量型	4182948
21491816	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path DNA+; Resp path DNA+RNA; Resp path DNA+RNA Pnl; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21491816	Resp path DNA+RNA Pnl Nph NAA+probe	4180186
21491816	呼吸道病原体类 DNA 与 RNA 组套:-:时间点:鼻咽:-:探针法.基因扩增.靶向	4182948
21491820	CorePlaybook; Document; Films; Finding; Findings; GE 2V; II; Imaging; Minimum 2 views; Pelvic; Plain Films; Playbook; Point in time; Rad; RADIOLOGY; Random; View; VWS; Xray; X-ray	4180186
21491820	XR Sacrum+Coccyx GE 2V	4180186
21491820	多重视图 GE 双重:发现:时间点:盆腔>骶骨+尾骨:文档型:X射线摄影术	4182948
21491822	Arm; Document; EXT; Extr-R; Films; Finding; Findings; GE 2V; II; Imaging; Minimum 2 views; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; Should-R; UE; UE-R; Up; Upper extremity joint; View; VWS; Xray; X-ray	4180186
21491822	XR Should-R GE 2V	4180186
21491822	多重视图 GE 双重:发现:时间点:上肢.右侧>肩部:文档型:X射线摄影术	4182948
21491824	Aryl sulfatase B; Arylsulfatase B; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; GalNAc6S sulfatase; Maroteaux-Lamy disease; MPS VI; Point in time; QNT; Quan; Quant; Quantitative; Random; rh4S; rhASB; WB; Whole blood	4180186
21491824	Arylsulfatase B DBS-cCnc	4180186
21491824	N-乙酰半乳糖胺-4-硫酸酯酶:催化浓度:时间点:全血.斑点:定量型	4182948
21491825	Phosphorylase RBC-cCnt	4180186
21491825	Catalytic Content; Chemistry; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491825	磷酸化酶:催化含量:时间点:红细胞:定量型	4182948
21491826	ALA dehydratase; Catalytic Content; Chemistry; Erythrocytes; Hematology; Heme; PBG; PBG Synthase; Point in time; Porph; Porphobili; Porphoblngn; Porpoblngn; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491826	PBG Synthase RBC-cCnt	4180186
21491826	胆色素原合酶:催化含量:时间点:红细胞:定量型	4182948
21491827	PNP cSub RBC	4180186
21491827	Chemistry; Erythrocytes; PNP; PNPase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21491827	嘌呤核苷酸磷酸化酶:单位物质的量相对型催化活性:时间点:红细胞:定量型	4182948
21491830	Appearance; Colour; Eye; EYE.PX; EYE.PX.NEI; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Typ; Vision; Visual	4180186
21491830	R eye Color vision	4180186
21491830	色觉:类型:时间点:眼睛.右侧:名义型	4182948
21491832	Appearance; Colour; Eye; EYE.PX; EYE.PX.NEI; Eyeball; Meth; Method of; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
21491832	Color vision exam type	4180186
21491832	色觉检查方法:类型:时间点:眼睛:名义型:*	4182948
21491835	Calc; Calculation; CARD.US; CARD.US.DICOM; Cardio; Cardiology; Dias; Dias.max; Diast; Diastoli; DOP; DUPLEX; Echography; Grad; Gradient dia; Heart Disease; Largest; Max grad dia; Max press grad dias; Maximal; Maximum; Peak; Point in time; Press grad; QNT; Quan; Quant; Quantitative; Random; Simp Bern; Sonogram; Sonograph; Sonography; TV; TVG max; ULS; Ultrasound	4180186
21491835	TV Max press grad dias Simp Bern	4180186
21491835	压力梯度.舒张期.最大值:压差:时间点:三尖瓣:定量型:超声.多普勒+简化 Bernoulli 公式计算法	4182948
21491837	2D US; CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED minor axis; Heart Disease; Hrt; Hrt ventr; L; Length; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; SAX; short axis; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
21491837	LV ED minor axis 2D US	4180186
21491837	短轴.舒张末期:长度:时间点:心脏.心室.左侧:定量型:超声.2D	4182948
21491838	CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED minor axis; Heart Disease; Hrt; Hrt ventr; L; Length; LT; LV; MM; mmode; Point in time; QNT; Quan; Quant; Quantitative; Random; SAX; short axis; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
21491838	LV ED minor axis M-mode	4180186
21491838	短轴.舒张末期:长度:时间点:心脏.心室.左侧:定量型:超声.M 型	4182948
21491839	Bdy surface; bod; Bodies; BSA; CARD.US; CARD.US.DICOM; Cardiac; Cardio; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED minor axis; Heart Disease; Hrt; Hrt ventr; L; LT; LV; LVAD; MM; mmode; Point in time; QNT; Quan; Quant; Quantitative; Random; SAX; short axis; Sonogram; Sonograph; Sonography; Surf; ULS; Ultrasound; Ventricular	4180186
21491839	LV ED minor axis (M-mode)/BSA	4180186
21491839	短轴.舒张末期/体表面积:长度/面积:时间点:心脏.心室.左侧:定量型:超声.M 型	4182948
21491840	2D US; Art; CARD.US; CARD.US.DICOM; Cardio; Cardiology; DIA; Diam; Echography; ES; ES diameter; Heart Disease; Length; PA; PA-R; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; Sonogram; Sonograph; Sonography; Sys; Syst; ULS; Ultrasound; Ultrasound - 2-dimensional	4180186
21491840	Right PA ES diameter 2D US	4180186
21491840	直径.收缩末期:长度:时间点:肺动脉.右侧:定量型:超声.2D	4182948
21491853	c; CARD.PROC; Cardio; Cardiology; Contr; Contra; Contrst; Gvn; Heart Disease; Ident; Identifier; IV contrast; IV contrast given; Nominal; Point in time; Rad; Radiology; Random	4180186
21491853	IV contrast Gvn	4180186
21491853	静脉内对比剂 给予的:标识符:时间点:^患者:名义型	4182948
21491856	Card name Provider	4180186
21491856	Card name; CLIN; Nominal; Person name; Point in time; Random	4180186
21491856	心脏病学专家姓名:人员姓名:时间点:服务提供者:名义型	4182948
21491859	Angio balloon prod name	4180186
21491859	Angio balloon prod name; Angio device; Ident; Identifier; Nominal; Point in time; Random	4180186
21491859	血管成形术扩张球囊产品名称:标识符:时间点:血管成形术装置:名义型	4182948
21491864	Arbitrary concentration; Big prolactin; Chemistry; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491864	Prolactin.dim SerPl-aCnc	4180186
21491864	催乳素.二聚体:任意型浓度:时间点:血清/血浆:定量型	4182948
21491865	Prolactin.dim/Prolactin % SerPl	4180186
21491865	%; Big prolactin; Chemistry; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491865	催乳素.二聚体/催乳素:任意型分数:时间点:血清/血浆:定量型	4182948
21491866	Chemistry; Copeptin; CT-proAVP; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; SUDS	4180186
21491866	CT-proAVP SerPl IA-sCnc	4180186
21491866	精氨酸加压素原.C-末端:物质的量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
21491868	Cryo; Cryoglobulins; Cryoprecipitate; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
21491868	Cryoglob Ser-mCnc	4180186
21491868	冷球蛋白:质量浓度:时间点:血清:定量型	4182948
21491869	B4 Hemosan; Chemistry; FAD; Leuco-4; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit B4; Vitamin B4	4180186
21491869	FAD SerPl-sCnc	4180186
21491869	黄素腺嘌呤二核苷酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21491874	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Vision; Visual	4180186
21491874	L eye Gross defects	4180186
21491874	大体缺陷:发现:时间点:眼睛.左侧:名义型	4182948
21491876	Corneal; DIA; Diam; EYE; EYE.PX; EYE.PX.NEI; Horiz diam; Length; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT	4180186
21491876	R cornea Horiz diam	4180186
21491876	水平直径:长度:时间点:角膜.右侧:定量型	4182948
21491878	Inheritance pattern based on fam hx	4180186
21491878	EYE; EYE.HX; EYE.HX.NEI; History; Hx; Inheritance pattern based on fam hx; Nominal; Point in time; Random	4180186
21491878	基于家族史的遗传模式:历史记录:时间点:^患者:名义型	4182948
21491880	at init diagnosis; Dx; Eye; EYE.HX; EYE.HX.NEI; Eyeball; Intraocular RB class; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
21491880	ICRB class as init diagnosis Eye-L	4180186
21491880	眼内视网膜母细胞瘤分类^初步诊断时:分类:时间点:眼睛.左侧:序数型:ICRB	4182948
21491881	at final dis stage; Dis; Disease stg; Diseases; Dz; Eye; EYE.HX; EYE.HX.NEI; Eyeball; Intraocular RB class; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; R; R eye; Random; RT; Screen; Vision; Visual	4180186
21491881	ICRB class final dis stage Eye-R	4180186
21491881	眼内视网膜母细胞瘤分类^最终疾病分期时:分类:时间点:眼睛.右侧:序数型:ICRB	4182948
21491882	at final dis stage; Dis; Disease stg; Diseases; Dz; Eye; EYE.HX; EYE.HX.NEI; Eyeball; Intraocular RB class; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
21491882	ICRB class final dis stage Eye-L	4180186
21491882	眼内视网膜母细胞瘤分类^最终疾病分期时:分类:时间点:眼睛.左侧:序数型:ICRB	4182948
21491883	at final dis stage; Dis; Disease stg; Diseases; Dz; Extraocular RB class; Eye; EYE.HX; EYE.HX.NEI; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; R; R eye; Random; RT; Screen; Vision; Visual	4180186
21491883	Reese-Ells class final dis stage Eye-R	4180186
21491883	眼外视网膜母细胞瘤分类^最终疾病分期时:分类:时间点:眼睛.右侧:序数型:Reese-Ellsworth 系统	4182948
21491884	Eye; EYE.HX; EYE.HX.NEI; Eyeball; History; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Vision; Visual	4180186
21491884	Hx of Prob Eye-R	4180186
21491884	眼睛问题:历史记录:时间点:眼睛.右侧:名义型	4182948
21491887	Eye; EYE.HX; EYE.HX.NEI; Eyeball; History; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmologic tx; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; R; R eye; Random; RT; Tx; Vision; Visual	4180186
21491887	Right eye Ophthalmologic treatment	4180186
21491887	R eye Ophthalmologic tx	4180186
21491887	眼科治疗:历史记录:时间点:眼睛.右侧:名义型	4182948
21491889	EYE; EYE.HX; EYE.HX.NEI; History; Narrative; Ophthalmology; Ophtho; Ophthy; Point in time; Prior molec test related to ophth cond; Random; Report	4180186
21491889	Prior molec test related to ophth cond	4180186
21491889	既往与眼科疾病相关的分子检测:历史记录:时间点:^患者:叙述型	4182948
21491891	Eye; EYE.HX; EYE.HX.NEI; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
21491891	斜视:类型:时间点:眼睛:名义型	4182948
21491892	Assoc; EYE; EYE.HX; EYE.HX.NEI; Identity or presence; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; System find + dis assoc w ophth cond	4180186
21491892	System find + dis assoc w ophth cond	4180186
21491892	与眼科疾病相关联的全身性发现与疾病:存在与否或特征标识:时间点:^患者:名义型	4182948
21491894	Corneal; DIA; Diam; EYE; EYE.PX; EYE.PX.NEI; Length; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT; Vert diam	4180186
21491894	R cornea Vert diam	4180186
21491894	垂直直径:长度:时间点:角膜.右侧:定量型	4182948
21491895	Corneal; DIA; Diam; EYE; EYE.PX; EYE.PX.NEI; L; L cornea; Length; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Vert diam	4180186
21491895	L cornea Vert diam	4180186
21491895	垂直直径:长度:时间点:角膜.左侧:定量型	4182948
21491898	Brain; Cranial; Cranium; EYE; EYE.PX; EYE.PX.NEI; Finding; Findings; Head post nystag null-point; Intracranial; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Skull	4180186
21491898	Head post nystag null-point	4180186
21491898	眼球震颤零点头部姿势:发现:时间点:头部:名义型	4182948
21491899	Eye; EYE.PX; EYE.PX.NEI; Eyeball; Finding; Findings; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
21491899	Eye Nystagmus freq	4180186
21491899	眼球震颤频率:发现:时间点:眼睛:序数型	4182948
21491900	Plt dense bodies Bld Ql EM	4180186
21491900	Blood; bod; Body; EM; HEMATOLOGY/CELL COUNTS; Micro; Micros; Microscopic; Ordinal; Pl; Platelets; Platelt; Plt; Plt dense bodies; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
21491900	血小板致密小体:存在情况或阈值:时间点:全血:序数型:显微镜检查.电子	4182948
21491904	EOG; EYE; EYE.EOG; EYE.EOG.NEI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Study report	4180186
21491904	Overall study imp L ret EOG	4180186
21491904	检查观察结果.总体:印象:时间点:视网膜.左侧:序数型:眼电图	4182948
21491905	Atrial wave; Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT; Voltage	4180186
21491905	a-wave amp R ret dark-adapt ERG	4180186
21491905	a-波振幅^暗适应型:电势:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491906	Atrial wave; Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
21491906	a-wave amp L ret dark-adapt ERG	4180186
21491906	a-波振幅^暗适应型:电势:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491907	Atrial wave; Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT; Voltage	4180186
21491907	a-wave amp R ret light-adapt ERG	4180186
21491907	a-波振幅^明适应型:电势:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491908	Atrial wave; Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
21491908	a-wave amp L ret light-adapt ERG	4180186
21491908	a-波振幅^明适应型:电势:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491909	Atrial wave; a-wave impl time; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT	4180186
21491909	a-wave impl time R ret dark-adapt ERG	4180186
21491909	a-波潜伏时间^暗适应型:时间:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491910	Atrial wave; a-wave impl time; ERG; EYE; EYE.ERG; EYE.ERG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491910	a-wave impl time L ret dark-adapt ERG	4180186
21491910	a-波潜伏时间^暗适应型:时间:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491911	Atrial wave; a-wave impl time; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT	4180186
21491911	a-wave impl time R ret light-adapt ERG	4180186
21491911	a-波潜伏时间^明适应型:时间:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491914	Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
21491914	b-wave amp L ret dark-adapt ERG	4180186
21491914	b-波振幅^暗适应型:电势:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491915	Electrical potential; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT; Voltage	4180186
21491915	b-wave amp R ret light-adapt ERG	4180186
21491915	b-波振幅^明适应型:电势:时间点:视网膜.右侧:定量型:视网膜电图	4182948
21491917	b-wave impl time; ERG; EYE; EYE.ERG; EYE.ERG.NEI; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21491917	b-wave impl time L ret dark-adapt ERG	4180186
21491917	b-波潜伏时间^暗适应型:时间:时间点:视网膜.左侧:定量型:视网膜电图	4182948
21491921	ERG; EYE; EYE.ERG; EYE.ERG.NEI; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; R; R ret; Random; RT	4180186
21491921	R ret Oscillatory pot ERG	4180186
21491921	振荡电位:发现:时间点:视网膜.右侧:名义型:视网膜电图	4182948
21491923	Brain; Cranial; Cranium; ERG; EYE; EYE.ERG; EYE.ERG.NEI; Intracranial; Location; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Ref electrode; Skull	4180186
21491923	ERG Ref electrode Loc	4180186
21491923	参比电极:位置:时间点:头部:名义型:视网膜电图	4182948
21491930	Addiction; Blood; Carisoma; Carisoprodol metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; Flexartal; Illicit; Isopropylmeprobamate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Rela; Sanoma; Scn; Scr; Screen; Scrn; Soma; Somadril; Somalgit; WB; Whole blood	4180186
21491930	Carisoprodol+Meprob Bld Ql Scn	4180186
21491930	异丙基甲丁双脲+氨甲丙二酯:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
21491933	4-methylephedrone; 4-methylmethcathinone; 4-MMC; Bath salts; Cfm; Charge Plus; Cloud 9; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Ivory Wave Ocean; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; White Lightning	4180186
21491933	Mephedrone CtO Ur Cfm-mCnc	4180186
21491933	甲氧麻黄酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491934	MDPV CtO Ur Cfm-mCnc	4180186
21491934	Bath salts; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; MDPV; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21491934	亚甲基二氧吡咯戊酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21491935	Ethyl glucuronide CtO Ur Scn-mCnc	4180186
21491935	CtO; DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; Gluc; Glucouronide; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
21491935	乙基葡糖苷酸 截止点:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
21491942	Document; EXT; Films; Finding; Findings; GE 2V; II; Imaging; LE; Leg; Low; Minimum 2 views; Phalange; Plain Films; Point in time; Rad; RADIOLOGY; Random; View; VWS; Xray; X-ray	4180186
21491942	XR Toe GE 2V	4180186
21491942	多重视图 GE 双重:发现:时间点:下肢>脚趾:文档型:X射线摄影术	4182948
21491944	Acd; Acid fast Stn; Acids; AFB stain; Convalescent; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lower respiratory; Lung; Microbiology; Nominal; Point in time; Post immunization; Pulmonary; Pulmonology; Random; Respiratory; Second; sp2; Spec; Spt; Sputum; St; Stains; Stn; ZN Stn	4180186
21491944	ZN Stn sp2 Spt	4180186
21491944	显微镜观察^第2个标本:存在与否或特征标识:时间点:痰液:名义型:抗酸染色法.Ziehl-Neelsen	4182948
21491949	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491950	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491951	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491953	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491954	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491955	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491956	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491958	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491960	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491963	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491967	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491968	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491971	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491972	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491973	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21491976	B4 Hemosan; Blood; Chemistry; FAD; Leuco-4; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vit B4; Vitamin B4; WB; Whole blood	4180186
21491976	FAD Bld-sCnc	4180186
21491976	黄素腺嘌呤二核苷酸:物质的量浓度:时间点:全血:定量型	4182948
21491978	Prolactin isoforms Pnl SerPl	4180186
21491978	Chemistry; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PRL; Prol; Prolactin isoforms Pnl; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491978	催乳素同工型组套:-:时间点:血清/血浆:-	4182948
21491979	Arbitrary concentration; Chemistry; fPRL; Free prolactin; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; mPRL; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491979	Prolactin.monomeric SerPl-aCnc	4180186
21491979	催乳素.单体:任意型浓度:时间点:血清/血浆:定量型	4182948
21491980	%; Chemistry; fPRL; Free prolactin; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; mPRL; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21491980	Prolactin.monomeric/Prolactin % SerPl	4180186
21491980	催乳素.单体/催乳素:任意型分数:时间点:血清/血浆:定量型	4182948
21491983	Finding; Findings; No; Num; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491984	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491985	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491986	Finding; Findings; No; Num; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491987	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491988	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491990	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491991	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491993	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21491999	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; T prime	4180186
21492000	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492002	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492008	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492009	Finding; Findings; Job; Occupation; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492011	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492012	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492014	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492016	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492017	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492018	Finding; Findings; Mice; Murine; Mus musculus; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492021	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492023	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492024	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492031	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492032	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492043	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492045	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492046	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492047	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492048	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492051	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492052	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492053	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492055	1 week; FCN; Func; Funct; Ordinal; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Up	4180186
21492058	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; T prime	4180186
21492059	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492060	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492061	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492064	AO; AoV; AV; Average; Avg; Calc; Calculation; CARD.US; Cardio; Cardiology; Dias; Diast; Diastoli; DOP; DUPLEX; Echography; Grad; Gradient dia; Heart Disease; Mean grad dia; Mean press grad dias; Mean regurg press gradient dia; Point in time; Press grad; QNT; Quan; Quant; Quantitative; Random; Simp Bern; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
21492064	AV Mean reg press grad dias Simp Bern	4180186
21492064	反流压力梯度.舒张期.平均值:压差:时间点:主动脉瓣:定量型:超声.多普勒+简化 Bernoulli 公式计算法	4182948
21492065	Average; Avg; CARD.US; Cardio; Cardiology; DOP; DUPLEX; Echography; Grad; Heart Disease; Mean press grad; Mean regurg press gradient; MV; MVG; Point in time; Press grad; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
21492065	MV Mean regurg press gradient DOP	4180186
21492065	反流压力梯度.平均值:压差:时间点:二尖瓣:定量型:超声.多普勒	4182948
21492066	2D US; CARD.US; Cardio; Cardiology; Echography; Heart Disease; MV; MVA; PLN; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; US.2D.PLN	4180186
21492066	MV Orifice area US.2D.PLN	4180186
21492066	口面积:面积:时间点:二尖瓣:定量型:超声.2D.面积测量法	4182948
21492067	CARD.US; Cardiac; Cardio; Cardiology; DOP; DUPLEX; Echography; Heart Disease; Hrt; Hrt ventr; Intrachamber pres; Intrachamber.sys pres; Intrachamber.sys.max; Largest; Maximal; Maximum; Peak; Point in time; Pressure; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Sonogram; Sonograph; Sonography; Sys; Sys.max; Syst; ULS; Ultrasound; Ventricular	4180186
21492067	RV Intrachamber.sys.max DOP	4180186
21492067	心腔内.收缩期.最大值:压力或压强:时间点:心脏.心室.右侧:定量型:超声.多普勒	4182948
21492069	CARD.US; Cardio; Cardiology; Dias; Dias.max; Diast; Diastoli; DOP; DUPLEX; Echography; Grad; Gradient dia; Heart Disease; Largest; Max grad dia; Max press grad dias; Max regurg press grad dia; Maximal; Maximum; Peak; Point in time; Press grad; PV; PVG; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
21492069	PV Max regurg press grad dia DOP	4180186
21492069	反流压力梯度.舒张期.最大值:压差:时间点:肺动脉瓣:定量型:超声.多普勒	4182948
21492070	CARD.US; Cardio; Cardiology; Echography; Heart Disease; Largest; Lat; Max V; Maximal; Maximum; MV; MV ann; MV lat ann; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sonogram; Sonograph; Sonography; s-prime Vmax; TDI; ULS; Ultrasound; V max; Vel; Velocity; Vmax	4180186
21492070	MV lat ann s-prime Vmax TDI	4180186
21492070	组织速度.S 波.最大值:速度:时间点:二尖瓣.环.侧部:定量型:超声.组织多普勒	4182948
21492074	CARD.US; Cardiac; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Hrt; Hrt ventr; Inf; L; LT; LV; LV.basal inf; LV.basal inf septum; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; Sonogram; Sonograph; Sonography; SWM; ULS; Ultrasound; Ventricular; WM	4180186
21492074	LV.basal inf septum SWM US	4180186
21492074	节段性壁运动:发现:时间点:心脏.心室.左侧.间隔下底部:序数型:超声	4182948
21492076	Arterial Stenosis; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492078	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492079	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492080	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492081	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492082	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492084	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492086	Finding; Findings; Ordinal; Othr; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492087	Difficulty removing wrappings; Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492090	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492091	FCN; Func; Funct; Ordinal; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
21492093	FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
21492097	Asympt; Asymptomatic; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Scn; Thorax; W contr IV; WC	4180186
21492097	CT Chest Screening W contr IV	4180186
21492097	针对筛查的多层^采用静脉注射对比剂:发现:时间点:胸部:文档型:CT	4182948
21492098	Abd; Abd+Pelvis; Abdo; Abdominal; Asympt; Asymptomatic; c; CAT scan; Colonography; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; LGI; Pelvic; Playbook; Point in time; Rad; Radiology; Random; Rectal; Rectum+colon; Scn; Virtual colonoscopy; W Air contr PR; without contrast; WO contr IV+W air contr PR	4180186
21492098	CT Colon+Rec Screen WO contr IV+W air PR	4180186
21492098	针对筛查的多层^不采用静脉注射对比剂+采用经直肠给予空气对比剂:发现:时间点:腹部+盆腔>结肠+直肠:文档型:CT	4182948
21492100	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Colonography; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; LGI; Pelvic; Playbook; Point in time; Rad; Radiology; Random; Rectal; Rectum+colon; Virtual colonoscopy; W Air contr PR; without contrast; WO contr IV+W air contr PR	4180186
21492100	CT Colon+Rect WO contr IV+W air contr PR	4180186
21492100	多层^不采用静脉注射对比剂+采用经直肠给予空气对比剂:发现:时间点:腹部+盆腔>结肠+直肠:文档型:CT	4182948
21492102	Ang; Angio; Angiography; Angm; Arteriogram; c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; Coronary aa; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Heart; Hrt; Hrt+CA; Imaging; Playbook; Point in time; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
21492102	CTA Hrt+CA W contr IV	4180186
21492102	多层^采用静脉注射对比剂:发现:时间点:胸部>心脏+冠状动脉类:文档型:CT.血管造影术	4182948
21492104	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
21492104	CT Pelvis by reconstr W contr IV	4180186
21492104	基于重建的多层^采用静脉注射对比剂:发现:时间点:盆腔:文档型:CT	4182948
21492105	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Pelvic; Playbook; Point in time; Rad; Radiology; Random; without contrast	4180186
21492105	CT Pelvis by reconstr WO contr	4180186
21492105	基于重建的多层^不采用对比剂:发现:时间点:盆腔:文档型:CT	4182948
21492109	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Playbook; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord; W contr IV; WC	4180186
21492109	CT L-spine by reconstr W contr IV	4180186
21492109	基于重建的多层^采用静脉注射对比剂:发现:时间点:腹部>脊椎.腰段:文档型:CT	4182948
21492110	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; without contrast	4180186
21492110	CT L-spine by reconstr WO contr	4180186
21492110	基于重建的多层^不采用对比剂:发现:时间点:腹部>脊椎.腰段:文档型:CT	4182948
21492113	BON; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Playbook; Point in time; Rad; Radiology; Random; Skull; without contrast	4180186
21492113	CT Temporal bone by reconstr WO contr	4180186
21492113	基于重建的多层^不采用对比剂:发现:时间点:头部>颞骨:文档型:CT	4182948
21492115	Asympt; Asymptomatic; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; Radiology; Random; Scn; Thorax; without contrast	4180186
21492115	CT Chest Screening WO contr	4180186
21492115	针对筛查的多层^不采用对比剂:发现:时间点:胸部:文档型:CT	4182948
21492116	c; Ca; Cal; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; Coronary aa; CT scan; Document; Finding; Findings; Heart; Hrt; Hrt+CA; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax; without contrast	4180186
21492116	CT Hrt+CA for Calcium Score WO contr	4180186
21492116	针对钙化评分的多层^不采用对比剂:发现:时间点:胸部>心脏+冠状动脉类:文档型:CT	4182948
21492117	c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Dis; Diseases; Document; Dz; Finding; Findings; Hrt; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC	4180186
21492117	CT Hrt for congenital disease W contr IV	4180186
21492117	针对先天性疾病的多层^采用静脉注射对比剂:发现:时间点:胸部>心脏:文档型:CT	4182948
21492118	c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Hrt; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC	4180186
21492118	CT Hrt W contr IV	4180186
21492118	多层^采用静脉注射对比剂:发现:时间点:胸部>心脏:文档型:CT	4182948
21492119	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; without contrast	4180186
21492119	CT.Dens L-spine WO contr	4180186
21492119	多层^不采用对比剂:发现:时间点:腹部>脊椎.腰段:文档型:CT.密度测定法	4182948
21492120	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; without contrast	4180186
21492120	CT T-spine by reconstr WO contr	4180186
21492120	基于重建的多层^不采用对比剂:发现:时间点:胸部>脊椎.胸段:文档型:CT	4182948
21492122	After; CAT scan; Computed tomography; Computerized tomography; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; Misc; Miscellaneous; Other; p 3D proc; Playbook; Point in time; PST; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
21492122	CT p 3D proc	4180186
21492122	三维后处理类多层:发现:时间点:XXX:文档型:CT	4182948
21492123	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Cystogram; Document; Finding; Findings; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; W contr IUB; WC	4180186
21492123	CT Bladder W contr IUB	4180186
21492123	多层^采用膀胱内对比剂:发现:时间点:盆腔>膀胱:文档型:CT	4182948
21492124	Brain; CAT scan; Computed tomography; Computerized tomography; CorePlaybook; Cranial; Cranium; CT scan; Dental scan; Dentascan; Document; Finding; Findings; Imaging; Intracranial; Playbook; Point in time; Rad; Radiology; Random; Skull	4180186
21492124	多层:发现:时间点:头部>牙齿:文档型:CT	4182948
21492125	After; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; p 3D proc; Playbook; Point in time; PST; Rad; RADIOLOGY; Random; Thorax; without contrast	4180186
21492125	CT Chest p 3D proc WO contr	4180186
21492125	三维后处理类多层^不采用对比剂:发现:时间点:胸部:文档型:CT	4182948
21492126	Abd; Abdo; Abdomen+; Abdominal; After; c; CAT scan; Chest + Abd; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; p 3D proc; Playbook; Point in time; PST; Rad; Radiology; Random; Thorax; without contrast	4180186
21492126	CT Chest+Abd p 3D proc WO contr	4180186
21492126	三维后处理类多层^不采用对比剂:发现:时间点:腹部+胸部:文档型:CT	4182948
21492128	ADMIN; Ident; Identifier; Intradermal; Nominal; NPI; Point in time; Random	4180186
21492128	全国服务提供者标识符:标识符:时间点:组织机构:名义型	4182948
21492129	ADMIN; Ident; Identifier; Nominal; Point in time; Random	4180186
21492129	名称:标识符:时间点:组织机构:名义型	4182948
21492131	CARD.US; Cardiac; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Hrt; Hrt ventr; Inf; L; Lat; LT; LV; LV.basal inf; LV.basal inf lat; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; Sonogram; Sonograph; Sonography; SWM; ULS; Ultrasound; Ventricular; WM	4180186
21492131	LV.basal inf lat SWM US	4180186
21492131	节段性壁运动:发现:时间点:心脏.心室.左侧.侧面下底部:序数型:超声	4182948
21492132	CARD.US; Cardiac; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Hrt; Hrt ventr; L; Lat; LT; LV; LV.basal ant; LV.basal ant lat; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; Sonogram; Sonograph; Sonography; SWM; ULS; Ultrasound; Ventricular; WM	4180186
21492132	LV.basal ant lat SWM US	4180186
21492132	节段性壁运动:发现:时间点:心脏.心室.左侧.侧面前底部:序数型:超声	4182948
21492133	CARD.US; Cardiac; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Hrt; Hrt ventr; Inf; L; LT; LV; LV.mid inf; LV.mid inf septum; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; Sonogram; Sonograph; Sonography; SWM; ULS; Ultrasound; Ventricular; WM	4180186
21492133	LV.mid inf septum SWM US	4180186
21492133	节段性壁运动:发现:时间点:心脏.心室.左侧.间隔中下部:序数型:超声	4182948
21492135	CARD.US; Cardiac; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Hrt; Hrt ventr; L; Lat; LT; LV; LV.mid ant; LV.mid ant lat; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; Sonogram; Sonograph; Sonography; SWM; ULS; Ultrasound; Ventricular; WM	4180186
21492135	LV.mid ant lat SWM US	4180186
21492135	节段性壁运动:发现:时间点:心脏.心室.左侧.侧面中前部:序数型:超声	4182948
21492136	CARD.US; Cardiac; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Hrt; Hrt ventr; L; LT; LV; LV apex; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; Sonogram; Sonograph; Sonography; SWM; ULS; Ultrasound; Ventricular; WM	4180186
21492136	LV apex SWM US	4180186
21492136	节段性壁运动:发现:时间点:心脏.心室.左侧.心尖:序数型:超声	4182948
21492137	CARD.US; Cardio; Cardiology; Cent CVS; CVS; Dx; Echography; Heart Disease; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Sonogram; Sonograph; Sonography; Study dx; Study report; ULS; Ultrasound	4180186
21492137	Cent CVS US Study dx	4180186
21492137	检查诊断:印象:时间点:心血管系统.中央:叙述型:超声	4182948
21492138	MISC; Nominal; Point in time; Random	4180186
21492138	Resource ID URI Study	4180186
21492138	资源标识符:统一资源标识符:时间点:检查:名义型	4182948
21492139	4q12 rearrange; Blood; Chromosom; Chromosomes; Cyto loc; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Nominal; Point in time; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492139	4q12 rearrange Bld/T FISH	4180186
21492139	4q12 染色体区域重排:存在与否或特征标识:时间点:全血/组织:名义型:FISH	4182948
21492143	ALK rearrange; ALK receptor tyrosine kinase; Anaplastic lymphoma kinase (Ki-1); Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; NBLST3; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492143	ALK rearrange Bld/T Ql FISH	4180186
21492143	ALK 基因重排:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492146	B-cell CLL; BCL5; BCL-6; BCL6A; Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; LAZ3; Lymphoma 6; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Narrative; Non-Hodgkin lymphoma; Point in time; Random; Rearr; Rearrangement; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; ZBTB27; Zinc finger protein 51; ZNF51	4180186
21492146	BCL6 gene Rear Bld/T FISH-Imp	4180186
21492146	BCL6 基因重排:印象:时间点:全血/组织:叙述型:FISH	4182948
21492147	Amplification; B-cell CLL; BCL1; BCL-1; Blood; Cyclin D1; D11S287E; Dp; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; HGNC:988; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Lymphoma 1; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Narrative; Parathyroid adenomatosis 1; Point in time; PRAD1; Random; Report; Tissue; Tissue, unspecified; U21B31; WB; Whole blood; Whole blood or Tissue	4180186
21492147	CCND1 gene Dp Bld/T FISH-Imp	4180186
21492147	CCND1 基因 复制:印象:时间点:全血/组织:叙述型:FISH	4182948
21492148	ALK rearrange; ALK receptor tyrosine kinase; Anaplastic lymphoma kinase (Ki-1); Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Narrative; NBLST3; Point in time; Random; Rearr; Rearrangement; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492148	ALK rearrange Bld/T FISH-Imp	4180186
21492148	ALK 基因重排:印象:时间点:全血/组织:叙述型:FISH	4182948
21492150	ABL; bcr/abl; Blood; Cell; Cellularity; Chromosom; Chromosomes; Chronic myeloid leukemia; CML; Cyto loc; Del; Deletions; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492150	Cells.9q34 Del/Cells cnt NFr Bld/T FISH	4180186
21492150	细胞.9q34 染色体区域 缺失/已计数的细胞:计数型分数:时间点:全血/组织:定量型:FISH	4182948
21492153	bHLHe39; Blood; Burkitt lymphoma; Burkitts lymphoma; c-MYC; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; MRTL; MYCC; Ordinal; Point in time; PR; Protooncogene homologous to myelocytomatosis virus; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Tissue; Tissue, unspecified; v-myc avian myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
21492153	MYC gene Rear Bld/T Ql FISH	4180186
21492153	MYC 基因重排:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492154	Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Tissue; Tissue, unspecified; TRA+TRD rearrange; WB; Whole blood; Whole blood or Tissue	4180186
21492154	TRA+TRD rearrange Bld/T Ql FISH	4180186
21492154	TRA+TRD 基因重排:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492156	B-cell CLL; B-cell leukemia/lymphoma 2; Bcl-2; Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Lymphoma 2; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; Point in time; PPP1R50; PR; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492156	BCL2 gene Rear Bld/T Ql FISH	4180186
21492156	BCL2 基因重排:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492157	ALL1; ALL-1; Blood; CXXC7; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; HRX; HTRX; HTRX1; Inherited; lysine (K)-specific methyltransferase 2A; MLL; MLL/GAS7; MLL1; MLL1A; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; TET1-MLL; Tissue; Tissue, unspecified; TRX1; WB; WDSTS; Whole blood; Whole blood or Tissue	4180186
21492157	MLL gene Rear Bld/T Ql FISH	4180186
21492157	MLL 基因重排:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492158	Beta platelet-derived growth factor receptor precursor; Blood; CD140B; CD140B gene; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; IBGC4; IMF1; Inherited; JTK12; KOGS; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; PDGFbetaR; PDGFR; PDGFR1; PDGFR-1; PDGFRB rearrange; PDGF-R-BETA; PENTT; platelet derived growth factor receptor beta; Point in time; PR; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492158	PDGFRB rearrange Bld/T Ql FISH	4180186
21492158	PDGFRB 基因重排:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492159	Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; IGH.1@; IGH@; IGHD@; IGHDY1; IGHJ; IGHJ@; IGHV; IGHV@; immunoglobulin heavy locus; Inherited; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rearr; Rearrangement; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492159	IGH gene rearrange Bld/T Ql FISH	4180186
21492159	IGH 基因重排:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492160	bHLHe39; Blood; Burkitt lymphoma; Burkitts lymphoma; c-MYC; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; MRTL; MYCC; Narrative; Point in time; Protooncogene homologous to myelocytomatosis virus; Random; Rearr; Rearrangement; Report; Tissue; Tissue, unspecified; v-myc avian myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
21492160	MYC gene Rear Bld/T FISH-Imp	4180186
21492160	MYC 基因重排:印象:时间点:全血/组织:叙述型:FISH	4182948
21492162	Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Narrative; NR1B1; Point in time; Random; RAR alpha form; RARA rearrange; RARalpha; Rearr; Rearrangement; Report; Retinoic acid receptor alpha; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492162	RARA rearrange Bld/T FISH-Imp	4180186
21492162	RARA 基因重排:印象:时间点:全血/组织:叙述型:FISH	4182948
21492163	B-cell CLL; B-cell leukemia/lymphoma 2; Bcl-2; Blood; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Lymphoma 2; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Narrative; Point in time; PPP1R50; Random; Rearr; Rearrangement; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492163	BCL2 gene Rear Bld/T FISH-Imp	4180186
21492163	BCL2 基因重排:印象:时间点:全血/组织:叙述型:FISH	4182948
21492167	bHLHe39; Blood; Burkitt lymphoma; Burkitts lymphoma; Cell; Cells.MYC rearr; Cellularity; c-MYC; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; MRTL; MYCC; Number fraction; Percent; Point in time; Protooncogene homologous to myelocytomatosis virus; QNT; Quan; Quant; Quantitative; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified; v-myc avian myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
21492167	Cells.MYC rear/Cells cnt NFr Bld/T FISH	4180186
21492167	细胞.MYC 基因重排/已计数的细胞:计数型分数:时间点:全血/组织:定量型:FISH	4182948
21492170	B-cell CLL; B-cell leukemia/lymphoma 2; Bcl-2; BCL2 Cells; Blood; Cell; Cells.BCL2 rearr; Cellularity; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Lymphoma 2; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Number Fraction; Percent; Point in time; PPP1R50; QNT; Quan; Quant; Quantitative; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492170	Cells.BCL2 rear/Cells cnt NFr Bld/T FISH	4180186
21492170	细胞.BCL2 基因重排/已计数的细胞:计数型分数:时间点:全血/组织:定量型:FISH	4182948
21492171	ALK rearrange; ALK receptor tyrosine kinase; Anaplastic lymphoma kinase (Ki-1); Blood; Cell; Cells.ALK rearr; Cellularity; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; NBLST3; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492171	Cells.ALK rear/Cells cnt NFr Bld/T FISH	4180186
21492171	细胞.ALK 基因重排/已计数的细胞:计数型分数:时间点:全血/组织:定量型:FISH	4182948
21492172	After; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT scan; Document; Finding; Findings; Imaging; p 3D proc; Pelvic; Playbook; Point in time; PST; Rad; RADIOLOGY; Random; without contrast	4180186
21492172	CT Pelvis p 3D proc WO contr	4180186
21492172	三维后处理类多层^不采用对比剂:发现:时间点:盆腔:文档型:CT	4182948
21492175	Blood; Calc; Calc.AlloMap; Calculation; Heart tx acute rejection; Molecular pathology; MOLPATH; PBMC; Peripheral blood mononuclear cells; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; WB; Whole blood	4180186
21492175	Heart tx acute reject Score MC AlloMap	4180186
21492175	心脏移植急性细胞排斥风险:评分:时间点:全血单个核细胞:定量型:计算法.AlloMap	4182948
21492181	Can report current news; Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GPCOG	4180186
21492183	Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GPCOG	4180186
21492184	Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GPCOG	4180186
21492185	Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GPCOG	4180186
21492186	Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GPCOG	4180186
21492187	General Practitioner Assessment of Cognition; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GPCOG; Tot; Totl	4180186
21492188	Pan; Panel; PANEL.SURVEY.GPCOG; Panl; Pnl; Point in time; Random; Survey; SURVEY.GPCOG	4180186
21492193	Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GPCOG	4180186
21492194	Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GPCOG	4180186
21492195	Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GPCOG	4180186
21492196	Finding; Findings; General Practitioner Assessment of Cognition; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GPCOG	4180186
21492197	General Practitioner Assessment of Cognition; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GPCOG; Tot; Totl	4180186
21492201	1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; III; Isom; Mass rate; mRate; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; UA; UR; Urn; Urophorph; Uropor3; Uroporphyrin III	4180186
21492201	Uropor3 24h Ur-mRate	4180186
21492201	尿卟啉 III 同分异构体:质量速率:24小时:尿液:定量型	4182948
21492205	4OH-midazolam Fld-mCnc	4180186
21492205	4-Hydroxy midazolam; 4OH-midazolam; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Midazolam metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492205	4-羟基咪达唑仑:质量浓度:时间点:体液:定量型	4182948
21492206	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Invega; Level; Mass concentration; Paliperidone; Point in time; QNT; Quan; Quant; Quantitative; Random; Risperidone metabolite	4180186
21492206	9OH-risperidone Fld-mCnc	4180186
21492206	9-羟基利培酮:质量浓度:时间点:体液:定量型	4182948
21492207	Abacavir CSF-mCnc	4180186
21492207	1592U89; ABC; Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Ziagen	4180186
21492207	阿巴卡韦:质量浓度:时间点:脑脊液:定量型	4182948
21492209	ACE; Acetylpromazine; AcP; Atravet; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Notensil; Plegicil; Point in time; QNT; Quan; Quant; Quantitative; Random; Vet; Veterinary	4180186
21492209	Acepromazine Fld-mCnc	4180186
21492209	乙酰丙嗪:质量浓度:时间点:体液:定量型	4182948
21492210	G-OH-Butyr Fld-mCnc	4180186
21492210	4-hydroxybutyrate; 4-hydroxybutyric acid; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Level; Liquidx; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492210	Gamma 羟基丁酸:质量浓度:时间点:体液:定量型	4182948
21492211	Mercury Nail-sCnt	4180186
21492211	DRUG/TOXICOLOGY; Drugs; HG; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Ungal nail	4180186
21492211	汞:物质的量含量:时间点:甲:定量型	4182948
21492213	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Nucynta; Ordinal; Palexia; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Tapal; WB; Whole blood	4180186
21492213	Tapentadol Bld Ql Cfm	4180186
21492213	他喷他多:存在情况或阈值:时间点:全血:序数型:毒理学确认试验	4182948
21492214	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nucynta; Ordinal; Palexia; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tapal; WB; Whole blood	4180186
21492214	Tapentadol Bld Ql Scn	4180186
21492214	他喷他多:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
21492215	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Tramal; Ultram; WB; Whole blood	4180186
21492215	traMADol Bld Ql Cfm	4180186
21492215	曲马多:存在情况或阈值:时间点:全血:序数型:毒理学确认试验	4182948
21492217	Alimazine; Amisal; Apamezin; B/F; Benalgen; BF; bod; Bodies; Body fluid; Body fluid, unsp; Coplexens; Crasin; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Meparil; Nedeltran; Normain A; Palpex; Panectyl; Point in time; Pramin; QNT; Quan; Quant; Quantitative; Random; Repeltin; Spansule; Telmatin; Temaridin; Temaril; Theralen; Theralene; Trixin; Turysin; Vallergan; Variargil; Vetalen	4180186
21492217	Trimeprazine Fld-mCnc	4180186
21492217	三甲泼拉嗪:质量浓度:时间点:体液:定量型	4182948
21492219	Allergies to food environment	4180186
21492219	Allergies to food environment; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
21492219	对于食物或环境因素的已知变态反应:发现:时间点:^患者:名义型	4182948
21492221	Alfenta; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fanaxal; Fl; Fld; FLU; Fluid; Level; Limefen; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rapifen	4180186
21492221	Alfentanil Fld-mCnc	4180186
21492221	阿芬太尼:质量浓度:时间点:体液:定量型	4182948
21492222	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Litican; Mass concentration; Plitican; Point in time; QNT; Quan; Quant; Quantitative; Random; Superan; Vergentan	4180186
21492222	Alizapride Fld-mCnc	4180186
21492222	阿立必利:质量浓度:时间点:体液:定量型	4182948
21492224	CA 1h p Inc Titr Ser Inc	4180186
21492224	冷凝集素^在孵育之后1小时:滴定度:时间点:血清:定量型:37℃孵育	4182948
21492224	@37c; 1 hour; 1.0Hr; 1h p Inc; 60 min; 60 minutes; 60M; 60min; After; Agglut; Agglutination; Agglutinins; Agglutins; AGT; CA; Cold agglutinin titration; degree; Dilution factor; Dilution Factor (Titer); Point in time; PST; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
21492225	CA 1h p Inc Titr Ser 22 deg C inc	4180186
21492225	冷凝集素^在孵育之后1小时:滴定度:时间点:血清:定量型:22℃孵育	4182948
21492225	1 hour; 1.0Hr; 1h p Inc; 60 min; 60 minutes; 60M; 60min; After; Agglut; Agglutination; Agglutinins; Agglutins; AGT; CA; Cold agglutinin titration; degree; Dilution factor; Dilution Factor (Titer); Point in time; PST; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
21492227	CA 24H p inc Titr Ser 4 deg C inc	4180186
21492227	冷凝集素^在孵育之后24小时:滴定度:时间点:血清:定量型:4℃孵育	4182948
21492227	24H p inc; After; Agglut; Agglutination; Agglutinins; Agglutins; AGT; CA; Cold agglutinin titration; degree; Dilution factor; Dilution Factor (Titer); Point in time; PST; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
21492228	Cardiac; Cardio; Cardiology; CO; Flow; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Ventricular; Volume rate; vRate	4180186
21492228	LV Output Cont	4180186
21492228	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:连续法	4182948
21492231	%; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Cardio; Cardiology; CARDIO-PULM; Heart Disease; Lung; Point in time; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SpO2	4180186
21492231	Transmission % BldA PulseOx	4180186
21492231	透射:任意型分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
21492233	Cardio; Cardiology; CARDIO-PULM; Fluid conductance; Heart Disease; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; TFC; Thor fl conductivity; Thorax	4180186
21492233	Thor fl conductivity Chest	4180186
21492233	胸腔液体电导率:液体传导性:时间点:胸部:定量型	4182948
21492235	Aric energy; Bdy surface; bod; Bodies; BSA; Cardiac; Cardio; Cardiology; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; Job; L; LT; LV; Occupation; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf; Ventricular	4180186
21492235	LV Work/BSA NI-ICG	4180186
21492235	工作/体表面积:能量/面积:时间点:心脏.心室.左侧:定量型:NI-ICG	4182948
21492236	Breathing; Lung; Lungs; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
21492236	Press Airway	4180186
21492236	压力:压力或压强:时间点:呼吸系统.气道:定量型	4182948
21492238	BP by Noninvasive	4180186
21492238	Art sys; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21492238	血管内:压力或压强:时间点:动脉系统:定量型:无创法	4182948
21492242	Average; Avg; BP; BP cuff; BP device; Cuff press.mean; Mean Pres; Point in time; Pressure; Pressure mean; QNT; Quan; Quant; Quantitative; Random	4180186
21492242	BP device Cuff press.mean	4180186
21492242	袖套压力.平均值:压力或压强:时间点:血压装置:定量型	4182948
21492243	BP; BP cuff; BP device; Cardio; Cardiology; Cuff press.sys; Heart Disease; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
21492243	BP device Cuff press.sys	4180186
21492243	袖套压力.收缩期:压力或压强:时间点:血压装置:定量型	4182948
21492245	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
21492247	Beta platelet-derived growth factor receptor precursor; Blood; CD140B; CD140B gene; Cell; Cells.PDGFRB rearr; Cellularity; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; IBGC4; IMF1; Inherited; JTK12; KOGS; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Number Fraction; PDGFbetaR; PDGFR; PDGFR1; PDGFR-1; PDGFRB rearrange; PDGF-R-BETA; PENTT; Percent; platelet derived growth factor receptor beta; Point in time; QNT; Quan; Quant; Quantitative; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492247	Cells.PDGFRB rear/Cells cnt Bld/T FISH	4180186
21492247	细胞.PDGFRB 基因重排/已计数的细胞:计数型分数:时间点:全血/组织:定量型:FISH	4182948
21492248	Blood; Cell; Cells.IGH rearr; Cellularity; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; IGH.1@; IGH@; IGHD@; IGHDY1; IGHJ; IGHJ@; IGHV; IGHV@; immunoglobulin heavy locus; Inherited; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492248	Cells.IGH rear/Cells cnt NFr Bld/T FISH	4180186
21492248	细胞.IGH 基因重排/已计数的细胞:计数型分数:时间点:全血/组织:定量型:FISH	4182948
21492250	Blood; CEP3; Chr 3 copy num; Chromosom; Chromosomes; Entitic; Entitic number; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; III; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; Ts; WB; Whole blood; Whole blood or Tissue	4180186
21492250	Chr 3 copy num/nucleus EntNum Bld/T FISH	4180186
21492250	染色体 3 拷贝数/核:实体数量:时间点:全血/组织:定量型:FISH	4182948
21492253	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gastro; Gastroenterology; GI; notes; Operative note; Point in time; Random; Surg; Visit note	4180186
21492253	Gastroenterology Operative note	4180186
21492253	外科手术记录:发现:时间点:{环境}:文档型:胃肠病学	4182948
21492255	Vascular surgery Operative note	4180186
21492255	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Operative note; Point in time; Random; Surg; Visit note	4180186
21492255	外科手术记录:发现:时间点:{环境}:文档型:血管外科学	4182948
21492257	6q deletion; Blood; Chronic lymphocytic leukemia; CLL; Del; del 6q; del 6q23; Deletions; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Leukemia; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; MYB Deletion; Non-Hodgkin lymphoma; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492257	MYB Del Bld/T Ql FISH	4180186
21492257	MYB 基因 缺失:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492258	Admit H&P note; DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
21492258	Mental health Admit H&P note	4180186
21492258	入院史与体格检查记录:发现:时间点:{环境}:文档型:心理健康	4182948
21492259	clinical genomics; Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; Medical Genetics; medical genomics; notes; Point in time; Random; Visit note	4180186
21492259	会诊记录:发现:时间点:{环境}:文档型:临床遗传学	4182948
21492261	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gastro; Gastroenterology; GI; notes; Point in time; Random; Study report; Visit note	4180186
21492261	Gastroenterology Diag study note	4180186
21492261	诊断性检查记录:发现:时间点:{环境}:文档型:胃肠病学	4182948
21492263	Diag study note; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; ID; Infectious Disease; InfectiousDisease; notes; Point in time; Random; Study report; Visit note	4180186
21492263	Infectious disease Diag study note	4180186
21492263	诊断性检查记录:发现:时间点:{环境}:文档型:感染性疾病	4182948
21492264	Dentistry Diag study note	4180186
21492264	Dentist; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
21492264	诊断性检查记录:发现:时间点:{环境}:文档型:牙科学	4182948
21492265	Dermatology Diag study note	4180186
21492265	Derm; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
21492265	诊断性检查记录:发现:时间点:{环境}:文档型:皮肤病学	4182948
21492268	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492268	Mental health D/C sum	4180186
21492268	出院摘要记录:发现:时间点:{环境}:文档型:心理健康	4182948
21492269	General medicine D/C sum	4180186
21492269	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492269	出院摘要记录:发现:时间点:{环境}:文档型:普通内科学	4182948
21492270	Disch; Discharge teach note; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492270	ED Discharge teach note	4180186
21492270	出院宣教记录:发现:时间点:急诊科:文档型:{角色}	4182948
21492272	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492272	General medicine Discharge teach note	4180186
21492272	出院宣教记录:发现:时间点:{环境}:文档型:普通内科学	4182948
21492273	Multi-spec prog Educ note	4180186
21492273	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Multi-spec prog; notes; Point in time; Random; Visit note	4180186
21492273	教育记录:发现:时间点:{环境}:文档型:多专业计划	4182948
21492274	Dermatology Educ note	4180186
21492274	Derm; DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492274	教育记录:发现:时间点:{环境}:文档型:皮肤病学	4182948
21492276	Col+rec surg Educ note	4180186
21492276	Col+rec surg; DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
21492276	教育记录:发现:时间点:{环境}:文档型:结肠与直肠外科学	4182948
21492281	clinical genomics; DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; Medical Genetics; medical genomics; notes; Point in time; Random; Visit note	4180186
21492281	Clinical genetics Educ note	4180186
21492281	教育记录:发现:时间点:{环境}:文档型:临床遗传学	4182948
21492282	Fam Med Educ note	4180186
21492282	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492282	教育记录:发现:时间点:{环境}:文档型:家庭医学	4182948
21492286	Dis; Diseases; DOC.ONT; Document; Dz; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; ID; Infectious Disease; InfectiousDisease; notes; Point in time; Random; Visit note	4180186
21492286	Infectious disease Educ note	4180186
21492286	教育记录:发现:时间点:{环境}:文档型:感染性疾病	4182948
21492289	Dis; Diseases; DOC.ONT; Document; Dz; Finding; Findings; ID; Infectious Disease; InfectiousDisease; Point in time; Random	4180186
21492289	流程记录单:发现:时间点:{环境}:文档型:感染性疾病	4182948
21492291	DOC.ONT; Document; Endocrine; Endocrinology; Finding; Findings; Point in time; Random	4180186
21492291	流程记录单:发现:时间点:{环境}:文档型:内分泌学	4182948
21492293	DOC.ONT; Document; Finding; Findings; Gastro; Gastroenterology; GI; Point in time; Random	4180186
21492293	流程记录单:发现:时间点:{环境}:文档型:胃肠病学	4182948
21492301	DOC.ONT; Document; Emotional stability; Finding; Findings; Point in time; Random	4180186
21492301	表单:发现:时间点:{环境}:文档型:心理健康	4182948
21492308	Blood; carboxylesterase 1; CE-1; CEH; CES1 c.428G&gt;A; CES2; Genetics; hCE-1; Heredity; Heritable; HMSE; HMSE1; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCE-1; PCR; Point in time; PR; QL; Qual; Qualitative; Random; REH; Screen; SES1; TGH; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492308	CES1 c.428G>A Bld/T Ql	4180186
21492308	CES1 基因.c.428G>A:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
21492310	A603; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f095; f95; III; Immune globulin E; Immunoglobulin E; P prime; Peach; Peach (nPru p) 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
21492310	Peach (nPru p) 3 IgE Qn	4180186
21492310	桃子 原生 (nPru p) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
21492312	Cherry (rPru av) 4 IgE Qn	4180186
21492312	A600; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bing cherry; Cherry; Cherry (rPru av) 4; f242; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
21492312	甜樱桃 重组 (rPru av) 4 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
21492314	A597; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bing cherry; Cherry; Cherry (rPru av) 1; f242; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
21492314	Cherry (rPru av) 1 IgE Qn	4180186
21492314	甜樱桃 重组 (rPru av) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
21492317	120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
21492317	GH 2h p chal SerPl-aCnc	4180186
21492317	生长激素^在XXX刺激之后2小时:任意型浓度:时间点:血清/血浆:定量型	4182948
21492318	1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
21492318	GH 1.5h p chal SerPl-aCnc	4180186
21492318	生长激素^在XXX刺激之后1.5小时:任意型浓度:时间点:血清/血浆:定量型	4182948
21492319	1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
21492319	GH 1h p chal SerPl-aCnc	4180186
21492319	生长激素^在XXX刺激之后1小时:任意型浓度:时间点:血清/血浆:定量型	4182948
21492320	30M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
21492320	GH 30M p chal SerPl-aCnc	4180186
21492320	生长激素^在XXX刺激之后30分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
21492327	First name Guardian	4180186
21492327	Given name; MISC; Nominal; Person name; Point in time; Random	4180186
21492327	名字:人员姓名:时间点:^监护人或合法授权代表:名义型	4182948
21492328	MISC; Nominal; Past; Person name; Point in time; Random	4180186
21492328	Last name Guardian	4180186
21492328	姓氏:人员姓名:时间点:^监护人或合法授权代表:名义型	4182948
21492330	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; Inducer T cells; L3T4; Leu2; Leu-2; Leu3; Leu-3; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T3; T4; T-4; T4 helper/inducer cells; T8; T-8; Tsuppressor; W3/25; WB; Whole blood	4180186
21492330	CD3+CD4+CD8+ # Bld	4180186
21492330	细胞.CD3+CD4+CD8+:计数型浓度:时间点:全血:定量型	4182948
21492333	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; ZIKV; ZIKV RNA	4180186
21492333	ZIKV RNA Spec Ql NAA+probe	4180186
21492333	寨卡病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
21492334	Patient demographics Pnl	4180186
21492334	CLIN; Demographic; Demographics; Pan; PANEL.CLINICAL; Panl; Patient demographics Pnl; Pnl; Point in time; Random	4180186
21492334	患者人口统计学信息组套:-:时间点:^患者:-	4182948
21492335	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; Narrative; P prime; Point in time; Pregnancies; Random; Report	4180186
21492335	Maternal pregnancy info	4180186
21492335	妊娠信息:发现:时间点:^母亲:叙述型	4182948
21492341	135 Minutes; 135M; 2.25h p Arg+Ins; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente	4180186
21492341	GH 2.25h p Arg+Ins SerPl-mCnc	4180186
21492341	生长激素^在给予剂量精氨酸+胰岛素之后2.25小时:质量浓度:时间点:血清/血浆:定量型	4182948
21492343	2.5h p Arg+Ins; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente	4180186
21492343	GH 2.5h p Arg+Ins SerPl-mCnc	4180186
21492343	生长激素^在给予剂量精氨酸+胰岛素之后2.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
21492347	1 1/4 H; 1.25 hours; 1.25 Hr; 1.25h p Arg+Ins; 75 min; 75 minutes; 75min; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente	4180186
21492347	GH 1.25h p Arg+Ins SerPl-mCnc	4180186
21492347	生长激素^在剂量精氨酸+胰岛素之后1.25小时:质量浓度:时间点:血清/血浆:定量型	4182948
21492348	1 1/2 hours; 1 1/2 HR; 1.5h p Arg; 1.5h p Arg+Ins; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente	4180186
21492348	GH 1.5h p Arg+Ins SerPl-mCnc	4180186
21492348	生长激素^在给予剂量精氨酸+胰岛素之后1.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
21492349	Anaplastic lymphoma kinase (Ki-1); Blood; DNA; Fluorescent in situ hybridization; gene fusion; gene translocation; Genetics; Heredity; Heritable; II; Inherited; inv(2)(EML4,ALK); Molecular pathology; MOLPATH; MOLPATH.INV; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
21492349	inv(2)(EML4,ALK) Bld/T Ql FISH	4180186
21492349	inv(2)(p21;p23)(EML4,ALK) 融合转录物:存在情况或阈值:时间点:全血/组织:序数型:FISH	4182948
21492351	Ashkenazi jewish workup; Blood; BRCA; BRCC2; Breast cancer 2, early onset; BROVCA2; Document; FACD; FAD; FAD1; Fam Mut Anl; FANCB; FANCD; FANCD1; Finding; Findings; Genetics; GLM3; Heredity; Heritable; Inherited; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Mutations; Muts; Oncology; PCR; PNCA2; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; XRCC11	4180186
21492351	BRCA2 gene Fam Mut Anl Bld/T	4180186
21492351	BRCA2 基因 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
21492357	Clinical genetics Initial eval note	4180186
21492357	Assessment; clinical genomics; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; H&P; History and physical; Initial eval note; Medical Genetics; medical genomics; notes; Point in time; Random; Visit note	4180186
21492357	初步评价记录:发现:时间点:{环境}:文档型:临床遗传学	4182948
21492358	Assessment; DOC.ONT; Document; Encounter; Endocrine; Endocrinology; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21492358	Endocrinology Initial eval note	4180186
21492358	初步评价记录:发现:时间点:{环境}:文档型:内分泌学	4182948
21492362	Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; ID; Infectious Disease; InfectiousDisease; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21492362	Infectious disease Prog note	4180186
21492362	病程记录:发现:时间点:{环境}:文档型:感染性疾病	4182948
21492363	Derm; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21492363	Dermatology Prog note	4180186
21492363	病程记录:发现:时间点:{环境}:文档型:皮肤病学	4182948
21492364	DOC.ONT; Document; Encounter; Endocrine; Endocrinology; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21492364	Endocrinology Prog note	4180186
21492364	病程记录:发现:时间点:{环境}:文档型:内分泌学	4182948
21492366	Col+rec surg Referral note	4180186
21492366	Col+rec surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
21492366	转诊记录:发现:时间点:{环境}:文档型:结肠与直肠外科学	4182948
21492367	clinical genomics; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; Medical Genetics; medical genomics; notes; Point in time; Random; Visit note	4180186
21492367	转诊记录:发现:时间点:{环境}:文档型:临床遗传学	4182948
21492369	Fam Med Referral note	4180186
21492369	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492369	转诊记录:发现:时间点:{环境}:文档型:家庭医学	4182948
21492370	Assessment; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; ID; Infectious Disease; InfectiousDisease; Initial eval note; notes; Point in time; Random; Visit note	4180186
21492370	Infectious disease Initial eval note	4180186
21492370	初步评价记录:发现:时间点:{环境}:文档型:感染性疾病	4182948
21492371	Dermatology Initial eval note	4180186
21492371	Assessment; Derm; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21492371	初步评价记录:发现:时间点:{环境}:文档型:皮肤病学	4182948
21492374	Assessment; DOC.ONT; Document; ED; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21492374	ED Initial eval note	4180186
21492374	初步评价记录:发现:时间点:急诊科:文档型:{角色}	4182948
21492375	Fam Med Initial eval note	4180186
21492375	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21492375	初步评价记录:发现:时间点:{环境}:文档型:家庭医学	4182948
21492376	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Gastro; Gastroenterology; GI; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
21492376	Gastroenterology Initial eval note	4180186
21492376	初步评价记录:发现:时间点:{环境}:文档型:胃肠病学	4182948
21492377	Col+rec surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Transfer sum note; Visit note	4180186
21492377	Col+rec surg Transfer sum note	4180186
21492377	移交摘要记录:发现:时间点:{环境}:文档型:结肠与直肠外科学	4182948
21492379	6q deletion; Blood; Chronic lymphocytic leukemia; CLL; Del; del 6q; del 6q23; Deletions; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Leukemia; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; MYB Deletion; Narrative; Non-Hodgkin lymphoma; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492379	MYB Del Bld/T FISH-Imp	4180186
21492379	MYB 基因 缺失:印象:时间点:全血/组织:叙述型:FISH	4182948
21492380	6q deletion; Blood; Cell; Cellularity; Chronic lymphocytic leukemia; CLL; Del; del 6q; del 6q23; Deletions; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Leukemia; Molecular pathology; MOLPATH; MOLPATH.DELETIONS; MYB Deletion; Non-Hodgkin lymphoma; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492380	Cells.MYB Del/Cells cnt NFr Bld/T FISH	4180186
21492380	细胞.MYB 基因 缺失/已计数的细胞:计数型分数:时间点:全血/组织:定量型:FISH	4182948
21492383	C16:1w9; Chemistry; Entitic substance; Erythrocytes; Hexadecenoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21492383	Hexadecenoate EntSub RBC	4180186
21492383	十六碳烯酸:实体物质的量:时间点:红细胞:定量型	4182948
21492384	C22:5w3; Chemistry; Docosapentaenic acid; DPA; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21492384	DPA EntSub RBC	4180186
21492384	二十二碳五烯酸 w3:实体物质的量:时间点:红细胞:定量型	4182948
21492385	Docosapentaenate w6 EntSub RBC	4180186
21492385	C22:5w6; Chemistry; Docosapentaenic acid; DPA; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21492385	二十二碳四烯酸 w6:实体物质的量:时间点:红细胞:定量型	4182948
21492387	C10:1; Chemistry; Decenoic acid; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21492387	Decenoate EntSub RBC	4180186
21492387	壬烯酸:实体物质的量:时间点:红细胞:定量型	4182948
21492389	Vaccenate EntSub RBC	4180186
21492389	C18:1w7; Chemistry; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Vaccenic acid	4180186
21492389	花生油酸:实体物质的量:时间点:红细胞:定量型	4182948
21492394	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Bronchial alveolar lavage; Bronchoalveolar lavage; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; M tb; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TB; TMA; Transcription mediated amplification; Tuberculosis	4180186
21492394	M tb DNA BAL Ql NAA+probe	4180186
21492394	结核分枝杆菌 DNA:存在情况或阈值:时间点:支气管肺泡灌洗液:序数型:探针法.基因扩增.靶向	4182948
21492397	ACADs Fib Myristate-cCnt	4180186
21492397	ACADs; Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492397	酰基 CoA 脱氢酶:催化含量:时间点:成纤维细胞:定量型:[9,10-3H] 肉豆蔻酸底物法	4182948
21492399	Imipramine+Desipr Trough SerPl-mCnc	4180186
21492399	Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipra; Imipramine metabolite; Level; Mass concentration; Norpramin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tofranil	4180186
21492399	丙咪嗪+去甲丙咪嗪^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
21492400	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydrocodone metabolite; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
21492400	Norhydrocodone Sal Ql Cfm	4180186
21492400	去甲基氢可酮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
21492402	Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipra; Imipramine metabolite; Imiprn Trgh and Desiprn Pnl; Norpramin; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tofranil	4180186
21492402	Imiprn Trgh and Desiprn Pnl SerPl	4180186
21492402	丙咪嗪波谷与丙咪嗪+去甲丙咪嗪波谷与去甲丙咪嗪组套:-:时间点:血清/血浆:定量型	4182948
21492404	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e23; e91; e93; Feces; Ge91; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pigeon ser prot+feathers+dropp; Point in time; Protein; QNT; Quan; Quant; Quantitative; Random; RGe91; Ser; Serum; SR; stool	4180186
21492404	Pigeon ser prot+feathers+dropp IgG-mCnc	4180186
21492404	鸽子血清蛋白质+羽毛+粪便 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
21492408	Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Microdel risk; Molecular pathology; MOLPATH; Next generation sequencing; NGS; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
21492408	Fet Microdel risk Plas.cfDNA Seq-Imp	4180186
21492408	胎儿微缺失风险:印象:时间点:血浆.cfDNA:序数型:序列测定	4182948
21492410	^Program; CLIN; Educ Prog; Nominal; Point in time; Random	4180186
21492410	Education program URI	4180186
21492410	资源标识符:统一资源标识符:时间点:教育计划:名义型	4182948
21492411	Educ prog online access code	4180186
21492411	CLIN; Educ prog online access code; Ident; Identifier; Nominal; Point in time; Random	4180186
21492411	教育计划在线访问代码:标识符:时间点:^患者:名义型	4182948
21492414	CLIN; Date ed prog completed; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492414	Date ed prog completed	4180186
21492414	教育计划完成日期:日期:时间点:^患者:定量型	4182948
21492415	CLIN; Date educ prog expires; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492415	Date educ prog expires	4180186
21492415	教育计划失效日期:日期:时间点:^患者:定量型	4182948
21492420	Addiction; B/F; Baclosan; Beklo; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Gablofen; Illicit; Kemstro; Level; Liofen; Lioresal; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
21492420	Baclofen Fld-mCnc	4180186
21492420	巴氯芬:质量浓度:时间点:体液:定量型	4182948
21492423	Addiction; Amobarb; Amylobarbitone; Amytal; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random	4180186
21492423	Amobarbital Fld-mCnc	4180186
21492423	异戊巴比妥:质量浓度:时间点:体液:定量型	4182948
21492425	Amit; Amitrip; Amitriptylene; Amitriptyln; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Trepiline; Tryptanol; Tryptizol	4180186
21492425	Amitrip Fld-mCnc	4180186
21492425	阿米替林:质量浓度:时间点:体液:定量型	4182948
21492426	Cordarone; DRUG/TOXICOLOGY; Drugs; Har; Mass content; Pacerone; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492426	Amiodarone Hair-mCnt	4180186
21492426	胺碘酮:质量含量:时间点:毛发:定量型	4182948
21492427	Amox; Asendin; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Defanyl; Demolox; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Moxadil; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492427	Amoxapine Fld-mCnc	4180186
21492427	阿莫沙平:质量浓度:时间点:体液:定量型	4182948
21492429	Bath salts; Beta naphyrone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; naphthylpyrovalerone; NRG-1; O-2482; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21492429	Naphyrone CtO Ur Cfm-mCnc	4180186
21492429	萘吡咯戊酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492430	Addiction; Bath salts; Beta-keto-N-methylbenzodioxolylbutanamine; bk-MBDB; Cat; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21492430	bk-MBDB Ur Cfm-mCnc	4180186
21492430	丁基卡西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492431	bk-MBDB CtO Ur Cfm-mCnc	4180186
21492431	Bath salts; Beta-keto-N-methylbenzodioxolylbutanamine; bk-MBDB; Cat; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21492431	丁基卡西酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492432	3,4-methylenedioxy-N-ethylcathinone; Bath salts; bk-MDEA; Cat; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; MDEC; methylenedioxyethylcathinone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21492432	bk-MDEA CtO Ur Cfm-mCnc	4180186
21492432	乙基卡西酮 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492434	4-methoxymethcathinone; Addiction; Bath salts; bk-PMMA; Cat; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; PMMC; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21492434	Methedrone Ur Cfm-mCnc	4180186
21492434	甲氧麻黄酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492435	MDMA CtO Sal Cfm-mCnc	4180186
21492435	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Ecstasy; GCMS; Level; Mass concentration; MDMA; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
21492435	亚甲基二氧甲基苯丙胺 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21492437	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; METD; Methadose; MTD; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
21492437	Methadone CtO Sal Cfm-mCnc	4180186
21492437	美沙酮 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21492438	EDDP CtO Sal Cfm-mCnc	4180186
21492438	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; EDDP; GCMS; i; II; III; Level; Mass concentration; Methadone metabolite; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
21492438	2-亚乙基-1,5-二甲基-3,3-四氢吡咯 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21492439	c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Stesolid; Valium	4180186
21492439	diazePAM CtO Sal Cfm-mCnc	4180186
21492439	安定 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21492441	HYDROcodone CtO Sal Cfm-mCnc	4180186
21492441	Anexsia; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Vicodin	4180186
21492441	氢可酮 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21492443	CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Diaf; DiafP; Dialysate; Dialysis fluid; Kidney; Level; Nephrology; Ovrngt Dwell; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration	4180186
21492443	Creat Ovrngt Dwell DiafP-sCnc	4180186
21492443	肌酐^过夜存放:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21492444	Glucose Ovrngt Dwell DiafP-sCnc	4180186
21492444	CHEMISTRY.CHALLENGE TESTING; Diaf; DiafP; Dialysate; Dialysis fluid; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Ovrngt Dwell; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
21492444	葡萄糖^过夜存放:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21492445	Blood urea nitrogen; CHEMISTRY.CHALLENGE TESTING; Diaf; DiafP; Dialysate; Dialysis fluid; Level; N; N2; Nit; Ovrngt Dwell; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UN	4180186
21492445	Urea nit Ovrngt Dwell DiafP-sCnc	4180186
21492445	尿素氮^过夜存放:物质的量浓度:时间点:腹膜透析液:定量型	4182948
21492446	DRUG/TOXICOLOGY; Drugs; Esoteric; Mass Content; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492446	Lead Dentin-mCnt	4180186
21492446	铅:质量含量:时间点:牙质:定量型	4182948
21492447	2,6-diaminohexanoic acid; 3-Hydroxy-N6,N6,N6-trimethyl-L-lysine; 3-hydroxy-N6-trimethyl-lysine; 3-hydroxy-trimethyl-lysine; 3OH-trimethyl-L-lysine; Carnitine deficiency disorder; Chemistry; HTML; III; Left; Level; Levo; Lys; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492447	3OH-trimethyl-L-lysine SerPl-sCnc	4180186
21492447	3-羟基三甲基-L-赖氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492448	2,6-diaminohexanoic acid; 3-Hydroxy-N6,N6,N6-trimethyl-L-lysine; 3-hydroxy-N6-trimethyl-lysine; 3-hydroxy-trimethyl-lysine; 3OH-trimethyl-L-lysine; Carnitine deficiency disorder; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; HTML; III; Left; Level; Levo; Lys; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
21492448	3OH-trimethyl-L-lysine CSF-sCnc	4180186
21492448	3-羟基三甲基-L-赖氨酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21492450	2,6-diaminohexanoic acid; 3-Hydroxy-N6,N6,N6-trimethyl-L-lysine; 3-hydroxy-N6-trimethyl-lysine; 3-hydroxy-trimethyl-lysine; 3OH-trimethyl-L-lysine; Carnitine deficiency disorder; Chemistry; CR; Crea; Creat; HTML; III; Left; Levo; Lys; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21492450	3OH-trimethyl-L-lysine/Creat Ur-sRto	4180186
21492450	3-羟基三甲基-L-赖氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21492451	2,6-diaminohexanoic acid; 3-Hydroxy-N6,N6,N6-trimethyl-L-lysine; 3-hydroxy-N6-trimethyl-lysine; 3-hydroxy-trimethyl-lysine; 3OH-trimethyl-L-lysine; 6-N-L-trimethyl-L-lysine; Carnitine deficiency disorder; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Epsilon-Trimethyllysine; HTML; III; Left; Levo; Lys; N(6),N(6),N(6)-trimethyl-L-lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration ratio; Substance ratio; TML	4180186
21492451	3OH-trimethyl-L-lysine/TML CSF-sRto	4180186
21492451	3-羟基三甲基-L-赖氨酸/三甲基赖氨酸:物质的量比率:时间点:脑脊液:定量型	4182948
21492458	Alpha-AASA SerPl-sCnc	4180186
21492458	Alfa; Alpha-AASA; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492458	Alpha-氨基己二酸半醛:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492460	Aldehydo-D-arabinose; Chemistry; CR; Crea; Creat; D-Arabinose; L-Arabinose; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribose 5-phosphate isomerase deficiency; RPI; Scrto; Substance concentration ratio; Substance ratio; TALDO; Transaldolase deficiency; UA; UCr; UR; Urn	4180186
21492460	Arabinose/Creat Ur-sRto	4180186
21492460	阿拉伯糖/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21492468	1 day; 24 hours; 24HR; 3beta-Hydroxy-5beta-tetrahydroprogesterone; C21H34O2; Chemistry; Pregnanolone I; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
21492468	Epipregnanolone 24h Ur-sRate	4180186
21492468	表孕烷醇酮:物质的量速率:24小时:尿液:定量型	4182948
21492469	1 day; 24 hours; 24HR; 3beta-Hydroxy-5beta-tetrahydroprogesterone; C21H34O2; Chemistry; Level; Pregnanolone I; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
21492469	Epipregnanolone 24h Ur-sCnc	4180186
21492469	表孕烷醇酮:物质的量浓度:24小时:尿液:定量型	4182948
21492472	CCM; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Operative note; Point in time; Random; Surg; Visit note	4180186
21492472	CCM Operative note	4180186
21492472	外科手术记录:发现:时间点:{环境}:文档型:危重病监护医学	4182948
21492473	Col+rec surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Operative note; Point in time; Random; Surg; Visit note	4180186
21492473	Col+rec surg Operative note	4180186
21492473	外科手术记录:发现:时间点:{环境}:文档型:结肠与直肠外科学	4182948
21492474	ABC35; ABCC7; Blood; CBAVD; CF; CFA; CFTR/MRP; Cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7); dJ760C5.1; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MRP7; Mut; Mut Anl; Mutations; Nominal; Point in time; Random; Tissue; Tissue, unspecified; TNR-CFTR; WB; Whole blood; Whole blood or Tissue	4180186
21492474	CFTR Mut Anl Bld/T MS.MALDI-TOF Nom	4180186
21492474	CFTR 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:MS.MALDI-TOF	4182948
21492475	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492475	OT Discharge teach note	4180186
21492475	出院宣教记录:发现:时间点:{环境}:文档型:职业疗法	4182948
21492477	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Australian parrot; Autoantibodies; Autoantibody; Budgeriar; Budgie; Budgie ser prot+feathers+dropp; Budgie Serum Prot; e79; e90; Feces; Ge90; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; Protein; QNT; Quan; Quant; Quantitative; Random; RGe90; Ser; Serum; SR; stool	4180186
21492477	Budgie ser prot+feathers+dropp IgG-mCnc	4180186
21492477	虎皮鹦鹉血清蛋白质+羽毛+粪便 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
21492478	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Lung; notes; Point in time; Pulmonary; Pulmonology; Random; Resp therapy; Respiratory; Visit note	4180186
21492478	Resp therapy Educ note	4180186
21492478	教育记录:发现:时间点:{环境}:文档型:呼吸疗法	4182948
21492479	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492479	Pain medicine Educ note	4180186
21492479	教育记录:发现:时间点:{环境}:文档型:疼痛医学	4182948
21492481	DOC.ONT; Document; Ear Nose Throat; Educ note; Encounter; ENT; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oto; Otolaryngology; Otorhinolaryngology; Point in time; Random; Visit note	4180186
21492481	Otolaryngology Educ note	4180186
21492481	教育记录:发现:时间点:{环境}:文档型:耳鼻喉科学	4182948
21492482	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Path; Point in time; Random; Speech pathology; Speech therapy; Speech-lang path; Visit note	4180186
21492482	Speech-lang path Educ note	4180186
21492482	教育记录:发现:时间点:{环境}:文档型:言语-语言病理学	4182948
21492483	Plastic surgery Educ note	4180186
21492483	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
21492483	教育记录:发现:时间点:{环境}:文档型:成形外科学	4182948
21492484	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Visit note	4180186
21492484	Peds Educ note	4180186
21492484	教育记录:发现:时间点:{环境}:文档型:儿科学	4182948
21492487	DOC.ONT; Document; Ear Nose Throat; ENT; Finding; Findings; Oto; Otolaryngology; Otorhinolaryngology; Point in time; Random	4180186
21492487	流程记录单:发现:时间点:{环境}:文档型:耳鼻喉科学	4182948
21492490	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
21492490	流程记录单:发现:时间点:{环境}:文档型:疼痛医学	4182948
21492491	DOC.ONT; Document; Finding; Findings; Genitourinary; GU; Point in time; Random; URO; Urology	4180186
21492491	流程记录单:发现:时间点:{环境}:文档型:泌尿外科学	4182948
21492493	Continuity assessment record and evaluation; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
21492493	流程记录单:发现:时间点:{环境}:文档型:初级保健服务	4182948
21492494	DOC.ONT; Document; Finding; Findings; Mental health; MentalHealth; Point in time; Psych; Psychiatric; Psychiatry; Random	4180186
21492494	Psychiatric Flowsheet	4180186
21492494	流程记录单:发现:时间点:{环境}:文档型:精神病学	4182948
21492495	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Finding; Findings; Heart Disease; Point in time; Random; Surg	4180186
21492495	Cardiothor surg Flowsheet	4180186
21492495	流程记录单:发现:时间点:{环境}:文档型:胸心外科学	4182948
21492496	JWH-210 carboxypentyl CtO Ur Cfm-mCnc	4180186
21492496	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; JWH-210 carboxypentyl; JWH-210 N-(5-carboxypentyl) metabolite; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21492496	JWH-210 5-羧戊基 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492497	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21492497	JWH-210 5-Hydroxypentyl Ur Cfm-mCnc	4180186
21492497	JWH-210 5-羟戊基:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492500	m-CPP Hair-mCnt	4180186
21492500	1,3 - Chlorophenyl piperazine; DRUG/TOXICOLOGY; Drugs; Har; Mass content; mCPP; m-CPP; meta-chlorophenylpiperazine; Nefazodone metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Trazodone metabolite	4180186
21492500	间氯苯哌嗪:质量含量:时间点:毛发:定量型	4182948
21492503	Cardio; Cardiology; Cath+angio proc perf Pnl; Heart Disease; Pan; PANEL.CARDIAC; Panl; Pnl; Point in time; Random	4180186
21492503	Cath+angio proc perf Pnl	4180186
21492503	已执行导管插入术与血管造影术操作项目组套:-:时间点:^患者:-	4182948
21492505	Ang; Angio; Angm; CARD.PROC; Cardiac; Cardio; Cardiology; Finding; Findings; Heart Disease; Hrt; Hrt ventr; L; LT; LV; LV.basal ant; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Segment; Segment appearance; SWM; Ventricular; WM	4180186
21492505	LV.basal ant SWM by Angiogram	4180186
21492505	节段性壁运动:发现:时间点:心脏.心室.左侧.前底部:序数型:血管造影	4182948
21492510	Ativan; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
21492510	LORazepam CtO Sal Cfm-mCnc	4180186
21492510	氯羟安定 截止点:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
21492514	Carisoprodol metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Equanil; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
21492514	Meprobamate CtO Ur Cfm-mCnc	4180186
21492514	氨甲丙二酯 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492515	fentaNYL CtO Ur Cfm-mCnc	4180186
21492515	Actiq; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Duragesic; Durogesic; Fenpat; fentanil; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sublimaze; UA; UR; Urn	4180186
21492515	芬太尼 截止点:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
21492516	Actiq; CtO; DRUG/TOXICOLOGY; Drugs; Duragesic; Durogesic; Fenpat; fentanil; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Sublimaze; UA; UR; Urn	4180186
21492516	fentaNYL CtO Ur Scn-mCnc	4180186
21492516	芬太尼 截止点:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
21492517	Salicylurate SerPl-sCnc	4180186
21492517	2-hydroxybenzoylglycine; Chemistry; Level; N-(2-hydroxybenzoyl)glycine; N-(o-hydroxybenzoyl)glycine; o-hydroxyhippurate; o-hydroxyhippuric acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; salicylglycine; salicyluric acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492517	水杨尿酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492519	Blood; Carnitine biosynthesis Panel; Carnitine.total; Chemistry; DBS; Dried blood spot; Filter paper; FP; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
21492519	Carnitine biosynthesis Panel DBS	4180186
21492519	肉碱生物合成中间产物组套:-:时间点:全血.斑点:-	4182948
21492522	Carnitine biosynthesis Panel; Carnitine.total; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
21492522	Carnitine biosynthesis Panel Ur	4180186
21492522	肉碱生物合成中间产物组套:-:时间点:尿液:-	4182948
21492523	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Cr and GAA Pnl; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21492523	Cr and GAA Pnl CSF	4180186
21492523	肌酸与胍基乙酸组套:-:时间点:脑脊液:定量型	4182948
21492526	Chemistry; Cr and GAA pattern; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21492526	Cr and GAA pattern SerPl-Imp	4180186
21492526	肌酸与胍基乙酸模式:印象:时间点:血清/血浆:叙述型	4182948
21492527	Cr, GAA and Creat pattern Ur-Imp	4180186
21492527	Chemistry; CR; Cr, GAA and Creat pattern; Crea; Creat; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; UA; UCr; UR; Urn	4180186
21492527	肌酸、胍基乙酸与肌酐模式:印象:时间点:尿液:叙述型	4182948
21492528	Cr and GAA pattern CSF-Imp	4180186
21492528	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Cr and GAA pattern; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21492528	肌酸与胍基乙酸模式:印象:时间点:脑脊液:叙述型	4182948
21492529	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; D2HG and L2HG Pnl; Dextro; Hydroxyglutaric aciduria; II; L2HG; L-2-HG; L2HGA; L-2-HGA; Left; Levo; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21492529	D2HG and L2HG Pnl CSF	4180186
21492529	D-2-羟基戊二酸与 L-2-羟基戊二酸组套:-:时间点:脑脊液:-	4182948
21492532	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Chemistry; D2HG and L2HG Pnl; Dextro; Hydroxyglutaric aciduria; II; L2HG; L-2-HG; L2HGA; L-2-HGA; Left; Levo; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
21492532	D2HG and L2HG Pnl Ur	4180186
21492532	D-2-羟基戊二酸与 L-2-羟基戊二酸组套:-:时间点:尿液:-	4182948
21492533	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Blood; Chemistry; D2HG and L2HG Pnl; DBS; Dextro; Dried blood spot; Filter paper; FP; Hydroxyglutaric aciduria; II; L2HG; L-2-HG; L2HGA; L-2-HGA; Left; Levo; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
21492533	D2HG and L2HG Pnl DBS	4180186
21492533	D-2-羟基戊二酸与 L-2-羟基戊二酸组套:-:时间点:全血.斑点:-	4182948
21492536	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Blood; Chemistry; D2HG + L2HG pattern; DBS; Dextro; Dried blood spot; Filter paper; FP; Hydroxyglutaric aciduria; II; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L2HG; L-2-HG; L2HGA; L-2-HGA; Left; Levo; Narrative; Point in time; Random; Report; WB; Whole blood	4180186
21492536	D2HG + L2HG pattern DBS-Imp	4180186
21492536	D-2-羟基戊二酸与 L-2-羟基戊二酸模式:印象:时间点:全血.斑点:叙述型	4182948
21492538	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Chemistry; D2HG + L2HG pattern; Dextro; Hydroxyglutaric aciduria; II; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L2HG; L-2-HG; L2HGA; L-2-HGA; Left; Levo; Narrative; Point in time; Random; Report; UA; UR; Urn	4180186
21492538	D2HG + L2HG pattern Ur-Imp	4180186
21492538	D-2-羟基戊二酸与 L-2-羟基戊二酸模式:印象:时间点:尿液:叙述型	4182948
21492540	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Chemistry; D2HG; D-2-HG; D2HGA; D-2-HGA; Dextro; Hydroxyglutaric aciduria; II; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492540	D2HG SerPl-sCnc	4180186
21492540	D-2-羟基戊二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492541	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Blood; Chemistry; D2HG; D-2-HG; D2HGA; D-2-HGA; DBS; Dextro; Dried blood spot; Filter paper; FP; Hydroxyglutaric aciduria; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
21492541	D2HG DBS-sCnc	4180186
21492541	D-2-羟基戊二酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
21492543	Chemistry; G-butyrobetaine; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TMLHE; Trimethyllysine hydroxylase epsilon deficiency	4180186
21492543	G-butyrobetaine SerPl-sCnc	4180186
21492543	Gamma 丁酰甜菜碱:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492544	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; G-butyrobetaine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; TMLHE; Trimethyllysine hydroxylase epsilon deficiency	4180186
21492544	G-butyrobetaine CSF-sCnc	4180186
21492544	Gamma 丁酰甜菜碱:物质的量浓度:时间点:脑脊液:定量型	4182948
21492546	G-butyrobetaine/Creat Ur-sRto	4180186
21492546	Chemistry; CR; Crea; Creat; G-butyrobetaine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; TMLHE; Trimethyllysine hydroxylase epsilon deficiency; UA; UCr; UR; Urn	4180186
21492546	Gamma 丁酰甜菜碱/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21492549	6-N-L-trimethyl-L-lysine; Blood; Carnitine deficiency disorder; Chemistry; DBS; Dried blood spot; Epsilon-Trimethyllysine; Filter paper; FP; G-butyrobetaine; N(6),N(6),N(6)-trimethyl-L-lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; TML; TMLHE; Trimethyllysine hydroxylase epsilon deficiency; WB; Whole blood	4180186
21492549	G-butyrobetaine/TML DBS-sRto	4180186
21492549	Gamma 丁酰甜菜碱/三甲基赖氨酸:物质的量比率:时间点:全血.斑点:定量型	4182948
21492550	G-butyrobetaine/TML CSF-sRto	4180186
21492550	6-N-L-trimethyl-L-lysine; Carnitine deficiency disorder; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Epsilon-Trimethyllysine; G-butyrobetaine; N(6),N(6),N(6)-trimethyl-L-lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration ratio; Substance ratio; TML; TMLHE; Trimethyllysine hydroxylase epsilon deficiency	4180186
21492550	Gamma 丁酰甜菜碱/三甲基赖氨酸:物质的量比率:时间点:脑脊液:定量型	4182948
21492556	Adrenoleukodystrophies; Adrenoleukodystrophies, X-Linked; Blood; C26:0; C26:0-LPC; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; LysoPC(26:0); Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood; X-ALD	4180186
21492556	LysoPC(26:0) DBS-sCnc	4180186
21492556	溶血磷脂酰胆碱(26:0):物质的量浓度:时间点:全血.斑点:定量型	4182948
21492557	Adrenoleukodystrophies; Adrenoleukodystrophies, X-Linked; C26:0; C26:0-LPC; Chemistry; Level; LysoPC(26:0); Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; X-ALD	4180186
21492557	LysoPC(26:0) SerPl-sCnc	4180186
21492557	溶血磷脂酰胆碱(26:0):物质的量浓度:时间点:血清/血浆:定量型	4182948
21492559	PLP + PL + Vit B6 Pnl CSF	4180186
21492559	C8H10NO6P; C8H11NO3; C8H9NO3; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Codecarboxylase; i Phos; Inorganic phosphate; Pan; PANEL.CHEMISTRY; Panl; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PLP; PLP + PL + Vit B6 Pnl; Pnl; PO4; Point in time; Pyridoxal 5-Phosphate; Pyridoxaldehyde; Pyridoxol; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Vit B6; Vit B6 coenzyme; Vitamin B6; Vitamin B6 coenzyme; Vitamin B6 hydrochloride	4180186
21492559	磷酸吡哆醛与吡哆醛与吡哆醇组套:-:时间点:脑脊液:-	4182948
21492560	PLP + PL + Vit B6 Pnl SerPl	4180186
21492560	C8H10NO6P; C8H11NO3; C8H9NO3; Chemistry; Codecarboxylase; i Phos; Inorganic phosphate; Pan; PANEL.CHEMISTRY; Panl; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; PLP; PLP + PL + Vit B6 Pnl; Plsm; Pnl; PO4; Point in time; Pyridoxal 5-Phosphate; Pyridoxaldehyde; Pyridoxol; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit B6; Vit B6 coenzyme; Vitamin B6; Vitamin B6 coenzyme; Vitamin B6 hydrochloride	4180186
21492560	磷酸吡哆醛与吡哆醛与吡哆醇组套:-:时间点:血清/血浆:-	4182948
21492563	6-N-L-trimethyl-L-lysine; Carnitine deficiency disorder; Chemistry; Epsilon-Trimethyllysine; Level; N(6),N(6),N(6)-trimethyl-L-lysine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TML	4180186
21492563	TML SerPl-sCnc	4180186
21492563	三甲基赖氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492565	TML DBS-sCnc	4180186
21492565	6-N-L-trimethyl-L-lysine; Blood; Carnitine deficiency disorder; Chemistry; DBS; Dried blood spot; Epsilon-Trimethyllysine; Filter paper; FP; Level; N(6),N(6),N(6)-trimethyl-L-lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TML; WB; Whole blood	4180186
21492565	三甲基赖氨酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
21492568	Visc Cerv mucus Ql	4180186
21492568	Cerv mucus; Cervical mucus; Genital tract; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SPEC; Vicos; Viscos; Viscosity	4180186
21492568	粘性:粘度属性:时间点:子宫颈粘液:序数型	4182948
21492569	DRUG/TOXICOLOGY; Drugs; Har; Oral Hypogly; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
21492569	Oral Hypogly Hair Ql Scn	4180186
21492569	降糖药.口服型:存在情况或阈值:时间点:毛发:序数型:毒理学筛查试验	4182948
21492575	Furoylglycine SerPl-sCnc	4180186
21492575	2-Furoylglycine; Chemistry; Furfuroylglycine; Level; Pl; Plasma; Plsm; Point in time; Pyromucurate; Pyromucuric acid; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492575	呋喃甲酰基甘氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492577	Chemistry; CR; Crea; Creat; Heptanedioate; Heptanedioic acid; Pimelic Acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21492577	Pimelate/Creat Ur-sRto	4180186
21492577	庚二酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21492578	Azelaic acid; Azelex; Chemistry; Level; Nonanedioate; Nonanedioic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492578	Azelate SerPl-sCnc	4180186
21492578	壬二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492579	Hydantoin-5-propionate SerPl-sCnc	4180186
21492579	3-(2,5-dioxoimidazolidin-4-yl)propanoic acid; Chemistry; Formiminoglutamic aciduria; Hydantoin-propionate; Level; Pl; Plasma; Plsm; Point in time; Propanoic acid; Propioate; Propioic acid; Propionic acid; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492579	乙内酰脲-5-丙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492580	3-aminoisobutyrate; 3-aminoisobutyric acid; B; B-AIB; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dextro; Left; Levo; Levo-serine; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; R- + S-BAIB + D- + L-serine panel; R prime; Random; Right; S prime; S-B-AIB; Ser; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21492580	R- + S-BAIB + D- + L-serine panel CSF	4180186
21492580	R- 与 S-beta 氨基异丁酸与 D- 与 L-丝氨酸组套:-:时间点:脑脊液:-	4182948
21492581	(S)-2-Amino-6-guanidinohexanoic acid; Chemistry; CR; Crea; Creat; Esoteric; Homoarginine; Homo-L-arginine; Left; Levo; N6-(Aminoiminomethyl)-L-lysine; N6-amidino-L-Lysine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21492581	L-homoarginine/Creat Ur-sRto	4180186
21492581	L-高精氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21492582	(2S,4R)-4-hydroxy-1-[(2S)-pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid; Chemistry; Esoteric; H-Pro-Hyp-OH; Level; L-Pro-L-Hyp; L-Prolyl-L-hydroxyproline; Pl; Plasma; Plsm; Point in time; Proline-hydroxyproline; Prolyl-OH-proline; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492582	Prolyl-OH-proline SerPl-sCnc	4180186
21492582	脯氨酰羟脯氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492583	Acetylglucosaminylasparagine; Asparaginylglucosamine; Aspartylglucosamine; Aspartylglucosylamine; Chemistry; Esoteric; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492583	Aspartylglycosamine SerPl-sCnc	4180186
21492583	天冬氨酰氨基葡萄糖:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492585	A-Acetyllysine; Alfa; Chemistry; Esoteric; Level; N-A-acetyllysine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492585	N-A-acetyllysine SerPl-sCnc	4180186
21492585	N-alpha 乙酰赖氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492586	Chemistry; CR; Crea; Creat; Esoteric; Hci; HOMCIT; Homocit; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
21492586	Homocitrulline/Creat Ur-sRto	4180186
21492586	同型瓜氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21492588	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; Kidney; Nephrology; notes; Point in time; Random; Renal; Visit note	4180186
21492588	Nephrology Admit H&P note	4180186
21492588	入院史与体格检查记录:发现:时间点:{环境}:文档型:肾病学	4182948
21492590	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; Neuro; Neurology; notes; Point in time; Random; Visit note	4180186
21492590	Neurology Admit H&P note	4180186
21492590	入院史与体格检查记录:发现:时间点:{环境}:文档型:神经病学	4182948
21492592	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; nursing; Point in time; Random; Visit note	4180186
21492592	Nurse pract Admit H&P note	4180186
21492592	入院史与体格检查记录:发现:时间点:{环境}:文档型:执业护士	4182948
21492595	Nurse pract Consult note	4180186
21492595	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
21492595	会诊记录:发现:时间点:{环境}:文档型:执业护士	4182948
21492597	Nurse pract Counseling note	4180186
21492597	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
21492597	咨询记录:发现:时间点:{环境}:文档型:执业护士	4182948
21492598	Nurse Daily/end shift signout note	4180186
21492598	Daily/end shift signout note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
21492598	每日或班次结束注销记录:发现:时间点:{环境}:文档型:护士	4182948
21492600	Disch; DOC.ONT; Document; Finding; Findings; Kidney; Nephrology; Point in time; Random; Renal	4180186
21492600	Nephrology Discharge instruct	4180186
21492600	出院指导:发现:时间点:{环境}:文档型:肾病学	4182948
21492603	Nurse pract Discharge instruct	4180186
21492603	Disch; DOC.ONT; Document; Finding; Findings; nursing; Point in time; Random	4180186
21492603	出院指导:发现:时间点:{环境}:文档型:执业护士	4182948
21492605	OT Discharge instruct	4180186
21492605	Disch; DOC.ONT; Document; Finding; Findings; OT; Point in time; Random	4180186
21492605	出院指导:发现:时间点:{环境}:文档型:职业疗法	4182948
21492607	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; Point in time; Random; Visit note	4180186
21492607	Neo peri med D/C sum	4180186
21492607	出院摘要记录:发现:时间点:{环境}:文档型:新生儿围产医学	4182948
21492610	Oncology D/C sum	4180186
21492610	Cancer; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Visit note	4180186
21492610	出院摘要记录:发现:时间点:{环境}:文档型:肿瘤学	4182948
21492613	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neurology; notes; Point in time; Random; Visit note	4180186
21492613	Neurology Discharge teach note	4180186
21492613	出院宣教记录:发现:时间点:{环境}:文档型:神经病学	4182948
21492614	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
21492614	Nurse Discharge teach note	4180186
21492614	出院宣教记录:发现:时间点:{环境}:文档型:护士	4182948
21492616	Nutr+diet Discharge teach note	4180186
21492616	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nutr+diet; Nutrition+Dietetics; Point in time; Random; Visit note	4180186
21492616	出院宣教记录:发现:时间点:{环境}:文档型:营养学与膳食学	4182948
21492617	Cancer; Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Visit note	4180186
21492617	Oncology Discharge teach note	4180186
21492617	出院宣教记录:发现:时间点:{环境}:文档型:肿瘤学	4182948
21492618	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; Point in time; Random; Visit note	4180186
21492618	Neo peri med Educ note	4180186
21492618	教育记录:发现:时间点:{环境}:文档型:新生儿围产医学	4182948
21492620	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neuro surgery; Neurology; notes; Point in time; Random; Surg; Visit note	4180186
21492620	Neuro surgery Educ note	4180186
21492620	教育记录:发现:时间点:{环境}:文档型:神经外科学	4182948
21492622	Carbamazapine; Carbamezapine; Carbazepine; Carbmzpn Trgh + Metab Pnl; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; FR; Non-protein bound; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril; Tot; Totl	4180186
21492622	Carbmzpn Trgh + Metab Pnl SerPl	4180186
21492622	游离型与总卡马西平波谷与 10,11-环氧化物组套:-:时间点:血清/血浆:定量型	4182948
21492623	Avanza; Desmethylmirtazapine; DRUG/TOXICOLOGY; Drugs; Mirtaz Trough + Normirtaz Pnl; Mirtazapine metabolite; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Reflex; Remeron; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zispin	4180186
21492623	Mirtaz Trough + Normirtaz Pnl SerPl	4180186
21492623	米氮平波谷与去甲基米氮平组套:-:时间点:血清/血浆:定量型	4182948
21492625	(S)-Norfluoxetine; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluox, Floux+Nor Trgh + Nor Pnl; Fluoxetine metabolite; Norfluoxetin; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; Seproxetine; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21492625	Fluox, Floux+Nor Trgh + Nor Pnl SerPl	4180186
21492625	氟西汀波谷与氟西汀+去甲基氟西汀波谷与去甲基氟西汀组套:-:时间点:血清/血浆:定量型	4182948
21492626	Sertraline Trough + Nor Pnl SerPl	4180186
21492626	Desmeth; Desmethylsertraline; DRUG/TOXICOLOGY; Drugs; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Sertraline metabolite; Sertraline Trough + Nor Pnl; Serum; Serum or plasma; Setralinemetab; SR; Zoloft	4180186
21492626	舍曲林波谷与去甲基舍曲林组套:-:时间点:血清/血浆:定量型	4182948
21492629	Bilirub Conj Prt-sCnc	4180186
21492629	Ascites; Ascitic fluid; Ascitis; Bc; Bili; Bilirub Conj; Bilirubin conjugated; Bilirubin glucuronides; Bilirubins; Billirubin; Chemistry; Level; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL	4180186
21492629	胆红素.葡糖醛酸化:物质的量浓度:时间点:腹膜液:定量型	4182948
21492631	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Oral Hypogly; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
21492631	Oral Hypogly Fld Ql Scn	4180186
21492631	降糖药.口服型:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
21492637	Chemistry; DMA pattern; Erythrocytes; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Red blood cells; Red blood corpusles; Report	4180186
21492637	DMA pattern RBC-Imp	4180186
21492637	二甲基乙缩醛模式:印象:时间点:红细胞:叙述型	4182948
21492638	PLP + PL + Vit B6 pattern SerPl-Imp	4180186
21492638	C8H10NO6P; C8H11NO3; C8H9NO3; Chemistry; Codecarboxylase; i Phos; Impression; Impression/interpretation of study; Impressions; Inorganic phosphate; Interp; Interpretation; Narrative; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; PLP; PLP + PL + Vit B6 pattern; Plsm; PO4; Point in time; Pyridoxal 5-Phosphate; Pyridoxaldehyde; Pyridoxol; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit B6; Vit B6 coenzyme; Vitamin B6; Vitamin B6 coenzyme; Vitamin B6 hydrochloride	4180186
21492638	磷酸吡哆醛与吡哆醛与吡哆醇模式:印象:时间点:血清/血浆:叙述型	4182948
21492639	C8H10NO6P; C8H11NO3; C8H9NO3; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Codecarboxylase; i Phos; Impression; Impression/interpretation of study; Impressions; Inorganic phosphate; Interp; Interpretation; Narrative; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PLP; PLP + PL + Vit B6 pattern; PO4; Point in time; Pyridoxal 5-Phosphate; Pyridoxaldehyde; Pyridoxol; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Vit B6; Vit B6 coenzyme; Vitamin B6; Vitamin B6 coenzyme; Vitamin B6 hydrochloride	4180186
21492639	PLP + PL + Vit B6 pattern CSF-Imp	4180186
21492639	磷酸吡哆醛与吡哆醛与吡哆醇模式:印象:时间点:脑脊液:叙述型	4182948
21492641	T sulfate/Creat Ur-sRto	4180186
21492641	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SO4; SO4-2; Substance concentration ratio; Substance ratio; Sulf; T sulfate; Tot; Totl; UA; UCr; UR; Urn	4180186
21492641	硫酸类.总计/肌酐:物质的量比率:时间点:尿液:定量型	4182948
21492642	Weight used for drug calc	4180186
21492642	Bdy weight; bod; Bodies; CLIN; Drugs; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
21492642	体重^用于药物计算:质量:时间点:^患者:定量型	4182948
21492647	Arm; CorePlaybook; Document; EXT; Films; Finding; Findings; GE 3V; III; Imaging; Minimum 3 views; MSK; Musculoskeletal; Olecranon; Ortho; Orthopedics; Plain Films; Playbook; Point in time; Rad; Radiology; Random; UE; Up; Upper extremity joint; View; VWS; Xray; X-ray	4180186
21492647	XR Elbow GE 3V	4180186
21492647	多重视图 GE 三重:发现:时间点:上肢>肘关节:文档型:X射线摄影术	4182948
21492649	3V; 3VW; Document; EXT; Films; Finding; Findings; Ft; III; Imaging; LE; Leg; Low; Lower extremity; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Rad; RADIOLOGY; Random; Stand); View; VWS; WB; Weight bearing; Xray; X-ray	4180186
21492649	XR Foot 3V W Stand	4180186
21492649	多重视图 三重^采用直立位:发现:时间点:下肢>足部:文档型:X射线摄影术	4182948
21492650	1V or 2V; Arm; CorePlaybook; Document; EXT; Films; Finding; Findings; i; II; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Playbook; Point in time; Rad; Radiology; Random; UE; Up; Upper extremity; View; Views LE 2; VWS; Xray; X-ray	4180186
21492650	XR Hand 1V or 2V	4180186
21492650	多重视图 单一 or 双重:发现:时间点:上肢>手部:文档型:X射线摄影术	4182948
21492653	Document; EXT; Extr-L; Films; Finding; Findings; GE 2V; Hip-L; II; Imaging; L; LE; Leg; LE-L; LLE; Low; Lower extremity joint; LT; Minimum 2 views; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Rad; Radiology; Random; View; VWS; Xray; X-ray	4180186
21492653	XR Hip-L GE 2V	4180186
21492653	多重视图 GE 双重:发现:时间点:下肢.左侧>髋关节:文档型:X射线摄影术	4182948
21492656	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
21492656	死亡原因:发现:时间点:^患者:名义型	4182948
21492658	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV 1 RNA+prov DNA; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
21492658	HIV 1 RNA+proviral DNA Bld Ql NAA+probe	4180186
21492658	HIV 1 型 RNA+前病毒 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
21492659	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; GI pathogens; GI pathogens Pnl; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492659	GI pathogens Pnl Stl NAA+probe	4180186
21492659	胃肠道病原体类组套:-:时间点:大便:-:探针法.基因扩增.靶向	4182948
21492662	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification; V chol+para rfbL+trkH+tnaA; V cholera; V cholerae	4180186
21492662	V chol+para rfbL+trkH+tnaA Stl Ql NAA+pr	4180186
21492662	霍乱弧菌+副溶血弧菌 rfbL+trkH+tnaA 基因:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
21492663	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification; Y entero recN; Y enterocol; Y enterocolitica	4180186
21492663	Y entero recN Stl Ql NAA+probe	4180186
21492663	小肠结肠炎耶尔森氏菌 recN 基因:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
21492665	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E.coli Shiga-like toxin gene; EC stx2 gene; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shiga Like Toxin II; Shiga-Like Toxins; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492665	EC stx2 gene Stl Ql NAA+probe	4180186
21492665	大肠埃希菌 Stx2 毒素 stx2 基因:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
21492667	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; RVA nsp5; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492667	RVA nsp5 Stl Ql NAA+probe	4180186
21492667	轮状病毒 A 组 nsp5 基因:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
21492668	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; GI pathogens; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492668	GI pathogens Stl NAA+probe	4180186
21492668	胃肠道病原体类 已鉴定的:存在与否或特征标识:时间点:大便:名义型:探针法.基因扩增.靶向	4182948
21492669	Catecholamine metab Pnl; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Metabolite; Metb; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21492669	Catecholamine metab Pnl CSF	4180186
21492669	儿茶酚胺代谢产物组套:-:时间点:脑脊液:定量型	4182948
21492670	Catecholamine pattern; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Metabolite; Metb; Narrative; Point in time; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
21492670	Catecholamine pattern CSF-Imp	4180186
21492670	儿茶酚胺代谢产物模式:印象:时间点:脑脊液:叙述型	4182948
21492671	Flavin mononucleotide SerPl-sCnc	4180186
21492671	Chemistry; FMN; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
21492671	黄素单核苷酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
21492672	Chemistry; Fac; Fact; Hepatopoietin A; HGF; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scatter factor; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21492672	HGF SerPl-mCnc	4180186
21492672	肝细胞生长因子:质量浓度:时间点:血清/血浆:定量型	4182948
21492673	Catalytic Content; Chemistry; Coenzyme Q reductase; Complex I (electron transport chain); Complex I (mitochondrial electron transport); Dihydronicotinamide adenine dinucleotide-coenzyme Q reductase; DPNH-coenzyme Q reductase; DPNH-ubiquinone reductase; Electron transfer complex I; Fib; Fibr; NADH ubiq red; NADH-Coenzyme Q Reductase; NADH-CoQ oxidoreductase; NADH-CoQ Reductase; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492673	NADH ubiq red Fib-cCnt	4180186
21492673	NADH:泛醌还原酶:催化含量:时间点:成纤维细胞:定量型	4182948
21492674	Catalytic Content; Chemistry; Coenzyme Q reductase; Complex I (electron transport chain); Complex I (mitochondrial electron transport); Dihydronicotinamide adenine dinucleotide-coenzyme Q reductase; DPNH-coenzyme Q reductase; DPNH-ubiquinone reductase; Electron transfer complex I; NADH ubiq red; NADH-Coenzyme Q Reductase; NADH-CoQ oxidoreductase; NADH-CoQ Reductase; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
21492674	NADH ubiq red Tiss-cCnt	4180186
21492674	NADH:泛醌还原酶:催化含量:时间点:组织与涂片:定量型	4182948
21492675	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Mastic tree; Pis l; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t402	4180186
21492675	Mastic tree IgE Qn	4180186
21492675	乳香黄连木 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
21492676	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; Narrative; Pl; Plasma; Plsm; Point in time; PRL; Prol; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21492676	Prolactin isoforms pattern SerPl-Imp	4180186
21492676	催乳素同工型模式:印象:时间点:血清/血浆:叙述型	4182948
21492678	VMA CSF-sCnc	4180186
21492678	香草扁桃酸:物质的量浓度:时间点:脑脊液:定量型	4182948
21492678	3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; HMMA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; Level; MHMA; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Tumor marker; Vanillylmandelic acid; Vanilmandelate; VMA	4180186
21492680	Blood; Chemistry; Level; Nicotinic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vit B3; Vitamin B3; WB; Whole blood	4180186
21492680	Niacin Bld-sCnc	4180186
21492680	烟酸:物质的量浓度:时间点:全血:定量型	4182948
21492682	Vendor FISH prod name Bld/T	4180186
21492682	Blood; Ident; Identifier; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Vendor FISH prod name; WB; Whole blood; Whole blood or Tissue	4180186
21492682	厂商 FISH 产品名称:标识符:时间点:全血/组织:名义型	4182948
21492683	Blood; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Tested; Mutation; Muts; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492683	Deprecated Gene Mut Tested Bld/T	4180186
21492684	Blood; CLIN; Dis; Diseases; Dz; Ident; Identifier; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492684	Disease assessed Bld/T	4180186
21492684	所评估的疾病:标识符:时间点:全血/组织:名义型	4182948
21492685	Blood; CLIN; Dis; Disease anl overall imp; Diseases; Dz; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492685	Disease anl overall imp Bld/T	4180186
21492685	疾病分析总体解释:印象:时间点:全血/组织:叙述型	4182948
21492689	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492692	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492694	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492696	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492698	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492700	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492703	Admit H&P note; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
21492703	ED Admit H&P note	4180186
21492703	入院史与体格检查记录:发现:时间点:急诊科:文档型:{角色}	4182948
21492704	Col+rec surg; Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
21492704	Col+rec surg Consult note	4180186
21492704	会诊记录:发现:时间点:{环境}:文档型:结肠与直肠外科学	4182948
21492706	Multi-spec prog Consult note	4180186
21492706	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Multi-spec prog; notes; Point in time; Random; Visit note	4180186
21492706	会诊记录:发现:时间点:{环境}:文档型:多专业计划	4182948
21492710	ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-HAV; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HAV; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; IAA; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
21492710	HAV IgG+IgM SerPl IA-aCnc	4180186
21492710	甲型肝炎病毒 抗体.IgG+IgM:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
21492713	DOC.ONT; Document; ED; Finding; Findings; Point in time; Random	4180186
21492713	ED Checklist	4180186
21492713	检查清单:发现:时间点:急诊科:文档型:{角色}	4182948
21492715	DOC.ONT; Document; Finding; Findings; Neuro; Neuro surgery; Neurology; Point in time; Random; Surg	4180186
21492715	Neuro surgery Checklist	4180186
21492715	检查清单:发现:时间点:{环境}:文档型:神经外科学	4182948
21492718	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492718	OT Educ note	4180186
21492718	教育记录:发现:时间点:{环境}:文档型:职业疗法	4182948
21492719	Cancer; DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Visit note	4180186
21492719	Oncology Educ note	4180186
21492719	教育记录:发现:时间点:{环境}:文档型:肿瘤学	4182948
21492721	Neo peri med Flowsheet	4180186
21492721	DOC.ONT; Document; Finding; Findings; Neo peri med; Point in time; Random	4180186
21492721	流程记录单:发现:时间点:{环境}:文档型:新生儿围产医学	4182948
21492722	DOC.ONT; Document; Finding; Findings; Kidney; Nephrology; Point in time; Random; Renal	4180186
21492722	流程记录单:发现:时间点:{环境}:文档型:肾病学	4182948
21492724	DOC.ONT; Document; Finding; Findings; Neuro; Neurology; Point in time; Random	4180186
21492724	流程记录单:发现:时间点:{环境}:文档型:神经病学	4182948
21492725	DOC.ONT; Document; Finding; Findings; nursing; Point in time; Random	4180186
21492725	Nurse pract Flowsheet	4180186
21492725	流程记录单:发现:时间点:{环境}:文档型:执业护士	4182948
21492728	Cancer; DOC.ONT; Document; Finding; Findings; Oncology; Point in time; Random	4180186
21492728	流程记录单:发现:时间点:{环境}:文档型:肿瘤学	4182948
21492731	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Oncology; Point in time; Random; Visit note	4180186
21492731	Oncology H&P note	4180186
21492731	病史与体格检查记录:发现:时间点:{环境}:文档型:肿瘤学	4182948
21492736	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Nutr+diet; Nutrition+Dietetics; Point in time; Random; Visit note	4180186
21492736	Nutr+diet Initial eval note	4180186
21492736	初步评价记录:发现:时间点:{环境}:文档型:营养学与膳食学	4182948
21492738	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21492738	Neo peri med Prog note	4180186
21492738	病程记录:发现:时间点:{环境}:文档型:新生儿围产医学	4182948
21492739	Nephrology Prog note	4180186
21492739	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Kidney; Nephrology; notes; Point in time; Prog note; Random; Renal; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21492739	病程记录:发现:时间点:{环境}:文档型:肾病学	4182948
21492740	Nutr+diet Prog note	4180186
21492740	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nutr+diet; Nutrition+Dietetics; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21492740	病程记录:发现:时间点:{环境}:文档型:营养学与膳食学	4182948
21492741	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
21492741	Oncology Prog note	4180186
21492741	病程记录:发现:时间点:{环境}:文档型:肿瘤学	4182948
21492743	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
21492743	Nurse pract Referral note	4180186
21492743	转诊记录:发现:时间点:{环境}:文档型:执业护士	4182948
21492746	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neuro surgery; Neurology; notes; Operative note; Point in time; Random; Surg; Visit note	4180186
21492746	Neuro surgery Operative note	4180186
21492746	外科手术记录:发现:时间点:{环境}:文档型:神经外科学	4182948
21492747	DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Transfer sum note; Visit note	4180186
21492747	Mental health Transfer sum note	4180186
21492747	移交摘要记录:发现:时间点:{环境}:文档型:心理健康	4182948
21492748	Neo peri med Transfer sum note	4180186
21492748	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; Point in time; Random; Transfer sum note; Visit note	4180186
21492748	移交摘要记录:发现:时间点:{环境}:文档型:新生儿围产医学	4182948
21492750	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neurology; notes; Point in time; Random; Transfer sum note; Visit note	4180186
21492750	Neurology Transfer sum note	4180186
21492750	移交摘要记录:发现:时间点:{环境}:文档型:神经病学	4182948
21492751	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neuro surgery; Neurology; notes; Point in time; Random; Surg; Transfer sum note; Visit note	4180186
21492751	Neuro surgery Transfer sum note	4180186
21492751	移交摘要记录:发现:时间点:{环境}:文档型:神经外科学	4182948
21492752	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Transfer sum note; Visit note	4180186
21492752	Oncology Transfer sum note	4180186
21492752	移交摘要记录:发现:时间点:{环境}:文档型:肿瘤学	4182948
21492754	CCM Consult note	4180186
21492754	CCM; Consult note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492754	会诊记录:发现:时间点:{环境}:文档型:危重病监护医学	4182948
21492756	Cardio+Pulm disease; Cardiology; cards; Consult note; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Pulmonary; Random; Respirology; Visit note	4180186
21492756	Cardio+Pulm disease Consult note	4180186
21492756	会诊记录:发现:时间点:{环境}:文档型:心血管疾病+肺病	4182948
21492758	Cardio+Pulm disease; Cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Finding; Findings; Point in time; Pulmonary; Random; Respirology	4180186
21492758	Cardio+Pulm disease Flowsheet	4180186
21492758	流程记录单:发现:时间点:{环境}:文档型:心血管疾病+肺病	4182948
21492763	Col+rec surg; DOC.ONT; Document; Finding; Findings; Point in time; Random; Surg	4180186
21492763	Col+rec surg Checklist	4180186
21492763	检查清单:发现:时间点:{环境}:文档型:结肠与直肠外科学	4182948
21492766	Admit H&P note; Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Heart Disease; Hx; notes; Point in time; Random; Surg; Visit note	4180186
21492766	Cardiothor surg Admit H&P note	4180186
21492766	入院史与体格检查记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
21492768	Adenosine deaminase cSub RBC	4180186
21492768	ADA; ADO; ANED; Chemistry; Erythrocytes; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21492768	腺苷脱氨酶:单位物质的量相对型催化活性:时间点:红细胞:定量型	4182948
21492771	Catecholamine pattern SerPl-Imp	4180186
21492771	Catecholamine pattern; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Metabolite; Metb; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21492771	儿茶酚胺代谢产物模式:印象:时间点:血清/血浆:叙述型	4182948
21492772	cloBAZam + Nor Pnl SerPl	4180186
21492772	Clarmyl; cloBAZam + Nor Pnl; Clobazam metabolite; cloBAZam+Norclobazam; Clopax; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; Frisium; N-desmethylclobazam; Noiafren; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Sederlona; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Urbadan; Urbanol; Urbanyl	4180186
21492772	氯巴詹与去甲基氯巴詹组套:-:时间点:血清/血浆:定量型	4182948
21492775	CrT protein Fib Creat uptake-cCnt	4180186
21492775	Catalytic Content; Chemistry; Creat uptake; CrT protein; Fib; Fibr; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random	4180186
21492775	肌酸转运蛋白:催化含量:时间点:成纤维细胞:定量型:肌酸摄取法	4182948
21492778	Amplification; Blood; Del; Del+Dup; Deletions; Document; Dp; Finding; Findings; G/T mismatch-binding protein gene; Genetics; GTBP; GTMBP; Heredity; Heritable; HNPCC; HNPCC5; HSAP; Inherited; Lynch syndrome; Molecular pathology; MOLPATH; MOLPATH.DELDUP; mutS homolog 6; p160; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
21492778	MSH6 gene Del+Dup Bld/T MLPA	4180186
21492778	MSH6 基因 缺失+重复:发现:时间点:全血/组织:文档型:多重连接探针扩增技术	4182948
21492781	Amplification; Blood; Del; Del+Dup; Deletions; Document; Dp; Finding; Findings; Genetics; Hereditary Nonpolyposis Colorectal Cancer; Heredity; Heritable; HNPCC4; Inherited; Lynch syndrome; MLH4; Molecular pathology; MOLPATH; MOLPATH.DELDUP; PMS2CL; PMSL2; Point in time; Primitive Neuroectodermal Tumor; Random; Tissue; Tissue, unspecified; Turcot syndrome; WB; Whole blood; Whole blood or Tissue	4180186
21492781	PMS2 gene Del+Dup Bld/T MLPA	4180186
21492781	PMS2 基因 缺失+重复:发现:时间点:全血/组织:文档型:多重连接探针扩增技术	4182948
21492782	Amplification; Blood; Del; Del+Dup; Deletions; DIAR5; Document; Dp; EGP-2; EGP314; EGP40; EPCAM Exons 8 + 9; epithelial cell adhesion molecule; ESA; Finding; Findings; Genetics; Heredity; Heritable; HNPCC8; Inherited; KS1/4; KSA; Lynch syndrome; M4S1; MIC18; MK-1; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Point in time; Random; TACSTD1; Tissue; Tissue, unspecified; TROP1; WB; Whole blood; Whole blood or Tissue	4180186
21492782	EPCAM Exons 8 + 9 Del+Dup Bld/T MLPA	4180186
21492782	EPCAM 基因外显子 8 与 9 缺失+重复:发现:时间点:全血/组织:文档型:多重连接探针扩增技术	4182948
21492783	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Hereditary Nonpolyposis Colorectal Cancer; HNPCC4; Lynch syndrome; MLH4; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PMS2CL; PMSL2; Point in time; Primitive Neuroectodermal Tumor; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; Turcot syndrome; WB; Whole blood; Whole blood or Tissue	4180186
21492783	PMS2 gene Del+Dup + Full Mut Anl Bld/T	4180186
21492783	PMS2 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
21492784	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alrgen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; LimitedUseLabOrders; Misc Allergen; Misc allergen IgE; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
21492784	Misc Allergen IgE Qn	4180186
21492784	变应原.杂项 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
21492786	APTA; Ortho; Ortho func index; Orthopaedic; Physical Therapy; Point in time; PT; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
21492786	Ortho func index Score CareConn	4180186
21492792	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
21492792	会诊记录:发现:时间点:{环境}:文档型:快速反应团队	4182948
21492797	ADL score; ADL score change; Exchange; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Replace; Score difference; Survey; SURVEY.GNHLTH	4180186
21492803	Exchange; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Replace; Score difference; Survey; SURVEY.GNHLTH; Sx	4180186
21492805	Exchange; Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Replace; Score difference; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
21492807	Exchange; Meth; Method of; Obl; Point in time; QNT; Quan; Quant; Quantitative; Random; Replace; Score difference; SF-12; SF-36; Survey; SURVEY.GNHLTH; T-score; Veterans RAND	4180186
21492810	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Neulactil; Periciazine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; Propericiazine; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21492810	Pericyazine SerPl-mCnc	4180186
21492810	氰噻嗪:质量浓度:时间点:血清/血浆:定量型	4182948
21492812	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; Microbiology; MRSA; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; o71; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; S aureus; SA+MRSA Pnl; SDA; Smell; Staficyn; Staph; Staphicillin; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492812	SA+MRSA Pnl Nose NAA+probe	4180186
21492812	金黄色葡萄球菌与甲氧西林耐药性金黄色葡萄球菌组套:-:时间点:鼻:-:探针法.基因扩增.靶向	4182948
21492813	Addiction; c700; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Formic acid; Illicit; Level; methanoate; methanoic acid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
21492813	Formate Ur-sCnc	4180186
21492813	甲酸:物质的量浓度:时间点:尿液:定量型	4182948
21492815	Adenosine deaminase WBC-cCnt	4180186
21492815	ADA; ADO; ANED; Catalytic Content; Chemistry; Leukocytes; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
21492815	腺苷脱氨酶:催化含量:时间点:白细胞:定量型	4182948
21492816	ADSL cSub RBC	4180186
21492816	ADSL; Chemistry; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Succinyl AMP	4180186
21492816	腺苷酸基琥珀酸裂解酶:单位物质的量相对型催化活性:时间点:红细胞:定量型	4182948
21492817	ADH; Alc; alcoholic; Catalytic Content; Chemistry; Dehydrog; Dehyrdogenase; Hepar; Hepatic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
21492817	ADH Liver-cCnt	4180186
21492817	醇脱氢酶:催化含量:时间点:肝脏:定量型	4182948
21492818	A-Fucosidase; Alfa; Alpha-L-fucosidase; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Fucosidosis; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
21492818	A-Fucosidase DBS-cCnc	4180186
21492818	Alpha 岩藻糖苷酶:催化浓度:时间点:全血.斑点:定量型	4182948
21492820	Arginase RBC-cCnt	4180186
21492820	Catalytic Content; Chemistry; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
21492820	精氨酸酶:催化含量:时间点:红细胞:定量型	4182948
21492821	B; B-Glucuronidase; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Sly disease; WB; Whole blood	4180186
21492821	B-Glucuronidase DBS-cCnc	4180186
21492821	Beta 葡萄糖醛酸苷酶:催化浓度:时间点:全血.斑点:定量型	4182948
21492823	Hx of Surg proc of MS system	4180186
21492823	H+P; H+P.PX; History; Nominal; P prime; Point in time; Random; Surg; Surg proc; Surg proc of MS system	4180186
21492823	肌肉骨骼系统外科手术操作:历史记录:时间点:^患者:名义型	4182948
21492825	Date+time last void GU	4180186
21492825	Date and time; Date+time; Date+time last void; GU; H+P; H+P.PX; P prime; Past; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
21492825	最后排尿日期和时间:时间戳:时间点:泌尿生殖系统:定量型	4182948
21492826	Finding; Findings; GU; H+P; H+P.PX; Nominal; P prime; Point in time; Random	4180186
21492826	Voiding pattern GU	4180186
21492826	排尿模式:发现:时间点:泌尿生殖系统:名义型	4182948
21492827	H+P; H+P.PX; Nominal; Othr; P prime; Point in time; Random; Typ; UA; UR; Urn	4180186
21492827	Other elements Ur	4180186
21492827	其他成分:类型:时间点:尿液:名义型	4182948
21492828	Coll; Collect; Collected; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Typ; UA; UR; Urine collect device; Urn	4180186
21492828	Urine collect device	4180186
21492828	尿液收集装置:类型:时间点:尿液:名义型	4182948
21492830	Hx of Surg proc of GU system	4180186
21492830	GU; H+P; H+P.PX; History; Nominal; P prime; Point in time; Random; Surg; Surg proc; Surg proc of GU system	4180186
21492830	泌尿生殖系统外科手术操作:历史记录:时间点:^患者:名义型	4182948
21492841	H+P; H+P.PX; Ordinal; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
21492841	Mucous membrane integrity	4180186
21492841	黏膜完整性:存在情况或阈值:时间点:粘膜:序数型	4182948
21492842	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EPEC; EPEC eae gene; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492842	EPEC eae gene Stl Ql NAA+non-probe	4180186
21492842	大肠埃希菌肠致病型 eae 基因:存在情况或阈值:时间点:大便:序数型:非探针法.基因扩增.靶向	4182948
21492844	3 Self-Sustaining Sequence Replication; 3SR SR; Ag; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; EIEC; enteroinvasive E coli; enteroinvasive Escherichia coli; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shigella; Shigella sp+EIEC ipaH; Shigellosis; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492844	Shigella sp+EIEC ipaH St NAA+non-probe	4180186
21492844	志贺菌+肠侵袭性大肠埃希菌侵袭质粒抗原 H (ipaH) 基因:存在情况或阈值:时间点:大便:序数型:非探针法.基因扩增.靶向	4182948
21492846	Env temp transport; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Specimen temperature; Temp; Temperature; Transport temperature	4180186
21492846	Env temp transport	4180186
21492846	运输过程中的环境温度:温度:时间点:环境:定量型	4182948
21492847	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; Deoxythymidine; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV 1 DNA pol reg B+TK reg C; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TK; TMA; Transcription mediated amplification	4180186
21492847	HSV 1 DNA pol regB+TK regC Anogn Ql NAA+pr	4180186
21492847	单纯疱疹病毒 1 基因组 DNA 聚合酶区域 B+胸腺嘧啶核苷激酶区域 C:存在情况或阈值:时间点:肛门生殖器:序数型:探针法.基因扩增.靶向	4182948
21492848	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 DNA Pnl; HSV1; HSV1+2; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492848	HSV 1+2 DNA Pnl Anogenital NAA+probe	4180186
21492848	单纯疱疹病毒 1 与 2 型组套:-:时间点:肛门生殖器:-:探针法.基因扩增.靶向	4182948
21492852	沙眼衣原体 rRNA:存在情况或阈值:时间点:肛门直肠:序数型:探针法.基因扩增.靶向	4182948
21492852	C trach rRNA Anorectl Ql NAA+probe	4180186
21492852	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectum; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification	4180186
21492856	淋病奈瑟菌:存在情况或阈值:时间点:肛门直肠:序数型:微生物特异性培养	4182948
21492856	Anorectl; C&S; Cult; Cultures; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; Microbiology; N gonorrhoea; N gonorrhoeae; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rectum; Screen; Spec	4180186
21492856	N gonorrhoea Anorectl Ql Cult	4180186
21492857	Anorectl; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Rectum; Spec; species; spp	4180186
21492857	Neisseria Anorectl Cult	4180186
21492857	奈瑟菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:肛门直肠:名义型:微生物特异性培养	4182948
21492858	Catalytic Content; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21492858	Biotinidase SerPl-cCnt	4180186
21492858	生物素化物酶:催化含量:时间点:血清/血浆:定量型	4182948
21492860	Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FOB; Gastro; Gastrocult; Gastroenterology; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; Hemoccult; Hemocult; Hgb; IAA; MEIA; Occult blood; Occult blood in stool; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS	4180186
21492860	Hemoccult Stl Ql IA.rapid	4180186
21492860	血红蛋白.胃肠道:存在情况或阈值:时间点:大便:序数型:免疫测定法.快速	4182948
21492861	Antigen; Antigens; Bowel movement; C pylori; Campylobacter pylori; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; H pyl; H pylori; IAA; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; SUDS	4180186
21492861	H pylori Ag Stl Ql IA.rapid	4180186
21492861	幽门螺杆菌 抗原:存在情况或阈值:时间点:大便:序数型:免疫测定法.快速	4182948
21492862	Adeno virus; Bowel movement; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; HAdV; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotavirus + Adenovirus Ag Pnl; Rotaviurs; RV; Stl; Stool = Fecal; SUDS	4180186
21492862	Rota + Adeno Ag Pnl Stl EIA.rapid	4180186
21492862	轮状病毒与腺病毒抗原组套:-:时间点:大便:-:免疫测定法.快速	4182948
21492863	B; Beta-hexosaminidase subunit alpha; Blood; B-NAH; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Esoteric; Filter paper; FP; GM2 Gangliosidoses; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Hexosaminidase A; Point in time; QNT; Quan; Quant; Quantitative; Random; Sandhoff disease; Tay Sachs Disease; WB; Whole blood	4180186
21492863	Hexosaminidase A DBS-cCnc	4180186
21492863	Beta-N-乙酰己糖胺酶.A:催化浓度:时间点:全血.斑点:定量型	4182948
21492870	ADMIN; ADMIN.PATIENT; Last; Location; Nominal; Point in time; Random	4180186
21492870	前任雇主城市:位置:时间点:^患者:名义型	4182948
21492872	ADMIN; ADMIN.PATIENT; Last; Location; Nominal; Point in time; Random	4180186
21492872	前任雇主州别:位置:时间点:^患者:名义型	4182948
21492875	Chemistry; Cryo; Cryoglob IgA; Cryoglobulins; Cryoprecipitate; Immune globulin A; Immunoglobulin A; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
21492875	Cryoglob IgA Ser Ql	4180186
21492875	冷球蛋白.IgA:存在情况或阈值:时间点:血清:序数型	4182948
21492876	Cryoglob IgM Ser Ql	4180186
21492876	Chemistry; Cryo; Cryoglob IgM; Cryoglobulins; Cryoprecipitate; Immune globulin M; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
21492876	冷球蛋白.IgM:存在情况或阈值:时间点:血清:序数型	4182948
21492877	Cryoglobulin C3 Ser Ql	4180186
21492877	Beta 1 C-globulin; Chemistry; Comp; Complmt; Cryo; Cryoglobulin C3; Cryoglobulins; Cryoprecipitate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
21492877	冷球蛋白.补体 C3:存在情况或阈值:时间点:血清:序数型	4182948
21492878	Palatinase TSMI-cCnt	4180186
21492878	Catalytic Content; Chemistry; Congenital Sucrose Intolerance; CSID; Disaccharidase; Disaccharide Intolerance I; Point in time; QNT; Quan; Quant; Quantitative; Random; SI Deficiency; Sucrase-isomaltase; Sucrose intolerance; Tissue small intestine	4180186
21492878	蔗糖酶异麦芽糖酶复合物:催化含量:时间点:小肠组织:定量型	4182948
21492881	Add; Addl path findings; Identity or presence; Nominal; Path; Pathology; Point in time; Random; Spec	4180186
21492881	Addl path findings Spec	4180186
21492881	额外的病理学发现:存在与否或特征标识:时间点:标本:名义型	4182948
21492883	Auto; Automated detection; Cnt; Count; Ejaculate; Elec; Elect; Electr; FERTILITY TESTING; Genitourinary; GU; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Prog; URO; Urology	4180186
21492883	Sperm Prog Smn Auto	4180186
21492883	精子.前向运动型:数量(计数):时间点:精液:定量型:自动化计数方法	4182948
21492885	FLUAV H5 Asian RNA Ct Resp Qn NAA H5b	4180186
21492885	流感病毒 A 型血凝素 H5 型亚洲亚型 RNA:阈值循环圈数:时间点:呼吸道:定量型:探针法.基因扩增.靶向.引物-探针组 H5b	4182948
21492885	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H5; FLUAV H5 Asian; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Lungs; Microbiology; NAA H5b; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; PH; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; Ribonucleic acid; RS; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
21492888	GTT gest 2h Pnl SerPl	4180186
21492888	120 min; 120 minutes; 120min; 2 hours; Chemistry; Gest; Gestation; Glu; Glu tol; Gluc; Glucoseur; GTT; GTT gest 2h Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Prenatal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
21492888	2小时葡萄糖耐量妊娠期组套:-:-:血清/血浆:-	4182948
21492892	C&S; CMV; Cult; Cultures; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; SVC	4180186
21492892	CMV Lower resp Ql Shell Vial Cult	4180186
21492892	巨细胞病毒:存在情况或阈值:时间点:呼吸道.下:序数型:细胞培养瓶培养法	4182948
21492893	Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
21492894	Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
21492895	Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
21492896	Finding; Findings; Fld; Narrative; Point in time; Random; Report; Survey; Thoughts on IV fluid+support	4180186
21492897	Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
21492898	Advanced; DOC.MISC; Document; Finding; Findings; MISC; Pers adv care plan; Point in time; Random	4180186
21492898	Personal adv care plan	4180186
21492898	个人事前医疗服务计划:发现:时间点:{环境}:文档型:患者	4182948
21492899	Healthcare agent	4180186
21492899	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
21492899	医疗保健服务代理:发现:时间点:{环境}:文档型:患者	4182948
21492902	GPP for care experience	4180186
21492902	关于医疗服务体验方面的目标、偏好与及优先事项:发现:时间点:{环境}:文档型:患者	4182948
21492902	DOC.ONT; Document; Finding; Findings; GPP for care experience; Point in time; Random	4180186
21492904	Finding; Findings; Goals +or pref priority; Nominal; Point in time; Random; Survey	4180186
21492906	Agent appt valid any jurisdiction; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
21492907	Nominal; Person name; Point in time; Random; Survey	4180186
21492910	Finding; Findings; Limitations on healthcare agent; Narrative; Point in time; Random; Report; Survey	4180186
21492914	Finding; Findings; Narrative; Point in time; Random; Report; Survey; Thoughts pain management	4180186
21492916	Finding; Findings; Narrative; Near death thghts+feelings to share; Point in time; Random; Report; Survey	4180186
21492917	Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
21492919	Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
21492921	Finding; Findings; Narrative; Point in time; Random; Religious/cultural beliefs; Report; Survey	4180186
21492922	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492923	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
21492927	1.75 hours; 1.75 Hr; 1.75h p Arg+Ins; 105 min; 105 minutes; 105min; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; HUM; Human growth hormone; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente	4180186
21492927	GH 1.75h p Arg+Ins SerPl-mCnc	4180186
21492927	生长激素^在给予剂量精氨酸+胰岛素之后1.75小时:质量浓度:时间点:血清/血浆:定量型	4182948
21492929	(牛肉+鸡肉+卵黄+猪肉+吐绶鸡肉) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492929	Food Allerg Mix10 IgE RAST	4180186
21492929	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bos spp; f026; f027; f075; f083; f26; f27; f284; f75; f83; Food Allerg Mix10; fx10; Gallus spp; IgE RAST; Immune globulin E; Immunoglobulin E; Meleagis gallopavo; Pig; Point in time; Porcine; PR; Random; Serum; SmQn; SR; Sus spp; Swine; Turkey meat Ab.IgE.RAST class	4180186
21492931	(蘑菇+西葫芦+水稻+黑麦+马铃薯) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492931	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C. maxima; C. mixta; C. moschata; Champignon; Cucumis pepo; f005; f009; f035; f212; f225; f35; f5; f9; Food Allerg Mix12; fx12; IgE RAST; Immune globulin E; Immunoglobulin E; Mushroom; Mushrooms; Point in time; Potato; PR; Pumpkin; Random; Rf212; Rfx12; Rice; Rye; Serum; SmQn; Solanum tuberosum Ab.IgE.RAST class; SR; White potato	4180186
21492931	Food Allerg Mix12 IgE RAST	4180186
21492932	Food Allerg Mix12 IgE Qn	4180186
21492932	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C. maxima; C. mixta; C. moschata; Champignon; Cucumis pepo; f005; f009; f035; f212; f225; f35; f5; f9; Food Allerg Mix12; fx12; Immune globulin E; Immunoglobulin E; Mushroom; Mushrooms; Point in time; Potato; Pumpkin; QNT; Quan; Quant; Quantitative; Random; Rf212; Rfx12; Rice; Rye; Serum; SR; White potato	4180186
21492932	(蘑菇+西葫芦+水稻+黑麦+马铃薯) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
21492933	(胡萝卜+菜豆+豌豆+马铃薯) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492933	Food Allerg Mix13 IgE RAST	4180186
21492933	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carrot; f012; f031; f035; f12; f31; f35; Food Allerg Mix13; FP13; fx13; Green pea; IgE RAST; Immune globulin E; Immunoglobulin E; Pea; peas; Point in time; Potato; PR; Random; Serum; SmQn; Solanum tuberosum Ab.IgE.RAST class; SR; Vegetable mix; White potato	4180186
21492939	(黄瓜+胡萝卜+马铃薯+菠菜) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492939	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carrot; Cucumber; f031; f035; f214; f244; f31; f35; Food Allerg Mix19; fx19; Gherkin; IgE RAST; Immune globulin E; Immunoglobulin E; Point in time; Potato; PR; Random; Rfx19; Serum; SmQn; Spinach; Spinacia oleracea Ab.IgE.RAST class; SR; White potato	4180186
21492939	Food Allerg Mix19 IgE RAST	4180186
21492940	(榛子+大西洋鳕+大豆+小麦) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492940	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; Cod; Codfish; f003; f004; f014; f017; f14; f17; f3; f4; Filbert; Fish; Food Allerg Mix27; fx27; Gly; Hazel nut; Hazelnut; IgE RAST; Immune globulin E; Immunoglobulin E; Largest; Maximal; Maximum; Peak; Point in time; PR; Random; Scrod; Serum; SmQn; Soja hispida; Soy bean; Soya bean; Soyabean; Soybean; SR; Triticum sativum; Wheat	4180186
21492940	Food Allerg Mix27 IgE RAST	4180186
21492941	(中华猕猴桃+牛肉+长额虾+芝麻籽) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492941	Food Allerg Mix28 IgE RAST	4180186
21492941	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bos spp; Chinese gooseberry; f010; f024; f027; f084; f10; f24; f27; f84; Food Allerg Mix28; fx28; IgE RAST; Immune globulin E; Immunoglobulin E; Kiwi fruit; Kiwifruit; Point in time; PR; Prawns; Random; Serum; Sesame Seed; Sesamum indicum Ab.IgE.RAST class; Sesamum orientale; Shrimp; SmQn; SR	4180186
21492943	Citrus mix IgE Qn	4180186
21492943	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C reticula; Citrus mix; Clementine; f033; f208; f209; f302; f33; fx29; Immune globulin E; Immunoglobulin E; Lemon; Mandarin; Mandarine; Orange; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf302; satsumas; Serum; SR; tangerine	4180186
21492943	(甜橙+柠檬+葡萄柚+柑橘) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
21492947	(葛缕子+小豆蔻+肉豆蔻衣+丁香) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492947	Food Allerg Mix71 IgE RAST	4180186
21492947	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Caraway; Cardamon; Clove; Cloves; Dried arrillus; f265; f266; f267; f268; Food Allerg Mix71; fx71; IgE RAST; Immune globulin E; Immunoglobulin E; Myristica fragrans; Point in time; PR; Random; Rf265; Rf266; Rf267; Rf268; Serum; SmQn; SR; Syzygium aromaticum Ab.IgE.RAST class	4180186
21492949	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Anise; Aniseed; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Basil; f219; f269; f270; f271; Fennel; Fennel Seed; Finocchio; Food Allerg Mix72; fx72; Ginger; Ginger IgE; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf219; Rf269; Rf270; Rf271; Seeds; Serum; SR	4180186
21492949	Food Allerg Mix72 IgE Qn	4180186
21492949	(小茴香籽+罗勒+茴芹+姜) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
21492953	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Apple; Arbitrary Concentration; Autoantibodies; Autoantibody; Barcelona nut; Brazil nut; Cacao; Cob nut; Cocoa; f017; f018; f033; f049; f17; f18; f33; f49; f93; Filbert; Food Allerg Mix8; fx8; Hazel nut; Hazelnut; Immune globulin E; Immunoglobulin E; Orange; Point in time; Pyrus malus; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
21492953	Food Allerg Mix8 IgE Qn	4180186
21492953	(巴西坚果+甜橙+榛子+苹果+可可) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
21492954	(中华猕猴桃+甜瓜+芭蕉属+杏仁+酿酒葡萄) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492954	Food Allerg Mix9 IgE RAST	4180186
21492954	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Almond; Amygdalus communis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Banana; Chinese gooseberry; f020; f084; f092; f20; f259; f84; f92; Food Allerg Mix9; Fruit mix; fx9; Grape; Grapes; IgE RAST; Immune globulin E; Immunoglobulin E; Kiwi fruit; Kiwifruit; Musa sp; Point in time; PR; Prunus amygdalus; Random; Serum; SmQn; SR; Vitis vinifera Ab.IgE.RAST class	4180186
21492956	(黄花茅+多年生黑麦草+草地梯牧草+黑麦+白毛茅) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492956	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f005; f5; g001; g005; g006; g013; g1; g13; g5; g6; Grass Allerg Mix3; Grass mix (late flowering); gx3; Holcus lanatus Ab.IgE.RAST class; IgE RAST; Immune globulin E; Immunoglobulin E; Italian Ryegrass; Per rye grass; Perennial ryegrass; Phleum pretense; Point in time; PR; Random; Rye; Rye grass; Ryegrass; Serum; SmQn; SR; Sw Vernal grass; Sweet vernal grass; Timothy; Timothy grass; Velvet grass; Yorkshire fog	4180186
21492956	Grass Allerg Mix3 IgE RAST	4180186
21492957	(黄花茅+白毛茅+多年生黑麦草+芦苇+黑麦) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492957	Grass Allerg Mix4 IgE RAST	4180186
21492957	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common reed; Common reed grass; f005; f5; g001; g005; g007; g013; g1; g13; g5; g7; GP4; Grass Allerg Mix4; gx4; IgE RAST; Immune globulin E; Immunoglobulin E; Italian Ryegrass; Per rye grass; Perennial ryegrass; Point in time; PR; Random; Rye; Rye grass; Ryegrass; Secale cereale Ab.IgE.RAST class; Serum; SmQn; SR; Sw Vernal grass; Sweet vernal grass; Velvet grass; Yorkshire fog	4180186
21492958	(链格孢+烟曲霉+白色假丝酵母+多主枝孢+蠕孢菌+特异青霉) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492958	A alternata; A fumigatus; A tenuis; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Alternaria tenuis; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; C albicans; C herbarum; Cand; Candidiasis; Farmers lung; Fum; H halodes; Helminthosporium halodes; Hormodendrum; IgE RAST; Immune globulin E; Immunoglobulin E; m001; m002; m003; m005; m006; m1; m2; m3; m5; m6; m8; Mold Allerg Mix2; Mold mix; Monilia; Mould mix; mx2; P chrysogenum; P notatum; Penicillium notatum Ab.IgE.RAST class; Point in time; PR; Random; S rostrata; Serum; SmQn; SR; Thrush	4180186
21492958	Mold Allerg Mix2 IgE RAST	4180186
21492959	(烟曲霉+黑曲霉+土曲霉+黄曲霉) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492959	Mold Allerg Mix4 IgE RAST	4180186
21492959	A flavus; A fumigatus; A fumigatus+A niger; A niger; A terreus; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergillus flavus Ab.IgE.RAST class; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Fum; IgE RAST; Immune globulin E; Immunoglobulin E; m003; m207; m228; m3; m309; m311; m36; m54; Mold Allerg Mix4; mx4; Point in time; PR; Random; Serum; SmQn; SR	4180186
21492960	Mold Allerg Mix4 IgE Qn	4180186
21492960	A flavus; A fumigatus; A fumigatus+A niger; A niger; A terreus; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Fum; Immune globulin E; Immunoglobulin E; m003; m207; m228; m3; m309; m311; m36; m54; Mold Allerg Mix4; mx4; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
21492960	(烟曲霉+黑曲霉+土曲霉+黄曲霉) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
21492962	(粗足粉螨+腐酪食螨+肠胃蝇+谷象) 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
21492962	Occup Allerg Mix2 IgE RAST	4180186
21492962	A siro; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d071; d70; d71; Flour mite; Grain Weevel; Grain weevil; Horse bot fly; i201; i202; IgE RAST; Immune globulin E; Immunoglobulin E; L destructor; Mite; Occup Allerg Mix2; pax2; Point in time; PR; Random; Ri202; Serum; Sitophilus granarius Ab.IgE.RAST class; SmQn; SR; Storage mite	4180186
21492963	A siro; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; d071; d70; d71; Flour mite; Grain Weevel; Grain weevil; Horse bot fly; i201; i202; Immune globulin E; Immunoglobulin E; L destructor; Mite; Occup Allerg Mix2; pax2; Point in time; QNT; Quan; Quant; Quantitative; Random; Ri202; Serum; SR; Storage mite	4180186
21492963	Occup Allerg Mix2 IgE Qn	4180186
21492963	(粗足粉螨+腐酪食螨+肠胃蝇+谷象) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
21492964	活化凝血时间.白陶土诱导型:时间:时间点:全血:定量型:凝血功能分析	4182948
21492964	ACT; ACT Kaolin Ind; Activ; Activated coagulation time; Blood; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation assay; Coagulation time; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; Tilt tube; WB; Whole blood	4180186
21492964	ACT Kaolin Ind Bld	4180186
21492966	Appearance; Colour; Diaf; DiafP; Dialysate; Dialysis fluid; Nominal; Peritoneal Dialysis fluid; Point in time; Random; SPEC; Typ	4180186
21492966	Color DiafP	4180186
21492966	颜色:类型:时间点:腹膜透析液:名义型	4182948
21492967	Specimen vol DiafP	4180186
21492967	Diaf; DiafP; Dialysate; Dialysis fluid; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Vol; Volume	4180186
21492967	标本体积:体积型属性:时间点:腹膜透析液:定量型	4182948
21492970	BMD; Bone Densiometry; Bone Density Scan; Calcaneous; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Extr-L; Films; Heel; Heel-L; Imaging; L; LE; Leg; LE-L; LLE; Low; LT; Os calcis; Oscalcis; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; Standard score; View; Views for BMD; VWS; Z score; Z value; Z-score	4180186
21492970	DXA Heel-L Z-score BMD	4180186
21492970	针对骨密度的多重视图:Z评分:时间点:下肢.左侧>跟骨:定量型:双能X线吸收法	4182948
21492972	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Extr-L; Films; Forearm; Imaging; L; LT; LUE; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Radius+Ulna-L; Random; T-score; UE; UE-L; Up; Upper extremity; View; Views for BMD; VWS	4180186
21492972	DXA Radius+Ulna-L T-score BMD	4180186
21492972	针对骨密度的多重视图:T评分:时间点:上肢.左侧>桡骨+尺骨:定量型:双能X线吸收法	4182948
21492973	1 day; 24 hours; 24HR; Diet; Dietetics; Est; estimation; Mass rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative	4180186
21492973	Phosphorus intake 24h Est	4180186
21492973	磷摄入:质量速率:24小时:^患者:定量型:估计法	4182948
21492974	1 day; 24 hours; 24HR; Diet; Dietetics; Est; estimation; Fibers; Mass rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative; Roughage	4180186
21492974	Fiber intake 24h Est	4180186
21492974	纤维摄入:质量速率:24小时:^患者:定量型:估计法	4182948
21492975	1 day; 24 hours; 24HR; Diet; Dietetics; Folacin; Folate; Folic acid; Mass rate; mRate; Nutrition; Pteroylglutamic acid; QNT; Quan; Quant; Quantitative; Vit B9; Vit B9 intake; Vitamin B9	4180186
21492975	Vit B9 intake 24h Measured	4180186
21492975	维生素 B9 摄入:质量速率:24小时:^患者:定量型:测量法	4182948
21492976	1 day; 24 hours; 24HR; B3; Diet; Dietetics; Est; estimation; Mass rate; mRate; Niacin; Nicotinic acid; Nutrition; QNT; Quan; Quant; Quantitative; Vit B3; Vit B3 intake; Vitamin B3	4180186
21492976	Vit B3 intake 24h Est	4180186
21492976	维生素 B3 摄入:质量速率:24小时:^患者:定量型:估计法	4182948
21492977	1 day; 24 hours; 24HR; Diet; Dietetics; Mass Rate; mRate; Nutrition; QNT; Quan; Quant; Quantitative; Sat fat intake	4180186
21492977	Sat fat intake 24h Measured	4180186
21492977	脂肪.饱和 摄入:质量速率:24小时:^患者:定量型:测量法	4182948
21492978	Gastric cancer Path Pnl	4180186
21492978	CA; Cancer Path Pnl; Gastric cancer; Gastric Cancers; Pan; PANEL.PATH; Panl; Path; Pathology; Pnl; Point in time; Random	4180186
21492978	癌症病理学组套:-:时间点:胃癌:-	4182948
21492979	Non-regional nodes examined Spec	4180186
21492979	Cnt; Count; LN exam; Non-regional nodes examined; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Reg LN examined; Spec	4180186
21492979	已检查的非局部淋巴结:数量(计数):时间点:标本:定量型	4182948
21492982	Encd Encounter Nte CDP1 R1.0+1.1	4180186
21492982	Encd Encounter Nte CDP1 R1.0+1.1; Encounter; Evaluation and management; Evaluation and management note; i; notes; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random; Visit note	4180186
21492982	增强型就医记录 - 推荐 CDP 集合 1 R1.0 与 R1.1 小节:-:时间点:{环境}:-	4182948
21492986	Master HL7 gen var Pnl	4180186
21492986	Genetics; Genomic; Master HL7 gen var Pnl; Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; Pnl; Point in time; Random	4180186
21492986	HL7 遗传变异报告主控组套:-:时间点:^患者:-	4182948
21492987	流感病毒 A 型与 B 型抗原组套:-:时间点:呼吸道.上:-:免疫测定法.快速	4182948
21492987	A,B; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLU; FLUA; FLUAV; FLUAV + FLUBV; FLUAV + FLUBV Ag Pnl; FLUAV+FLUBV; FLUB; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza; Influenza A; Influenza A virus; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; SUDS; Up; Upper resp	4180186
21492987	FLUAV + FLUBV Ag Pnl Upper resp IA.rapid	4180186
21492988	流感病毒 A 型 抗原:存在情况或阈值:时间点:呼吸道.上:序数型:免疫测定法.快速	4182948
21492988	FLUAV Ag Upper resp Ql IA.rapid	4180186
21492988	Antigen; Antigens; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; Up; Upper resp	4180186
21492989	流感病毒 B 型 抗原:存在情况或阈值:时间点:呼吸道.上:序数型:免疫测定法.快速	4182948
21492989	Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS; Up; Upper resp	4180186
21492989	FLUBV Ag Upper resp Ql IA.rapid	4180186
21492990	CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; EIA; ELFA; ELISA; Enzyme immunoassay; Gestation; Gestations; Gravida; Gyn; Gynecology; HCG; HCG Preg; Human chorionic gonadotropin; IAA; MEIA; OB; ObGyn; Obstetrics; Ordinal; PG test; Point in time; PR; Preg test; Pregnancies; QL; Qual; Qualitative; Random; Screen; SUDS; UA; UR; Urn	4180186
21492990	HCG Preg Ur Ql IA.rapid	4180186
21492990	绒毛膜促性腺激素 (妊娠试验):存在情况或阈值:时间点:尿液:序数型:免疫测定法.快速	4182948
21492992	Bladder tumor Ag Ur Ql IA.rapid	4180186
21492992	Antigen; Antigens; BT; BTA; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS; Tumor marker; UA; UR; Urn	4180186
21492992	膀胱肿瘤 抗原:存在情况或阈值:时间点:尿液:序数型:免疫测定法.快速	4182948
21492995	H+P; H+P.HX; Ident; Identifier; Nominal; P prime; Point in time; Random	4180186
21492995	家庭统一代码:标识符:时间点:^患者:名义型	4182948
21492997	Special accommodation Type	4180186
21492997	DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Point in time; Random; Typ	4180186
21492997	特殊照顾:类型:时间点:^患者:名义型	4182948
21492999	DEEDS; EM incident type; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Nominal; Point in time; Random; Typ	4180186
21492999	EM incident type	4180186
21492999	突发事件管理事件类型:类型:时间点:^事件:名义型	4182948
21493002	Gyn; Gynecology; No; Num; Num of W postpartum; OB; OBGYN; Obstetrics; Point in time; Postpart; Postpartm; QNT; Quan; Quant; Quantitative; Random	4180186
21493002	Num of W postpartum	4180186
21493002	产后星期数:时间:时间点:^患者:定量型	4182948
21493003	Ident; Identifier; Nominal; Point in time; Random; SPEC	4180186
21493003	Unique ID Current sample	4180186
21493003	唯一性标识符:标识符:时间点:当前样品:名义型	4182948
21493005	Testing facility Pnl	4180186
21493005	CLIN; ESRD; Facility Pnl; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Testing facility Pnl	4180186
21493005	测试设施组套:-:时间点:设施:-	4182948
21493007	Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Finding; Findings; Med equip or product list; Point in time; Random	4180186
21493007	Comm hlth care Med equip or product list	4180186
21493007	医疗设备或产品列表:发现:时间点:{环境}:文档型:社区医疗保健服务	4182948
21493009	DOC.ONT; Document; Emotional stability; Finding; Findings; Point in time; Random	4180186
21493009	强制性报告表单:发现:时间点:{环境}:文档型:心理健康	4182948
21493011	Diet; Dietetics; Fld; Fluid in Pnl; Nutrition; Pan; Panl; Pnl	4180186
21493011	Fluid in Pnl	4180186
21493011	液体摄入组套:-:-:^患者:-	4182948
21493012	Diet; Dietetics; Food amt Pnl; Nutrition; Pan; Panl; Pnl	4180186
21493012	Food amt Pnl	4180186
21493012	食物数量组套:-:-:^患者:-	4182948
21493013	Diet; Dietetics; Inf formula int; Inf formula intake Pnl; Nutrition; Pan; Panl; Pnl	4180186
21493013	Inf formula intake Pnl	4180186
21493013	婴幼儿配方奶摄入组套:-:-:^患者:-	4182948
21493014	Diet; Dietetics; Meal +or snack pattern Pnl; Nutrition; Pan; Panl; Pnl	4180186
21493014	Meal +or snack pattern Pnl	4180186
21493014	正餐和或零食模式组套:-:-:^患者:-	4182948
